<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:g-custom="http://base.google.com/cns/1.0" xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
  <channel>
    <title>ncas-australia</title>
    <link>https://www.ncas-australia.org</link>
    <description />
    <atom:link href="https://www.ncas-australia.org/feed/rss2" type="application/rss+xml" rel="self" />
    <item>
      <title>Nurses: an underused, vital asset against drug-resistant infections</title>
      <link>https://www.ncas-australia.org/nurses-an-underused-vital-asset-against-drug-resistant-infections</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;h1&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Nurses: an underused, vital asset against drug-resistant infections
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/h1&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Enrique Castro-Sánchez, Jo Bosanquet, Molly Courtenay, Rose Gallagher, Fiona Gotterson, Elizabeth Manias, Jo McEwen, Val Ness, Rita Olans, Maria Clara Padoveze, Briette du Toit &amp;amp;  Miquel Bennasar-Veny
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the correspondence
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)01531-8/fulltext#" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            , in response to Murray, C. et al Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis, also published in The Lancet (found
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02724-0/fulltext" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            :
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Castro-Sánchez, E., Bosanquet, J., Courtenay, M., Gallagher, R., Gotterson, F., Manias, E., ... &amp;amp; Bennasar-Veny, M. (2022). Nurses: an underused, vital asset against drug-resistant infections. The Lancet, 400(10354), 729. doi:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/S0140-6736(22)01531-8" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1016/S0140-6736(22)01531-8
          &#xD;
    &lt;/a&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-5721386.jpeg" length="139621" type="image/jpeg" />
      <pubDate>Sat, 03 Sep 2022 01:14:37 GMT</pubDate>
      <guid>https://www.ncas-australia.org/nurses-an-underused-vital-asset-against-drug-resistant-infections</guid>
      <g-custom:tags type="string">Nursing,Hospital paper,NCAS publications,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-5721386.jpeg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-5721386.jpeg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>A novel GPPAS model: Guiding the implementation of antimicrobial stewardship in primary care utilising collaboration between general practitioners and community pharmacists</title>
      <link>https://www.ncas-australia.org/a-novel-gppas-model-guiding-the-implementation-of-antimicrobial-stewardship-in-primary-care-utilising-collaboration-between-general-practitioners-and-community-pharmacists</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;h1&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            A novel GPPAS model: Guiding the implementation of antimicrobial stewardship in primary care utilising collaboration between general practitioners and community pharmacists
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/h1&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Sajal K Saha, Karin Thursky, David C.M. Kong and Danielle Mazza
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Interprofessional collaboration between general practitioners (GPs) and community pharmacists (CPs) is central to implement antimicrobial stewardship (AMS) programmes in primary care.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            This study aimed to design a GP/pharmacist antimicrobial stewardship (GPPAS) model for primary care in Australia.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            An exploratory study design was followed that included seven studies conducted from 2017 to 2021 for the development of the GPPAS model. We generated secondary and primary evidence through a systematic review, a scoping review, a rapid review, nationwide surveys of Australian GPs and CPs including qualitative components, and a pilot study of a GPPAS submodel. All study evidence was synthesised, reviewed, merged, and triangulated to design the prototype GPPAS model using a Systems Engineering Initiative for Patient Safety theoretical framework. The secondary evidence provided effective GPPAS interventions, and the primary evidence identified GP/CP interprofessional issues, challenges, and future needs for implementing GPPAS interventions.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The framework of the GPPAS model informed five GPPAS implementation submodels to foster implementation of AMS education program, antimicrobial audits, diagnostic stewardship, delayed prescribing, and routine review of antimicrobial prescriptions, through improved GP–CP collaboration. The GPPAS model could be used globally as a guide for GPs and CPs to collaboratively optimise antimicrobial use in primary care. Implementation studies on the GPPAS model and submodels are required to integrate the GPPAS model into GP/pharmacist interprofessional care models in Australia for improving AMS in routine primary care.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.mdpi.com/2079-6382/11/9/1158" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            :
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Saha, S. K., Thursky, K., Kong, D., &amp;amp; Mazza, D. (2022). A Novel GPPAS Model: Guiding the Implementation of Antimicrobial Stewardship in Primary Care Utilising Collaboration between General Practitioners and Community Pharmacists. Antibiotics, 11(9), 1158. doi: 10.3390/antibiotics11091158
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/d820f98f/dms3rep/multi/alexandr-podvalny-tE7_jvK-_YU-unsplash.jpg" length="185448" type="image/jpeg" />
      <pubDate>Sat, 27 Aug 2022 01:15:26 GMT</pubDate>
      <guid>https://www.ncas-australia.org/a-novel-gppas-model-guiding-the-implementation-of-antimicrobial-stewardship-in-primary-care-utilising-collaboration-between-general-practitioners-and-community-pharmacists</guid>
      <g-custom:tags type="string">Community paper,NCAS publications,GP,community pharmacy,Primary care,Community</g-custom:tags>
      <media:content medium="image" url="https://irp.cdn-website.com/d820f98f/dms3rep/multi/alexandr-podvalny-tE7_jvK-_YU-unsplash.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/d820f98f/dms3rep/multi/alexandr-podvalny-tE7_jvK-_YU-unsplash.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Influences on nurses’ engagement in antimicrobial stewardship behaviours: A multi-country survey using the Theoretical Domains Framework</title>
      <link>https://www.ncas-australia.org/influences-on-nurses-engagement-in-antimicrobial-stewardship-behaviours-a-multi-country-survey-using-the-theoretical-domains-framework</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;h1&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Influences on nurses’ engagement in antimicrobial stewardship behaviours: A multi-country survey using the Theoretical Domains Framework
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/h1&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Angel Marie Chater, Hannah Family, Ligia Maria Abraao, Emma Burnett, Enrique Castro-Sanchez, Briëtte Du Toit, Rose Gallagher, Fiona Gotterson, Elizabeth Manias, Jo Mcewen, Rosely Moralez de Figueiredo, Martina Nathan, Val Ness, Rita Olans, Maria Clara Padoveze &amp;amp; Molly Courtenay
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antimicrobial resistance (AMR) is significantly affected by inappropriate antibiotic use, and is one of the greatest threats to human health. Antimicrobial stewardship (AMS) is a programme of actions promoting responsible antimicrobial use, and is essential for limiting AMR. Nurses have an important role to play in this context. 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Aim
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           This study investigated the determinants of nurse AMS behaviours and the impact of past training.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Method
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A cross-sectional multi-country survey design with mixed methods was employed. Participants were 262 nurses (223 female; mean age = 44.45; SD = 10.77 years) from ten nationalities, with individual survey links sent via professional networks in 5 countries, alongside Twitter. Nine AMS behaviours and 14 behavioural determinants were quantitatively assessed using the Theoretical Domains Framework (TDF), and mapped to the COM-B (Capability, Opportunity, Motivation – Behaviour) model. Analysis identified differences between nurses with and without AMS training. The influence of COVID-19 on AMS behaviour was qualitatively investigated using free text data.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Findings
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Nurses performed all nine AMS behaviours, which were significantly higher (t(238) = -4.14, p &amp;lt; .001), by those who had training (M = 53.15; SD = 7.40) compared to those who had not (M = 48.30; SD = 10.75). Those with AMS training scored significantly higher in all of the TDF domains. The TDF was able to explain 27% of the variance in behaviour, with ‘Skills’ and ‘Behavioural Regulation’ (e.g. ability to self-monitor and plan), shown to be the most predictive of AMS actions. Both of these domains are situated in the Capability construct of COM-B, which can be enhanced with the intervention strategies of education and training. An increase in AMS behaviours was reported since COVID-19, regardless of previous training. Six core themes were linked to AMS: 1) Infection prevention and control, 2) Antimicrobials and antimicrobial resistance, 3) The diagnosis of infection and the use of antibiotics, 4) Antimicrobial prescribing practice, 5) Person-centred care, and 6) Interprofessional collaborative practice.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusion
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           This research, has identified the significant benefit of nurse training on AMS behaviour, and its determinants. Those who had training, scored higher in all TDF determinants of behaviour, compared to those who had had no training, resulting in higher Capability, Opportunity and Motivation to perform AMS behaviours. AMS education and training should be offered to nurses to enhance these factors. Future research should consider the optimal level of training to optimise AMS behaviour, with a focus on developing skills and behavioural regulation.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.journalofhospitalinfection.com/article/S0195-6701(22)00227-4/fulltext" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            :
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Chater, A. M., Family, H., Abraao, L. M., Burnett, E., Castro-Sanchez, E., Du Toit, B., Gallagher, R., Gotterson, F. ... &amp;amp; Courtenay, M. (2022). Influences on nurses’ engagement in antimicrobial stewardship behaviours: A multi-country survey using the Theoretical Domains Framework. Journal of Hospital Infection. 2022 July. doi:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.journalofhospitalinfection.com/article/S0195-6701(22)00227-4/fulltext"&gt;&#xD;
      
           https://doi.org/10.1016/j.jhin.2022.07.010
          &#xD;
    &lt;/a&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-6098054.jpeg" length="200496" type="image/jpeg" />
      <pubDate>Thu, 18 Aug 2022 01:48:10 GMT</pubDate>
      <guid>https://www.ncas-australia.org/influences-on-nurses-engagement-in-antimicrobial-stewardship-behaviours-a-multi-country-survey-using-the-theoretical-domains-framework</guid>
      <g-custom:tags type="string">Nursing,Hospital paper,NCAS publications,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-6098054.jpeg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-6098054.jpeg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Prophylactic antimicrobial prescribing in Australian residential aged-care facilities: Improvement is required.</title>
      <link>https://www.ncas-australia.org/prophylactic-antimicrobial-prescribing-in-australian-residential-aged-care-facilities-improvement-is-required</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;h3&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Prophylactic antimicrobial prescribing in Australian residential aged-care facilities: Improvement is required
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/h3&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;a href="https://pubmed.ncbi.nlm.nih.gov/?term=Bennett+N&amp;amp;cauthor_id=35962922" target="_blank"&gt;&#xD;
      
           Noleen Bennett
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            ,
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://pubmed.ncbi.nlm.nih.gov/?term=Malloy+MJ&amp;amp;cauthor_id=35962922" target="_blank"&gt;&#xD;
      
           Michael J Malloy
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://pubmed.ncbi.nlm.nih.gov/?term=James+R&amp;amp;cauthor_id=35962922" target="_blank"&gt;&#xD;
      
           Rodney James
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            ,
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://pubmed.ncbi.nlm.nih.gov/?term=Fang+X&amp;amp;cauthor_id=35962922" target="_blank"&gt;&#xD;
      
           Xin Fang
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://pubmed.ncbi.nlm.nih.gov/?term=Thursky+K&amp;amp;cauthor_id=35962922" target="_blank"&gt;&#xD;
      
           Karin Thursky
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            &amp;amp;
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://pubmed.ncbi.nlm.nih.gov/?term=Worth+LJ&amp;amp;cauthor_id=35962922" target="_blank"&gt;&#xD;
      
           Leon J Wort
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           h
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background and objective: Inappropriate antimicrobial use can lead to adverse consequences, including antimicrobial resistance. The objective of our study was to describe patterns of prophylactic antimicrobial prescribing in Australian residential aged-care facilities and thereby provide insight into antimicrobial stewardship strategies that might be required.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods: Annual point prevalence data submitted by participating residential aged-care facilities as part of the Aged Care National Antimicrobial Prescribing Survey between 2016 and 2020 were extracted. All antimicrobials except anti-virals were counted; methenamine hippurate was classified as an antibacterial agent.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results: The overall prevalence of residents prescribed one or more prophylactic antimicrobial on the survey day was 3.7% (n = 4643, 95% confidence interval 3.6-3.8). Of all prescribed antimicrobials (n = 15,831), 27.1% (n = 4871) were for prophylactic use. Of these prophylactic antimicrobials, 87.8% were anti-bacterials and 11.4% antifungals; most frequently, cefalexin (28.7%), methenamine hippurate (20.1%) and clotrimazole (8.8%). When compared with prescribing of all antimicrobial agents, prophylactic antimicrobials were less commonly prescribed for pro re nata administration (7.0% vs 20.3%) and more commonly prescribed greater than 6 months (52.9% vs 34.1%). The indication and review or stop date was less frequently documented (67.5% vs 73.8% and 20.9% vs 40.7%, respectively). The most common body system for which a prophylactic antimicrobial was prescribed was the urinary tract (54.3%). Of all urinary tract indications (n = 2575), about two thirds (n = 1681, 65.3%) were for cystitis and 10.6% were for asymptomatic bacteriuria.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions: Our results clearly identified immediate antimicrobial stewardship strategies that aim to improve prophylactic antimicrobial prescribing in Australian residential-aged care facilities are required.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://pubmed.ncbi.nlm.nih.gov/35962922/" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           :  Bennett, N., Malloy, MJ., James, R., Fang, X., Thursky, K., &amp;amp; Worth, LJ. (2022). Prophylactic Antimicrobial Prescribing in Australian Residential Aged-Care Facilities: Improvement is Required. Drugs Real World Outcomes. DOI: 10.1007/s40801-022-00323-5.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/d820f98f/dms3rep/multi/photo-1584362917137-56406a73241c-5ac34103.jpg" length="852056" type="image/png" />
      <pubDate>Wed, 17 Aug 2022 03:30:29 GMT</pubDate>
      <guid>https://www.ncas-australia.org/prophylactic-antimicrobial-prescribing-in-australian-residential-aged-care-facilities-improvement-is-required</guid>
      <g-custom:tags type="string">NCAS publications,Aged care,Aged care paper,Primary care</g-custom:tags>
      <media:content medium="image" url="https://irp.cdn-website.com/d820f98f/dms3rep/multi/photo-1584362917137-56406a73241c-5ac34103.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/d820f98f/dms3rep/multi/photo-1584362917137-56406a73241c-5ac34103.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Improving management of urinary tract infections in residential aged care facilities</title>
      <link>https://www.ncas-australia.org/improving-management-of-urinary-tract-infections-in-residential-aged-care-facilities</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Improving management of urinary tract infections in residential aged care facilities
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Lyn-Li Lim, Noleen Bennett
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antimicrobial resistance rates are higher in Australian residential aged care facilities (RACFs) than other community or hospital settings. This is driven by antibiotic overuse and misuse. Urinary tract infection (UTI) is consistently the most common infection treated with antibiotics in Australian RACFs. The aim of this article is to provide an overview of how general practitioners (GPs) can support appropriate UTI management in RACFs following antimicrobial stewardship (AMS) principles. GPs are well placed to improve UTI management in RACFs. In this article, criteria for suspected, proven, recurrent and relapsed UTI are outlined, in addition to key AMS practices for the assessment, prevention, treatment and review of UTIs. Included are recommendations for the judicious use of urine dipstick testing, a widespread and longstanding practice in RACFs, and first-line empirical antibiotic prescribing for suspected UTIs.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www1.racgp.org.au/getattachment/d140bdeb-d0ae-475b-a2ff-27c7f9584064/UTIs-in-residential-aged-care-facilities.aspx" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation:
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Lim, L. L., &amp;amp; Bennett, N. (2022). Improving management of urinary tract infections in residential aged care facilities. Australian journal of general practice, 51(8), 551-557. DOI: https://doi.org/
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.31128/ajgp-05-22-6413" target="_blank"&gt;&#xD;
      
           10.31128/AJGP-05-22-6413
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/d820f98f/dms3rep/multi/Urine.png" length="61778" type="image/png" />
      <pubDate>Sun, 07 Aug 2022 23:35:32 GMT</pubDate>
      <guid>https://www.ncas-australia.org/improving-management-of-urinary-tract-infections-in-residential-aged-care-facilities</guid>
      <g-custom:tags type="string">NCAS publications,Aged care,Primary care</g-custom:tags>
      <media:content medium="image" url="https://irp.cdn-website.com/d820f98f/dms3rep/multi/Urine.png">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/d820f98f/dms3rep/multi/Urine.png">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Opportunities for nurse involvement in surgical antimicrobial stewardship strategies: A qualitative study</title>
      <link>https://www.ncas-australia.org/opportunities-for-nurse-involvement-in-surgical-antimicrobial-stewardship-strategies-a-qualitative-study</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Opportunities for nurse involvement in surgical antimicrobial stewardship strategies: A qualitative study
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Courtney Ierano, Arjun Rajkhowa, Fiona Gotterson, Caroline Marshall, Trisha Peel, Darshini Ayton, Karin Thursky
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Multi-disciplinary antimicrobial stewardship teams are a common strategy employed to optimise antimicrobial prescribing. Nurses play a pivotal role in patient care and safety; however, their role and potential opportunities across surgical antimicrobial stewardship are not well-established. This study aims to highlight health professional perspectives of the nurse's role and relevant opportunities for nurses to engage in and lead surgical antimicrobial stewardship initiatives.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           An exploratory, multi-site, collective qualitative case study. Transcribed audio-recordings of focus groups with health professionals underwent thematic analysis, with mapping to established frameworks.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Four key themes were identified; surgical antimicrobial prophylaxis is not prioritised for quality improvement, but nurses perceive benefits from surgical antimicrobial prophylaxis education and training; professional hierarchy hinders nurse engagement and leadership in antimicrobial stewardship; nurses are consistently engaged with patient care throughout the surgical journey; and clarity of roles and accountability for surgical antimicrobial prophylaxis review and follow-up can bolster quality improvement initiatives.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Discussion
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Many opportunities exist for nurse engagement in surgical antimicrobial stewardship. Identification of barriers and enablers support theoretically informed strategies i.e., education and guideline accessibility; multidisciplinary collaborations; executive support for nursing capacity building and the standardisation of surgical antimicrobial prophylaxis workflow and documentation.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Nurses are critical to patient safety and to supporting antimicrobial stewardship, in the operating theatre, and throughout the patient's surgical journey. Applying theoretical frameworks to understand barriers and enablers to nurses’ contribution to antimicrobial stewardship has given insights to inform interventions to support nurse engagement.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Tweetable abstract
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Nurses are critical for patient safety. Many opportunities exist to support them as surgical antimicrobial stewards.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.ijnurstu.2022.104186" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Ierano, C., Rajkhowa, A., Gotterson, F., Marshall, C., Peel, T., Ayton, D., &amp;amp; Thursky, K. (2022). Opportunities for nurse involvement in surgical antimicrobial stewardship strategies: A qualitative study. International Journal of Nursing Studies, 128, 104186. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.ijnurstu.2022.104186" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1016/j.ijnurstu.2022.104186
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-4586993.jpeg" length="959417" type="image/jpeg" />
      <pubDate>Sun, 30 Jan 2022 07:06:55 GMT</pubDate>
      <guid>https://www.ncas-australia.org/opportunities-for-nurse-involvement-in-surgical-antimicrobial-stewardship-strategies-a-qualitative-study</guid>
      <g-custom:tags type="string">Nursing,Hospital paper,NCAS publications,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-4586993.jpeg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-4586993.jpeg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>A systems thinking approach for antimicrobial stewardship in primary care</title>
      <link>https://www.ncas-australia.org/a-systems-thinking-approach-for-antimicrobial-stewardship-in-primary-care</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Sajal K. Saha, David C.M. Kong, Danielle Mazza &amp;amp; Karin Thursky
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Introduction
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The establishment of antimicrobial stewardship (AMS) in primary care is central to substantially reduce the antimicrobial use and the associated risk of resistance. This perspective piece highlights the importance of systems thinking to set up and facilitate AMS programs in primary care.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Areas covered
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The challenges that primary care faces to incorporate AMS programmes is multifactorial: an implementation framework, relevant resources, team composition, and system structures remain under-researched, and these issues are often overlooked and/or neglected in most parts of the world. Progress in the field remains slow in developed countries but potentially limited in low- and middle-income countries.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Expert opinion
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The key AMS strategies to optimize antimicrobial use in primary care are increasingly known; however, health system components that impact effective implementation of AMS programs remain unclear. We highlight the importance of systems thinking to identify and understand the resource arrangements, system structures, dynamic system behaviors, and intra- and interprofessional connections to optimally design and implement AMS programs in primary care. An AMS systems thinking systemigram (i.e. a visual representation of overall architecture of a system) could be a useful tool to foster AMS implementation in primary care.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1080/14787210.2022.2023010" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            ﻿
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Saha, S. K., Kong, D. C. M., Mazza, D., &amp;amp; Thursky, K. (2022). A systems thinking approach for antimicrobial stewardship in primary care. Expert Review of Anti-Infective Therapy, 20(6), 819-827. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1080/14787210.2022.2023010" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1080/14787210.2022.2023010
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .  
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1547489432-cf93fa6c71ee.jpg" length="123987" type="image/jpeg" />
      <pubDate>Thu, 30 Dec 2021 07:46:56 GMT</pubDate>
      <guid>https://www.ncas-australia.org/a-systems-thinking-approach-for-antimicrobial-stewardship-in-primary-care</guid>
      <g-custom:tags type="string">Community paper,NCAS publications,Primary care,Community</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1547489432-cf93fa6c71ee.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1547489432-cf93fa6c71ee.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021</title>
      <link>https://www.ncas-australia.org/consensus-guidelines-for-antifungal-stewardship-surveillance-and-infection-prevention</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Anna Khanina, Shio Yen Tio, Michelle R. Ananda-Rajah, Sarah E. Kidd, Eloise Williams, Lynette Chee, Karen Urbancic, Karin A. Thursky and Australasian Antifungal Guidelines Steering Committee
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            ﻿
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Invasive fungal diseases (IFD) are serious infections associated with high mortality, particularly in immunocompromised patients. The prescribing of antifungal agents to prevent and treat IFD is associated with substantial economic burden on the health system, high rates of adverse drug reactions, significant drug–drug interactions and the emergence of antifungal resistance. As the population at risk of IFD continues to grow due to the increased burden of cancer and related factors, the need for hospitals to employ antifungal stewardship (AFS) programmes and measures to monitor and prevent infection has become increasingly important. These guidelines outline the essential components, key interventions and metrics, which can help guide implementation of an AFS programme in order to optimise antifungal prescribing and IFD management. Specific recommendations are provided for quality processes for the prevention of IFD in the setting of outbreaks, during hospital building works, and in the context of Candida auris infection. Recommendations are detailed for the implementation of IFD surveillance to enhance detection of outbreaks, evaluate infection prevention and prophylaxis interventions and to allow benchmarking between hospitals. Areas in which information is still lacking and further research is required are also highlighted.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/https://doi.org/10.1111/imj.15586" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Khanina, A., Tio, S. Y., Ananda-Rajah, M. R., Kidd, S. E., Williams, E., Chee, L., Urbancic, K., Thursky, K. A., &amp;amp; Australasian Antifungal Guidelines Steering, C. (2021, 2021/11/01). Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021. Internal Medicine Journal, 51 (S7), 18-36. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/https://doi.org/10.1111/imj.15586" target="_blank"&gt;&#xD;
      
           https://doi.org/https://doi.org/10.1111/imj.15586
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            . 
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-5726697.jpeg" length="843922" type="image/jpeg" />
      <pubDate>Wed, 22 Dec 2021 03:51:20 GMT</pubDate>
      <guid>https://www.ncas-australia.org/consensus-guidelines-for-antifungal-stewardship-surveillance-and-infection-prevention</guid>
      <g-custom:tags type="string">Hospital paper,NCAS publications,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-5726697.jpeg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-5726697.jpeg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>NCAS AAW 2021: AMS in aged care</title>
      <link>https://www.ncas-australia.org/ncas-aaw-2021-ams-in-aged-care</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Antimicrobial Awareness Week 2021 - webinar
           &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           ANTIMICROBIAL STEWARDSHIP IN AGED CARE
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Chair: A/Prof. Noleen Bennett (NCAS &amp;amp; VICNISS, Melbourne Health)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;a href="https://irp.cdn-website.com/d820f98f/files/uploaded/AAW%20Nov%202021_Lyn-li%20Lim.pdf" target="_blank"&gt;&#xD;
        
            Quality use of antimicrobials in residential aged care services: An update from the Aged Care Quality and Safety Commission
           &#xD;
      &lt;/a&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Lyn-li Lim (Aged Care Quality and Safety Commission)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Basic principles of antimicrobial use 
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Ms. Xin Fang (NCAS, Melbourne Health)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           The Royal Commission into Aged Care and the implications for AMS
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Janet Sluggett (Registry of Senior Australians, South Australian Health and Medical Research Institute)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           National Infection Surveillance Program for Aged Care (NISPAC)
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          A/Prof. Leon Worth (VICNISS, Melbourne Health)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Preliminary results: Barriers and enablers to the implementation of a national infection and antimicrobial surveillance system
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Ms. Eliza Watson (NISPAC, Melbourne Health)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Recommended resources for IPC and AMS
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          A/Prof. Noleen Bennett (NCAS &amp;amp; VICNISS, Melbourne Health)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/d820f98f/dms3rep/multi/Aged+Care+image+shutterstock_113018524-4635x3168.jpg" length="523433" type="image/jpeg" />
      <pubDate>Mon, 22 Nov 2021 06:47:57 GMT</pubDate>
      <guid>https://www.ncas-australia.org/ncas-aaw-2021-ams-in-aged-care</guid>
      <g-custom:tags type="string">AAW 2021 webinar</g-custom:tags>
      <media:content medium="image" url="https://irp.cdn-website.com/d820f98f/dms3rep/multi/Aged+Care+image+shutterstock_113018524-4635x3168.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/d820f98f/dms3rep/multi/Aged+Care+image+shutterstock_113018524-4635x3168.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>NCAS AAW 2021: How to use data</title>
      <link>https://www.ncas-australia.org/ncas-aaw-2021-how-to-use-data</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Antimicrobial Awareness Week 2021 - webinar
           &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           HOW TO USE DATA – SUCCESS STORIES, PITFALLS AND OPPORTUNITIES
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Chair: Prof. Karin Thursky (NCAS, Department of Infectious Diseases, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Optimising audit and feedback: recent evidence from implementation research
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Prof. Jill Francis (School of Health Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           CASE STUDIES
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           How to optimise antimicrobial allergy documentation
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          A/Prof. Jason Trubiano (Austin Hospital, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           How big is this problem? Quantifying paediatric infections using activity-based management data
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Brendan McMullan (Sydney Children's Hospital)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           An innovative AMS program for children in remote and regional areas: optimising antibiotic use through early intravenous-to-oral conversion 
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Minyon Avent (State-wide AMS Program, Queensland Health)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Repurposing disease surveillance to capture social drivers of AMR
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Teresa Wozniak (CSIRO)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Applying big data to general practice: implementation of AMS
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Brian Hur (NCAS &amp;amp; APCAH, Faculty of Veterinary and Agricultural Sciences, University of Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Evaluating the implementation of a pilot quality improvement program to support appropriate antimicrobial prescribing in general practice
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Ruby Biezen (Department of General Practice &amp;amp; NCAS, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Embedding clinical trials in the electronic medical record to improve antibiotic use
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Coen Butters (John Hunter Children’s Hospital, Newcastle)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Q&amp;amp;A
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           The National Antimicrobial Prescribing Survey and the Clinical Care Standards
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Rodney James (NCAS, Melbourne Health), Ms. Xin Fang (NCAS, Melbourne Health) and Ms. Fiona Doukas (Australian Commission on Safety and Quality in Health Care)
         &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-669615.jpeg" length="364111" type="image/jpeg" />
      <pubDate>Fri, 19 Nov 2021 23:15:45 GMT</pubDate>
      <guid>https://www.ncas-australia.org/ncas-aaw-2021-how-to-use-data</guid>
      <g-custom:tags type="string">AAW 2021 webinar</g-custom:tags>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-669615.jpeg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-669615.jpeg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>NCAS AAW 2021: Veterinary AMS</title>
      <link>https://www.ncas-australia.org/ncas-aaw-2021-veterinary-ams</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Antimicrobial Awareness Week 2021 - webinar
           &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           VETERINARY ANTIMICROBIAL STEWARDSHIP
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Chair: Prof. James Gilkerson (NCAS &amp;amp; APCAH, Faculty of Veterinary and Agricultural Sciences, University of Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Antimicrobial stewardship trial in companion animal veterinary practice
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Kirsten Bailey and Dr. Laura Hardefeldt (NCAS &amp;amp; APCAH, Faculty of Veterinary and Agricultural Sciences, University of Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           How veterinary laboratories can contribute to antimicrobial stewardship
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Ri Scarborough (NCAS &amp;amp; APCAH, Faculty of Veterinary and Agricultural Sciences, University of Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Know your audience! Evidence-based ways to talk to pet owners about responsible antibiotic use
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Ri Scarborough (NCAS &amp;amp; APCAH, Faculty of Veterinary and Agricultural Sciences, University of Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Unravelling the spread of antimicrobial (and biocide) resistance(s) in a veterinary hospital through environmental surveillance
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Marc Marenda (Faculty of Veterinary and Agricultural Sciences, University of Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/veterinarian-clinic-dog-cat.jpg" length="212259" type="image/jpeg" />
      <pubDate>Thu, 18 Nov 2021 06:35:59 GMT</pubDate>
      <guid>https://www.ncas-australia.org/ncas-aaw-2021-veterinary-ams</guid>
      <g-custom:tags type="string">AAW 2021 webinar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/veterinarian-clinic-dog-cat.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/veterinarian-clinic-dog-cat.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial stewardship in Australia: the role of qualitative research in programme development</title>
      <link>https://www.ncas-australia.org/antimicrobial-stewardship-in-australia-the-role-of-qualitative-research-in-programme-development</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Karin A Thursky, Laura Y Hardefeldt, Arjun Rajkhowa, Courtney Ierano, Jaclyn Bishop, Lesley Hawes, Ruby Biezen, Sajal K Saha, Leslie Dowson, Kirsten E Bailey, Ri Scarborough, Stephen B Little, Fiona Gotterson, Brian Hur, Anna Khanina, Karen Urbancic, Helen K Crabb, Suzanna Richards, Anna Sri, Rodney James, David C M Kong, Caroline Marshall, Danielle Mazza, Trisha Peel, Rhonda L Stuart, Jo-Anne Manski-Nankervis, N Deborah Friedman, Noleen Bennett, Thomas Schulz, Helen Billman-Jacobe, Evette Buono, Leon Worth, Ann Bull, Michael Richards, Darshini Ayton, James R Gilkerson, Glenn F Browning, Kirsty L Buising, National Centre for Antimicrobial Stewardship
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antimicrobial stewardship (AMS) in Australia is supported by a number of factors, including enabling national policies, sectoral clinical governance frameworks and surveillance programmes, clinician-led educational initiatives and health services research. A One Health research programme undertaken by the National Centre for Antimicrobial Stewardship (NCAS) in Australia has combined antimicrobial prescribing surveillance with qualitative research focused on developing antimicrobial use-related situational analyses and scoping AMS implementation options across healthcare settings, including metropolitan hospitals, regional and rural hospitals, aged care homes, general practice clinics and companion animal and agricultural veterinary practices. Qualitative research involving clinicians across these diverse settings in Australia has contributed to improved understanding of contextual factors that influence antimicrobial prescribing, and barriers and facilitators of AMS implementation. This body of research has been underpinned by a commitment to supplementing ‘big data’ on antimicrobial prescribing practices, where available, with knowledge of the sociocultural, technical, environmental and other factors that shape prescribing behaviours. NCAS provided a unique opportunity for exchange and cross-pollination across the human and animal health programme domains. It has facilitated synergistic approaches to AMS research and education, and implementation of resources and stewardship activities. The NCAS programme aimed to synergistically combine quantitative and qualitative approaches to AMS research. In this article, we describe the qualitative findings of the first 5 years.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1093/jacamr/dlab166" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Thursky, K. A., Hardefeldt, L. Y., Rajkhowa, A., Ierano, C., Bishop, J., Hawes, L., Biezen, R., Saha, S. K., Dowson, L., Bailey, K. E., Scarborough, R., Little, S. B., Gotterson, F., Hur, B., Khanina, A., Urbancic, K., Crabb, H. K., Richards, S., Sri, A., James, R., Kong, D. C. M., Marshall, C., Mazza, D., Peel, T., Stuart, R. L., Manski-Nankervis, J.-A., Friedman, N. D., Bennett, N., Schulz, T., Billman-Jacobe, H., Buono, E., Worth, L., Bull, A., Richards, M., Ayton, D., Gilkerson, J. R., Browning, G. F., Buising, K. L., &amp;amp; National Centre for Antimicrobial, S. (2021). Antimicrobial stewardship in Australia: the role of qualitative research in programme development. JAC-Antimicrobial Resistance, 3(4), dlab166. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1093/jacamr/dlab166" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1093/jacamr/dlab166
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .  
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-3985163.jpeg" length="205089" type="image/jpeg" />
      <pubDate>Thu, 18 Nov 2021 03:35:53 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-stewardship-in-australia-the-role-of-qualitative-research-in-programme-development</guid>
      <g-custom:tags type="string">Community paper,Hospital paper,NAPS paper,NCAS publications,Aged care,Aged care paper,Hospital,Veterinary,Community,Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-3985163.jpeg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-3985163.jpeg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Water distribution systems in pig farm buildings: critical elements of design and management</title>
      <link>https://www.ncas-australia.org/water-distribution-systems-in-pig-farm-buildings-critical-elements-of-design-and-management</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Stephen Little, Andrew Woodward, Glenn Browning and Helen Billman-Jacobe
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Summary
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The piped water systems within buildings on pig farms provide pigs with continuous access to drinking water, and on many farms are also used for short periods to medicate growing pigs with antibiotics to help keep them healthy and productive. We surveyed managers of 25 medium to large pig farms across eastern and southern Australia to investigate critical elements of the design and management of water systems that impact water provision to pigs. We found wide variation in the configuration, length, and pipe materials and diameters of water systems in buildings across farms. In many buildings, main pipelines were larger in diameter than required. While this helps ensure that drinkers always provide plenty of water to pigs, it means water flows through pipes very slowly. We also found that in many buildings the number of pigs per drinker was above the recommended maximum, cleaning and disinfection of water systems was not done on many farms, and few managers were aware of the risks to water quality and pig health. We have identified important aspects of water provision to pigs for which recommendations could be added to industry guidelines used by pig farm managers.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Drinking water distribution systems (WDSs) within buildings on pig farms have critical elements of their design and management that impact water provision to pigs, water quality, the efficacy of in-water antimicrobial dosing, and, thus, pig health and performance. We used a mixed-methods approach to survey managers of 25 medium to large single-site and multi-site pig farming enterprises across eastern and southern Australia. We found wide variation in the configuration (looped or branched) and total length of WDSs within buildings across farms and in pipe materials and diameters. Within many conventional buildings and some eco-shelters, WDSs were ‘over-sized’, comprising large-diameter main pipelines with high holding volumes, resulting in slow velocity water flows through sections of a WDS’s main pipeline. In over half of the weaner buildings and one-third of grower/finisher buildings, the number of pigs per drinker exceeded the recommended maximum. Few farms measured flow rates from drinkers quantitatively. WDS sanitization was not practiced on many farms, and few managers were aware of the risks to water quality and pig health. We identified important aspects of water provision to pigs for which valuable recommendations could be added to industry guidelines available to pig farm managers.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.3390/ani11113268" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Little, S., Woodward, A., Browning, G., &amp;amp; Billman-Jacobe, H. (2021). Water distribution systems in pig farm buildings: critical elements of design and management. Animals, 11(11). DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.3390/ani11113268" target="_blank"&gt;&#xD;
      
           https://doi.org/10.3390/ani11113268
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .  
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-4425158.jpeg" length="616025" type="image/jpeg" />
      <pubDate>Mon, 15 Nov 2021 07:39:20 GMT</pubDate>
      <guid>https://www.ncas-australia.org/water-distribution-systems-in-pig-farm-buildings-critical-elements-of-design-and-management</guid>
      <g-custom:tags type="string">NCAS publications,Veterinary,Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-4425158.jpeg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-4425158.jpeg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Pet owners and antibiotics: knowledge, opinions, expectations, and communication preferences</title>
      <link>https://www.ncas-australia.org/pet-owners-and-antibiotics-knowledge-opinions-expectations-and-communication-preferences</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Ri Scarborough, Laura Hardefeldt, Glenn Browning and Kirsten Bailey
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Despite the important role of antimicrobial use in companion animals in the global challenge presented by antimicrobial resistance (AMR), very few studies have quantified pet owner factors that can contribute to suboptimal veterinary antimicrobial use. We conducted an online survey of pet owners, asking about their experiences with veterinarians, their opinions on antibiotic use and knowledge of antibiotics, and their communication preferences regarding judicious prescribing. Just over half (54%) of the 558 pet owners had received antibiotics for their pet at their last non-routine veterinary consultation and most owners were happy (83%) with the antibiotic prescribing decision of their veterinarian. A quarter (25%) indicated that they had been surprised, disappointed or frustrated when a veterinarian had not given their pet antibiotics; 15% had explicitly requested them. Owners placed a higher priority on their pet receiving the most effective treatment than on treatment being cheap or convenient. Most respondents recognized the limitations of antibiotic therapy and the risks associated with antibiotic use, but 50% believed the risks were confined to the treated animal; only a minority was aware of inter-species transfer of bacteria. Pet owners indicated that they would find judicious prescribing messages focused on the direct risks of antibiotics to their pet more compelling than those about public health. Our findings suggest that veterinary communications about responsible antibiotic use should focus on pet owners’ priorities and address or bypass their gaps in understanding regarding antibiotic resistance.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.3390/antibiotics10111326" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Scarborough, R., Hardefeldt, L., Browning, G., &amp;amp; Bailey, K. (2021). Pet owners and antibiotics: knowledge, opinions, expectations, and communication preferences. Antibiotics, 10(11). DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.3390/antibiotics10111326" target="_blank"&gt;&#xD;
      
           https://doi.org/10.3390/antibiotics10111326
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-5749807.jpeg" length="917923" type="image/jpeg" />
      <pubDate>Fri, 29 Oct 2021 03:24:04 GMT</pubDate>
      <guid>https://www.ncas-australia.org/pet-owners-and-antibiotics-knowledge-opinions-expectations-and-communication-preferences</guid>
      <g-custom:tags type="string">NCAS publications,Veterinary,Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-5749807.jpeg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-5749807.jpeg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Implementation of a cellulitis management plan in three Australian regional health services to address an evidence–practice gap in antibiotic prescribing</title>
      <link>https://www.ncas-australia.org/implementation-of-a-cellulitis-management-plan-in-three-australian-regional-health-services-to-address-an-evidencepractice-gap-in-antibiotic-prescribing</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Jaclyn Bishop, Mark Jones, James Farquharson, Kathrine Summerhayes, Roxanne Tucker, Mary Smith, Raquel Cowan, N. Deborah Friedman, Thomas Schulz, David Kong and Kirsty Buising
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Despite the availability of evidence-based guidelines, antibiotics for cellulitis remain inappropriately prescribed. This evidence–practice gap is more evident in low-resource settings, such as rural hospitals. This implementation study developed and introduced a cellulitis management plan to improve antibiotic prescribing for cellulitis in three health services in regional Australia. Appropriateness of antibiotic prescribing for cellulitis at Day 1 was the primary outcome measure. Adults with ICD-10-AM codes for lower-limb cellulitis admitted as inpatients of the three health services between May and November 2019 (baseline, n = 165) and March and October 2020 (post-implementation, n = 127) were included in the assessment. The uptake of the cellulitis management plan was 29.1% (37/127). The appropriateness of antibiotic prescribing for cellulitis at Day 1 was similar at baseline (78.7%, 144/183) and in the intention-to-treat post-implementation group (81.8%, 126/154) [95% CI −5.6% to 11.3%, p = 0.50]. Commencement of the cellulitis management plan resulted in a non-statistically significant increase in antibiotic appropriateness at Day 1 compared to when a cellulitis management plan was not commenced (88.1% vs. 79.5%; 95% CI −5.6% to 19.8%; p = 0.20) Evaluation of more real-world strategies to address evidence–practice gaps, such as the appropriateness of antibiotic prescribing for cellulitis, is required.
           &#xD;
      &lt;span&gt;&#xD;
        
            ﻿
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.3390/antibiotics10111288" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Bishop, J., Jones, M., Farquharson, J., Summerhayes, K., Tucker, R., Smith, M., Cowan, R., Friedman, N. D., Schulz, T., Kong, D., &amp;amp; Buising, K. (2021). Implementation of a Cellulitis Management Plan in Three Australian Regional Health Services to Address an Evidence–Practice Gap in Antibiotic Prescribing. Antibiotics, 10(11). DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.3390/antibiotics10111288" target="_blank"&gt;&#xD;
      
           https://doi.org/10.3390/antibiotics10111288
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .  
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-6129681.jpeg" length="282783" type="image/jpeg" />
      <pubDate>Fri, 22 Oct 2021 06:45:57 GMT</pubDate>
      <guid>https://www.ncas-australia.org/implementation-of-a-cellulitis-management-plan-in-three-australian-regional-health-services-to-address-an-evidencepractice-gap-in-antibiotic-prescribing</guid>
      <g-custom:tags type="string">Hospital paper,NCAS publications,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-6129681.jpeg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-6129681.jpeg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial Awareness Week 2021</title>
      <link>https://www.ncas-australia.org/antimicrobial-awareness-week-2021</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp.cdn-website.com/d820f98f/dms3rep/multi/2021.10.13+NCAS+AAW+2021.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antimicrobial Awareness Week aims to increase public awareness of the threat of antimicrobial resistance and the importance of efforts to improve antimicrobial use in all healthcare settings. NCAS will host a webinar series on antimicrobial stewardship research and practice on 18-22 November. The webinars will cover antimicrobial stewardship in veterinary medicine, using data for antimicrobial stewardship, and antimicrobial stewardship in aged care.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Dates:
          &#xD;
    &lt;/b&gt;&#xD;
    
          18-22 November 2021
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Format:
          &#xD;
    &lt;/b&gt;&#xD;
    
          Webinar
         &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-3183169.jpeg" length="199223" type="image/jpeg" />
      <pubDate>Wed, 01 Sep 2021 08:26:37 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-awareness-week-2021</guid>
      <g-custom:tags type="string">News and events</g-custom:tags>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-3183169.jpeg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-3183169.jpeg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>It’s not just about quantity: The importance of qualitative research to AMS</title>
      <link>https://www.ncas-australia.org/its-not-just-about-quantity-the-importance-of-qualitative-research-to-ams</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Antimicrobial Awareness Week 2020 - webinar
           &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           It’s not just about quantity: The importance of qualitative research to AMS
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Chair: A/Prof. Mark Davis
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           General public awareness and action on the reduction of AMR: Which publics and what can they do?
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          A/Prof. Mark Davis (School of Social Sciences, Monash University, Melbourne) 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Antimicrobial resistance and culturally and linguistically diverse communities in Australia
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Prof. Andrea Whittaker (School of Social Sciences, Monash University, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Fears, formulations and fractious patients: Influences on antimicrobial use in Australian dogs and cats
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Ri Scarborough (National Centre for Antimicrobial Stewardship, University of Melbourne, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1521737604893-d14cc237f11d.jpg" length="220928" type="image/jpeg" />
      <pubDate>Tue, 24 Nov 2020 06:26:47 GMT</pubDate>
      <guid>https://www.ncas-australia.org/its-not-just-about-quantity-the-importance-of-qualitative-research-to-ams</guid>
      <g-custom:tags type="string">AAW 2020 webinar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1521737604893-d14cc237f11d.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1521737604893-d14cc237f11d.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>AMS capacity building</title>
      <link>https://www.ncas-australia.org/ams-capacity-building</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Antimicrobial Awareness Week 2020 - webinar
           &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           AMS capacity building
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Chair: Ron Cheah
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           What is a DOT? Do we like it a lot?
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Nadine Hillock (National Antimicrobial Utilisation Surveillance Program, South Australian Expert Advisory Group on Antimicrobial Resistance, SA Health, Adelaide)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Measuring antibiotic stewardship across primary healthcare: An umbrella review in medical care and a systematic review in dental care
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Leanne Teoh (University of Melbourne, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           A multidisciplinary approach to antimicrobial stewardship in a specialist hospital for women and newborns
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Vi Pham, Dr. Sushena Krishnaswamy and Sharon Heap (Royal Women’s Hospital, Melbourne) 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Improving patients’ knowledge and understanding of their antimicrobial therapy
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Kim Yeoh (Royal Melbourne Hospital, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Urinalysis practices and subsequent antibiotic prescribing in a geriatric inpatient setting
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Nupur Goyal and Dr. LynLi Lim (Eastern Health, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Understanding and responding to antimicrobial resistance in Timor Leste: Towards a One Health approach
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Shawn Ting (Menzies School of Health Research, Charles Darwin University, Darwin)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Antimicrobial stewardship pharmacy technicians: ‘Tech-ing’ AMS to the next level
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           AMS technician: The hidden gem – Experiences from Monash Health and Eastern Health
          &#xD;
    &lt;/b&gt;&#xD;
    
           
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Marnie Horne-Spalling (Monash Health, Melbourne), Sonia Koning (Eastern Health, Melbourne) and Erika Roberts (Monash Health, Melbourne) 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
           
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Antimicrobial stewardship as part of the MDT: Sharing best practice and highlighting how pharmacy technicians add value in this field
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Julie Chatters (East Suffolk and North Essex Foundation Trust NHS, UK) and Leanne Nixon (East Suffolk and North Essex Foundation Trust NHS, UK)
         &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1516841273335-e39b37888115.jpg" length="136625" type="image/jpeg" />
      <pubDate>Tue, 24 Nov 2020 05:48:39 GMT</pubDate>
      <guid>https://www.ncas-australia.org/ams-capacity-building</guid>
      <g-custom:tags type="string">AAW 2020 webinar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1516841273335-e39b37888115.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1516841273335-e39b37888115.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Paediatrics</title>
      <link>https://www.ncas-australia.org/paediatrics</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Antimicrobial Awareness Week 2020 - webinar
           &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Paediatrics
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Chair: A/Prof. Penelope Bryant
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Introduction to paediatric AMS research 
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          A/Prof. Penelope Bryant (Royal Children’s Hospital &amp;amp; Murdoch Children Research Institute, Melbourne) 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Paediatric AMS in Australia in 2020 – stumbling blocks and opportunities
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Brendan McMullan (Sydney Children’s Hospital &amp;amp; University of Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Approaches to antibiotic stewardship in febrile neutropenia: Balancing risks and benefits
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Gabrielle Haeusler (Peter MacCallum Cancer Centre &amp;amp; Royal Children’s Hospital, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576766125468-a5d48274c5b4.jpg" length="263781" type="image/jpeg" />
      <pubDate>Mon, 23 Nov 2020 06:16:38 GMT</pubDate>
      <guid>https://www.ncas-australia.org/paediatrics</guid>
      <g-custom:tags type="string">AAW 2020 webinar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576766125468-a5d48274c5b4.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576766125468-a5d48274c5b4.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Surgical antimicrobial prophylaxis prescribing</title>
      <link>https://www.ncas-australia.org/surgical-antimicrobial-prophylaxis-prescribing</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Antimicrobial Awareness Week 2020 - webinar
           &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Surgical antimicrobial prophylaxis (SAP) prescribing
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Chair: Dr. Rodney James
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Surgical antimicrobial prophylaxis – is there low-hanging fruit left to pick?
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Kristin Xenos (Australian Commission on Safety and Quality in Health Care, Sydney)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Dissecting the Surgical NAPS
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Rodney James, Xin Fang and Dr. Courtney Ierano (National Centre for Antimicrobial Stewardship, Melbourne Health &amp;amp; University of Melbourne, Melbourne) 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Mind the gap: Clinical trials targeting barriers to prophylaxis guideline uptake in surgery
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          A/Prof. Trisha Peel (Alfred Hospital and Monash University, Melbourne) 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Tailored SAP tools: Collaborations with the NSW Clinical Excellence Commission
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Semun (Sim) Galimam (Wyong Hospital &amp;amp; Central Coast Local Health District, Hamlyn Terrace, New South Wales)
         &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551190822-a9333d879b1f.jpg" length="209506" type="image/jpeg" />
      <pubDate>Mon, 23 Nov 2020 03:50:06 GMT</pubDate>
      <guid>https://www.ncas-australia.org/surgical-antimicrobial-prophylaxis-prescribing</guid>
      <g-custom:tags type="string">AAW 2020 webinar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551190822-a9333d879b1f.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551190822-a9333d879b1f.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Infections in the immunocompromised</title>
      <link>https://www.ncas-australia.org/infections-in-the-immunocompromised</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Antimicrobial Awareness Week 2020 - webinar
           &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Infections in the immunocompromised
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Chair: Prof. Monica Slavin
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           The impact and scaling of antibiotic allergy de-labelling in Australia
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          A/Prof. Jason Trubiano (Austin Health, Peter MacCallum Cancer Centre &amp;amp; University of Melbourne, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Improving outcomes of cytomegalovirus infection in recipients of haematopoietic stem cell transplant
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Michelle Yong (Peter MacCallum Cancer Centre &amp;amp; University of Melbourne, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Antifungal stewardship in Australia
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Anna Khanina (Peter MacCallum Cancer Centre, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           The role of the antimicrobial stewardship nurse practitioner 
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Belinda Lambros (Peter MacCallum Cancer Centre, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1581594294883-5109c202942f.jpg" length="334318" type="image/jpeg" />
      <pubDate>Fri, 20 Nov 2020 07:30:34 GMT</pubDate>
      <guid>https://www.ncas-australia.org/infections-in-the-immunocompromised</guid>
      <g-custom:tags type="string">AAW 2020 webinar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1581594294883-5109c202942f.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1581594294883-5109c202942f.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>COVID-19, regional AMS and antibiotic development</title>
      <link>https://www.ncas-australia.org/covid-19-regional-ams-and-antibiotic-development</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Antimicrobial Awareness Week 2020 - webinar
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           COVID-19, regional AMS and antibiotic development
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Chair: Dr. Krispin Hajkowicz
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Antibiotic stewardship in suspected and confirmed COVID-19
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Krispin Hajkowicz (Royal Brisbane and Women's Hospital, Brisbane)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Lessons learned from the early adoption and evidence for COVID-19 therapeutics 
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Prof. Jason Roberts (CRE Reduce, University of Queensland, Brisbane) 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Antimicrobial stewardship in rural and remote Queensland 
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Jacinta Shanahan (Queensland State-wide Antimicrobial Stewardship Program, Brisbane)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           The CARB-X award – accelerated development of last-resort antibiotics to treat multidrug-resistant infections 
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Mark Blaskovich (Centre for Superbug Solutions, Institute for Molecular Bioscience, University of Queensland, Brisbane)
         &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Antibiotics-for-Infection-672x372-672x372.jpg" length="39457" type="image/jpeg" />
      <pubDate>Fri, 20 Nov 2020 03:42:48 GMT</pubDate>
      <guid>https://www.ncas-australia.org/covid-19-regional-ams-and-antibiotic-development</guid>
      <g-custom:tags type="string">AAW 2020 webinar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Antibiotics-for-Infection-672x372-672x372.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Antibiotics-for-Infection-672x372-672x372.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>National Antimicrobial Prescribing Survey (NAPS) (international projects)</title>
      <link>https://www.ncas-australia.org/thinking-big-scaling-up-a-small-antimicrobial-stewardship-initiative-into-a-successful-national-and-international-program-the-national-antimicrobial-prescribing-survey</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Antimicrobial Awareness Week 2020 - webinar
           &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Thinking big: Scaling up a small antimicrobial stewardship initiative into a successful national and international program - the National Antimicrobial Prescribing Survey
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Chair: Caroline Chen
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           10 years on: Scaling the NAPS from a single survey to a successful national and international program
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Caroline Chen (National Centre for Antimicrobial Stewardship &amp;amp; Guidance Group, Royal Melbourne Hospital, Melbourne) 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           NAP-ping outside the box: Beyond international border, beyond the general population
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Yoshiko Nakamachi and Dr. Miranda So (Sinai Health-University Health Network Antimicrobial Stewardship Program, Toronto, Canada)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Implementation of the NAPS in Malaysia
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          A/Prof. Sasheela Sri La Sri Ponnampalavanar (University Malaya Medical Centre, Kuala Lumpur, Malaysia) 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Experience of the NAPS program in developing countries
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Rodney James (National Centre for Antimicrobial Stewardship &amp;amp; Guidance Group, Royal Melbourne Hospital, Melbourne) 
         &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1434626881859-194d67b2b86f.jpg" length="326882" type="image/jpeg" />
      <pubDate>Thu, 19 Nov 2020 22:48:36 GMT</pubDate>
      <guid>https://www.ncas-australia.org/thinking-big-scaling-up-a-small-antimicrobial-stewardship-initiative-into-a-successful-national-and-international-program-the-national-antimicrobial-prescribing-survey</guid>
      <g-custom:tags type="string">AAW 2020 webinar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1434626881859-194d67b2b86f.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1434626881859-194d67b2b86f.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>International One Health AMR and AMS capacity building</title>
      <link>https://www.ncas-australia.org/international-one-health-amr-and-ams-capacity-building</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Antimicrobial Awareness Week 2020 - webinar
           &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           International One Health AMR and AMS capacity building
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Chair: Prof. Kirsty Buising
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Regional capacity building and training approaches to support prevention and surveillance of antimicrobial resistance
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Prof. Kirsty Buising (Doherty Institute, University of Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Approach to addressing AMR in Papua New Guinea
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Ms. Judith Nui (Fleming Fund Fellowship Program, Papua New Guinea)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           WHO antimicrobial resistance and stewardship programs in the Western Pacific Region
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Soccoro Escalante (Essential Medicines and Health Technologies, Division of Health Systems and Services, WHO Western Pacific Regional Office, Manila)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           One Health perspectives on regional AMR programs
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Joanna McKenzie (Massey University, New Zealand)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Passive AMR surveillance in poultry specimens 2018-2019 in Nepal
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Tulsi Gompo (Fleming Fund Fellowship Program, Nepal)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           A practical approach to AMR capacity building and training in Pacific Island Countries
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Tebuka Toatu (The Pacific Community [SPC], Fiji)
         &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1517245386807-bb43f82c33c4.jpg" length="290797" type="image/jpeg" />
      <pubDate>Thu, 19 Nov 2020 06:45:39 GMT</pubDate>
      <guid>https://www.ncas-australia.org/international-one-health-amr-and-ams-capacity-building</guid>
      <g-custom:tags type="string">AAW 2020 webinar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1517245386807-bb43f82c33c4.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1517245386807-bb43f82c33c4.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>One Health data analytics and decision-support</title>
      <link>https://www.ncas-australia.org/one-health-data-analytics-and-decision-support</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Antimicrobial Awareness Week 2020 - webinar
           &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           One Health data analytics and decision-support
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Chair: Prof. Karin Thursky
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Using EHR to monitor appropriateness of antimicrobial prescribing (and moving to
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           big data for surveillance)
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Prof. Karin Thursky (National Centre for Antimicrobial Stewardship, University of Melbourne, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Guidance GP: Pilot of a quality improvement program for antimicrobial stewardship in general practice
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          A/Prof. Jo-Anne Manski-Nankervis (Department of General Practice, University of Melbourne, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Use of administrative data to support infection surveillance and health services research: Limitations and opportunities
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Jake Valentine (National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne) 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Use of machine learning to support meaningful passive data extraction in community veterinary practices 
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Brian Hur (National Centre for Antimicrobial Stewardship, University of Melbourne, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1460925895917-afdab827c52f.jpg" length="242353" type="image/jpeg" />
      <pubDate>Thu, 19 Nov 2020 01:13:22 GMT</pubDate>
      <guid>https://www.ncas-australia.org/one-health-data-analytics-and-decision-support</guid>
      <g-custom:tags type="string">AAW 2020 webinar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1460925895917-afdab827c52f.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1460925895917-afdab827c52f.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial stewardship in the community</title>
      <link>https://www.ncas-australia.org/antimicrobial-stewardship-ams-in-the-community</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Antimicrobial Awareness Week 2020 - webinar
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Antimicrobial stewardship (AMS) in the community 
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Chair: A/Prof. Noleen Bennett
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Infographics about antibiotics: Making facts accessible
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Oliver van Hecke (University of Oxford, Oxford, UK)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Co-creation of AMS information sheets with health professionals and consumers: Creating resources that fit the needs of the community
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Ruby Biezen (Department of General Practice &amp;amp; National Centre for Antimicrobial Stewardship, University of Melbourne, Melbourne) 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           The Royal Commission into Aged Care Quality and Safety: Helpful for AMS?
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          A/Prof. Noleen Bennett (National Centre for Antimicrobial Stewardship, University of Melbourne, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Optimising antimicrobial use in aged care homes
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Leslie Dowson (National Centre for Antimicrobial Stewardship, Monash University, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Antimicrobial stewardship in general practice: A scoping review of the component parts
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Lesley Hawes (National Centre for Antimicrobial Stewardship, Monash University, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Engaging the community pharmacist in promoting judicious antimicrobial use
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Sajal Saha (National Centre for Antimicrobial Stewardship, Monash University, Melbourne) 
         &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576091160550-2173dba999ef.jpg" length="124795" type="image/jpeg" />
      <pubDate>Wed, 18 Nov 2020 21:07:04 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-stewardship-ams-in-the-community</guid>
      <g-custom:tags type="string">AAW 2020 webinar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576091160550-2173dba999ef.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576091160550-2173dba999ef.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial resistance in regional and remote Australia</title>
      <link>https://www.ncas-australia.org/antimicrobial-resistance-amr-in-regional-and-remote-australia</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Antimicrobial Awareness Week 2020 - webinar
           &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Antimicrobial resistance (AMR) in regional and remote Australia
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Chair: Dr. Teresa Wozniak
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Geography and burden of AMR in northern Australia
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Trent Yarwood (Queensland Health, State-wide Antimicrobial Stewardship Program, Brisbane), Dr. Teresa Wozniak (Menzies School of Health Research, Brisbane) and A/Prof. Asha Bowen (Telethon Kids Institute, Perth)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           HOT North Antimicrobial Academy for Indigenous Health Care Providers
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          A/Prof. Asha Bowen (Telethon Kids Institute, Perth), Dr. Trent Yarwood (Queensland Health, State-wide Antimicrobial Stewardship Program, Brisbane) and Dr. Caitlyn White (Kimberley Aboriginal Medical Services, Broome)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           National surveillance of AMR: Coordination and activities
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Sonali Coulter (Queensland Health, Brisbane)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Developing a platform for tracking and responding to AMR in regional Australia – HOTspots
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Teresa Wozniak and Mr. Will Cuningham (Menzies School of Health Research, Brisbane/Darwin)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Evaluation and implementation of HOTspots in northern Australia
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Ms. Laura Goddard (National Centre for Epidemiology and Population Health, Australia National University, Canberra) and Ms. Amy Legg (AMS pharmacist Top End Health Service, Darwin)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Modelling the contribution of the social determinants of health to the spread of AMR
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Karen McCulloch (Doherty Institute, University of Melbourne, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Influencing the national agenda on AMR
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Panel
         &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/bacteria-004-900x636.jpg" length="162721" type="image/jpeg" />
      <pubDate>Wed, 18 Nov 2020 06:25:50 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-resistance-amr-in-regional-and-remote-australia</guid>
      <g-custom:tags type="string">AAW 2020 webinar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/bacteria-004-900x636.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/bacteria-004-900x636.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Opening plenary</title>
      <link>https://www.ncas-australia.org/opening-plenary</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Antimicrobial Awareness Week 2020 - webinar
           &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Opening plenary
           &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Chair: Prof. Karin Thursky
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Opening remarks
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Prof. Paul Kelly (Australian Chief Medical Officer, Department of Health)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Opening remarks
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Dr. Mark Schipp (Australian Chief Veterinary Officer, Department of Agriculture, Water and the Environment)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Improving antimicrobial prescribing: Where to next? 
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Prof. Karin Thursky (National Centre for Antimicrobial Stewardship, University of Melbourne, Melbourne) 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Antimicrobial use in animal health in Australia: What do we know and what do we still need to find out?
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Prof. Glenn Browning (National Centre for Antimicrobial Stewardship, University of Melbourne, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Opportunities to enhance AMR surveillance using genomics
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Prof. Ben Howden (Doherty Institute, University of Melbourne, Melbourne)
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1542736667-069246bdbc6d.jpg" length="108473" type="image/jpeg" />
      <pubDate>Wed, 18 Nov 2020 01:56:57 GMT</pubDate>
      <guid>https://www.ncas-australia.org/opening-plenary</guid>
      <g-custom:tags type="string">AAW 2020 webinar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1542736667-069246bdbc6d.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1542736667-069246bdbc6d.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Telehealth antimicrobial stewardship at Goulburn Valley Health: Successfully implementing electronic post-prescription review</title>
      <link>https://www.ncas-australia.org/telehealth-antimicrobial-stewardship-at-goulburn-valley-health-successfully-implementing-electronic-post-prescription-review</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Ibrahim+et+al+V2.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Antimicrobial Awareness Week 2020 – poster
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Telehealth antimicrobial stewardship at Goulburn Valley Health: Successfully implementing electronic post-prescription review
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Shady Ibrahim, Thomas Schulz
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Goulburn Valley Health
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1557825835-70d97c4aa567.jpg" length="104377" type="image/jpeg" />
      <pubDate>Mon, 16 Nov 2020 09:37:31 GMT</pubDate>
      <guid>https://www.ncas-australia.org/telehealth-antimicrobial-stewardship-at-goulburn-valley-health-successfully-implementing-electronic-post-prescription-review</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1557825835-70d97c4aa567.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1557825835-70d97c4aa567.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Topical use of antimicrobials for surgical prophylaxis in Australian hospitals</title>
      <link>https://www.ncas-australia.org/topical-use-of-antimicrobials-for-surgical-prophylaxis-in-australian-hospitals</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;a&gt;&#xD;
    &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Ierano_et_al+V2.jpg" alt=""/&gt;&#xD;
  &lt;/a&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Antimicrobial Awareness Week 2020 – poster
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Topical use of antimicrobials for surgical prophylaxis in Australian hospitals
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           C. Ierano, R. Cheah, R. James, K. Thursky
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           University of Melbourne
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551190822-a9333d879b1f.jpg" length="209506" type="image/jpeg" />
      <pubDate>Mon, 16 Nov 2020 09:22:39 GMT</pubDate>
      <guid>https://www.ncas-australia.org/topical-use-of-antimicrobials-for-surgical-prophylaxis-in-australian-hospitals</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551190822-a9333d879b1f.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551190822-a9333d879b1f.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Timing and duration of surgical prophylaxis</title>
      <link>https://www.ncas-australia.org/timing-and-duration-of-surgical-prophylaxis</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Principles+of+surgical+prophylaxis_Page_01-b7215f4b.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  
                  
         NCAS has prepared a guidance document titled
         
                  &#xD;
  &lt;i&gt;&#xD;
    
                    
          Timing and duration of surgical prophylaxis
         
                  &#xD;
  &lt;/i&gt;&#xD;
  
                  
         to support quality improvement in surgical prophylaxis prescribing and address issues identified in the Surgical NAPS. Read
         
                  &#xD;
  &lt;a href="/Education"&gt;&#xD;
    
                    
          here
         
                  &#xD;
  &lt;/a&gt;&#xD;
  
                  
         . 
        
                &#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Principles+of+surgical+prophylaxis_Page_01-b7215f4b.jpg" length="69673" type="image/jpeg" />
      <pubDate>Fri, 13 Nov 2020 04:31:39 GMT</pubDate>
      <guid>https://www.ncas-australia.org/timing-and-duration-of-surgical-prophylaxis</guid>
      <g-custom:tags type="string">NAPS paper,News and events,Hospital,NAPS publications</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Principles+of+surgical+prophylaxis_Page_01-b7215f4b.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Principles+of+surgical+prophylaxis_Page_01-b7215f4b.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>The Surgical National Antimicrobial Prescribing Survey: 2019 report</title>
      <link>https://www.ncas-australia.org/the-surgical-national-antimicrobial-prescribing-survey-2019-report</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/SNAPS+2019.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           The 2019 Surgical NAPS Report has now been published by the
           
                      &#xD;
      &lt;a href="https://www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/program-partners/appropriateness-antimicrobial-use" target="_blank"&gt;&#xD;
        
                        
            Australian Commission on Safety and Quality in Health Care
           
                      &#xD;
      &lt;/a&gt;&#xD;
      
                      
           . Participation has continued to increase, with 144 public and private facilities contributing nationally. This report provides an analysis of procedural group specialty-level prescribing, highlighting differences across surgical specialty groups and offering targeted data to support targeted surgical AMS initiatives. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Participate in the NAPS program (coordinated by NCAS)
          
                    &#xD;
    &lt;a href="https://www.naps.org.au/Default.aspx" target="_blank"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    
                    
          . 
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/SNAPS+2019.jpg" length="397232" type="image/jpeg" />
      <pubDate>Fri, 13 Nov 2020 04:27:20 GMT</pubDate>
      <guid>https://www.ncas-australia.org/the-surgical-national-antimicrobial-prescribing-survey-2019-report</guid>
      <g-custom:tags type="string">NAPS,NAPS paper,News and events,Hospital,NAPS reports,NAPS publications</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/SNAPS+2019.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/SNAPS+2019.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Improving patients’ knowledge and understanding of their antimicrobial therapy</title>
      <link>https://www.ncas-australia.org/improving-patients-knowledge-and-understanding-of-their-antimicrobial-therapy</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Yeoh+et+al_Assessing+patient+understanding+of+their+antimicrobial+therapy_final.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
                        
            Antimicrobial Awareness Week 2020 – poster
           
                      &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Improving patients’ knowledge and understanding of their antimicrobial therapy
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Kim Yeoh, Catherine George, Arjun Rajkhowa, Irani Thevarajan, Kirsty Buising
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Royal Melbourne Hospital
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1581056771107-24ca5f033842.jpg" length="178285" type="image/jpeg" />
      <pubDate>Sun, 01 Nov 2020 13:20:23 GMT</pubDate>
      <guid>https://www.ncas-australia.org/improving-patients-knowledge-and-understanding-of-their-antimicrobial-therapy</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1581056771107-24ca5f033842.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1581056771107-24ca5f033842.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Information GPs can trust: What is the validity of the GP National Antimicrobial Prescribing Survey (GP NAPS) compared to an in-practice audit of antimicrobial prescribing?</title>
      <link>https://www.ncas-australia.org/information-gps-can-trust-what-is-the-validity-of-the-gp-national-antimicrobial-prescribing-survey-gp-naps-compared-to-an-in-practice-audit-of-antimicrobial-prescribing</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Wang+et+al_Validity+of+GP+NAPS.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
                        
            Antimicrobial Awareness Week 2020 – poster
           
                      &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Information GPs can trust: What is the validity of the GP National Antimicrobial Prescribing Survey (GP NAPS) compared to an in-practice audit of antimicrobial prescribing?
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Jimmy Wang, Christine Hallinan, Jo-Anne Nanski-Mankervis
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          University of Melbourne
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/patient-doctor-clinic-b9fabc3d.jpg" length="320596" type="image/png" />
      <pubDate>Sun, 01 Nov 2020 13:08:47 GMT</pubDate>
      <guid>https://www.ncas-australia.org/information-gps-can-trust-what-is-the-validity-of-the-gp-national-antimicrobial-prescribing-survey-gp-naps-compared-to-an-in-practice-audit-of-antimicrobial-prescribing</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/patient-doctor-clinic-b9fabc3d.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/patient-doctor-clinic-b9fabc3d.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Infographics about antibiotics: Making facts accessible</title>
      <link>https://www.ncas-australia.org/infographics-about-antibiotics-making-facts-accessible</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Van+Hecke+et+al.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Antimicrobial Awareness Week 2020 – poster
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Infographics about antibiotics: Making facts accessible
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Oliver van Hecke, Joseph Lee, Chris Butler, Michael Moore, Sarah Tonkin-Crine
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          University of Oxford, UK
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Antibiotics-for-Infection-672x372-672x372.jpg" length="39457" type="image/jpeg" />
      <pubDate>Sun, 01 Nov 2020 13:01:15 GMT</pubDate>
      <guid>https://www.ncas-australia.org/infographics-about-antibiotics-making-facts-accessible</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Antibiotics-for-Infection-672x372-672x372.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Antibiotics-for-Infection-672x372-672x372.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Innovation for online functionality to improve antimicrobial stewardship</title>
      <link>https://www.ncas-australia.org/innovation-for-online-functionality-to-improve-antimicrobial-stewardship</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Tumusiime+et+al_AMS+app.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
                        
            Antimicrobial Awareness Week 2020 – poster
           
                      &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Innovation for online functionality to improve antimicrobial stewardship
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          William Tumusiime
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          West Moreton Health, Queensland
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1545112969-bdd91ef544c7.jpg" length="169391" type="image/jpeg" />
      <pubDate>Sun, 01 Nov 2020 12:42:31 GMT</pubDate>
      <guid>https://www.ncas-australia.org/innovation-for-online-functionality-to-improve-antimicrobial-stewardship</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1545112969-bdd91ef544c7.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1545112969-bdd91ef544c7.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Understanding and responding to antimicrobial resistance in Timor-Leste - towards a One Health approach</title>
      <link>https://www.ncas-australia.org/understanding-and-responding-to-antimicrobial-resistance-in-timor-leste-towards-a-one-health-approach</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Ting+et+al_Understanding+and+responding+to+AMR+in+Timor-Leste+-+towards+a+One+Health+approach.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Antimicrobial Awareness Week 2020 – poster
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Understanding and responding to antimicrobial resistance in Timor-Leste - towards a One Health approach
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Shawn Ting, Karen Champlin, Nevio Sarmento, Abrao Pereira, Ian Marr, Jennifer Yan, Joshua Francis
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Charles Darwin University, Darwin
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1591325408953-ef9298125f96.jpg" length="340874" type="image/jpeg" />
      <pubDate>Sun, 01 Nov 2020 09:35:29 GMT</pubDate>
      <guid>https://www.ncas-australia.org/understanding-and-responding-to-antimicrobial-resistance-in-timor-leste-towards-a-one-health-approach</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1591325408953-ef9298125f96.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1591325408953-ef9298125f96.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Measuring antibiotic stewardship across primary healthcare: An umbrella review in medical care and a systematic review in dental care</title>
      <link>https://www.ncas-australia.org/measuring-antibiotic-stewardship-across-primary-healthcare-an-umbrella-review-in-medical-care-and-a-systematic-review-in-dental-care</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Teoh+et+al_Measuring+AMS+across+dental+care.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Antimicrobial Awareness Week 2020 – poster
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Measuring antibiotic stewardship across primary healthcare: An umbrella review in medical care and a systematic review in dental care
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Leanne Teoh, Alastair Sloan, Michael McCullough, Wendy Thompson
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          University of Melbourne
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1567568423327-a42bf243e0da.jpg" length="114496" type="image/jpeg" />
      <pubDate>Sun, 01 Nov 2020 09:24:56 GMT</pubDate>
      <guid>https://www.ncas-australia.org/measuring-antibiotic-stewardship-across-primary-healthcare-an-umbrella-review-in-medical-care-and-a-systematic-review-in-dental-care</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1567568423327-a42bf243e0da.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1567568423327-a42bf243e0da.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>A multidisciplinary approach to antimicrobial stewardship in a specialist hospital for women and newborns</title>
      <link>https://www.ncas-australia.org/a-multidisciplinary-approach-to-antimicrobial-stewardship-in-a-specialist-hospital-for-women-and-newborns</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Pham+et+al_A+multidisciplinary+aproach+to+AMS+in+a+specialist+hospital+for+women+and+newborns.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Antimicrobial Awareness Week 2020 – poster
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           A multidisciplinary approach to antimicrobial stewardship in a specialist hospital for women and newborns
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Vi Pham, Sharon Heap, Andrew Daley, Vanessa Clifford, Lai Yang Lee, 
Huda Ismail, Laura Leung, Deborah Rhodes, Joshua Puglia, Sushena Krishnaswamy
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          The Royal Women’s Hospital, Melbourne
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1470116945706-e6bf5d5a53ca.jpg" length="316657" type="image/jpeg" />
      <pubDate>Sun, 01 Nov 2020 09:14:51 GMT</pubDate>
      <guid>https://www.ncas-australia.org/a-multidisciplinary-approach-to-antimicrobial-stewardship-in-a-specialist-hospital-for-women-and-newborns</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1470116945706-e6bf5d5a53ca.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1470116945706-e6bf5d5a53ca.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>What are the barriers and facilitators to quality improvement strategies for antimicrobial stewardship in general practice?</title>
      <link>https://www.ncas-australia.org/what-are-the-barriers-and-facilitators-to-quality-improvement-strategies-for-antimicrobial-stewardship-in-general-practice</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Ngo+et+al_Barriers+and+facilitators+GP+AMS.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Antimicrobial Awareness Week 2020 – poster
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           What are the barriers and facilitators to quality improvement
 strategies for antimicrobial stewardship in general practice?
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Hoang Nam Phuong Ngo, Ruby Biezen, Jo-Anne Manski-Nankervis
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          University of Melbourne
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576766125468-a5d48274c5b4.jpg" length="263781" type="image/jpeg" />
      <pubDate>Sun, 01 Nov 2020 09:05:21 GMT</pubDate>
      <guid>https://www.ncas-australia.org/what-are-the-barriers-and-facilitators-to-quality-improvement-strategies-for-antimicrobial-stewardship-in-general-practice</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576766125468-a5d48274c5b4.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576766125468-a5d48274c5b4.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Electronic medical records (EMR) dosing calculators for gentamicin and vancomycin in adult non-critically ill patients</title>
      <link>https://www.ncas-australia.org/electronic-medical-records-emr-dosing-calculators-for-gentamicin-and-vancomycin-in-adult-non-critically-ill-patients</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Megallaa+et+al_V2.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Antimicrobial Awareness Week 2020 – poster
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;b&gt;&#xD;
    &lt;div&gt;&#xD;
      &lt;b&gt;&#xD;
        
                        
            Electronic medical records (EMR) dosing calculators for gentamicin and vancomycin in adult non-critically ill patients 
           
                      &#xD;
      &lt;/b&gt;&#xD;
    &lt;/div&gt;&#xD;
  &lt;/b&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Pauline Megallaa, Bryan Yeoh, Andrew Chong, Andrew May, Marion Kainer, Stephen Guy,
 Katherine Langan
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Western Health, Melbourne
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1599045118108-bf9954418b76.jpg" length="213351" type="image/jpeg" />
      <pubDate>Sun, 01 Nov 2020 08:38:44 GMT</pubDate>
      <guid>https://www.ncas-australia.org/electronic-medical-records-emr-dosing-calculators-for-gentamicin-and-vancomycin-in-adult-non-critically-ill-patients</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1599045118108-bf9954418b76.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1599045118108-bf9954418b76.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Mupirocin use in Australian hospitals</title>
      <link>https://www.ncas-australia.org/mupirocin-use-in-australian-hospitals</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hillock+et+al_Mupirocin_Australian_Hospitals_2020.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Antimicrobial Awareness Week 2020 – poster
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Mupirocin use in Australian hospitals: Analysis of prescribing at a hospital and state level
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          N. Hillock, E. Connor, C. Wilson
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          National Antimicrobial Utilisation Surveillance Program (NAUSP), SA Health
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1561541262-077c8353e49e.jpg" length="45651" type="image/jpeg" />
      <pubDate>Sun, 01 Nov 2020 08:12:03 GMT</pubDate>
      <guid>https://www.ncas-australia.org/mupirocin-use-in-australian-hospitals</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1561541262-077c8353e49e.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1561541262-077c8353e49e.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Increasing antifungal use in Australian hospitals</title>
      <link>https://www.ncas-australia.org/increasing-antifungal-use-in-australian-hospitals</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hillock+et+al_Increasing+Antifungal+Usage+in+Australian+Hospitals+FINAL.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Antimicrobial Awareness Week 2020 – poster
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Increasing antifungal use in Australian hospitals
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          C. Wilson, E. Connor, N. Hillock
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          National Antimicrobial Utilisation Surveillance Program (NAUSP), SA Health
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1542736667-069246bdbc6d.jpg" length="108473" type="image/jpeg" />
      <pubDate>Sun, 01 Nov 2020 07:55:06 GMT</pubDate>
      <guid>https://www.ncas-australia.org/increasing-antifungal-use-in-australian-hospitals</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1542736667-069246bdbc6d.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1542736667-069246bdbc6d.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial resistance awareness survey in Timor-Leste (2018)</title>
      <link>https://www.ncas-australia.org/antimicrobial-resistance-awareness-survey-in-timor-leste-2018</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hendriques+et+al_AMR+in+Timor-Leste.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Antimicrobial Awareness Week 2020 – poster
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Antimicrobial resistance awareness survey in Timor-Leste (2018)
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Delfim da C. Xavier Ferreira, Celeste Cham, Suzana Soares Hendriques
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Ministry of Health, Timor-Leste
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1600673741019-08bf15829529.jpg" length="353150" type="image/jpeg" />
      <pubDate>Sun, 01 Nov 2020 07:47:24 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-resistance-awareness-survey-in-timor-leste-2018</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1600673741019-08bf15829529.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1600673741019-08bf15829529.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Urine testing and antibiotic prescribing in a geriatric in-patient setting</title>
      <link>https://www.ncas-australia.org/urine-testing-and-antibiotic-prescribing-in-a-geriatric-in-patient-setting</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Goyal+et+al_Urine+testing+and+antibiotic+prescribing+in+a+geriatric+in-patient+setting.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Antimicrobial Awareness Week 2020 – poster
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Urine testing and antibiotic
prescribing in a geriatric in-patient setting
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Nupur Goyal, Lyn-Li Lim
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Eastern Health, Melbourne
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1581056771392-8a90ddb76831.jpg" length="222057" type="image/jpeg" />
      <pubDate>Sun, 01 Nov 2020 07:40:02 GMT</pubDate>
      <guid>https://www.ncas-australia.org/urine-testing-and-antibiotic-prescribing-in-a-geriatric-in-patient-setting</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1581056771392-8a90ddb76831.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1581056771392-8a90ddb76831.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Nursing staff knowledge and attitudes regarding urinalysis practice</title>
      <link>https://www.ncas-australia.org/nursing-staff-knowledge-and-attitudes-regarding-urinalysis-practice</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Goyal+et+al_Nursing+staff+knowledge+and+attitudes+regarding+urinalysis+practice.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Antimicrobial Awareness Week 2020 – poster
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Nursing staff knowledge and
attitudes regarding urinalysis practice
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Nupur Goyal, Kathy Marshall, Jo Holt, Lyn-Li Lim
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Eastern Health, Melbourne
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1584521764592-48f33fe7e088.jpg" length="141736" type="image/jpeg" />
      <pubDate>Sun, 01 Nov 2020 07:29:30 GMT</pubDate>
      <guid>https://www.ncas-australia.org/nursing-staff-knowledge-and-attitudes-regarding-urinalysis-practice</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1584521764592-48f33fe7e088.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1584521764592-48f33fe7e088.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Gentamicin dosing advisor – optimising patient safety</title>
      <link>https://www.ncas-australia.org/gentamicin-dosing-advisor-optimising-patient-safety</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Furtula+et+al_Gentamicin+dosing+advisor.JPG"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Antimicrobial Awareness Week 2020 – poster
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Gentamicin dosing advisor – optimising patient safety
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Furtula D., Cheung L., Chubaty A., Adhikari S., Butina E.,Crawford S., Shum O., Wales E., Reid M.,Orr M., Nguyen D., Packham D., Li-Yan-Hui S., Su Y., Konecny P.
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          South Eastern Sydney Local Health District, Illawarra Shoalhaven Local Health District and Children Hospital Network (Randwick)
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1557825835-70d97c4aa567.jpg" length="104377" type="image/jpeg" />
      <pubDate>Sun, 01 Nov 2020 07:16:13 GMT</pubDate>
      <guid>https://www.ncas-australia.org/gentamicin-dosing-advisor-optimising-patient-safety</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1557825835-70d97c4aa567.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1557825835-70d97c4aa567.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Exploring the barriers and enablers to antimicrobial stewardship in rural health services</title>
      <link>https://www.ncas-australia.org/exploring-the-barriers-and-enablers-to-antimicrobial-stewardship-in-rural-health-services</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Ervin+et+al_AMS+project+poster+for+NCAS.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
                        
            Antimicrobial Awareness Week 2020 – poster
           
                      &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Exploring the barriers and enablers to antimicrobial stewardship in rural health services
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Kaye E. Ervin, Ka Chun Tse, Carol Reid, Elizabeth Smith
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          University of Melbourne
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1583863105926-cf273fa0915f.jpg" length="169366" type="image/jpeg" />
      <pubDate>Sun, 01 Nov 2020 07:06:21 GMT</pubDate>
      <guid>https://www.ncas-australia.org/exploring-the-barriers-and-enablers-to-antimicrobial-stewardship-in-rural-health-services</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1583863105926-cf273fa0915f.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1583863105926-cf273fa0915f.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Use of an online learning module to enhance clinical pharmacist contributions to antimicrobial stewardship</title>
      <link>https://www.ncas-australia.org/use-of-an-online-learning-module-to-enhance-clinical-pharmacist-contributions-to-antimicrobial-stewardship</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Brownridge+et+al_Use+of+an+online+learning+module+to+enhance+clinical+pharmacist+contributions+to+AMS.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
                        
            Antimicrobial Awareness Week 2020 - poster
           
                      &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Use of an online learning module to enhance clinical pharmacist contributions to antimicrobial stewardship
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          D Brownridge, A Livori
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Ballarat Health Services
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1588912914074-b93851ff14b8.jpg" length="124664" type="image/jpeg" />
      <pubDate>Sun, 01 Nov 2020 04:08:17 GMT</pubDate>
      <guid>https://www.ncas-australia.org/use-of-an-online-learning-module-to-enhance-clinical-pharmacist-contributions-to-antimicrobial-stewardship</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1588912914074-b93851ff14b8.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1588912914074-b93851ff14b8.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Synergistic ceftazidime and tobramycin combinations for clinical hypermutable Pseudomonas aeruginosa isolates</title>
      <link>https://www.ncas-australia.org/synergistic-ceftazidime-and-tobramycin-combinations-for-clinical-hypermutable-pseudomonas-aeruginosa-isolates</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Bilal+et+al_PKPD.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
                        
            Antimicrobial Awareness Week 2020 - poster
           
                      &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Synergistic ceftazidime and tobramycin combinations for clinical hypermutable
           
                      &#xD;
      &lt;i&gt;&#xD;
        
                        
            Pseudomonas aeruginosa
           
                      &#xD;
      &lt;/i&gt;&#xD;
      
                      
           isolates: An innovative dosing approach to enhance bacterial killing and mitigate resistance in a dynamic biofilm model
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Hajira Bilal, Phillip J. Bergen, Wee L. Lee, Antonio Oliver, Anton Y. Peleg, Roger L. Nation, Cornelia B. Landersdorfer
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Monash University
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1580281658460-2d1114999983.jpg" length="334729" type="image/jpeg" />
      <pubDate>Sun, 01 Nov 2020 03:45:47 GMT</pubDate>
      <guid>https://www.ncas-australia.org/synergistic-ceftazidime-and-tobramycin-combinations-for-clinical-hypermutable-pseudomonas-aeruginosa-isolates</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1580281658460-2d1114999983.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1580281658460-2d1114999983.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Bacteriophages targeting Acinetobacter baumannii capsule induce antimicrobial resensitisation</title>
      <link>https://www.ncas-australia.org/bacteriophages-targeting-acinetobacter-baumannii-capsule-induce-antimicrobial-resensitisation</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Altamirano+et+al_Bacteriophages+targeting+A+baumannii+capsule+induce+antimicrobial+resensitisation.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Antimicrobial Awareness Week 2020 - poster
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Bacteriophages targeting
           
                      &#xD;
      &lt;i&gt;&#xD;
        
                        
            Acinetobacter baumannii
           
                      &#xD;
      &lt;/i&gt;&#xD;
      
                      
           capsule induce
 antimicrobial resensitisation
          
                    &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Fernando Gordillo Altamirano, John H. Forsyth, Ruzeen Patwa, Xenia Kostoulias, Michael Trim, Dinesh Subedi, Stuart Archer, Faye C. Morris, Cody Oliveira, Luisa Kielty, Denis Korneev, Moira K. O’Bryan, Trevor J. Lithgow, Anton Y. Peleg, Jeremy J. Barr
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Monash University
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/bacteria-002-800x600.jpg" length="106915" type="image/jpeg" />
      <pubDate>Sun, 01 Nov 2020 03:25:13 GMT</pubDate>
      <guid>https://www.ncas-australia.org/bacteriophages-targeting-acinetobacter-baumannii-capsule-induce-antimicrobial-resensitisation</guid>
      <g-custom:tags type="string">AAW 2020 poster</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/bacteria-002-800x600.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/bacteria-002-800x600.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Identifying targets for improvement using a nationally standardised survey: Surgical antimicrobial prophylaxis in orthopaedic surgery</title>
      <link>https://www.ncas-australia.org/identifying-targets-for-improvement-using-a-nationally-standardised-survey-surgical-antimicrobial-prophylaxis-in-orthopedic-surgery</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Courtney E. Ierano, Karin Thursky, Caroline Marshall, Sonia Koning, Rodney James, Sandra Johnson, Nabeel Imam, Leon J. Worth and Trisha Peel 
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Background:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           Surgical antimicrobial prophylaxis (SAP) is commonly administered in orthopaedic procedures. Research regarding SAP appropriateness for specific orthopaedic procedures is limited and is required to facilitate targeted orthopaedic prescriber behaviour change.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Objectives:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           To describe SAP prescribing and appropriateness for orthopaedic procedures in Australian hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Design, setting, and participants:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           Multi-center, national, quality improvement study with retrospective analysis of data collected from Australian hospitals via Surgical National Antimicrobial Prescribing Survey (Surgical NAPS) audits from January 1, 2016, to April 15, 2019, were analysed.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Methods:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           Logistic regression identified hospital, patient and surgical factors associated with appropriateness. Adjusted appropriateness was calculated from the multivariable model. Additional sub-analyses were conducted on smaller subsets to calculate the adjusted appropriateness for specific orthopaedic procedures.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Results:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           In total, 140 facilities contributed to orthopaedic audits in the Surgical NAPS, including 4,032 orthopaedic surgical episodes and 6,709 prescribed doses. Overall appropriateness was low, 58.0% (n = 3,894). This differed for prescribed procedural (n = 3,978, 64.7%) and post-procedural doses (n = 2,731, 48.3%). The most common reasons for inappropriateness, when prophylaxis was required, was timing for procedural doses (50.9%) and duration for post-procedural prescriptions (49.8%). The adjusted appropriateness of each orthopaedic procedure group was low for procedural SAP (knee surgery, 54.1% to total knee joint replacement, 74.1%). The adjusted appropriateness for post-procedural prescription was also low (from hand surgery, 40.7%, to closed reduction fractures, 68.7%).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Conclusions: 
          &#xD;
    &lt;/b&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Orthopaedic surgical specialties demonstrated differences across procedural and post-procedural appropriateness. The metric of appropriateness identifies targets for quality improvement and is meaningful for clinicians. Targeted quality improvement projects for orthopaedic specialties need to be developed to support optimisation of antimicrobial use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Read more
           &#xD;
      &lt;a href="https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/identifying-targets-for-improvement-using-a-nationally-standardized-survey-surgical-antimicrobial-prophylaxis-in-orthopedic-surgery/B21407C725DF508C414FF5735F3A0871" target="_blank"&gt;&#xD;
        
            here
           &#xD;
      &lt;/a&gt;&#xD;
      
           . 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Citation:
           &#xD;
      &lt;/b&gt;&#xD;
      
           Ierano, C. E., Thursky, K., Marshall, C., Koning, S., James, R., Johnson, S., ... &amp;amp; Peel, T. (2020). Identifying targets for improvement using a nationally standardized survey: Surgical antimicrobial prophylaxis in orthopedic surgery. Infection Control &amp;amp; Hospital Epidemiology, 1-10. DOI:
           &#xD;
      &lt;a href="https://doi.org/10.1017/ice.2020.320" target="_blank"&gt;&#xD;
        
            https://doi.org/10.1017/ice.2020.320
           &#xD;
      &lt;/a&gt;&#xD;
      
           . 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551190822-a9333d879b1f.jpg" length="209506" type="image/jpeg" />
      <pubDate>Tue, 25 Aug 2020 01:04:41 GMT</pubDate>
      <guid>https://www.ncas-australia.org/identifying-targets-for-improvement-using-a-nationally-standardised-survey-surgical-antimicrobial-prophylaxis-in-orthopedic-surgery</guid>
      <g-custom:tags type="string">Surgical,Hospital paper,NCAS publications,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551190822-a9333d879b1f.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551190822-a9333d879b1f.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Use of cefovecin in dogs and cats attending first-opinion veterinary practices in Australia</title>
      <link>https://www.ncas-australia.org/use-of-cefovecin-in-dogs-and-cats-attending-first-opinion-veterinary-practices-in-australia</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Laura Hardefeldt, Brian Hur, Karin Verspoor, Timothy Baldwin, Kirsten E Bailey, Ri Scarborough, Suzanna Richards, Helen Billman-Jacobe, Glenn Francis Browning and James Gilkerson
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Background:
          &#xD;
    &lt;/b&gt;&#xD;
    
          Cefovecin is a long-acting third-generation cephalosporin commonly used in veterinary medicine. Third-generation cephalosporins are critically important antimicrobials that should only be used after culture and susceptibility testing. The authors describe the common indications for cefovecin use in dogs and cats, and the frequency of culture and susceptibility testing.
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Materials and methods:
          &#xD;
    &lt;/b&gt;&#xD;
    
          A cross-sectional study was performed using clinical records extracted from VetCompass Australia. A previously described method was used to identify records containing cefovecin. The reason for cefovecin use was annotated in situ in each consultation text.
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Results:
          &#xD;
    &lt;/b&gt;&#xD;
    
          Over a six-month period (February and September 2018), 5180 (0.4 per cent) consultations involved cefovecin administration, of which 151 were excluded. Cats were administered cefovecin more frequently than dogs (1.9 per cent of cat consultations and 0.1 per cent of dog consultations). The most common reasons for cefovecin administration to cats were cat fight injuries and abscesses (28 per cent) and dermatitis (13 per cent). For dogs, the most common reasons for cefovecin administration were surgical prophylaxis (24 per cent) and dermatitis (19 per cent). Culture and susceptibility testing were reported in 16 cases (0.3 per cent).
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Conclusion:
          &#xD;
    &lt;/b&gt;&#xD;
    
          Cefovecin is used in many scenarios in dogs and cats where antimicrobials may be either not indicated or where an antimicrobial of lower importance to human health is recommended.
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Read more
          &#xD;
    &lt;a href="https://veterinaryrecord.bmj.com/content/early/2020/08/20/vr.105997" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          . 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Citation:
          &#xD;
    &lt;/b&gt;&#xD;
    
          Hardefeldt, L., Hur, B., Verspoor, K., Baldwin, T., Bailey, K. E., Scarborough, R., ... &amp;amp; Gilkerson, J. (2020). Use of cefovecin in dogs and cats attending first-opinion veterinary practices in Australia. Veterinary Record. DOI:
          &#xD;
    &lt;a href="http://dx.doi.org/10.1136/vr.105997" target="_blank"&gt;&#xD;
      
           http://dx.doi.org/10.1136/vr.105997
          &#xD;
    &lt;/a&gt;&#xD;
    
          . 
         &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1585849847025-256a1488e653.jpg" length="180889" type="image/jpeg" />
      <pubDate>Fri, 21 Aug 2020 00:56:53 GMT</pubDate>
      <guid>https://www.ncas-australia.org/use-of-cefovecin-in-dogs-and-cats-attending-first-opinion-veterinary-practices-in-australia</guid>
      <g-custom:tags type="string">Companion animal,NCAS publications,Veterinary,Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1585849847025-256a1488e653.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1585849847025-256a1488e653.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Assessing patient understanding of their antimicrobial treatment: how are we doing and how might we improve?</title>
      <link>https://www.ncas-australia.org/assessing-patient-understanding-of-their-antimicrobial-treatment-how-are-we-doing-and-how-might-we-improve</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Kim Yeoh, 
           &#xD;
      &lt;span&gt;&#xD;
        
            Catherine George, 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Arjun Rajkhowa and 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Kirsty Buising
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Highlights:
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;ul&gt;&#xD;
      &lt;li&gt;&#xD;
        &lt;span&gt;&#xD;
          
             This study identified gaps in communication with patients regarding in-hospital antimicrobial therapy.
            &#xD;
        &lt;/span&gt;&#xD;
      &lt;/li&gt;&#xD;
      &lt;li&gt;&#xD;
        &lt;span&gt;&#xD;
          
             There is a need for development and delivery of local quality improvement activities to address this gap.
            &#xD;
        &lt;/span&gt;&#xD;
      &lt;/li&gt;&#xD;
      &lt;li&gt;&#xD;
        &lt;span&gt;&#xD;
          
             Patients would like more information regarding their antimicrobials.
            &#xD;
        &lt;/span&gt;&#xD;
      &lt;/li&gt;&#xD;
      &lt;li&gt;&#xD;
        &lt;span&gt;&#xD;
          
             The value of written information about antimicrobial therapy was demonstrated.
            &#xD;
        &lt;/span&gt;&#xD;
      &lt;/li&gt;&#xD;
    &lt;/ul&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Background: 
           &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The Antimicrobial Stewardship Clinical Care Standard states that patients should receive certain information about their antimicrobial therapy. How well the patient communication recommendations of the standard are followed in clinical practice is not well established. The aim of this pilot quality improvement study was to assess current practices around communication with hospitalised patients about their antimicrobial therapy, to determine compliance with current recommendations, and develop and implement quality improvement actions focused on patient communication for antimicrobial stewardship in Australia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Methods:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           Adult inpatients receiving one or more antimicrobials for greater than 72 h were recruited. A survey was conducted to assess rates of compliance with requirements to inform patients about the indication, duration and potential side effects of current antimicrobial therapy; modes of delivery of information; and rates of patient satisfaction with the information provided. A paper-based survey was conducted on the general medical, infectious diseases, geriatric evaluation and management, and rehabilitation wards in a 500-bed tertiary Australian hospital. A sample size of 50 was determined as adequate for a baseline analysis of patient communication practices and the development of quality improvement resources and actions. Responses to categorical questions were analysed quantitatively, with additional feedback from patients was collated and analysed qualitatively.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Results:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           A total of 54 patients were surveyed. A majority (83%) of patients had been informed that they were taking antimicrobials, and, of these, 96% said they knew the indication, 18% were informed of potential side effects, and 36% knew the duration. Only 22% were informed of the review plan and 27% knew if antimicrobials would be continued on discharge. Written information was given to 11% of patients. Over half (62%) of patients either wanted more information or had concerns about their antimicrobial therapy. Patients reported difficulty in obtaining information. Fifty-eight percent of patients received antimicrobial information from doctors, 13% from nurses and 12% from pharmacists.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Conclusions: 
          &#xD;
    &lt;/b&gt;&#xD;
    &lt;span&gt;&#xD;
      
           This study identified gaps in communication with patients regarding in-hospital antimicrobial therapy, and highlighted the need for development and delivery of local quality improvement activities to address this gap.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Keywords:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           Antimicrobial stewardship, p
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           atient education, c
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           linical care standard
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://doi.org/10.1016/j.idh.2020.07.003" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          .
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Citation:
           &#xD;
      &lt;/b&gt;&#xD;
      
           Yeoh, K., George, C., Rajkhowa, A., &amp;amp; Buising, K. (2020). Assessing patient understanding of their antimicrobial treatment: How are we doing and how might we improve? Infection, Disease &amp;amp; Health. DOI:
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.idh.2020.07.003" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1016/j.idh.2020.07.003
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           . 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576766125468-a5d48274c5b4.jpg" length="263781" type="image/jpeg" />
      <pubDate>Tue, 11 Aug 2020 05:36:29 GMT</pubDate>
      <guid>https://www.ncas-australia.org/assessing-patient-understanding-of-their-antimicrobial-treatment-how-are-we-doing-and-how-might-we-improve</guid>
      <g-custom:tags type="string">Hospital paper,NCAS publications,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576766125468-a5d48274c5b4.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576766125468-a5d48274c5b4.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial stewardship in general practice: a scoping review of the component parts</title>
      <link>https://www.ncas-australia.org/antimicrobial-stewardship-in-general-practice-a-scoping-review-of-the-component-parts</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Lesley Hawes, Kirsty Buising and Danielle Mazza
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          There is no published health-system-wide framework to guide antimicrobial stewardship (AMS) in general practice. The aim of this scoping review was to identify the component parts necessary to inform a framework to guide AMS in general practice. Six databases and nine websites were searched. The sixteen papers included were those that reported on AMS in general practice in a country where antibiotics were available by prescription from a registered provider. Six multidimensional components were identified: 1. Governance, including a national action plan with accountability, prescriber accreditation, and practice level policies. 2. Education of general practitioners (GPs) and the public about AMS and antimicrobial resistance (AMR). 3. Consultation support, including decision support with patient information resources and prescribing guidelines. 4. Pharmacist and nurse involvement. 5. Monitoring of antibiotic prescribing and AMR with feedback to GPs. 6. Research into gaps in AMS and AMR evidence with translation into practice. This framework for AMS in general practice identifies health-system-wide components to support GPs to improve the quality of antibiotic prescribing. It may assist in the development and evaluation of AMS interventions in general practice. It also provides a guide to components for inclusion in reports on AMS interventions. 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Keywords:
           &#xD;
      &lt;/b&gt;&#xD;
      
           general practice; ambulatory care; general practitioner; family physician; antimicrobial stewardship; antibiotics; antibiotic prescriptions; health policy; framework
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://www.mdpi.com/2079-6382/9/8/498" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          . 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Citation:
          &#xD;
    &lt;/b&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Hawes, L., Buising, K., &amp;amp; Mazza, D. (2020). Antimicrobial stewardship in general practice: A scoping review of the component parts. Antibiotics, 9(8), 498. DOI:
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.3390/antibiotics9080498" target="_blank"&gt;&#xD;
      
           https://doi.org/10.3390/antibiotics9080498
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           . 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576765974102-b756026ecee3.jpg" length="153232" type="image/jpeg" />
      <pubDate>Sun, 09 Aug 2020 05:50:44 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-stewardship-in-general-practice-a-scoping-review-of-the-component-parts</guid>
      <g-custom:tags type="string">Community paper,NCAS publications,Community</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576765974102-b756026ecee3.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576765974102-b756026ecee3.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Measuring antimicrobial prescribing quality in outpatient parenteral antimicrobial therapy (OPAT) services: development and evaluation of a dedicated national antimicrobial prescribing survey</title>
      <link>https://www.ncas-australia.org/measuring-antimicrobial-prescribing-quality-in-outpatient-parenteral-antimicrobial-therapy-opat-services-development-and-evaluation-of-a-dedicated-national-antimicrobial-prescribing-survey</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           N. Deborah Friedman, Seok Lim, Rodney James, Robyn Ingram, Mary O’Reilly, James Pollard, Sonia Koning, Catherine George... Kirsty Buising
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Background:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           Antimicrobial stewardship programmes are important in driving safety and quality of antimicrobial prescribing. The National Antimicrobial Prescribing Survey (NAPS) is a point-prevalence audit of inpatient antimicrobial prescribing in Australian hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Objectives:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           To design and adapt the NAPS tool for use in the outpatient parenteral antimicrobial therapy (OPAT) and hospital-in-the-home (HITH) setting.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Methods: 
          &#xD;
    &lt;/b&gt;&#xD;
    &lt;span&gt;&#xD;
      
           An inter-disciplinary working group with expertise in OPAT and HITH services was established to adapt the NAPS template for use in the OPAT setting—called HITH-NAPS. This was initially trialled in 5 HITH services, subsequently adapted following participant feedback, then offered nationally to 50 services in 2017.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Results:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           There were 1154 prescriptions for 715 patients audited via the HITH-NAPS. The most common antimicrobials prescribed were cefazolin (22%), flucloxacillin (12%), piperacillin/tazobactam (10%) and ceftriaxone (10%). The most common infections treated were cellulitis (30%) and respiratory tract infections (14%). Eighty-seven percent of prescriptions were assessed as appropriate, 11% inappropriate and 2% not assessable. Prolonged durations of antimicrobials and unnecessarily broad-spectrum antibiotics were used in 9% of prescriptions.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Conclusions:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           The HITH-NAPS pilot project revealed that auditing of this type is feasible in HITH. It showed that antibiotic use in these HITH services was generally appropriate, but there are some areas for improvement. A national OPAT/HITH-NAPS can facilitate benchmarking between services, identify potentially inappropriate prescribing and help guide quality improvement.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://academic.oup.com/jacamr/article/2/3/dlaa058/5881852" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          . 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Citation:
           &#xD;
      &lt;/b&gt;&#xD;
      
           Friedman, N. D., Lim, S. M., James, R., Ingram, R., O’Reilly, M., Pollard, J. G. D., . . . Buising, K. L. (2020). Measuring antimicrobial prescribing quality in outpatient parenteral antimicrobial therapy (OPAT) services: Development and evaluation of a dedicated national antimicrobial prescribing survey. JAC-Antimicrobial Resistance, 2(3). DOI:
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1093/jacamr/dlaa058" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1093/jacamr/dlaa058
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           . 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1524067217094-584e94e61106.jpg" length="188438" type="image/jpeg" />
      <pubDate>Thu, 06 Aug 2020 06:02:50 GMT</pubDate>
      <guid>https://www.ncas-australia.org/measuring-antimicrobial-prescribing-quality-in-outpatient-parenteral-antimicrobial-therapy-opat-services-development-and-evaluation-of-a-dedicated-national-antimicrobial-prescribing-survey</guid>
      <g-custom:tags type="string">Hospital paper,NCAS publications,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1524067217094-584e94e61106.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1524067217094-584e94e61106.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial stewardship in remote primary healthcare across northern Australia</title>
      <link>https://www.ncas-australia.org/antimicrobial-stewardship-in-remote-primary-healthcare-across-northern-australia</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Will Cuningham, Lorraine Anderson, Asha C. Bowen, Kirsty Buising, Christine Connors, Kathryn Daveson, Joanna Martin, Stacey McNamara, Bhavini Patel, Rodney James, John Shanks, Kerr Wright, Trent Yarwood, Steven Tong and Jodie McVernon​
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Background:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           The high burden of infectious disease and associated antimicrobial use likely contribute to the emergence of antimicrobial resistance in remote Australian Aboriginal communities. We aimed to develop and apply context-specific tools to audit antimicrobial use in the remote primary healthcare setting.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Methods:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           We adapted the General Practice version of the National Antimicrobial Prescribing Survey (GP NAPS) tool to audit antimicrobial use over 2–3 weeks in 15 remote primary healthcare clinics across the Kimberley region of Western Australia (03/2018–06/2018), Top End of the Northern Territory (08/2017–09/2017) and far north Queensland (05/2018–06/2018). At each clinic we reviewed consecutive clinic presentations until 30 presentations where antimicrobials had been used were included in the audit. Data recorded included the antimicrobials used, indications and treating health professional. We assessed the appropriateness of antimicrobial use and functionality of the tool.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Results:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           We audited the use of 668 antimicrobials. Skin and soft tissue infections were the dominant treatment indications (WA: 35%; NT: 29%; QLD: 40%). Compared with other settings in Australia, narrow-spectrum antimicrobials like benzathine benzylpenicillin were commonly given and the appropriateness of use was high (WA: 91%; NT: 82%; QLD: 65%). While the audit was informative, non-integration with practice software made the process manually intensive.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Conclusions: 
          &#xD;
    &lt;/b&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Patterns of antimicrobial use in remote primary care are different from other settings in Australia. The adapted GP NAPS tool functioned well in this pilot study and has the potential for integration into clinical care. Regular stewardship audits would be facilitated by improved data extraction systems.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://peerj.com/articles/9409/" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          .
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Citation:
           &#xD;
      &lt;/b&gt;&#xD;
      
           Cuningham, W., Anderson, L., Bowen, A., Buising K., Connors, C., Daveson, K., Martin, J., McNamara, S., Patel, B., James, R., Shanks, J., Wright, K., Yarwood, T., Tong, S., McVernon, J. (2020). Antimicrobial stewardship in remote primary healthcare across northern Australia. PeerJ 8:e9409. DOI:
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.7717/peerj.9409" target="_blank"&gt;&#xD;
      
           https://doi.org/10.7717/peerj.9409
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           . 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1519789831942-bda53958cecc.jpg" length="236621" type="image/jpeg" />
      <pubDate>Wed, 22 Jul 2020 06:08:12 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-stewardship-in-remote-primary-healthcare-across-northern-australia</guid>
      <g-custom:tags type="string">Community paper,NCAS publications,Community</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1519789831942-bda53958cecc.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1519789831942-bda53958cecc.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Factors associated with antimicrobial choice for surgical prophylaxis in Australia</title>
      <link>https://www.ncas-australia.org/factors-associated-with-antimicrobial-choice-for-surgical-prophylaxis-in-australia</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Courtney Ierano, Karin Thursky, Trisha Peel, Sonia Koning, Rod James, Sandra Johnson, Lisa Hall, Leon J Worth and Caroline Marshall
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Background:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           Cefazolin is the most commonly recommended antimicrobial for surgical antimicrobial prophylaxis (SAP). However, the Australian Surgical National Antimicrobial Prescribing Survey revealed a wide range of antimicrobials prescribed for SAP. Inappropriate use of broad-spectrum antimicrobials is associated with increased patient harm and is a posited driver for antimicrobial resistance.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Objectives:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           To describe patient, hospital and surgical factors that are associated with appropriateness of the top five prescribed antimicrobials/antimicrobial classes for procedural SAP.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Methods:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           All procedures audited from 18 April 2016 to 15 April 2019 in the Surgical National Antimicrobial Prescribing Survey were included in the analysis. Estimated marginal means analyses accounted for a range of variables and calculated a rate of adjusted appropriateness (AA). Subanalyses of the top five audited antimicrobials/antimicrobial classes identified associations between variables and appropriateness.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Results:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           A total of 12 419 surgical episodes with 14 150 prescribed initial procedural doses were included for analysis. When procedural SAP was prescribed, appropriateness was low (57.7%). Allergy status, surgical procedure group and the presence of prosthetic material were positively associated with cefazolin and aminoglycoside appropriateness (P &amp;lt; 0.05). There were no significant positive associations with glycopeptides and third/fourth-generation cephalosporins. The use of broad-spectrum antimicrobials was the most common reason for inappropriate choice (67.9% of metronidazole to 83.3% of third/fourth-generation cephalosporin prescriptions).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Conclusions:
          &#xD;
    &lt;/b&gt;&#xD;
    
           
          &#xD;
    &lt;span&gt;&#xD;
      
           Various factors influence appropriateness of procedural SAP choice. Identification of these factors provides targets for antimicrobial stewardship interventions, e.g. procedures where surgeons are regularly prescribing broad-spectrum SAP. These can be tailored to address local hospital prescribing practices.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://doi.org/10.1093/jacamr/dlaa036" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          . 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Citation:
           &#xD;
      &lt;/b&gt;&#xD;
      
           Ierano, C., Thursky, K., Peel, T., Koning, S., James, R., Johnson, S., . . . Marshall, C. (2020). Factors associated with antimicrobial choice for surgical prophylaxis in Australia. JAC-Antimicrobial Resistance, 2(3). DOI:
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1093/jacamr/dlaa036" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1093/jacamr/dlaa036
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           . 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551190822-a9333d879b1f.jpg" length="209506" type="image/jpeg" />
      <pubDate>Sat, 18 Jul 2020 05:45:14 GMT</pubDate>
      <guid>https://www.ncas-australia.org/factors-associated-with-antimicrobial-choice-for-surgical-prophylaxis-in-australia</guid>
      <g-custom:tags type="string">Surgical,Hospital paper,NCAS publications,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551190822-a9333d879b1f.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551190822-a9333d879b1f.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Domain adaptation and instance selection for disease syndrome classification over veterinary clinical notes</title>
      <link>https://www.ncas-australia.org/domain-adaptation-and-instance-selection-for-disease-syndrome-classification-over-veterinary-clinical-notes</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Brian Hur, Timothy Baldwin, Karin Verspoor, 
           &#xD;
      &lt;span&gt;&#xD;
        
            Laura Hardefeldt and James Gilkerson
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Identifying the reasons for antibiotic administration in veterinary records is a critical component of understanding antimicrobial usage patterns. This informs antimicrobial stewardship 
          &#xD;
    &lt;span&gt;&#xD;
      
           programs designed to fight antimicrobial resistance, a major health crisis affecting both humans and animals in which veterinarians have 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           an important role to play. We propose a document classification approach to determine the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           reason for administration of a given drug, with 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           particular focus on domain adaptation from 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           one drug to another, and instance selection to 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           minimise annotation effort. 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Read the full paper
           &#xD;
      &lt;a href="https://www.aclweb.org/anthology/2020.bionlp-1.17.pdf" target="_blank"&gt;&#xD;
        
            here
           &#xD;
      &lt;/a&gt;&#xD;
      
           . 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;b&gt;&#xD;
    &lt;div&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Citation
           &#xD;
      &lt;/b&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Hur, B., Baldwin, T., Verspoor, K., Hardefeldt, L., &amp;amp; Gilkerson, J. (2020). Domain adaptation and instance selection for disease syndrome classification over veterinary clinical notes. Paper presented at the Proceedings of the 19th SIGBioMed Workshop on Biomedical Language Processing. DOI:
            &#xD;
        &lt;a href="https://www.aclweb.org/anthology/2020.bionlp-1.17.pdf" target="_blank"&gt;&#xD;
          
             https://www.aclweb.org/anthology/2020.bionlp-1.17.pdf
            &#xD;
        &lt;/a&gt;&#xD;
        
            . 
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/div&gt;&#xD;
  &lt;/b&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1557562645-4eee56b29bc1.jpg" length="569343" type="image/jpeg" />
      <pubDate>Thu, 09 Jul 2020 05:22:10 GMT</pubDate>
      <guid>https://www.ncas-australia.org/domain-adaptation-and-instance-selection-for-disease-syndrome-classification-over-veterinary-clinical-notes</guid>
      <g-custom:tags type="string">NCAS publications,Veterinary,Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1557562645-4eee56b29bc1.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1557562645-4eee56b29bc1.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia</title>
      <link>https://www.ncas-australia.org/re-evaluating-and-recalibrating-predictors-of-bacterial-infection-in-children-with-cancer-and-febrile-neutropenia</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Gabrielle M Haeusler, 
           &#xD;
      &lt;span&gt;&#xD;
        
            Robert Phillips, 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Monica A. Slavin, 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Franz E Babl, 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Richard De Abreu Lourenco, 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Francoise Mechinaud and 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Karin A. Thursky 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            on behalf of theAustralian PICNICC study group and the PREDICT network
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Background
          &#xD;
    &lt;/b&gt;&#xD;
    
          : 
          &#xD;
    &lt;span&gt;&#xD;
      
           Numerous paediatric febrile neutropenia (FN) clinical decision rules (CDRs) have been derived. Validation studies show reduced performance in external settings. We evaluated the association between variables common across published FN CDRs and bacterial infection and recalibrated existing CDRs using these data.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/b&gt;&#xD;
    
          : 
          &#xD;
    &lt;span&gt;&#xD;
      
           Prospective data from the Australian-PICNICC study which enrolled 858 FN episodes in children with cancer were used. Variables shown to be significant predictors of infection or adverse outcome in &amp;gt;1 CDR were analysed using multivariable logistic regression. Recalibration included re-evaluation of beta-coefficients (logistic model) or recursive-partition analysis (tree-based models).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Findings
          &#xD;
    &lt;/b&gt;&#xD;
    
          : 
          &#xD;
    &lt;span&gt;&#xD;
      
           Twenty-five unique variables were identified across 17 FN CDRs. Fourteen were included in &amp;gt;1 CDR and 10 were analysed in our dataset. On univariate analysis, location, temperature, hypotension, rigors, severely unwell and decreasing platelets, white cell count, neutrophil count and monocyte count were significantly associated with bacterial infection. On multivariable analysis, decreasing platelets, increasing temperature and the appearance of being clinically unwell remained significantly associated. Five rules were recalibrated. Across all rules, recalibration increased the AUC-ROC and low-risk yield as compared to non-recalibrated data. For the SPOG-adverse event CDR, recalibration also increased sensitivity and specificity and external validation showed reproducibility.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Interpretation
          &#xD;
    &lt;/b&gt;&#xD;
    
          : 
          &#xD;
    &lt;span&gt;&#xD;
      
           Degree of marrow suppression (low platelets), features of inflammation (temperature) and clinical judgement (severely unwell) have been consistently shown to predict infection in children with FN. Recalibration of existing CDRs is a novel way to improve diagnostic performance of CDRs and maintain relevance over time.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Keywords
          &#xD;
    &lt;/b&gt;&#xD;
    
          : Febrile neutropenia, r
          &#xD;
    &lt;span&gt;&#xD;
      
           isk stratification, c
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           linical decision rule, r
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ecalibration, c
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           hild
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://doi.org/10.1016/j.eclinm.2020.100394" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          . 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Citation
           &#xD;
      &lt;/b&gt;&#xD;
      
           : Haeusler, G. M., Phillips, R., Slavin, M. A., Babl, F. E., De Abreu Lourenco, R., Mechinaud, F., &amp;amp; Thursky, K. A. (2020). Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia. EClinicalMedicine, 100394. DOI:
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.eclinm.2020.100394" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1016/j.eclinm.2020.100394
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .  
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576089275776-b6cd5deabdad.jpg" length="241552" type="image/jpeg" />
      <pubDate>Mon, 15 Jun 2020 05:29:39 GMT</pubDate>
      <guid>https://www.ncas-australia.org/re-evaluating-and-recalibrating-predictors-of-bacterial-infection-in-children-with-cancer-and-febrile-neutropenia</guid>
      <g-custom:tags type="string">Hospital paper,NCAS publications,Hospital,Paediatrics</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576089275776-b6cd5deabdad.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576089275776-b6cd5deabdad.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Developing a clinical decision support tool for appropriate antibiotic prescribing in Australian general practice: a simulation study</title>
      <link>https://www.ncas-australia.org/developing-a-clinical-decision-support-tool-for-appropriate-antibiotic-prescribing-in-australian-general-practice-a-simulation-study</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Jo-Anne Manski-Nankervis, Ruby Biezen, Karin Thursky, Douglas Boyle, Malcolm Clark, Sean Lo and Kirsty Buising
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Background
          &#xD;
    &lt;/b&gt;&#xD;
    
          : Inappropriate antibiotic prescribing can lead to antimicrobial resistance and drug side effects. Tools that assist general practitioners (GPs) in prescribing decisions may help to optimise prescribing. The aim of this study was to explore the use, acceptability, and feasibility of a clinical decision support (CDS) tool that incorporates evidence-based guidelines and consumer information that integrates with the electronic medical record (EMR). 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/b&gt;&#xD;
    
          : Eight GPs completed an interview and brief survey after participating in 2 simulated consultations. The survey consisted of demographic questions, perception of realism and representativeness of consultations, Post-Study System Usability Questionnaire, and System Usability Scale. Qualitative data were analysed using framework analysis. Video data were reviewed, with length of consultation and time spent using the CDS tool documented. 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Results
          &#xD;
    &lt;/b&gt;&#xD;
    
          : Survey responses indicated that all GPs thought the consultations were “real” and representative of real-life consultations; 7 of 8 GPs were satisfied with usability of the tool. Key qualitative findings included that the tool assisted with clinical decision making and informed appropriate antibiotic prescribing. Accessibility and ease of use, including content (guideline and patient education resources), layout, and format, were key factors that determined whether GPs said that they would access the tool in everyday practice. Integration of the tool at multiple sites within the EMR facilitated access to guidelines and assisted in ensuring that the tool fit the clinical workflow. 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Conclusion
          &#xD;
    &lt;/b&gt;&#xD;
    
          : Our CDS tool was acceptable to GPs. Key features required for the tool were easy navigation, clear and useful guideline content, ability to fit into the clinical workflow, and incorporation into the EMR. Piloting of the tool in general practices to assess the impact and feasibility of use in real-world consultations will now be undertaken.
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Keywords
          &#xD;
    &lt;/b&gt;&#xD;
    
          : antibiotics, clinical decision support, clinical information system, electronic medical record, general practice, guidelines, prescribing, primary care. 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://doi.org/10.1177/0272989X20926136" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          . 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/b&gt;&#xD;
    
          : Manski-Nankervis, J.-A., Biezen, R., Thursky, K., Boyle, D., Clark, M., Lo, S., &amp;amp; Buising, K. (2020). Developing a clinical decision support tool for appropriate antibiotic prescribing in Australian general practice: A simulation study. Medical Decision Making. DOI:
          &#xD;
    &lt;a href="https://doi.org/10.1177/0272989X20926136" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1177/0272989X20926136
          &#xD;
    &lt;/a&gt;&#xD;
    
          .  
         &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1516321318423-f06f85e504b3.jpg" length="251348" type="image/jpeg" />
      <pubDate>Mon, 08 Jun 2020 05:06:30 GMT</pubDate>
      <guid>https://www.ncas-australia.org/developing-a-clinical-decision-support-tool-for-appropriate-antibiotic-prescribing-in-australian-general-practice-a-simulation-study</guid>
      <g-custom:tags type="string">Community paper,NCAS publications,Aged care,GP,Aged care paper,Community</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1516321318423-f06f85e504b3.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1516321318423-f06f85e504b3.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>A nation-wide survey of Australian general practitioners on antimicrobial stewardship: awareness, uptake, collaboration with pharmacists and improvement strategies</title>
      <link>https://www.ncas-australia.org/a-nation-wide-survey-of-australian-general-practitioners-on-antimicrobial-stewardship-awareness-uptake-collaboration-with-pharmacists-and-improvement-strategies</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Sajal Saha, David Kong, Karin Thursky and Danielle Mazza
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Implementing antimicrobial stewardship (AMS) programs is central to optimising antimicrobial use in primary care. This study aims to assess general practitioners’ (GPs’) awareness of AMS, uptake of AMS strategies, attitudes towards GP-pharmacist collaboration in AMS and future AMS improvement strategies. A paper-based survey of nationally representative GPs across Australia was conducted in 2019. Of 386 respondent GPs, 68.9% were familiar with AMS. Respondents most frequently used the Therapeutic Guidelines (TG) (83.2%, 321/385) and delayed antimicrobial prescribing (72.2%, 278/385) strategies, whereas few utilised point-of-care tests (18.4%, 71/382), patient information leaflets (20.2%, 78/384), peer prescribing reports (15.5%, 60/384) and audit and feedback (9.8%, 38/384). GPs were receptive to pharmacists’ recommendations on the choice (50.5%, 192/381) and dose (63%, 241/382) of antimicrobials, and more than 60% (235/381) supported a policy fostering increased GP-pharmacist collaboration. Most GPs agreed to have AMS training (72%, 278/386), integration of electronic TG (eTG) with prescribing software (88.3%, 341/386) and policies limiting the prescribing of selected antimicrobials (74.4%, 287/386) in the future. Conclusively, GPs are aware of the importance of judicious antimicrobial prescribing but indicated inadequate uptake of evidence-based AMS strategies. The majority of GPs support GP-pharmacist collaborative AMS approaches to optimising antimicrobial use. Developing a feasible GP-pharmacist collaborative AMS implementation model and facilitating AMS resources and training could foster AMS activities in primary care.
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Keywords
          &#xD;
    &lt;/b&gt;&#xD;
    
          : antimicrobial stewardship; general practitioners; GP-pharmacist collaboration; survey; primary care. 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://www.mdpi.com/2079-6382/9/6/310" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          . 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Citation
           &#xD;
      &lt;/b&gt;&#xD;
      
           : Saha, S.K., Kong, D.C., Thursky, K., Mazza, D. (2020). A nationwide survey of Australian general practitioners on antimicrobial stewardship: Awareness, uptake, collaboration with pharmacists and improvement strategies. Antibiotics, 9, 310. DOI:
           &#xD;
      &lt;a href="https://doi.org/10.3390/antibiotics9060310" target="_blank"&gt;&#xD;
        
            https://doi.org/10.3390/antibiotics9060310
           &#xD;
      &lt;/a&gt;&#xD;
      
           .  
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1547489432-cf93fa6c71ee.jpg" length="123987" type="image/jpeg" />
      <pubDate>Fri, 05 Jun 2020 04:52:28 GMT</pubDate>
      <guid>https://www.ncas-australia.org/a-nation-wide-survey-of-australian-general-practitioners-on-antimicrobial-stewardship-awareness-uptake-collaboration-with-pharmacists-and-improvement-strategies</guid>
      <g-custom:tags type="string">Community paper,NCAS publications,Aged care,GP,Aged care paper,Primary care,Community</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1547489432-cf93fa6c71ee.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1547489432-cf93fa6c71ee.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antibiotic prescribing in surgery: a clinically and socially complex problem in Australia</title>
      <link>https://www.ncas-australia.org/antibiotic-prescribing-in-surgery-a-clinically-and-socially-complex-problem-in-australia</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Courtney Ierano, 
           &#xD;
      &lt;span&gt;&#xD;
        
            Arjun Rajkhowa, 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Trisha Peel, 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Caroline Marshall, 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Darshini Ayton and 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Karin Thursky
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Highlights
           &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;ul&gt;&#xD;
      &lt;li&gt;&#xD;
        &lt;span&gt;&#xD;
          
             Antimicrobials for surgical prophylaxis are poorly prescribed in Australian hospitals.
            &#xD;
        &lt;/span&gt;&#xD;
      &lt;/li&gt;&#xD;
      &lt;li&gt;&#xD;
        &lt;span&gt;&#xD;
          
             Quantitative research has identified clinical issues associated with problematic antimicrobial use in surgery.
            &#xD;
        &lt;/span&gt;&#xD;
      &lt;/li&gt;&#xD;
      &lt;li&gt;&#xD;
        &lt;span&gt;&#xD;
          
             Qualitative research has identified barriers and enablers to appropriate antimicrobial prescribing.
            &#xD;
        &lt;/span&gt;&#xD;
      &lt;/li&gt;&#xD;
      &lt;li&gt;&#xD;
        &lt;span&gt;&#xD;
          
             Australia lacks a national surveillance program for surgical site complications to support prescriber behaviour change.
            &#xD;
        &lt;/span&gt;&#xD;
      &lt;/li&gt;&#xD;
    &lt;/ul&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;b&gt;&#xD;
        
            Abstract
           &#xD;
      &lt;/b&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Surgical prophylaxis is a common indication for antimicrobial use in Australian hospitals with demonstrated poor rates of appropriateness. Ongoing analysis of the Surgical National Antimicrobial Prescribing Survey and exploration of influences on antimicrobial prescribing decisions can help identify clinical and behavioural issues that contribute to problematic antimicrobial use. Triangulation of quantitative and qualitiatve data supports the development of surgical antimicrobial stewardship, i.e., quality improvement initiatives for the optimisation of surgical antimicrobial prophylaxis. Such initiatives should be developed and implemented at both local and national levels to ensure that they remain effective and sustainable.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Read the full paper 
          &#xD;
    &lt;a href="https://www.idhjournal.com.au/article/S2468-0451(20)30026-2/pdf" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          . 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/b&gt;&#xD;
    
          : Ierano, C., Rajkhowa, A., Peel, T., Marshall, C., Ayton, D., &amp;amp; Thursky, K. (2020). Antibiotic prescribing in surgery: A clinically and socially complex problem in Australia. Infection, Disease &amp;amp; Health. DOI:
          &#xD;
    &lt;a href="https://doi.org/10.1016/j.idh.2020.04.004" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1016/j.idh.2020.04.004
          &#xD;
    &lt;/a&gt;&#xD;
    
          . 
         &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1571772996211-2f02c9727629.jpg" length="129824" type="image/jpeg" />
      <pubDate>Mon, 18 May 2020 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antibiotic-prescribing-in-surgery-a-clinically-and-socially-complex-problem-in-australia</guid>
      <g-custom:tags type="string">Surgical,Hospital paper,NCAS publications,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1571772996211-2f02c9727629.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1571772996211-2f02c9727629.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>The implementation challenges of undertaking national antimicrobial usage surveillance</title>
      <link>https://www.ncas-australia.org/the-implementation-challenges-of-undertaking-national-antimicrobial-usage-surveillance</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Karin Thursky
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Excerpt
          &#xD;
    &lt;/b&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Understanding how and why antimicrobials are used in humans and animals, and the relationship between usage and the emergence of antimicrobial resistance (AMR), is a fundamental requirement for addressing the global challenge of AMR. Surveillance of antimicrobial usage (of both quantity and quality) is a core element of antimicrobial stewardship programs, which aim to improve the appropriateness of antimicrobial use. Understanding patterns of use, and facilitating benchmarking between hospitals (or general practices, aged care homes or farms) can be helpful in identifying targets for action. Yet, despite awareness of these prerequisites, we have not been able to obtain the necessary data in many settings and contexts, and there continue to be major implementation challenges. Even the most technologically advanced nations in the world are still struggling to obtain meaningful data. 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://doi.org/10.1093/cid/ciaa573" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          . 
         &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/b&gt;&#xD;
    
          : Thursky, K. (2020). The implementation challenges of undertaking national antimicrobial usage surveillance. Clinical Infectious Diseases. DOI:
          &#xD;
    &lt;a href="https://doi.org/10.1093/cid/ciaa573" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1093/cid/ciaa573
          &#xD;
    &lt;/a&gt;&#xD;
    
          . 
         &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1542736667-069246bdbc6d.jpg" length="108473" type="image/jpeg" />
      <pubDate>Mon, 18 May 2020 05:16:47 GMT</pubDate>
      <guid>https://www.ncas-australia.org/the-implementation-challenges-of-undertaking-national-antimicrobial-usage-surveillance</guid>
      <g-custom:tags type="string">NAPS,Hospital paper,NAPS paper,NCAS publications,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1542736667-069246bdbc6d.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1542736667-069246bdbc6d.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial Awareness Week 2020</title>
      <link>https://www.ncas-australia.org/antimicrobial-awareness-week-2020</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/aaw2020v2.png"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           World Antimicrobial Awareness Week aims to increase public awareness of the threat of antimicrobial resistance and the importance of efforts to improve antimicrobial use in all healthcare settings. The World Health Organisation has marked 18-24 November as the dates of this year's Antimicrobial Awareness Week, during which NCAS will host a webinar series. View the program and register below. Recordings of and resources from the webinar series will be published on our
           
                      &#xD;
      &lt;a href="/AAW2020"&gt;&#xD;
        
                        
            AAW 2020 webpage
           
                      &#xD;
      &lt;/a&gt;&#xD;
      
                      
           . 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Dates:
          
                    &#xD;
    &lt;/b&gt;&#xD;
    
                    
          18-24 November 2020
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
           Format:
          
                    &#xD;
    &lt;/b&gt;&#xD;
    
                    
          Webinar
         
                  &#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1494599948593-3dafe8338d71.jpg" length="218522" type="image/jpeg" />
      <pubDate>Wed, 15 Apr 2020 04:20:09 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-awareness-week-2020</guid>
      <g-custom:tags type="string">News and events</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1494599948593-3dafe8338d71.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1494599948593-3dafe8338d71.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Describing the antimicrobial usage patterns of companion animal veterinary practices</title>
      <link>https://www.ncas-australia.org/describing-the-antimicrobial-usage-patterns-of-companion-animal-veterinary-practices</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Brian A. Hur, Laura Y. Hardefeldt, Karin M. Verspoor, Timothy Baldwin and James R. Gilkerson
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Antimicrobial resistance is a global crisis that veterinarians contribute to through their use of antimicrobials in animals. Antimicrobial stewardship has been shown to be an effective means to reduce antimicrobial resistance in hospital environments. Effective monitoring of antimicrobial usage patterns is an essential part of antimicrobial stewardship and is critical in reducing the development of antimicrobial resistance. The aim of this study is to describe how frequently antimicrobials were used in veterinary consultations and identify the most frequently used antimicrobials. Using VetCompass Australia, Natural Language Processing techniques, and the Australian Strategic Technical Advisory Group’s (ASTAG) Rating system to classify the importance of antimicrobials, descriptive analysis was performed on the antimicrobials prescribed in consultations from 137 companion animal veterinary clinics in Australia between 2013 and 2017 (inclusive). Of the 4,400,519 consultations downloaded there were 595,089 consultations where antimicrobials were prescribed to dogs or cats. Antimicrobials were dispensed in 145 of every 1000 canine consultations; and 38 per 1000 consultations involved high importance rated antimicrobials. Similarly with cats, 108 per 1000 consultations had antimicrobials dispensed, and in 47 per 1000 consultations an antimicrobial of high importance rating was administered. The most common antimicrobials given to cats and dogs were cefovecin and amoxycillin clavulanate, respectively. The most common topical antimicrobial and high-rated topical antimicrobial given to dogs and cats was polymyxin B. This study provides a descriptive analysis of the antimicrobial usage patterns in Australia using methods that can be automated to inform antimicrobial use surveillance programs and promote antimicrobial stewardship.
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://doi.org/10.1371/journal.pone.0230049" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          .
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    
          : Hur, B. A., Hardefeldt, L. Y., Verspoor, K. M., Baldwin, T. &amp;amp; Gilkerson, J. R. (2020). Describing the antimicrobial usage patterns of companion animal veterinary practices; free text analysis of more than 4.4 million consultation records. PLOS ONE, 15, e0230049. DOI:
          &#xD;
    &lt;a href="https://doi.org/10.1371/journal.pone.0230049" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1371/journal.pone.0230049
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1460925895917-afdab827c52f.jpg" length="242353" type="image/jpeg" />
      <pubDate>Thu, 12 Mar 2020 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/describing-the-antimicrobial-usage-patterns-of-companion-animal-veterinary-practices</guid>
      <g-custom:tags type="string">Companion animal,NCAS publications,Veterinary,Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1460925895917-afdab827c52f.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1460925895917-afdab827c52f.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Animals, agriculture and antimicrobial stewardship</title>
      <link>https://www.ncas-australia.org/animals-agriculture-and-antimicrobial-stewardship</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Arjun Rajkhowa, Kirsten Bailey, Laura Hardefeldt, Helen Billman-Jacobe, James Gilkerson and Glenn Browning
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://insightplus.mja.com.au/2020/2/animals-agriculture-and-antimicrobial-stewardship/" target="_blank"&gt;&#xD;
      
           Medical Journal of Australia-Insight
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            )
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The rise of drug-resistant infections presents significant challenges globally. Antimicrobial resistance (AMR) threatens to jeopardise health care delivery through increased mortality and morbidity, length of stay in hospitals, and costs of hospitalisation. Effective treatment for infections fundamentally underpins all of health care. When this is irreparably undermined, health care outcomes will be detrimentally affected.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           AMR is one of the definitive 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.amr.gov.au/about-us/about-this-initiative"&gt;&#xD;
      
           One Health
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            problems of our times, spanning both 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://royalsocietypublishing.org/doi/10.1098/rstb.2014.0083"&gt;&#xD;
      
           human and animal health
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           . Globally, practices that contribute to AMR, such as the misuse or suboptimal use of antibiotics, undoubtedly occur in both human and animal sectors.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           However, agriculture is often portrayed in media reports as the prime culprit and the crux of the crisis.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Several 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://insightplus.mja.com.au/2019/30/time-to-focus-on-antibiotics-in-agriculture/"&gt;&#xD;
      
           misconceptions
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            about Australian veterinary and agricultural antimicrobial use abound. Perhaps, in our attempts to grapple with the ramifications of the emerging crisis and apportion blame for it, we may occasionally misrepresent antimicrobial use in veterinary medicine in Australia. Outdated practices long since discontinued in Australia and inappropriate antibiotic use practices from overseas are discussed as if they occur here.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Are antimicrobials used for growth promotion in Australia?
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           An episode of 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://iview.abc.net.au/show/ask-the-doctor/series/2/video/DO1708V006S00"&gt;&#xD;
      
           Ask the Doctor on the ABC
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            dealt with the issue of emerging AMR in people, but made some errors while discussing antibiotic use in animals. Most importantly, the presenters and featured (human health) experts suggested that antibiotics are used in every chicken, pig or cow for nearly all their lives.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           All antibiotics that are important for human health that had previously been labelled for use for growth promotion have had those label claims removed in recent years in Australia. This means that these antibiotics can no longer be used for this purpose in food-producing animals in Australia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Moreover, the program also represented the use of the “antibiotic-free” label in food production as a sort of panacea for perceived current problems.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           While it is commendable that many farmers and producers have minimised their antibiotic use, it is still important that farm animals with bacterial infections are appropriately treated with antibiotics. Health and welfare outcomes for sick animals will suffer if antibiotics are not appropriately used when they are needed. We need to ensure that sick animals receive the treatment they need, while preserving the efficacy of antibiotics for future use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antimicrobials registered for use in agricultural animals in Australia
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The threat posed by increasing rates of drug-resistant infections has made it necessary for us to ensure that critically important antimicrobials remain effective for humans into the future. This entails carefully regulating their use in animals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antimicrobials approved for use in Australia are different to those overseas. In particular, colistin and fluoroquinolones are not approved for use in food-producing animals, and no fourth-generation cephalosporins have been registered or approved for use in food-producing animals in Australia. Use of third generation cephalosporins is restricted.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Animal husbandry regulations in Australia are relatively quite advanced. 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.agriculture.gov.au/ag-farm-food/food/nrs/animal-residue-monitoring"&gt;&#xD;
      
           Animal product residue monitoring
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            is undertaken across production sectors, and antibiotics constitute one group of monitored drugs, alongside anthelmintics, hormones, corticosteroids, fungicides, herbicides and others. Antibiotic residue testing covers the major antibiotic classes. Withholding periods are intended to ensure that no residues remain in meat products when they are processed for human consumption. The national residue monitoring program 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.agriculture.gov.au/ag-farm-food/food/nrs/animal-residue-monitoring"&gt;&#xD;
      
           reports
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            high levels of compliance with the regulatory regime across sectors. The poultry sector, for example, is generally understood to have responsible use practices, and antibiotics are only sparingly prescribed to treat or prevent infections when other strategies have failed. Withholding periods are observed. No hormones or steroids are used in poultry.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           While antibiotic residues are routinely monitored, bacterial contamination or bacterial resistance have only been assessed in small pilot and snapshot 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://apvma.gov.au/sites/default/files/publication/27326-final_amr_report-_for_publishing_v02_140817_a939399.pdf"&gt;&#xD;
      
           studies
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antimicrobial stewardship
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;a href="https://veterinaryrecord.bmj.com/content/182/24/688.info"&gt;&#xD;
      
           Antimicrobial stewardship
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (AMS) is a key element of the fight against the rise of “superbugs”. AMS ensures that antibiotic use is appropriate to treat the particular infection in the patient, and that critically important antibiotics are reserved to treat the most serious infections in people.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncas-australia.org/"&gt;&#xD;
      
           National Centre for Antimicrobial Stewardship
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            brings together medical and veterinary infectious disease experts in a One Health research program focused on preserving the effectiveness of antibiotics for the future.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Our research on antimicrobial use in animals in Australia has examined several key aspects of antimicrobial prescribing in veterinary medicine. The centre has undertaken studies to examine and appraise:
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            antimicrobial prescribing by
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;span&gt;&#xD;
        &lt;/span&gt;&#xD;
      &lt;/span&gt;&#xD;
      &lt;a href="http://onlinelibrary.wiley.com/doi/10.1111/jvim.14733/full"&gt;&#xD;
        
            companion
           &#xD;
      &lt;/a&gt;&#xD;
      &lt;span&gt;&#xD;
        
             
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;a href="http://www.sciencedirect.com/science/article/pii/S0378113517301062"&gt;&#xD;
        
            animal
           &#xD;
      &lt;/a&gt;&#xD;
      &lt;span&gt;&#xD;
        
            , 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/28893972"&gt;&#xD;
        
            bovine
           &#xD;
      &lt;/a&gt;&#xD;
      &lt;span&gt;&#xD;
        
             and 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;a href="http://onlinelibrary.wiley.com/doi/10.1111/evj.12709/full"&gt;&#xD;
        
            equine
           &#xD;
      &lt;/a&gt;&#xD;
      &lt;span&gt;&#xD;
        
             veterinarians;
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            antimicrobial 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;a href="https://onlinelibrary.wiley.com/doi/abs/10.1111/avj.12848?casa_token=E3reGuNryTQAAAAA:uxYuBelDPGRTVBSa7YLwLpguTg88w9YAtX2wyb518RexooszgZq12iCBhIpDUUIvyjDq3VvN9ZsLbk71tQ"&gt;&#xD;
        
            prescribing guidelines
           &#xD;
      &lt;/a&gt;&#xD;
      &lt;span&gt;&#xD;
        
             for dogs, cats and horses in Australia;
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            antimicrobial 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;a href="https://onlinelibrary.wiley.com/doi/abs/10.1111/avj.12791?casa_token=jbJfEKUU0OAAAAAA:fMqJYyw2w8Ad_wItn_zH62jclbu0V_1PzikpdFDnM0eXLdrzKsEWa5-Ytqsn1dZpsh6qFfbLI5GrM8Bucg"&gt;&#xD;
        
            dosing
           &#xD;
      &lt;/a&gt;&#xD;
      &lt;span&gt;&#xD;
        
             for common equine drugs;
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            antimicrobial 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;a href="https://onlinelibrary-wiley-com.ezp.lib.unimelb.edu.au/doi/epdf/10.1111/avj.12685"&gt;&#xD;
        
            susceptibility testing
           &#xD;
      &lt;/a&gt;&#xD;
      &lt;span&gt;&#xD;
        
             by veterinary diagnostic laboratories;
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            antimicrobial 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;a href="https://onlinelibrary.wiley.com/doi/abs/10.1111/avj.12677"&gt;&#xD;
        
            drug labelling
           &#xD;
      &lt;/a&gt;&#xD;
      &lt;span&gt;&#xD;
        
             and its implications for AMS;
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;a href="https://onlinelibrary.wiley.com/doi/abs/10.1111/jvim.15083"&gt;&#xD;
        
            barriers
           &#xD;
      &lt;/a&gt;&#xD;
      &lt;span&gt;&#xD;
        
             to and enablers of antimicrobial stewardship in veterinary practices; and
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            veterinary students’ and trainees’ 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;a href="https://www.mdpi.com/2079-6382/7/2/34"&gt;&#xD;
        
            knowledge and perceptions
           &#xD;
      &lt;/a&gt;&#xD;
      &lt;span&gt;&#xD;
        
             about AMS and biosecurity.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           We are undertaking research on using information technology tools to extract antimicrobial usage data from medical records; using antimicrobial susceptibility information to assess the validity of guideline recommendations; developing infection control and AMS capacity among dairy farmers; and, most importantly, implementing an AMS trial across a nationwide network of clinics, where we provide resources to support different levels of AMS activities in different clinics to determine the acceptability and efficacy of targeted strategies.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           We have developed clinical 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://vetantibiotics.fvas.unimelb.edu.au/about/resources/"&gt;&#xD;
      
           resources
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            for veterinary AMS, including educational posters and 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://vetantibiotics.fvas.unimelb.edu.au/"&gt;&#xD;
      
           antimicrobial prescribing guidelines
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            for companion animal, equine and bovine practices, and these have been disseminated locally and nationally, with the support of Agriculture Victoria (which sponsored the development of these resources). Agriculture Victoria has supported efforts to disseminate these resources widely among veterinarians and farmers in Victoria. We have found engaging with veterinarians and farmers about AMS to be an overwhelmingly positive experience – there is a tremendous desire for more information and great support for the promotion of judicious antimicrobial use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Our prescribing guidelines have also been assessed in a wide-ranging 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://onlinelibrary.wiley.com/doi/abs/10.1111/avj.12848"&gt;&#xD;
      
           guideline-appraisal
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            project, and we aim to use this to inform how we refine and use the guidelines.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A One Health approach to the problem
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The Australian Government, through its 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.amr.gov.au/australias-response/national-amr-strategy"&gt;&#xD;
      
           National AMR Strategy
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (which, encouragingly, will be renewed later this year), has attempted to cohesively bring human and animal health sectors together to work collaboratively on tackling the problem of AMR.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           This necessary effort has yielded considerable success, in that we now have a clinical, scientific and policy environment where cross-pollination and collaboration can occur. This can be further consolidated in the future.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           However, at the moment, it is clear that we lack effective communication between different sectors, and there is still insufficient understanding, on either side, of the problems and challenges that affect the other. Conversely, we are also less aware about the myriad structural and environmental factors that may be seen as enablers of progress in this area in Australia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Undoubtedly, the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426470/"&gt;&#xD;
      
           global ramifications
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            of the problem of inappropriate antimicrobial use in agriculture are vastly more complex. As such, direct and unqualified comparisons between different geographical and political contexts may not be tenable.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Nevertheless, we can and must engage in nationally (and, ultimately, globally) coordinated efforts to improve 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://onlinelibrary.wiley.com/doi/abs/10.1111/avj.12821"&gt;&#xD;
      
           veterinary education and training
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , and support initiatives focused on improving antimicrobial use in different countries. Our team, alongside others in Australia and New Zealand, has 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://researchoutput.csu.edu.au/en/publications/development-of-an-online-antimicrobial-stewardship-training-progr"&gt;&#xD;
      
           engaged
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            in such work in the Asia–Pacific region. We recognise the importance of facilitating greater knowledge about optimal antimicrobial use in agriculture globally, and acknowledge that significant barriers to stewardship remain in many places.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           That said, insofar as veterinary medicine in Australia is concerned, we should attempt to avoid convenient mischaracterisations, encourage timely reporting of actual antimicrobial usage in agricultural industries, and aim to more accurately identify the challenges that continue to act as barriers to AMS here.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Mon, 20 Jan 2020 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/animals-agriculture-and-antimicrobial-stewardship</guid>
      <g-custom:tags type="string">Media,Veterinary</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Monitoring skin temperature at the wrist in hospitalised patients may assist in the detection of infection</title>
      <link>https://www.ncas-australia.org/monitoring-skin-temperature-at-the-wrist-in-hospitalised-patients-may-assist-in-the-detection-of-infection</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           S. G. Holt, J. H. Yo, C. Karschimkus, F. Volpato, S. Christov, E. R. Smith, T. D. Hewitson, L. J. Worth and P. Champion De Crespigny
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Measuring temperature has always been a key observation in the diagnosis of infection. No studies have examined the usefulness of measuring temperature at the wrist to detect infection
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Aim and hypothesis
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : We sought to determine whether a watch measuring wrist temperature could accurately identify patients who are infected.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Prospective cross‐sectional pilot study of temperature monitoring in an unselected patients in a tertiary referral adult nephrology unit.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : 104 data recording sessions revealed 88 useful data sets, with recording failures in the others. Patients were retrospectively classified as having no infection (Group A, n=60), clinically diagnosed infection with less than 24 hours of treatment with antibiotics (Group B, n=5), and clinically diagnosed infection with &amp;gt;24 hours on antibiotics (Group C, n=23). There was a significantly higher average maximum temperature in Group B (Mean (SEM)) 38°C (0.6) compared with Groups A (36.1°C(0.1)) and C (36.3°C(0.3)). Based on ROC analysis a cut‐off temperature of &amp;gt;=37.5°C gave sensitivity 80% specificity 98%. Mean electrodermal activity (EDA) was significantly higher in groups B and C. Receiver operating characteristics of peripheral skin temperature measurements suggest that such a device may identify many patients requiring treatment for infection.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Receiver operating characteristics of peripheral skin temperature measurements suggest that such a device may identify many patients requiring treatment for infection. This proof of principle study showed value in using a wearable device in the detection of infection and its potential as an early warning or monitoring device.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://onlinelibrary.wiley.com/doi/abs/10.1111/imj.14748" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Holt, S.G., Yo, J.H., Karschimkus, C., Volpato, F., Christov, S., Smith, E.R., Hewitson, T.D., Worth, L.J., Champion De Crespigny, P. (2020). Monitoring skin temperature at the wrist in hospitalised patients may assist in the detection of infection. Internal Medicine Journal. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1111/imj.14748" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1111/imj.14748
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1504868584819-f8e8b4b6d7e3.jpg" length="167147" type="image/jpeg" />
      <pubDate>Sun, 05 Jan 2020 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/monitoring-skin-temperature-at-the-wrist-in-hospitalised-patients-may-assist-in-the-detection-of-infection</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1504868584819-f8e8b4b6d7e3.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1504868584819-f8e8b4b6d7e3.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Sustainability of antimicrobial stewardship programs in Australian rural hospitals: a qualitative study</title>
      <link>https://www.ncas-australia.org/sustainability-of-antimicrobial-stewardship-programs-in-australian-rural-hospitals-a-qualitative-study</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Jaclyn L. Bishop, Thomas R. Schulz, David C. M. Kong and Kirsty L. Buising
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Objective
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           :
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            The aim of this study was to explore the features of sustainable antimicrobial stewardship (AMS) programs in Australian rural hospitals and develop recommendations on incorporating these features into rural hospitals’ AMS programs.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Lead AMS clinicians with knowledge of at least one AMS program sustained for &amp;gt;2 years in a health service in rural Australia were recruited to the study. A series of interviews was conducted and the transcripts analysed thematically using a framework method.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Fifteen participants from various professional disciplines were interviewed. Key features that positively affected the sustainability of AMS programs in rural hospitals included a hospital executive who provided strong governance and accountability, dedicated resources, passionate local champions, area-wide arrangements and adaptability to engage in new partnerships. Challenges to building AMS programs with these features were identified, particularly in engaging hospital executive to allocate AMS resources, managing the burn out of passionate champions and formalising network arrangements.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Strategies to increase the sustainability of AMS programs in rural hospitals include using accreditation as a mechanism to drive direct resource allocation, explicit staffing recommendations for rural hospitals, greater support to develop formal network arrangements and a framework for integrated AMS programs across primary, aged and acute care.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           What is known about the topic?
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : AMS programs facilitate the responsible use of antimicrobials. Implementation challenges have been identified for rural hospitals, but the sustainability of AMS programs has not been explored.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           What does this paper add?
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Factors that positively affected the sustainability of AMS programs in rural hospitals were a hospital executive that provided strong governance and accountability, dedicated resources, network or area-wide arrangements and adaptability. Challenges to building AMS programs with these features were identified.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           What are the implications for practitioners?
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Recommended actions to boost the sustainability of AMS programs in rural hospitals are required. These include using accreditation as a mechanism to drive direct resource allocation, explicit staffing recommendations for rural hospitals, greater support to develop network arrangements and support to create integrated AMS programs across acute, aged and primary care.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.publish.csiro.au/ah/AH19097" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Bishop, J.L., Schulz, T.R., Kong, D.C., Buising, K.L. (2020). Sustainability of antimicrobial stewardship programs in Australian rural hospitals: A qualitative study. Australian Health Review. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1071/AH19097" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1071/AH19097
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1517120026326-d87759a7b63b.jpg" length="351558" type="image/jpeg" />
      <pubDate>Thu, 02 Jan 2020 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/sustainability-of-antimicrobial-stewardship-programs-in-australian-rural-hospitals-a-qualitative-study</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper,Regional</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1517120026326-d87759a7b63b.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1517120026326-d87759a7b63b.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>The National Antimicrobial Prescribing Survey: 2018 reports</title>
      <link>https://www.ncas-australia.org/national-antimicrobial-prescribing-survey-2018-reports</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;h3&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           The reports of the 2018 Hospital NAPS, Surgical NAPS and Aged Care NAPS
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/h3&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/SNAPS+2018.png"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            The reports of the 2018 Hospital
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           National Antimicrobial Prescribing Survey
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            (
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            NAPS), Surgical NAPS and Aged Care NAPS have been published. See
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/ncas-publications"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            .
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
                    
          A summary of the flagship Hospital NAPS for 2018 is included below.
         
                  &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           The 2018 Hospital NAPS provides an overview of antimicrobial prescribing in Australian public and private hospitals. This is the sixth year that the survey has been conducted. Consistent themes continue to emerge in relation to the appropriateness of antimicrobial prescribing across Australia, in NAPS contributor hospitals. This report presents analyses of 26,714 prescriptions submitted to the Hospital NAPS database by 324 hospitals (231 public and 93 private) during 2018, and analyses of trends from 2013 to 2018. Key findings of the 2018 Hospital NAPS: 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            There were improvements in three key indicators of appropriateness of antimicrobial prescribing monitored by Hospital NAPS: 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Documentation of indication increased to 80.3% in 2018, compared with 70.0% in 2013. 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Documentation of review or stop date increased to 45.2%, compared with 34.8% in 2015 when this indicator was first reported. 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Proportion of surgical prophylaxis given for greater than 24 hours decreased to 28.0% in 2018, compared with 41.1% in 2013. 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Whilst these improvements are encouraging there are a number of concerning patterns in regard to other aspects of appropriateness of antimicrobial prescribing: 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Compliance with Therapeutic Guidelines: Antibiotic or local guidelines, declined from 72.1% in 2013 to 67.7% in 2018. 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            There was minimal improvement in overall appropriateness of prescribing from 2013 to 2018 (75.8% to 77.7%). 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            The five most commonly prescribed antimicrobials in Australian hospitals participating in NAPS in 2018 were: cefazolin, ceftriaxone, amoxicillin–clavulanic acid, piperacillin– tazobactam and metronidazole. 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            The antimicrobials with the highest rates of inappropriate prescribing in Australian hospitals participating in NAPS in 2018 were: cefalexin, cefazolin, azithromycin, amoxicillin–clavulanic acid, and metronidazole.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            The five most common indications for prescribing antimicrobials in Australian hospitals that contributed to NAPS in 2018 were: surgical prophylaxis, community-acquired pneumonia, medical prophylaxis, cystitis, and cellulitis/erysipelas. 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            The highest proportions of prescriptions assessed as inappropriate in Australian hospitals participating in NAPS in 2018 were for: chronic obstructive pulmonary disease (COPD), surgical prophylaxis, non-surgical wound infections, community-acquired pneumonia and cystitis.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/SNAPS+2018.png" length="272447" type="image/png" />
      <pubDate>Tue, 17 Dec 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/national-antimicrobial-prescribing-survey-2018-reports</guid>
      <g-custom:tags type="string">News and events,NCAS publications,NAPS reports,Hospital,Surgical,Aged care,Community</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/SNAPS+2018.png">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/SNAPS+2018.png">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Knowledge, perceptions and practices of community pharmacists towards antimicrobial stewardship: a systematic scoping review</title>
      <link>https://www.ncas-australia.org/knowledge-perceptions-and-practices-of-community-pharmacists-towards-antimicrobial-stewardship-a-systematic-scoping-review</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Sajal K. Saha, Chris Barton, Shukla Promite and Danielle Mazza
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          The scope of antimicrobial stewardship (AMS) surveys on community pharmacists (CPs) is uncertain. This study examines the breadth and quality of AMS survey tools measuring the stewardship knowledge, perceptions and practices (KPP) of CPs and analyse survey outcomes. Following PRISMA-ScR checklist and Arksey and O’Malley’s methodological framework seven medical databases were searched. Two reviewers independently screened the literatures, assessed quality of surveys and KPP outcomes were analysed and described. Ten surveys were identified that assessed CPs’ AMS perceptions (n = 7) and practices (n = 8) but none that assessed AMS knowledge. Three survey tools had been formally validated. Most CPs perceived that AMS improved patient care (median 86.0%, IQR, 83.3–93.5%, n = 6), and reduced inappropriate antibiotic use (84.0%, IQR, 83–85%, n = 2). CPs collaborated with prescribers for infection control (54.7%, IQR 34.8–63.2%, n = 4) and for uncertain antibiotic treatment (77.0%, IQR 55.2–77.8%, n = 5). CPs educated patients (53.0%, IQR, 43.2–67.4%, n = 5) and screened guideline-compliance of antimicrobial prescriptions (47.5%, IQR, 25.2–58.3%, n = 3). Guidelines, training, interactions with prescribers, and reimbursement models were major barriers to CP-led AMS implementation. A limited number of validated survey tools are available to assess AMS perceptions and practices of CPs. AMS survey tools require further development to assess stewardship knowledge, stewardship targets, and implementation by CPs.
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://doi.org/10.3390/antibiotics8040263" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          .
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    
          : Saha SK, Barton C, Promite S, Mazza D. (2019). Knowledge, perceptions and practices of community pharmacists towards antimicrobial stewardship: A systematic scoping review . Antibiotics, 8(4), 263. DOI:
          &#xD;
    &lt;a href="https://doi.org/10.3390/antibiotics8040263" target="_blank"&gt;&#xD;
      
           https://doi.org/10.3390/antibiotics8040263
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1547489432-cf93fa6c71ee.jpg" length="123987" type="image/jpeg" />
      <pubDate>Tue, 10 Dec 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/knowledge-perceptions-and-practices-of-community-pharmacists-towards-antimicrobial-stewardship-a-systematic-scoping-review</guid>
      <g-custom:tags type="string">NCAS publications,Community,Community paper,GP</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1547489432-cf93fa6c71ee.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1547489432-cf93fa6c71ee.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>The role of nurses in antimicrobial stewardship near the end of life in aged care homes: a qualitative study</title>
      <link>https://www.ncas-australia.org/the-role-of-nurses-in-antimicrobial-stewardship-near-the-end-of-life-in-aged-care-homes-a-qualitative-study</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Leslie Dowson, N. Deborah Friedman, Caroline Marshall, Rhonda Stuart, Kirsty Buising, Arjun Rajkhowa, Fiona Gotterson, David C. M. Kong
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : The excessive use of antimicrobials in aged-care homes is a widely recognised phenomenon. This is problematic because it can harm residents, and is detrimental to public health. Residents in the final month of life are increasingly likely to be prescribed an antimicrobial, commonly without having signs and symptoms of infection that support antimicrobial use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Objectives
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : We aimed to describe the perspectives of health professionals on antimicrobial use near the end of life in aged-care homes and investigate the potential opportunities for nurses to undertake antimicrobial stewardship activities near the end of life in aged-care homes.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Design
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : One-on-one, semi-structured, qualitative interviews.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Settings and participants
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Twelve nurses, six general practitioners and two pharmacists providing routine care to residents of aged-care homes in Victoria, Australia, were interviewed. Diversity in terms of years of experience, aged-care funding type (government, private-for-profits and not-for-profits) and location (metropolitan and regional) was sought.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Interviews were transcribed and open coded in a descriptive manner using validated frameworks for understanding behaviour change. The descriptive code was then used to build an interpretive code structure based on questions founded in grounded theory.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Thematic saturation was reached after fourteen interviews, and an additional six interviews were conducted to ensure emergent themes were consistent and definitive. There are opportunities for aged-care home nurses to undertake antimicrobial stewardship activities near the end of life in the provision of routine care. Aged-care home nurses are influential in antimicrobial decisions near the end of life in routine care because of their leadership in advance care planning, care co-ordination and care provision in an environment with stopgap and visiting medical resources. Nurses also have social influence among residents, families and medical professionals during critical conversations near the end of life. Past negative social interactions within the aged-care home environment between nurses and families can result in ‘fear-based’ social influences on antimicrobial prescribing.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : The work of facilitating advance care planning, care coordination, care delivery, and communicating with families and medical professionals provide important opportunities for aged-care home nurses to lead appropriate antimicrobial stewardship activities near the end of life.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.ijnurstu.2019.103502" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Dowson, L., Friedman, N.D., Marshall, C., Stuart, R.L., Buising, K., Rajkhowa, A., Gotterson, F. and Kong, D.C. (2020). The role of nurses in antimicrobial stewardship near the end of life in aged-care homes: A qualitative study. International Journal of Nursing Studies, p.103502. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.ijnurstu.2019.103502" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1016/j.ijnurstu.2019.103502
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .  
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1583267458362-7ddbdd670d42.jpg" length="490757" type="image/jpeg" />
      <pubDate>Tue, 10 Dec 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/the-role-of-nurses-in-antimicrobial-stewardship-near-the-end-of-life-in-aged-care-homes-a-qualitative-study</guid>
      <g-custom:tags type="string">NCAS publications,Community,Community paper,Aged care,Aged care paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1583267458362-7ddbdd670d42.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1583267458362-7ddbdd670d42.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antibiotic use too long in surgery</title>
      <link>https://www.ncas-australia.org/antibiotic-use-too-long-in-surgery</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Courtney Ierano, Arjun Rajkhowa and Karin Thursky 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://pursuit.unimelb.edu.au/articles/antibiotic-use-too-long-in-surgery" target="_blank"&gt;&#xD;
      
           Pursuit
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , University of Melbourne)
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           More than half of the antibiotics used to prevent infection before, during and after surgery may not be appropriately prescribed.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antibiotics are commonly used to prevent infections before, during and after surgery (known as surgical antibiotic prophylaxis). In fact, surgical antibiotic prophylaxis has been identified as the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           most common reason
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            for antibiotic use in Australian hospitals since 2013.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Our new 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           study
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , a collaboration between the University of Melbourne and 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           Monash University
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , has found that antibiotics are often prescribed at the incorrect time and for unnecessarily long durations after surgery.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Not all surgical procedures 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           require
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            antibiotics, and when they are needed, only a single dose is usually recommended beforehand.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           For many procedures, the guidelines do not recommend additional doses after surgery.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The Hospital 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           National Antimicrobial Prescribing Survey
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (Hospital NAPS) program at the University of Melbourne and Melbourne Health has consistently 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           highlighted
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            that surgical antibiotic prophylaxis is often prescribed inappropriately.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The program has expanded to include a new module, the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           Surgical NAPS
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , that specifically evaluates prescribing practices in surgical settings, with the aim of helping health services to monitor and improve prescribing.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Our research has found that less than half – 48.7 per cent – of 15,395 prescriptions for 9,351 surgeries (from 2016 to 2018) were assessed as appropriate.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Procedural antibiotic prescribing (antibiotics given before or during surgery) was assessed as inappropriate in 40.5 per cent of doses, while post-procedural prescribing was found to be inappropriate in more than 60 per cent of doses.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           We also compared prescribing appropriateness across different types of surgeries (adjusting for hospital, patient and other surgical factors).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Our research has found that appropriateness of procedural prescribing ranged from 33.7 per cent to 68.9 per cent, while the appropriateness of post-procedural prescribing ranged from 21.5 per cent to 58.7 per cent.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           When antibiotics were prescribed as required before surgery but were assessed as inappropriate, the most common reason for inappropriateness was timing (49.5 per cent) – that is, the antibiotics were administered too early or too late.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           However, the exact time that the surgery started (the time the first incision was made) was documented in only 65.6 per cent of cases, which makes it difficult to comprehensively assess appropriateness for the timing of antibiotic administration.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           When antibiotics were prescribed as required after surgery but were assessed as inappropriate, the most common reason for inappropriateness was prolonged duration, at 54.3 per cent.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Our research highlights some key issues around the duration of post-procedural antimicrobial use, timing of antibiotic use and documentation of the time of surgical incision.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           It’s also important to consider that decision making about antibiotic prescribing is complex and involves multiple healthcare professionals who work across pre-, intra- and post-operative surgical settings.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           We conducted a second 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           study
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            to better understand what drives the prescribing of antibiotics in surgical settings, and what other factors may help facilitate quality improvement.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           We found that improving antibiotic prescribing before and after surgery was considered a low priority, and guidelines were not regularly consulted.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The culture of prescribing (described 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           elsewhere
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            as ‘prescribing etiquette’) appears to reinforce established practices.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           For example, some junior surgeons say that they feel uncomfortable challenging the practices of their seniors, for fear of professional repercussions.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “As a resident. . . it’s not within my power to say, ‘Just stop it [the antibiotics].’ I have to ask someone else.” (Public orthopaedic surgeon.)
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The senior consultant has primary responsibility over the patient, and they will invariably determine how that patient is looked after.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “It’s (up to) the consultants. You can’t (change practice to single dose surgical antibiotic prophylaxis). . . They’ve got to be on board with it. Because, at the end of the day, you stop the antibiotics based on evidence, and something goes wrong – it will be your fault. Often, I’ll just go with what my seniors have told me because, you know, that’s what we do.” (Public surgical resident/registrar.)
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Many senior surgeons and anaesthetists describe their fears about missing infections. It’s apparent that their perceptions about the risk of infection, and justified fears about the consequences of missing infection, can hinder appropriate prescribing.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Clinicians also identified a need for improved communication, documentation and collection of local data for action.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The Surgical NAPS helps to facilitate this. But we need more resources to collect data on surgical outcomes that might support prescriber behaviour change.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           However, clinicians have provided some positive feedback about current practices that could be used to improve antibiotic use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Clinicians commonly use a 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           time-out
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            to plan a procedure and check that all the requirements have been met.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “They (surgeons, anaesthetists and scrub nurses) definitely use the time-out. Everyone uses the time-out.” (Private theatre nurse.)
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In the future, factoring in a discussion about the prescribing of appropriate surgical prophylaxis before and after surgery within the time-out could be a practical way forward.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Our study follows on from qualitative research on surgical antibiotic prescribing culture conducted in both 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           Australia
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            and the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           UK
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           . It also highlights factors that influence decision-making, and multiple barriers to, and enablers of, appropriate surgical prophylaxis prescribing.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Potential solutions could include targeting antimicrobial stewardship at senior surgical consultants, rather than junior surgeons. Surgeons should (and want to) be actively involved in addressing national and global concerns about the overuse of antibiotics.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Healthcare in Australia is multi-disciplinary and collaborative, so improving surgical antibiotic use is not solely a surgeon’s problem.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           It requires extensive collaboration from everyone – from surgeons, anaesthetists and infectious diseases physicians, to pharmacists and nurses.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           But it must be done with the backing of professional bodies such as the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           Royal Australasian College of Surgeons 
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           and the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           Australian and New Zealand College of Anaesthetists
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , as well as hospital executives and government.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Wed, 04 Dec 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antibiotic-use-too-long-in-surgery</guid>
      <g-custom:tags type="string">Surgical,Media,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial stewardship near the end of life in aged care homes</title>
      <link>https://www.ncas-australia.org/antimicrobial-stewardship-near-the-end-of-life-in-aged-care-homes</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Leslie Dowson, N. Deborah Friedman, Caroline Marshall, Rhonda L. Stuart, Kirsty Buising, Arjun Rajkhowa, Fiona Gotterson, David C. M. Kong
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Highlights
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           :
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Antimicrobial stewardship should clearly be part of an aged care home nurse's role.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Addressing family confidence in resident wellbeing is critical.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Promoting the understanding that antimicrobial stewardship improves resident care is important.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Accreditation standards are important motivators for behaviour change in aged care.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : The objective of this study was to understand how aged care home health professionals perceive antimicrobial use near the end of life and how they perceive potential antimicrobial stewardship activities near the end of life in aged care homes.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Qualitative semi-structured interviews were undertaken with general practitioners, nurses, and pharmacists who provide routine care in aged care homes in Victoria, Australia. Interviews were coded using frameworks for understanding behaviour change.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Themes were established within 14 interviews, and an additional 6 interviews were undertaken to ensure thematic saturation. Two major themes emerged: (i) Antimicrobial stewardship activities near the end of life in aged care homes need to enable aged care home nurses to make decisions substantiated by evidence-based clinical knowledge. Antimicrobial stewardship should clearly be part of an aged care home nurse's role, and accreditation standards provide powerful motivation for behaviour change. (ii) Antimicrobial stewardship activities near the end of life in aged care homes must address family confidence in resident wellbeing. Antimicrobial stewardship activities should be inclusive of family involvement, and messages should highlight the point that antimicrobial stewardship improves care.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Antimicrobial stewardship activities that reinforce evidence-based clinical decision-making by aged care home nurses and address family confidence in resident wellbeing are required near the end of life in aged care homes. Accreditation standards are important motivators for behaviour change in aged care homes.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.sciencedirect.com/science/article/abs/pii/S0196655319309022" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          ﻿
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            :
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Dowson, L., Friedman, N. D., Marshall, C., Stuart, R. L., Buising, K., Rajkhowa, A., Gotterson, F., Kong, D. C. (2019). Antimicrobial stewardship near the end of life in aged care homes. American Journal of Infection Control. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.ajic.2019.10.010" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1016/j.ajic.2019.10.010
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            . 
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Aged+Care+image+shutterstock_113018524-4635x3168.jpg" length="523433" type="image/jpeg" />
      <pubDate>Mon, 02 Dec 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-stewardship-near-the-end-of-life-in-aged-care-homes</guid>
      <g-custom:tags type="string">NCAS publications,Community,Community paper,Aged care,Aged care paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Aged+Care+image+shutterstock_113018524-4635x3168.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Aged+Care+image+shutterstock_113018524-4635x3168.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>The 2018 Aged Care National Antimicrobial Prescribing Survey: results show room for improvement</title>
      <link>https://www.ncas-australia.org/the-2018-aged-care-national-antimicrobial-prescribing-survey-results-show-room-for-improvement</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Leslie Dowson, Arjun Rajkhowa, Kirsty Buising, David CM Kong, Rhonda L Stuart, Karin Thursky and Noleen Bennett
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The annual Aged Care National Antimicrobial Prescribing Survey aims to identify local and national prescribing issues and guide antimicrobial stewardship goals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In the 2018 point prevalence survey, medication charts of over 20,000 residents were reviewed from 407 participating facilities across Australia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           On the day of the survey, almost 10% of residents were prescribed an antimicrobial.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Nearly two-thirds of recently prescribed antimicrobials were for residents who had no documented signs or symptoms of infection.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Over a quarter of antimicrobials had been prescribed for longer than six months.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Incomplete documentation was a prominent barrier to proper review of antimicrobial therapy, with the indication, review date or stop date not documented for many prescriptions.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Recommendations include using appropriate microbiological testing to guide prescribing, following national antimicrobial prescribing guidelines, documenting the indication for the antimicrobial, and its start, stop and review dates, and monitoring and re-evaluating long-term antimicrobial use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.18773/austprescr.2019.066" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Dowson, L., Rajkhowa, A., Buising, K., Kong, D.C.M., Stuart, R., Thursky, K., Bennet, N. (2019). The 2018 Aged Care National Antimicrobial Prescribing Survey: results show room for improvement. Australian Prescriber, 42, 200–203. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.18773/austprescr.2019.066" target="_blank"&gt;&#xD;
      
           https://doi.org/10.18773/austprescr.2019.066
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AgedCare_NAPS-887x277.jpg" length="33417" type="image/jpeg" />
      <pubDate>Sun, 01 Dec 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/the-2018-aged-care-national-antimicrobial-prescribing-survey-results-show-room-for-improvement</guid>
      <g-custom:tags type="string">NCAS publications,Community,Community paper,Aged care,Aged care paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AgedCare_NAPS-887x277.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AgedCare_NAPS-887x277.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>An Introduction to Infection Control and Antimicrobial Stewardship 2019</title>
      <link>https://www.ncas-australia.org/an-introduction-to-infection-control-and-antimicrobial-stewardship-2019</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/NCAS+ASID_1.1.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           The Introduction to Infection Control and Antimicrobial Stewardship Course was a two-day course for doctors that provided practical advice on how to run an infection control and antimicrobial stewardship service. We offered tips and guidelines on how to deal with the tricky situations, with interactive panel discussions around real-life scenarios dealing with the day-to-day problems and challenges faced by doctors in these situations. We assembled a panel of experienced infectious diseases physicians, microbiologists and infection control practitioners to guide participants through these issues.This is the fourth iteration of this course. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Dates
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           : 29-30 November 2019
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Venue
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           : RMH Function and Convention Centre, Royal Melbourne Hospital, 300 Grattan Street, Melbourne
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            See
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.asid.net.au/events/event/intro-to-ic-and-ams" target="_blank"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            .
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/NCAS+ASID_1.1.jpg" length="158030" type="image/jpeg" />
      <pubDate>Fri, 29 Nov 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/an-introduction-to-infection-control-and-antimicrobial-stewardship-2019</guid>
      <g-custom:tags type="string">News and events,Seminar,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/NCAS_RGB_whitebox-3998x5263.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/NCAS+ASID_1.1.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial Stewardship in Primary Care</title>
      <link>https://www.ncas-australia.org/antimicrobial-stewardship-in-primary-care</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Flyer_Antimicrobial+stewardship+in+primary+care+1.5.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           At this seminar, Prof. Karen Tu and A/Prof. Noah Ivers from the University of Toronto, Canada, presented on antimicrobial use and stewardship in primary care in Canada. Researchers from the National Centre for Antimicrobial Stewardship and the Department of General Practice at the University of Melbourne and Monash University presented research findings on antimicrobial use and stewardship in primary care in Australia.
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Prof. Karen Tu (MD, MSc) is a professor in the Department of Family and Community Medicine, University of Toronto, and has an interest in primary care EMR research. A/Prof. Noah Ivers (MD, PhD) is an assistant professor at the Institute of Health Policy, Management and Evaluation at the University of Toronto, and has an interest in research on primary care quality improvement initiatives. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Date
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           : 26 November 2019
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Venue
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           : GM002, Doherty Institute, 792 Elizabeth Street, Melbourne
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            See
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/primary-care-seminar-2019"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            .
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Flyer_Antimicrobial+stewardship+in+primary+care+1.5.jpg" length="116418" type="image/jpeg" />
      <pubDate>Tue, 26 Nov 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-stewardship-in-primary-care</guid>
      <g-custom:tags type="string">News and events,Seminar,Primary care</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/NCAS_RGB_whitebox-3998x5263.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Flyer_Antimicrobial+stewardship+in+primary+care+1.5.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Curbing inappropriate antimicrobial use in children</title>
      <link>https://www.ncas-australia.org/curbing-inappropriate-antimicrobial-use-in-children</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Brendan McMullan, Arjun Rajkhowa and Karin Thursky
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://insightplus.mja.com.au/2019/46/curbing-inappropriate-antimicrobial-use-in-children/?fbclid=IwAR2j48AK9XJGzH8r7SBFgW-3Orc9oqMJOMrs6wUIXFvC7ulIn3M64x_xG4c" target="_blank"&gt;&#xD;
      
           Medical Journal of Australia-Insight
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           )
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antibiotic use in Australia has been found to be 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/sites/default/files/migrated/1.2-Text-Antibiotics-dispensing-in-children-9-years-and-under.pdf"&gt;&#xD;
      
           highest
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            in children in the 0–9 years age group and in adults in the over 65 years age group. International 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/26586337"&gt;&#xD;
      
           studies
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            have indicated that inappropriate antimicrobial use in children may be common.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Australia is internationally unique in that it collects information about the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/antimicrobial-resistance/antimicrobial-use-and-resistance-australia-surveillance-system-aura/hospital-antimicrobial-use/antimicrobial-use-australian-hospitals"&gt;&#xD;
      
           prevalence
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            and 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/antimicrobial-resistance/antimicrobial-use-and-resistance-australia-surveillance-system-aura/program-partners/appropriateness-antimicrobial-use"&gt;&#xD;
      
           quality
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            of antimicrobial use across acute care settings nationally, and has access to nationally aggregated data.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.naps.org.au/Default.aspx"&gt;&#xD;
      
           National Antimicrobial Prescribing Survey (NAPS)
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            is an online antimicrobial prescribing auditing program that has been available in Australia since 2013. Public 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncas-australia.org/ncas-publications"&gt;&#xD;
      
           reports
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            on the nationally aggregated results of these audits have been published annually since 2014, but, until recently, no specific analysis of prescribing for children was included in these reports.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In a recent 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://academic.oup.com/jac/advance-article-abstract/doi/10.1093/jac/dkz474/5614369?redirectedFrom=fulltext"&gt;&#xD;
      
           study
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , we reviewed information on antibiotic prescribing for children from Hospital NAPS audits undertaken across Australia from 2014 to 2017, which covered public and private, and major city, regional and remote hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           How good is antibiotic prescribing for children in Australian hospitals?
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Among over 6000 antibiotic prescriptions for children in 253 hospitals, almost 20% of prescriptions were assessed as inappropriate. Appropriateness assessments take into account a range of factors such as antimicrobial choice, timing of administration, dose, duration and others. More than half of surgical antimicrobial prophylaxis prescriptions were assessed as inappropriate. Risk factors for inappropriate prescribing included being admitted outside a specialist children’s hospital or being admitted in a rural or regional hospital.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           An indication for antimicrobial use was documented in 79% (4903/6219) of prescriptions; the most frequent indications included empiric therapy for sepsis (586, 9.4% of prescriptions) and antifungal prophylaxis (571, 9.4% of prescriptions, mainly in immunocompromised children and neonates). The agents that were most commonly used for antifungal prophylaxis were oral nystatin, followed by trimethoprim-sulfamethoxazole and then the azole antifungal agents. These were generally used appropriately.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In contrast, prescriptions for surgical antimicrobial prophylaxis were assessed as appropriate in 41% of cases. Surgical prophylaxis prescriptions were assessed as inappropriate often because of incorrect duration of use (generally prolonged use). In 8% (38/459) of surgical prophylaxis prescriptions, the agent selected was assessed as inappropriate (in most cases, a broad-spectrum agent was selected when it was unnecessary).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           For another common indication, community-acquired pneumonia, 25% of prescriptions were assessed as inappropriate, mainly because of inappropriate agent selection (19%; 73/378). Appropriateness also varied by antimicrobial class; for example, antiviral use was assessed as appropriate in over 95% of cases, whereas carbapenem use was assessed as appropriate in 60% of cases.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           There was also less use of 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.tg.org.au/"&gt;&#xD;
      
           Therapeutic Guidelines
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Antibiotic for children admitted to hospital compared with adults, perhaps reflecting a lack of specific information for children and newborns until an update in June 2019.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In primary care, audit tools to measure appropriateness do not exist. National data show a high proportion of antibiotic prescriptions for young children by global standards: in 2016–17, there were 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/healthcare-variation/atlas-2018/atlas-2018-1-neonatal-and-paediatric-health"&gt;&#xD;
      
           over 3 million antibiotic prescriptions for children
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (a per capita rate far higher than countries such as the Netherlands and Norway). The prescribing was highly variable. Children in the highest prescribing area received antibiotics 16.5 times more than those in the lowest prescribing area. A Victorian 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/30040141"&gt;&#xD;
      
           study
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            conducted from 2010 to 2014 showed one in five individual children was prescribed an antibiotic each year, and noted an inconsistency between prescribing practice and Therapeutic Guidelines: Antibiotic recommendations.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antimicrobial stewardship and meeting standards of care
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antimicrobial stewardship (AMS) encompasses a range of strategies and programs that can improve prescribing and limit the spread of antibiotic resistance. Since 2013, all Australian hospitals have been required to meet AMS criteria within the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/standards/nsqhs-standards"&gt;&#xD;
      
           National Safety and Quality Health Service Standards
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , which require services to provide access to guidelines and review prescribing practice in their facilities. An updated version of Therapeutic Guidelines: Antibiotic was published in June 2019, and included more detailed recommendations for antimicrobial use in children and newborns. Hospitals also have access to the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.naps.org.au/Default.aspx"&gt;&#xD;
      
           Hospital and Surgical NAPS
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , which can help monitor and improve antimicrobial prescribing. Undertaking quality audits can enhance AMS activities.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           There are currently no national standards that specifically include AMS in general practice. GPs must also pay to access Therapeutic Guidelines. The product information for antibiotics contained in 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.mims.com.au/"&gt;&#xD;
      
           MIMS
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , which can be accessed more easily, may not be up-to-date.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           We don’t have much information about the quality of prescribing in general practice. The 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.naps.org.au/Default.aspx"&gt;&#xD;
      
           Aged Care NAPS
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            module was developed (and has been undertaken nationally since 2015) to improve prescribing in aged care homes, and a module for general practice was piloted in 2017–18. However, at present, we don’t have a nationally available audit tool to measure and improve prescribing for Australian children seen in primary care.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Room for improvement
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           We have an obligation to provide children with the best possible care. The consequences of unnecessary medication use in children can be 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://theconversation.com/antibiotics-before-birth-and-in-early-life-can-affect-long-term-health-97778"&gt;&#xD;
      
           significant
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           . Clearly, there is room to improve antibiotic care for children. Health care providers must act together with the community to better promote and support high quality antibiotic prescribing for children.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Sun, 24 Nov 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/curbing-inappropriate-antimicrobial-use-in-children</guid>
      <g-custom:tags type="string">Media,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antibiotic use for children in Australian hospitals: recent evidence suggests improvement is needed</title>
      <link>https://www.ncas-australia.org/antibiotic-use-for-children-in-australian-hospitals-recent-evidence-suggests-improvement-is-needed</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Brendan McMullan, Arjun Rajkhowa and Karin Thursky 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://croakey.org/antibiotic-use-for-children-in-australian-hospitals-recent-evidence-suggests-improvement-is-needed/" target="_blank"&gt;&#xD;
      
           Croakey
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            )
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           B
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ased on the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://academic.oup.com/jac/advance-article/doi/10.1093/jac/dkz474/5614369" target="_blank"&gt;&#xD;
      
           latest evidence
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ,
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            around 20 percent of antibiotic prescribing for children in Australian hospitals may be deemed inappropriate.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           C
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           hildren in the 0-9 age group (along with adults in the older than 65 age group) account for the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/sites/default/files/migrated/1.2-Text-Antibiotics-dispensing-in-children-9-years-and-under.pdf" target="_blank"&gt;&#xD;
      
           highest
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           proportion of antibiotic use in Australia. While Australia has collected data about the quality of antibiotic use in hospitals annually since 2013, we have not, until recently, had detailed information about the quality of antibiotic use for hospitalised children.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ustralia has a national antibiotic prescribing quality audit program, the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.naps.org.au/Default.aspx" target="_blank"&gt;&#xD;
      
           National Antimicrobial Prescribing Survey
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;a href="https://www.naps.org.au/Default.aspx" target="_blank"&gt;&#xD;
      
            
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           (
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           NAPS), to which hospitals around the country can submit assessments of their antibiotic prescribing throughout the year. This activity contributes to a hospital’s antibiotic stewardship (or antibiotic use quality improvement) activities.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           F
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           rom a national perspective, this dataset provides information on the quality of antibiotic use across hospitals, which can be used to identify priorities for improvement efforts.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           W
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           e 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://academic.oup.com/jac/advance-article/doi/10.1093/jac/dkz474/5614369" target="_blank"&gt;&#xD;
      
           reviewed
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           the data collected through Hospital NAPS audits from 2014 to 2017 on antibiotic prescribing for children. These included over 6,000 antibiotic prescriptions for children in 253 hospitals (public and private, and major-city, regional and remote). These data came from hospitals that voluntarily participated in the program.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           W
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           e analysed this representative sample to identify how often and why antibiotics were used to treat hospitalised children, and how appropriately antibiotics were used. Appropriateness assessments take into account factors such as antibiotic choice, timing of administration, dose and duration.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antibiotic use in hospitalised children
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           I
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           n the 79 percent (4903/6219) of prescriptions where an indication (or reason for the prescription) was recorded, the most common indications were therapy for sepsis (586, 9.4% of prescriptions) and prophylaxis (preventive therapy) for the prevention of fungal infections (571, 9.4% of prescriptions, mainly in newborns and in children with compromised immune systems). Antifungal prophylaxis appeared generally to have been prescribed appropriately.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           I
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           n contrast, antibiotic use for the prevention of infections during and after surgery was assessed as appropriate in only 41 percent of cases. Surgical prophylaxis prescriptions were often assessed as inappropriate due to prolonged use (with antibiotics continued unnecessarily after the surgical operation, often for several days). In eight percent (38/459) of cases, prescriptions were assessed as inappropriate because a broad-spectrum agent was selected when it was not required.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           F
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           or community-acquired pneumonia, another common indication for antibiotic use in children, 25 percent of prescriptions were assessed as inappropriate (frequently because of the antibiotic chosen).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           P
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           rescribing quality also varied by the type of drug: for example, antiviral drugs were generally prescribed appropriately (in more than 95% of cases), whereas some very broad-spectrum antibiotics, such as those of the carbapenem class, were not used as well (60% appropriate).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A part of a bigger problem
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           T
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           he spectre of drug-resistant infections poses a serious threat to human health and society.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           T
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           he 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://amr-review.org/" target="_blank"&gt;&#xD;
      
           O’Neil report
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ,
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            commissioned by the UK government and sponsored by the Wellcome Trust in 2014, predicted that by 2050, the cost of a failure to deal with this crisis will be around US$100 trillion, with large increases in numbers of people dying from infections. The report also points out that the problem of antibiotic resistance is already causing premature deaths across the globe.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           C
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           hildren are particularly vulnerable to infections, and, while it’s important to ensure good prescribing for all age groups, until recently we have had less information about antibiotic prescribing for the treatment of infections in children, and, consequently, less of an appreciation of the magnitude of the program.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           R
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           educing unnecessary or inappropriate antibiotic prescribing for infants and children appears particularly important since emerging
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
            
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://theconversation.com/antibiotics-before-birth-and-in-early-life-can-affect-long-term-health-97778" target="_blank"&gt;&#xD;
      
           evidence
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           suggests that exposure to antibiotics before birth and in early life can affect long-term health, perhaps by killing off important ‘good’ bacteria.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Information to support good prescribing for children – what is available?
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ustralian hospitals are 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/standards/nsqhs-standards" target="_blank"&gt;&#xD;
      
           required
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           to provide doctors and other prescribers with access to guidelines for antibiotic prescribing, particularly
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
            
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.tg.org.au/" target="_blank"&gt;&#xD;
      
           Therapeutic Guidelines
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;a href="https://www.tg.org.au/" target="_blank"&gt;&#xD;
      
           :
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;a href="https://www.tg.org.au/" target="_blank"&gt;&#xD;
      
           Antibiotic
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           . These antibiotic guidelines are published independently from government and are regularly updated by an expert reviewer group.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           U
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ntil recently, however, these guidelines lacked recommendations for some important infections in children, and had no recommendations at all for infections in newborns. That changed with the most recent update in June 2019, and this is a step in the right direction. The inclusion of paediatric recommendations will hopefully support more evidence-based prescribing in hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           I
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           n primary care, however, many general practitioners do not currently use (or have access to) these guidelines.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           P
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           rescribing software used in primary care is often linked to drug company-provided 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.mims.com.au/" target="_blank"&gt;&#xD;
      
           databases
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            These list product information for drugs, including indications and doses, but the indications (or reasons for prescribing) and doses have often not been updated since the drugs were originally registered with the Therapeutic Goods Administration, often more than 20 years ago for common antibiotics. Thus, the information provided may not be up-to-date.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           F
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ollowing the recent update of Therapeutic Guidelines: Antibiotic,
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
            
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           a 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.tg.org.au/news/antibiotic-summary-table/" target="_blank"&gt;&#xD;
      
           summary table
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           of up-to-date antibiotic choice recommendations for common conditions in general practice was made freely available. Nevertheless, general practitioners must pay for a subscription to access the complete guidelines.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           O
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ther sources of information for prescribers in hospitals and primary care in Australia include guidelines from children’s hospitals such as The Royal Children’s Hospital in Melbourne. 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.nps.org.au/" target="_blank"&gt;&#xD;
      
           NPS MedicineWise
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           is an additional resource for prescribers of all types which aims to support quality use of medicines throughout Australia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           N
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ational prescribing quality audit programs can help monitor and improve antibiotic prescribing, and build capacity among clinicians through training in quality assessment and improvement.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           W
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           hile the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.naps.org.au/Default.aspx" target="_blank"&gt;&#xD;
      
           Hospital NAPS
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           program has been available nationally and undertaken annually in Australia since 2013, and while a NAPS module for aged care homes has been available nationally since 2015, we don’t have a quality assessment and improvement program in place for general practice.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           An opportunity to improve care
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ustralia is 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://insightplus.mja.com.au/2017/2/milestones-challenges-in-antimicrobial-stewardship/" target="_blank"&gt;&#xD;
      
           fortunate
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           to have nationally endorsed prescribing guidelines and large hospital audit programs that can help monitor and improve antibiotic prescribing. To a great extent, we have the resources we need to monitor and improve how we treat infections in children.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           O
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ur obligation to provide the best quality of care to children includes a responsibility to avoid unnecessary or inappropriate use of medicines, particularly when the broader long-term ramifications of such use are so deleterious.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Thu, 21 Nov 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antibiotic-use-for-children-in-australian-hospitals-recent-evidence-suggests-improvement-is-needed</guid>
      <g-custom:tags type="string">Media,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>It’s Antibiotic Awareness Week. How are we doing?</title>
      <link>https://www.ncas-australia.org/its-antibiotic-awareness-week-how-are-we-doing</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Arjun Rajkhowa
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://insightplus.mja.com.au/2019/45/its-antibiotic-awareness-week-how-are-we-doing/" target="_blank"&gt;&#xD;
      
           Medical Journal of Australia-Insight
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           )
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Identified as a key priority in Australia’s National Antimicrobial Resistance (AMR) Strategy, antimicrobial stewardship (AMS) refers to principles and practices that support better prescribing of antimicrobial drugs and the rationalisation of antimicrobial use. Stewardship programs aim to improve the safety and quality of patient care by optimising the prevention and treatment of infections.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Australia has achieved several milestones in the implementation of stewardship, including the incorporation of AMS into the National Safety and Quality Health Service Standards (and, as of 2019, aged care home accreditation standards as well), the implementation of electronic AMS systems in several hospitals nationally, and national participation in antimicrobial use reporting systems.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           There is now growing interest in building on stewardship efforts in primary care. Associate Professor Jo-Anne Manski-Nankervis, a GP and senior lecturer at the University of Melbourne, says that there is growing awareness of the need for judicious antimicrobial use in the community.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “In 2017, over four in 10 Australians had at least one antimicrobial agent dispensed by a pharmacist. Many antimicrobial prescriptions are provided for conditions that don’t always require antimicrobial treatment, [such as] upper respiratory tract infections. This is of concern. In some cases, people may experience side effects, [such as] diarrhoea and rash, without receiving any benefit from their antibiotic treatment.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “It is also important that people receive antibiotics when they do need them, at the right dose and for the right length of time.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The implementation of antimicrobial stewardship programs in hospitals has entailed multidisciplinary collaboration, primarily between infectious diseases physicians and pharmacists. Antimicrobial stewardship usually involves the monitoring and review of antimicrobial prescribing, as well as some restriction of the use of certain antimicrobial drugs. It fits within the health service quality improvement paradigm. Restrictive quality improvement interventions generally tend to be viewed with apprehension, at least until they have become part of standard practice.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Unintended consequences?
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Anecdotally, from the time efforts to combat AMR started to gather momentum in clinical practice, reservations about the restrictive and interventionist role that antimicrobial stewardship programs can play have been expressed by clinicians working in hospitals and in the community.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Stewardship should be viewed as an initiative that enhances the safety and quality of care, and not (primarily) as an initiative that counters AMR through the restriction of antimicrobial use. In fact, some experts have suggested that discussions about AMR and AMS should, in some respects, be de-linked.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Messages need to communicate the fact that antimicrobial stewardship involves a myriad of efforts – in community education, prescriber education, development of electronic resources and workflow tools, and other areas – and does not solely focus on prescription reviews.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Experts and policy makers could also consider how people conceive of interventionist quality improvement efforts more broadly, and how awareness campaigns can be honed to clarify what such efforts entail.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A crucial concern some people have is that efforts aimed at rationalising antibiotic use may come at the cost of patient safety. The concern is that, because AMR awareness campaigns and antimicrobial stewardship programs tend to emphasise the message that antimicrobials are being used suboptimally, clinicians may hesitate to prescribe antibiotics even when it is necessary for the patient to receive antibiotic treatment.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Consequently, it’s important for campaigns to emphasise the fact that antimicrobial stewardship is primarily about enhancing patient safety. It is not simply about reducing the overall consumption of antibiotics. It is about ensuring that patients who need antibiotics receive appropriate therapy, and those who do not need antibiotics are not exposed to possible side effects for no benefit and are provided with appropriate care.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Where antimicrobial stewardship programs have been implemented, such as in tertiary hospitals in Australia, generally the focus is on reviewing and refining ongoing therapy, and not on restricting empirical prescribing. Australian hospitals, particularly in New South Wales, Victoria and Queensland, have also achieved significant success in improving sepsis care while implementing AMS programs.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antibiotics can and do adversely affect individual patients. Antimicrobial stewardship is fundamentally about enhancing the appropriateness of antimicrobial therapy for the individual patient. It is about supporting prescribers to deliver the best care and using medicines optimally for patients.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In primary care research, GPs have highlighted the challenges they encounter while diagnosing infections (and trying to provide optimal treatment) and helping address patients’ concerns about their illness.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           GPs have pointed out that there is a need to increase the public’s knowledge about infectious diseases and the therapeutic utility of different antimicrobial medications. Efforts to raise awareness in the community can aim to help patients become better informed about different infections and how they may be treated, and help us better understand how and when to discuss concerns about infection (eg, if we have received a “delayed prescription” for uncomplicated acute bronchitis and our condition subsequently worsens).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           There are excellent examples of work on patient education in primary care, and clinicians are continually working on improving the resources that may be provided to patients during consultations. These resources serve to both educate and reassure. The National Centre for Antimicrobial Stewardship and the Department of General Practice at the University of Melbourne are working with GPs and the community to develop more such resources.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           How do we respond?
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           We can do more to develop awareness of the importance of appropriate antimicrobial use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           We must do more to address the sense of inevitability and helplessness that characterises the public discourse around antimicrobial resistance.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Unlike some lifestyle-related disorders, where individual lifestyle and behaviour may affect the risk of becoming ill, communicable diseases generally tend to induce fear and helplessness because we don’t believe we have the capacity to mitigate risk.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Moreover, discussions about antimicrobial use and stewardship are sometimes undermined by the notion that improvements in one sector or region will invariably be countermanded by continued misuse (and the seeming absence of antimicrobial stewardship) in other sectors or regions.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           As it may not be possible to comprehensively change practices in all sectors simultaneously, we may benefit from remaining committed to multi-pronged approaches. Collectively, doctors have an incentive to support evidence-based practices aimed at rationalising antimicrobial use locally, as local practices can influence the prevalence of drug-resistant infections. International comparisons have shown that there is an association between local antimicrobial usage and patterns of resistance. Some studies have suggested that changes in patterns of antimicrobial use within health care facilities may influence bacterial susceptibility locally. Thus, the impacts of rationalised use on rates of AMR cannot be denied.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Importantly, we can promote the idea that there are things that we can do as a community to minimise the risk of infection. Professor Kirsty Buising, an infectious diseases physician at the Royal Melbourne Hospital and the deputy director of the National Centre for Antimicrobial Stewardship at the University of Melbourne, says that infection control has a central role in controlling the fallout of AMR.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “Infection control is the first and most important step in controlling the rise of drug-resistant infections. When resistant bugs spread within facilities, our first priority is to contain this spread and to ensure that unaffected patients do not become colonised or infected. While we can incrementally change practices that contribute to AMR, in the immediate term, our priority is to ensure that infections do not spread.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “This requires improved hand hygiene and infection control in hospitals and aged care homes, safer sex practices in the community, and more.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           While most hospitals and aged care facilities in Australia have strong infection control programs, infection prevention and control strategies should always be on our radar, including across different sectors. The Australasian College for Infection Prevention and Control has contributed tremendously to AMR containment efforts in Australia. We should recognise that growing community awareness about the problem of drug-resistant infections has already contributed to substantial changes. Australia is now about to release its second National AMR Strategy.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Professor Sara Cosgrove is an infectious diseases physician at the Johns Hopkins Hospital in the US, and she spoke at the National AMR Forum at the University of Queensland and Royal Brisbane and Women’s Hospital on 7–8 November 2019. Referencing business academic John Kotter, she suggested these eight steps are key to promoting change around antimicrobial use practices:
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           • create a sense of urgency;
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           • form a powerful guiding coalition;
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           • create a compelling vision for change;
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           • communicate the vision effectively;
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           • empower others to act on the vision;
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           • plan for and create short term wins;
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           • consolidate improvements and create more change; and
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           • institutionalise the new approaches.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Our willingness to recognise and act on the issue has already had an impact on policy and practice. We must ensure that continued efforts build on this momentum.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Mon, 18 Nov 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/its-antibiotic-awareness-week-how-are-we-doing</guid>
      <g-custom:tags type="string">Media,Community</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>The right antibiotic at the right time</title>
      <link>https://www.ncas-australia.org/the-right-antibiotic-at-the-right-time</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Karin Thursky and Arjun Rajkhowa
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://pursuit.unimelb.edu.au/articles/the-right-antibiotic-at-the-right-time" target="_blank"&gt;&#xD;
      
           Pursuit
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , University of Melbourne)
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Every year, 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.who.int/news-room/events/detail/2019/11/18/default-calendar/world-antibiotic-awareness-week-2019"&gt;&#xD;
      
           Antibiotic Awareness Week
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            aims to raise awareness about the growing incidence of drug-resistant infections and the underlying phenomenon of antimicrobial resistance.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           For many years now, healthcare workers have raised awareness about the problem of antibiotic overuse and now the message has started to get some traction.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           To some extent, clinicians have succeeded in popularising the concept of antimicrobial stewardship – the practice of promoting judicious use, and reducing unnecessary or inappropriate use, of antimicrobials.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           There are two broad approaches to antimicrobial stewardship – the restrictive approach, where systems are put in place to monitor and rationalise antimicrobial prescribing, and the persuasive approach, where the hope is that education will improve decision-making.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           One of the key hurdles to implementing the restrictive approach has been a fear of sepsis.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Sepsis is the body’s overwhelming inflammatory response to infection. Many doctors fear missing sepsis, and this is not unjustified.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In a proportion of cases, sepsis can be seriously debilitating or even fatal. When severe sepsis isn’t treated in a timely manner, the consequences can be dire.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           So, the problem of antimicrobial overuse has to be balanced with the problem of missed or delayed antimicrobial therapy.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           It is, therefore, important for clinicians and healthcare workers to raise awareness about 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://insightplus.mja.com.au/2019/30/sepsis-time-for-doctors-to-get-their-house-in-order/?utm_source=InSight%2B&amp;amp;utm_campaign=d4b15603c9-EMAIL_CAMPAIGN_2019_08_02_05_15&amp;amp;utm_medium=email&amp;amp;utm_term=0_7346f35e23-d4b15603c9-43231201"&gt;&#xD;
      
           sepsis
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (and, within the healthcare system, 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://pursuit.unimelb.edu.au/articles/improving-how-we-manage-sepsis"&gt;&#xD;
      
           appropriate therapy for sepsis
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ), while talking about antimicrobial stewardship.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           There’s a need to acknowledge prescribers’ fears about missing sepsis.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           This represents the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://qualitysafety.bmj.com/content/28/9/758"&gt;&#xD;
      
           other side
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            of the coin, where the focus of the awareness-raising activity is on promoting prompt and appropriate recognition of sepsis and commencement of therapy in hospitals. In the community, we need people to recognise that sometimes we do require urgent care and shouldn’t delay seeking treatment.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Both antimicrobial stewardship and sepsis care improvement initiatives focus on the importance of patient safety.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Sepsis accounts for a large proportion of in-hospital mortality in Australia and around the world.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Sometimes, by the time that patients arrive in hospital with sepsis, it is already too late. Sometimes, as an 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.abc.net.au/4corners/health-hazard/11493580"&gt;&#xD;
      
           ABC Four Corners episode
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            showed earlier this year, even after the patient has arrived at the hospital, the signs and symptoms of sepsis are missed, and the patient deteriorates.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           There are complex reasons for this.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           It may be 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871479/"&gt;&#xD;
      
           difficult
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            to recognise the signs of sepsis, and there can be a lot of variation in how different clinicians and health services manage sepsis.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           But there appears to be increasing awareness of sepsis in the community.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In 2016, an Australian 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.georgeinstitute.org.au/media-releases/survey-reveals-the-common-killer-most-australians-have-never-heard-of"&gt;&#xD;
      
           survey
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            showed that less than half of the people involved had heard of sepsis, and only a very small proportion recognised fever, rigors, rapid breathing, rapid heart rate and delirium as signs of sepsis.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Since then, a considerable amount of media coverage about sepsis seems to have built up a greater awareness about the condition in the community.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Importantly, sepsis care improvement and antimicrobial stewardship go hand-in-hand. Both are about enhancing the safety and quality of the treatment of infection.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           When sepsis recognition and treatment are standardised, and this standardisation is embedded within the antimicrobial stewardship program, the de-escalation of therapy (the review and alteration of treatment in accordance with a patient’s microbiology results) can be properly managed.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           There is some concern that promoting faster initiation of therapy may have the unintended consequence of over-treating patients and this is a legitimate concern.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           This is why embedding antimicrobial stewardship goals – like the promotion of appropriate antimicrobial use – within 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://bmjopenquality.bmj.com/content/7/3/e000355"&gt;&#xD;
      
           sepsis care initiatives
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            is important.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Australian hospitals have made commendable progress in trialling system-wide initiatives to standardise and improve sepsis care – 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.cec.health.nsw.gov.au/patient-safety-programs/adult-patient-safety/sepsis-kills"&gt;&#xD;
      
           New South Wales
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.bettercare.vic.gov.au/our-work/innovation-fund/scaling-projects/sepsis-scaling"&gt;&#xD;
      
           Victoria
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            and 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://clinicalexcellence.qld.gov.au/events/sepsis-breakthrough-collaborative"&gt;&#xD;
      
           Queensland
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            have all trialled state-wide initiatives.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.bettersafercare.vic.gov.au/news-and-media/improving-the-management-of-sepsis-across-victoria"&gt;&#xD;
      
           Victorian sepsis pathway program
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            focused on standardising and improving sepsis recognition and treatment across 11 health services in Victoria, and it generated 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.bettercare.vic.gov.au/NewsAndEvents/News/saving-lives-innovations-sepsis-mgmt"&gt;&#xD;
      
           encouraging results
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , including significant improvements in appropriate commencement of therapy in hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The program results included a 50 per cent decrease in mortality, a 34 per cent decrease in admissions to intensive care units (ICU), and improved time-to-treatment and quality of prescribing.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The results also showed a six-fold return on investment, with $A11.7 million saved through fewer ICU admissions and reduced length of stay.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           So, a nationally consistent and coordinated approach can be beneficial, and there have now been 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.mja.com.au/journal/2019/211/9/who-resolution-sepsis-what-action-needed-australia"&gt;&#xD;
      
           calls
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            for a nation-wide sepsis initiative.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           We saw this with antimicrobial stewardship.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Clinicians and policymakers in Australia actively promoted the idea that there was a need for strategies to promote the careful use of antimicrobials within hospitals (to begin with).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The problem of rising rates of drug-resistant infections needed to be arrested and managed carefully, and one of the ways to do this was to rationalise antimicrobial use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Australia developed 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/sites/default/files/migrated/Antimicrobial-stewardship-in-Australian-Hospitals-2011.pdf"&gt;&#xD;
      
           educational
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.nps.org.au/"&gt;&#xD;
      
           resources
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/18550680"&gt;&#xD;
      
           electronic workflow tools
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/clinical-care-standards/antimicrobial-stewardship-clinical-care-standard"&gt;&#xD;
      
           clinical care standards
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/standards/nsqhs-standards/assessment-nsqhs-standards"&gt;&#xD;
      
           hospital accreditation criteria
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , a 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.amr.gov.au/australias-response/national-amr-strategy"&gt;&#xD;
      
           national action plan
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            and a 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.amr.gov.au/australias-response/objective-3-surveillance-amr-and-antibiotic-usage"&gt;&#xD;
      
           surveillance system
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            to address this need.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           We are still some way away from the goal of ensuring that all clinical settings – from tertiary hospitals to primary care clinics in the human health sector – have adequate support to promote the judicious use of antimicrobials.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           But we have made some progress, and it’s worthwhile acknowledging how we got here.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Improving the quality of care and enhancing patient safety are the bedrock of both antimicrobial stewardship and sepsis care improvement, and, as clinical programs in Victoria have shown, developing both concurrently can support better infection management.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Thu, 14 Nov 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/the-right-antibiotic-at-the-right-time</guid>
      <g-custom:tags type="string">Media,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Influences on surgical antimicrobial prophylaxis decision making by surgical craft groups, anaesthetists, pharmacists and nurses in public and private hospitals</title>
      <link>https://www.ncas-australia.org/influences-on-surgical-antimicrobial-prophylaxis-decision-making-by-surgical-craft-groups-anaesthetists-pharmacists-and-nurses-in-public-and-private-hospitals</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Courtney Ierano, Karin Thursky, Trisha Peel, Arjun Rajkhowa, Caroline Marshall and Darshini Ayton
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Surgical antimicrobial prophylaxis (SAP) is a leading indication for antibiotic use in the hospital setting, with demonstrated high rates of inappropriateness. Decision-making for SAP is complex and multifactorial. A greater understanding of these factors is needed to inform the design of targeted antimicrobial stewardship interventions and strategies to support the optimization of SAP and its impacts on patient care.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : A qualitative case study exploring the phenomenon of SAP decision-making. Focus groups were conducted with surgeons, anaesthetists, theatre nurses and pharmacists across one private and two public hospitals in Australia. Thematic analysis was guided by the Theoretical Domains Framework (TDF) and the Capabilities, Opportunities, Motivators-Behaviour (COM-B) model.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Fourteen focus groups and one paired interview were completed. Ten of the fourteen TDF domains were identified as relevant. Thematic analysis revealed six significant themes mapped to the COM-B model, and subthemes mapped to the relevant TDF domains in a combined framework. Key themes identified were: 1) Low priority for surgical antimicrobial prophylaxis prescribing skills; 2) Prescriber autonomy takes precedence over guideline compliance; 3) Social codes of prescribing reinforce established practices; 4) Need for improved communication, documentation and collection of data for action; 5) Fears and perceptions of risk hinder appropriate SAP prescribing; and 6) Lack of clarity regarding roles and accountability.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : SAP prescribing is a complex process that involves multiple professions across the pre-, intra- and post-operative surgical settings. The utilisation of behaviour change frameworks to identify barriers and enablers to optimal SAP prescribing supports future development of theory-informed antimicrobial stewardship interventions. Interventions should aim to increase surgeon engagement, enhance the prioritisation of and accountability for SAP, and address the underlying social factors involved in SAP decision-making, such as professional hierarchy and varied perceptions or risks and fears.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1371/journal.pone.0225011" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Ierano, C., Thursky, K., Peel, T., Rajkhowa, A., Marshall, C., Ayton, D. (2019). Influences on surgical antimicrobial prophylaxis decision making by surgical craft groups, anaesthetists, pharmacists and nurses in public and private hospitals. PLoS One, 14(11), e0225011. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1371/journal.pone.0225011" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1371/journal.pone.0225011
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1516841273335-e39b37888115.jpg" length="136625" type="image/jpeg" />
      <pubDate>Wed, 13 Nov 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/influences-on-surgical-antimicrobial-prophylaxis-decision-making-by-surgical-craft-groups-anaesthetists-pharmacists-and-nurses-in-public-and-private-hospitals</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper,Surgical</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1516841273335-e39b37888115.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1516841273335-e39b37888115.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Appropriateness of surgical antimicrobial prophylaxis practices in Australia</title>
      <link>https://www.ncas-australia.org/appropriateness-of-surgical-antimicrobial-prophylaxis-practices-in-australia</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Courtney Ierano, Karin Thursky, Caroline Marshall, Sonia Koning, Rod James, Sandra Johnson, Nabeel Imam, Leon J. Worth and Trisha Peel
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Key points
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Question
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : What are the current surgical antimicrobial prophylaxis prescribing practices in Australia, and what factors are associated with their appropriateness?
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Findings
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : This quality improvement study of 9351 surgical episodes found high rates of inappropriate procedural and postprocedural antimicrobial use across various hospital, patient, and surgical factors. The most common reason for inappropriate procedural use was incorrect timing, while duration greater than 24 hours was the most common reason for inappropriate postprocedural use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Meaning
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : These findings suggest that the identified hospital, patient, and surgical factors should be considered as targets for development of tailored interventions to ensure appropriateness of surgical antimicrobial prophylaxis prescriptions.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Importance
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Surgical antimicrobial prophylaxis (SAP) is a common indication for antibiotic use in hospitals and is associated with high rates of inappropriateness.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Objectiv
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           e
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : To describe the SAP prescribing practices and assess hospital, surgical, and patient factors associated with appropriate SAP prescribing.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Design, setting, and participants
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Multicenter, national, quality improvement study with retrospective analysis of data collected from Australian hospitals via Surgical National Antimicrobial Prescribing Survey audits from January 1, 2016, to June 30, 2018. Data were analyzed using multivariable logistic regression. Crude estimates of appropriateness were adjusted for factors included in the model by calculating estimated marginal means and presented as adjusted-appropriateness with 95% confidence intervals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Main outcomes and measures
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Adjusted appropriateness and factors associated with inappropriate prescriptions.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : A total of 9351 surgical episodes and 15 395 prescriptions (10 740 procedural and 4655 postprocedural) were analyzed. Crude appropriateness of total prescriptions was 48.7% (7492 prescriptions). The adjusted appropriateness of each surgical procedure group was low for procedural SAP, ranging from 33.7% (95% CI, 26.3%-41.2%) for dentoalveolar surgery to 68.9% (95% CI, 63.2%-74.5%) for neurosurgery. The adjusted appropriateness of postprocedural prescriptions was also low, ranging from 21.5% (95% CI, 13.4%-29.7%) for breast surgery to 58.7% (95% CI, 47.9%-69.4%) for ophthalmological procedures. The most common reason for inappropriate procedural SAP was incorrect timing (44.9%), while duration greater than 24 hours was the most common reason for inappropriate postprocedural SAP (54.3%).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions and relevance:
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            High rates of inappropriate procedural and postprocedural antimicrobial use were demonstrated across all surgical specialties. Reasons for inappropriateness, such as timing and duration, varied according to the type of SAP and surgical specialty. These findings highlight the need for improvement in SAP prescribing and suggest potential targeted areas for action.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2754258" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Ierano, C., Thursky, K., Marshall, C., Koning, S., James, R., Johnson, S., Imam, N., Worth, L., Peel, T. (2019). Appropriateness of surgical antimicrobial prophylaxis practices in Australia. JAMA Network Open, 2(11), e1915003-e1915003. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1001/jamanetworkopen.2019.15003" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1001/jamanetworkopen.2019.15003
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Surgical_NAPS.jpg" length="34430" type="image/jpeg" />
      <pubDate>Fri, 08 Nov 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/appropriateness-of-surgical-antimicrobial-prophylaxis-practices-in-australia</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper,Surgical,NAPS,NAPS publications</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Surgical_NAPS.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Surgical_NAPS.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Veterinary Workshop: National Antimicrobial Resistance and Stewardship Forum 2019</title>
      <link>https://www.ncas-australia.org/veterinary-workshop-national-antimicrobial-resistance-and-stewardship-forum-2019</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AMR+Forum+2019+banner.PNG"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           This veterinary workshop was delivered by NCAS (Faculty of Veterinary and Agricultural Sciences, University of Melbourne) and the School of Veterinary Science (University of Queensland) at the National AMR Forum 2019. It covered:
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Antimicrobial use and stewardship in veterinary settings 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            How antimicrobial prescribing guidelines are developed, reviewed and maintained
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            How to use the prescribing guidelines 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Dates
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           : 7 November 2019
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Venue
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           : Royal Brisbane and Women's Hospital Conference and Education Centre, Brisbane
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            See
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://cre-reduce.centre.uq.edu.au/event/session/848" target="_blank"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            .
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AMR+Forum+2019+banner.PNG" length="202181" type="image/png" />
      <pubDate>Thu, 07 Nov 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/veterinary-workshop-national-antimicrobial-resistance-and-stewardship-forum-2019</guid>
      <g-custom:tags type="string">News and events,Seminar,Veterinary</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AMR+Forum+2019+banner.PNG">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AMR+Forum+2019+banner.PNG">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antibiotic appropriateness and guideline adherence in hospitalised children: results of a nation-wide study</title>
      <link>https://www.ncas-australia.org/antibiotic-appropriateness-and-guideline-adherence-in-hospitalised-children-results-of-a-nation-wide-study</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Brendan J McMullan, Lisa Hall, Rodney James, Mona Mostaghim, Cheryl A Jones, Pamela Konecny, Christopher C Blyth and Karin A Thursky on behalf of the National Antimicrobial Prescribing Survey (NAPS)
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Information on the nature and appropriateness of antibiotic prescribing for children in hospitals is important, but scarce.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Objectives
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : To analyse antimicrobial prescribing and appropriateness, and guideline adherence, in hospitalised children across Australia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Patients and methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : We analysed data from the National Antimicrobial Prescribing Survey (NAPS) from 2014 to 2017. Surveys were performed in hospital facilities of all types (public and private; major city, regional and remote). Participants were admitted children &amp;lt;18 years old. Risk factors associated with inappropriate prescribing were explored using logistic regression models.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Among 6219 prescriptions for 3715 children in 253 facilities, 19.6% of prescriptions were deemed inappropriate. Risk factors for inappropriate prescribing included non-tertiary paediatric hospital admission [OR 1.37 (95% CI 1.20–1.55)] and non-major city hospital location [OR 1.52 (95% CI 1.30–1.77)]. Prescriptions for neonates, immunocompromised children and those admitted to an ICU were less frequently inappropriate. If a restricted antimicrobial was prescribed and not approved, the prescription was more likely to be inappropriate [OR 12.9 (95% CI 8.4–19.8)]. Surgical prophylaxis was inappropriate in 59% of prescriptions.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Inappropriate antimicrobial prescribing in children was linked to specific risk factors identified here, presenting opportunities for targeted interventions to improve prescribing. This information, using a NAPS dataset, allows for analysis of antimicrobial prescribing among different groups of hospitalised children. Further exploration of barriers to appropriate prescribing and facilitators of best practice in this population is recommended.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1093/jac/dkz474" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : McMullan, B. J., Hall, L., James, R., Mostaghim, M., Jones, C. A., Konecny, P., Blyth, C., Thursky, K. A. on behalf of the National Antimicrobial Prescribing Survey. (2019). Antibiotic appropriateness and guideline adherence in hospitalised children: Results of a nation-wide study. Journal of Antimicrobial Chemotherapy, 75(3), 738-746. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1093/jac/dkz474" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1093/jac/dkz474
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hospital_NAPS.jpg" length="33263" type="image/jpeg" />
      <pubDate>Wed, 06 Nov 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antibiotic-appropriateness-and-guideline-adherence-in-hospitalised-children-results-of-a-nation-wide-study</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper,Paediatrics,NAPS,NAPS publications</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hospital_NAPS.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hospital_NAPS.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Urinary tract infections in Australian aged care homes: antibiotic prescribing practices and concordance to national guidelines</title>
      <link>https://www.ncas-australia.org/urinary-tract-infections-in-australian-aged-care-homes-antibiotic-prescribing-practices-and-concordance-to-national-guidelines</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Leslie Dowson, Noleen Bennett, Kirsty Buising, Caroline Marshall, N. Deborah Friedman, Rhonda L. Stuart and David C.M. Kong
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Highlights
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           :
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Antibiotics for urinary tract indications were often not concordant to guidelines.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Prophylactic urinary tract infection prescriptions were infrequently reviewed.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Only 10.4% of cefalexin prescriptions for cystitis were concordant to guidelines.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Additional daily doses of cefalexin were common in cystitis treatment.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Since 2015 the Aged Care National Antimicrobial Prescribing Survey has collected and reported data on antibiotic use in Australian aged care homes (ACHs) as part of the Australian Commission on Safety and Quality in Health Care's Antimicrobial Use and Resistance in Australia project. The objective of this study was to analyse this data source with regards to prescribing for urinary tract infections (UTIs) to improve the use of antibiotics.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : This cross-sectional study analysed the 2016 and 2017 survey data. Antibiotic prescribing for urinary tract indications was compared with national guideline recommendations.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : A total of 662 antibiotic prescriptions from 247 ACHs were analysed. For all prophylactic antibiotics for UTI, 51.8% were prescribed for longer than 6 months, contrary to the guideline recommendation.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Most antibiotics prescribed for treatment (71.6%) were for cystitis. Cefalexin was most frequently selected for treatment of cystitis, with 10.4% of these prescriptions being concordant with the recommendations. Prescribing additional daily doses of cefalexin occurred in 63.2% of prescriptions.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Antimicrobial stewardship activities targeting UTI prophylaxis for durations longer than 6 months, and excessive daily doses of cefalexin to treat cystitis could yield significant reductions in unnecessary antibiotic consumption among Australian residents of ACHs.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Key words
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Long-term care, nursing home, antibacterial agents, anti-infective agents, cystitis.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.ajic.2019.08.034" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Dowson, L., Bennett, N., Buising, K., Marshall, C., Friedman, N.D., Stuart, R.L. and Kong, D.C. (2020). Urinary tract infections in Australian aged care homes: Antibiotic prescribing practices and concordance to national guidelines. American Journal of Infection Control, 48(3), 261-266. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.ajic.2019.08.034" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1016/j.ajic.2019.08.034
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1550657368-3db73991cb2c.jpg" length="115299" type="image/jpeg" />
      <pubDate>Tue, 29 Oct 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/urinary-tract-infections-in-australian-aged-care-homes-antibiotic-prescribing-practices-and-concordance-to-national-guidelines</guid>
      <g-custom:tags type="string">NCAS publications,Community,Community paper,Aged care,Aged care paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1550657368-3db73991cb2c.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1550657368-3db73991cb2c.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Leading role for nurses in antimicrobial stewardship</title>
      <link>https://www.ncas-australia.org/leading-role-for-nurses-in-antimicrobial-stewardship</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Fiona Gotterson
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.hospitalhealth.com.au/content/clinical-services/article/leading-role-for-nurses-in-antimicrobial-stewardship-900424318#axzz632UWIgBS" target="_blank"&gt;&#xD;
      
           Hospital and Healthcare
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            )
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antimicrobial stewardship (AMS) is an important element of a comprehensive infection prevention and control program. AMS aims to ensure that antimicrobials are used safely, so that people who require these medicines have the best possible outcomes. In hospital settings, AMS has been shown to improve appropriateness of antimicrobial prescribing, reduce unnecessary antimicrobial use and to positively impact rates of AMR. AMS is multidisciplinary, which means it involves all health professionals who are involved in prescribing, dispensing or administering antimicrobials. This includes nurses.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read more
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.hospitalhealth.com.au/content/clinical-services/article/leading-role-for-nurses-in-antimicrobial-stewardship-900424318#axzz632UWIgBS" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Mon, 21 Oct 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/leading-role-for-nurses-in-antimicrobial-stewardship</guid>
      <g-custom:tags type="string">Nursing,Media,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Dosing equine antimicrobials: ensuring clinical success and avoiding antimicrobial resistance</title>
      <link>https://www.ncas-australia.org/dosing-equine-antimicrobials-ensuring-clinical-success-and-avoiding-antimicrobial-resistance</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           L. Y. Hardefeldt
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Underdosing of equine antimicrobials is a global issue and may be contributing to antimicrobial resistance in horses. Recent research in Australia has identified that most antimicrobial use in peer‐reviewed literature is at a higher dose than that currently on the label for many common equine antimicrobials in the United States, the UK and Australia. These dosing regimens used are now considered the most appropriate doses to be using in horses and veterinarians treating equine patients should be aware of the contemporary dosing regimens.
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1111/eve.13190" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Hardefeldt, L. (2019). Dosing equine antimicrobials: Ensuring clinical success and avoiding antimicrobial resistance. Equine Veterinary Education. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1111/eve.13190" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1111/eve.13190
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1550785148-ace594ff7b61.jpg" length="234351" type="image/jpeg" />
      <pubDate>Mon, 07 Oct 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/dosing-equine-antimicrobials-ensuring-clinical-success-and-avoiding-antimicrobial-resistance</guid>
      <g-custom:tags type="string">NCAS publications,Equine,Veterinary,Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1550785148-ace594ff7b61.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1550785148-ace594ff7b61.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Workflow-based data solutions are required to support antimicrobial stewardship in general practice</title>
      <link>https://www.ncas-australia.org/workflow-based-data-solutions-are-required-to-support-antimicrobial-stewardship-in-general-practice</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Lesley Hawes, Lyle Turner, Kirsty L Buising and Danielle Mazza
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="http://dx.doi.org/10.1136/bmjoq-2019-000628" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          .
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    
          : Hawes, L. A., Turner, L., Buising, K. L., &amp;amp; Mazza, D. (2019). Workflow-based data solutions are required to support antimicrobial stewardship in general practice. BMJ Open Quality, 8(3), e000628. DOI:
          &#xD;
    &lt;a href="http://dx.doi.org/10.1136/bmjoq-2019-000628" target="_blank"&gt;&#xD;
      
           http://dx.doi.org/10.1136/bmjoq-2019-000628
          &#xD;
    &lt;/a&gt;&#xD;
    
          .
         &#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1460925895917-afdab827c52f.jpg" length="242353" type="image/jpeg" />
      <pubDate>Wed, 25 Sep 2019 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/workflow-based-data-solutions-are-required-to-support-antimicrobial-stewardship-in-general-practice</guid>
      <g-custom:tags type="string">NCAS publications,Community,Community paper,GP</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1460925895917-afdab827c52f.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1460925895917-afdab827c52f.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Implementation Science and Antimicrobial Stewardship</title>
      <link>https://www.ncas-australia.org/implementation-science-and-antimicrobial-stewardship</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Flyer_Implementation+science+and+antimicrobial+stewardship+1.4.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           At this seminar, Prof. Brian Oldenburg from the School of Population and Global Health at the University of Melbourne discussed implementation science methods and principles. Prof. Oldenburg's research group has prepared a WHO workbook on implementation research - 
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.who.int/ncds/governance/policies/NCD_MSA_plans/en/" target="_blank"&gt;&#xD;
      
                      
           A guide to implementation research on the prevention and control of non-communicable diseases
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           . 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Researchers from the National Centre for Antimicrobial Stewardship at the University of Melbourne and Monash University discussed the challenges of implementing antimicrobial stewardship across human and animal health settings. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Prof. Brian Oldenburg (BSc, MPsychol, PhD) is the chair of the Non-Communicable Disease Unit in the Melbourne School of Population and Global Health, University of Melbourne; director of the WHO Collaborating Centre for Implementation Research and Prevention and Control of NCDs; and director of the Centre of Research Excellence in Interactive Digital Technology to Transform Australia’s Chronic Disease Outcomes.
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Date
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           : 24 September 2019
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Venue
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           : GM002, Doherty Institute, 792 Elizabeth Street, Melbourne
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            See
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/implementation-science-seminar-2019"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            .
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Flyer_Implementation+science+and+antimicrobial+stewardship+1.4.jpg" length="129849" type="image/jpeg" />
      <pubDate>Tue, 24 Sep 2019 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/implementation-science-and-antimicrobial-stewardship</guid>
      <g-custom:tags type="string">News and events,Seminar,Hospital,Primary care,Aged care,Veterinary,Nursing</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/NCAS_RGB_whitebox-3998x5263.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Flyer_Implementation+science+and+antimicrobial+stewardship+1.4.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Surveillance and monitoring of antimicrobial resistance: limitations and lessons from the GRAM project</title>
      <link>https://www.ncas-australia.org/surveillance-and-monitoring-of-antimicrobial-resistance-limitations-and-lessons-from-the-gram-project</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Jesse Schnall, Arjun Rajkhowa, Kevin Ikuta, Puja Rao and Catrin E. Moore
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1186/s12916-019-1412-8" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    
          : Schnall, J., Rajkhowa, A., Ikuta, K., Rao, P., &amp;amp; Moore, C. E. (2019). Surveillance and monitoring of antimicrobial resistance: limitations and lessons from the GRAM project. BMC Medicine, 17(1), 176. DOI:
          &#xD;
    &lt;a href="https://doi.org/10.1186/s12916-019-1412-8" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1186/s12916-019-1412-8
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1460925895917-afdab827c52f.jpg" length="242353" type="image/jpeg" />
      <pubDate>Thu, 19 Sep 2019 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/surveillance-and-monitoring-of-antimicrobial-resistance-limitations-and-lessons-from-the-gram-project</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1460925895917-afdab827c52f.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1460925895917-afdab827c52f.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Better Care Victoria's 'Think sepsis. Act fast.'</title>
      <link>https://www.ncas-australia.org/better-care-victoria-s-think-sepsis-act-fast</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/think-sepsis.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Better Care Victoria has released an evaluation report on its ‘Think Sepsis. Act Fast.’ program, which was led by NCAS director Prof. Karin Thursky. The program has saved 52 lives and avoided 96 ICU admissions while in use at 11 Victorian health services over four months. Today is World Sepsis Day, bringing awareness to this critical health issue. Prof. Thursky has been shortlisted as a finalist for Research Australia's Health Services Research Award. Smarter use of antibiotics and other antimicrobial medicines – drawing upon data showing when and how they are being prescribed – has been a key focus of Prof. Thursky’s career. See
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.bettercare.vic.gov.au/our-work/innovation-fund/scaling-projects/sepsis-scaling" target="_blank"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            .
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/think-sepsis.jpg" length="7473" type="image/jpeg" />
      <pubDate>Fri, 13 Sep 2019 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/better-care-victoria-s-think-sepsis-act-fast</guid>
      <g-custom:tags type="string">News and events,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/think-sepsis.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/think-sepsis.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Evaluating the implementability of antibiotic surgical prophylaxis guidelines</title>
      <link>https://www.ncas-australia.org/evaluating-the-implementability-of-antibiotic-surgical-prophylaxis-guidelines</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Courtney Ierano, Darshini Ayton, Trisha Peel, Caroline Marshall and Karin Thursky
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Highlights
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           :
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Appraisal of Australian surgical antimicrobial prophylaxis guidelines implementability.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Current guidelines demonstrated overall implementability.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Facilitators such as measurability highlight the guidelines strengths.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Borderline barriers such as validity and flexibility require ongoing development.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Guideline developers/implementers should consider these factors to improve uptake.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            :
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Current Australian data highlight guideline noncompliant prescribing of antimicrobials for surgical prophylaxis. The study aim was to evaluate the implementability of the Australian national surgical prophylaxis (SAP) guidelines to identify facilitators for and barriers to compliance.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Key stakeholders appraised the surgical prophylaxis guidelines using the GuideLine Implementability Appraisal (GLIA) tool. Questions with 100% agreement for the response ‘Yes’ were identified as facilitators and those with 100% agreement for ‘No’, a barrier. Questions that did not receive 100% agreement, but had a majority (40–60%) ‘Yes’ or ‘No’ consensus were considered as borderline facilitators and barriers respectively.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Ten appraisals were completed. Guideline recommendations were rated as easily identifiable and concise and were thus facilitators for implementation. The ability to measure guideline adherence and outcomes, and recommendations that were consistent with guideline user abilities and beliefs were also identified as facilitators. Borderline facilitators related to the clarity of the recommendations and whether they were explicit in what to do and in what circumstances. Evidence quality underpinning recommendations (validity), inflexibility of recommendations (flexibility) and the lack of patient data at the point of use (computability) were identified as borderline barriers to implementation. No recommendation reached agreement as being a barrier.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusion
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : The GLIA appraisal demonstrated overall implementability of the current Australian national surgical prophylaxis guidelines. Facilitators (i.e., measurability) and borderline facilitators highlight strengths of the current guideline. Borderline barriers (i.e., validity, flexibility and computability) may negatively impact upon implementability. Guideline developers should consider these dimensions to optimise guideline uptake and consequently patient care.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Keywords
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Guideline implementability, surgical antimicrobial prophylaxis, guideline compliance.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.idh.2019.08.004" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Ierano, C., Ayton, D., Peel, T., Marshall, C., Thursky, K. (2019). Evaluating the implementability of antibiotic surgical prophylaxis guidelines. Infection, Disease and Health. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.idh.2019.08.004" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1016/j.idh.2019.08.004
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551190822-a9333d879b1f.jpg" length="209506" type="image/jpeg" />
      <pubDate>Wed, 11 Sep 2019 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/evaluating-the-implementability-of-antibiotic-surgical-prophylaxis-guidelines</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper,Surgical</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551190822-a9333d879b1f.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551190822-a9333d879b1f.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Water medication of growing pigs: sources of between-animal variability in systemic exposure to antimicrobials</title>
      <link>https://www.ncas-australia.org/water-medication-of-growing-pigs-sources-of-between-animal-variability-in-systemic-exposure-to-antimicrobials</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           S. B. Little, H. K. Crabb, A. P. Woodward, G. F. Browning and H. Billman-Jacobe 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          On many Australian commercial pig farms, groups of growing pigs are mass-medicated through their drinking water with selected antimicrobials for short periods to manage herd health. However, delivery of medication in drinking water cannot be assumed to deliver an equal dose to all animals in a group. There is substantial between-animal variability in systemic exposure to an antimicrobial (i.e. the antimicrobial concentration in plasma), resulting in under-dosing or over-dosing of many pigs. Three sources of this between-animal variability during a water medication dosing event are differences in: (1) concentration of the active constituent of the antimicrobial product in water available to pigs at drinking appliances in each pen over time, (2) medicated water consumption patterns of pigs in each pen over time, and (3) pharmacokinetics (i.e. oral bioavailability, volume of distribution and clearance between pigs and within pigs over time). It is essential that factors operating on each farm that influence the range of systemic exposures of pigs to an antimicrobial are factored into antimicrobial administration regimens to reduce under-dosing and over-dosing.
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1017/S1751731119001903" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Little, S.B., Crabb, H.K., Woodward, A.P., Browning, G.F. and Billman-Jacobe, H., 2019. Water medication of growing pigs: sources of between-animal variability in systemic exposure to antimicrobials. Animal, 13(12), 3031-3040. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1017/S1751731119001903" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1017/S1751731119001903
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1534073133331-c4b62a557083.jpg" length="317407" type="image/jpeg" />
      <pubDate>Sun, 01 Sep 2019 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/water-medication-of-growing-pigs-sources-of-between-animal-variability-in-systemic-exposure-to-antimicrobials</guid>
      <g-custom:tags type="string">NCAS publications,Pig (New Tag),Veterinary,Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1534073133331-c4b62a557083.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1534073133331-c4b62a557083.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>How to start an antimicrobial stewardship program in a hospital</title>
      <link>https://www.ncas-australia.org/how-to-start-an-antimicrobial-stewardship-program-in-a-hospital</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           M. Mendelso
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           n, A.M
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            M
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           or
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ris, K
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Thursky and C
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Pul
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ci
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ni
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Antimicrobial stewardship (AMS) describes a coherent set of actions that ensure optimal use of antimicrobials to improve patient outcomes, while limiting the risk of adverse events (including antimicrobial resistance (AMR)). Introduction of AMS programs in hospitals is part of most national action plans to mitigate AMR, yet the optimal components and actions of such a program remain undetermined.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Objectives
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : To describe how health-care professionals can start an AMS program in their hospital, the components of such a program and the evidence base for its implementation.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Sources
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : National and society-led guidelines on AMS, peer-reviewed publications and experience of AMS experts conducting AMS programs.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Content
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : We provide a step-by-step pragmatic guide to setting up and implementing a hospital AMS program in high-income or low-and-middle-income countries.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Implications
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Antimicrobial stewardship programs in hospitals are a vital component of national action plans for AMR, and have been shown to significantly reduce AMR, particularly when coupled with infection prevention and control interventions. This step-by-step guide of ‘how to’ set up an AMS program will help health-care professionals involved in AMS to optimally design and implement their actions.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.cmi.2019.08.007" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Mendelson, M., Morris, A. M., Thursky, K., Pulcini, C. (2019). How to start an antimicrobial stewardship programme in a hospital. Clinical Microbiology and Infection. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.cmi.2019.08.007" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1016/j.cmi.2019.08.007
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .  
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/hospital-building.jpg" length="113566" type="image/jpeg" />
      <pubDate>Wed, 21 Aug 2019 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/how-to-start-an-antimicrobial-stewardship-program-in-a-hospital</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/hospital-building.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/hospital-building.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Timely recommendations for addressing overuse of antibiotics</title>
      <link>https://www.ncas-australia.org/timely-recommendations-for-addressing-overuse-of-antibiotics</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Jesse Schnall, Lesley Hawes, Ruby Biezen and Arjun Rajkhowa 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://croakey.org/timely-recommendations-for-addressing-overuse-of-antibiotics/" target="_blank"&gt;&#xD;
      
           Croakey
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           )
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Community antibiotic prescribing has 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/antimicrobial-resistance/antimicrobial-use-and-resistance-australia-surveillance-system-aura/aura-2019" target="_blank"&gt;&#xD;
      
           decreased
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            for the first time since national surveillance began, yet antibiotics are still being overprescribed.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Drivers of inappropriate prescribing include unnecessary repeat prescriptions, which are often included by default through GP prescribing software; the absence of 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/antimicrobial-resistance/antimicrobial-use-and-resistance-australia-surveillance-system-aura/antimicrobial-prescribing-australian-residential-aged-care" target="_blank"&gt;&#xD;
      
           ‘review’ and ‘stop’ dates
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            on many prescriptions in aged-care homes; and the ongoing prescribing of antibiotics for typically viral conditions.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antibiotics are not recommended for influenza or acute bronchitis, yet nearly 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/antimicrobial-resistance/antimicrobial-use-and-resistance-australia-surveillance-system-aura/aura-2019" target="_blank"&gt;&#xD;
      
           50 percent and 90 percent
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            respectively of patients with these conditions receive a prescription.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           People living in the Australian community take more antibiotics than people living in many similar countries.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/antimicrobial-resistance/antimicrobial-use-and-resistance-australia-surveillance-system-aura/aura-2019" target="_blank"&gt;&#xD;
      
           2017
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , 41.5 percent of the Australian population had at least one systemic (by mouth or injected) antibiotic dispensed under the Pharmaceutical Benefits Scheme/Repatriation Pharmaceutical Benefits Scheme (PBS).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           This community use of antibiotics is 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/antimicrobial-resistance/antimicrobial-use-and-resistance-australia-surveillance-system-aura/aura-2019" target="_blank"&gt;&#xD;
      
           higher
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            than in countries such as the Netherlands, Sweden, the United Kingdom and Canada, and is 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.oecd.org/health/health-systems/health-at-a-glance-19991312.htm" target="_blank"&gt;&#xD;
      
           higher
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            than the OECD average.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The three 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/antimicrobial-resistance/antimicrobial-use-and-resistance-australia-surveillance-system-aura/aura-2019" target="_blank"&gt;&#xD;
      
           most commonly dispensed
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            antibiotics in 2017, accounting for over 50 percent of all antibiotics, were cefalexin, amoxicillin and amoxicillin–clavulanic acid.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Winter concerns
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The rate of dispensing for amoxicillin and amoxicillin–clavulanic acid is 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/antimicrobial-resistance/antimicrobial-use-and-resistance-australia-surveillance-system-aura/aura-2019" target="_blank"&gt;&#xD;
      
           higher in winter
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , with many of these antibiotics apparently being prescribed for 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.mja.com.au/journal/2017/207/2/antibiotics-acute-respiratory-infections-general-practice-comparison-prescribing" target="_blank"&gt;&#xD;
      
           acute respiratory infections
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Notably, 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.mja.com.au/journal/2017/207/2/antibiotics-acute-respiratory-infections-general-practice-comparison-prescribing" target="_blank"&gt;&#xD;
      
           85 percent of patients
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            with acute bronchitis/bronchiolitis received an antibiotic prescription, whereas antibiotics are not recommended for these conditions; 41 percent of patients presenting with acute rhinosinusitis received an antibiotic prescription, but less than nine percent of these patients would require an antibiotic. Higher than recommended 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.mja.com.au/journal/2017/207/2/antibiotics-acute-respiratory-infections-general-practice-comparison-prescribing" target="_blank"&gt;&#xD;
      
           prescribing rates
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            were also seen with acute otitis media, and acute pharyngitis or tonsillitis.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Our use of broad-spectrum antibiotics, such as cefalexin and amoxicillin–clavulanic acid, is also 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/31207679" target="_blank"&gt;&#xD;
      
           higher
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            than in many European countries, where narrow-spectrum penicillins are the most frequently prescribed antibiotics.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           GPs’ 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/wp-content/uploads/2019/05/AURA-2019-Report.pdf" target="_blank"&gt;&#xD;
      
           resource constraints
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            may serve as crucial contributors to inappropriate prescribing. Inadequate doctor-patient communication, the lack of time and resources, and diagnostic uncertainty all push GPs to prescribe antimicrobial drugs inappropriately.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Surveys of 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://bmjopen.bmj.com/content/8/3/e020439" target="_blank"&gt;&#xD;
      
           Australian GPs
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            are also consistent with 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://academic.oup.com/jac/article/70/9/2465/722814" target="_blank"&gt;&#xD;
      
           international studies
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            that have found that despite widespread understanding of the threat of resistance, GPs underestimate their own contribution to the problem.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Targeted initiatives
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Turning the tide on inappropriate prescribing will require targeted initiatives to shift these behaviours.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;a href="https://tgldcdp.tg.org.au/fulltext/quicklinks/GPSummary_v9.pdf" target="_blank"&gt;&#xD;
      
           Therapeutic Guidelines
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            has updated its antibiotic prescribing guidelines in 2019, and, to assist GPs, has released a 2-page summary table for the management of common conditions in primary care.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Efforts must also focus on correcting patient misperceptions.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Both 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://academic.oup.com/jac/article/71/1/27/2363966" target="_blank"&gt;&#xD;
      
           international
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           and 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://bmjopen.bmj.com/content/9/3/e026735" target="_blank"&gt;&#xD;
      
           Australian
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://academic.oup.com/jac/article/71/1/27/2363966" target="_blank"&gt;&#xD;
      
           studies
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            suggest that while most patients understand the role of antibiotics in driving resistance, they often minimise their vulnerability to, and contribution toward, drug-resistant infections.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           While there have been public health campaigns to raise awareness about the over-prescribing of antibiotics in the community, 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/25712495" target="_blank"&gt;&#xD;
      
           expectations
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            for antibiotics for common infections, especially for upper respiratory tract infections, are still widespread.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           However, some patients have 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://bmcfampract.biomedcentral.com/articles/10.1186/s12875-019-0936-5" target="_blank"&gt;&#xD;
      
           expressed
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           that they do not necessarily want antibiotics, but would like reassurance that the infection is not serious, suggesting there may be some dissonance between the views and perceptions of doctors and patients.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Encouraging 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://bjgp.org/content/66/642/e40" target="_blank"&gt;&#xD;
      
           better communication
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            between GPs and patients to better understand patient concerns, and public education about appropriate use of antibiotics, may reduce unnecessary antibiotics prescribing in the community.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Educational strategies
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In Australia, a 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://medicinetoday.com.au/2019/april/regular-series/antimicrobial-stewardship-community-understanding-data" target="_blank"&gt;&#xD;
      
           number of programs
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           report on antimicrobial use in the community. This data can be incorporated into clinical education sessions. Where information on guideline-discordant prescribing is available, this can be incorporated into discussions about potential antimicrobial stewardship strategies.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Members of the community should be educated at all opportunities by GPs, pharmacists and other community health workers on 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/infections-bacterial-and-viral" target="_blank"&gt;&#xD;
      
           common infections
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , and encouraged to follow doctors’ recommendations about treatment decisions and antibiotic courses.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Patient information 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/sites/default/files/migrated/Patient-Decision-Aid-Acute-bronchitis-Nov-2016.pdf" target="_blank"&gt;&#xD;
      
           resources
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            focused on common infections can be used in consultations and may help reassure patients.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Patients should be provided with information on how they can recognise the signs and symptoms of deterioration and follow up if required.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The inclusion of indications in medication records enables effective auditing, and can potentially facilitate quality improvement actions.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Aged care home prescriptions should include information about ‘review’ and ‘stop’ dates, which may help avert unnecessary prolongation of treatment or prophylaxis.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Where possible, access to antibiotic guidelines should be provided to all prescribers.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Tue, 13 Aug 2019 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/timely-recommendations-for-addressing-overuse-of-antibiotics</guid>
      <g-custom:tags type="string">Media,Community</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>How do general practitioners access guidelines and utilise electronic medical records to make clinical decisions on antibiotic use? Results from an Australian qualitative study</title>
      <link>https://www.ncas-australia.org/how-do-general-practitioners-access-guidelines-and-utilise-electronic-medical-records-to-make-clinical-decisions-on-antibiotic-use-results-from-an-australian-qualitative-study</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Ruby Biezen, Cassandra Roberts, Kirsty Buising, Karin Thursky, Douglas Boyle, Phyllis Lau, Malcolm Clark and Jo-Anne Manski-Nankervis
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Objective
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : This study aimed to explore how general practitioners (GPs) access and use both guidelines and electronic medical records (EMRs) to assist in clinical decision-making when prescribing antibiotics in Australia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Design
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : This is an exploratory qualitative study with thematic analysis interpreted using the Theory of Planned Behaviour (TPB) framework.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Setting
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : This study was conducted in general practice in Victoria, Australia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Participants
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Twenty-six GPs from five general practices were recruited to participate in five focus groups between February and April 2018.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : GPs expressed that current EMR systems do not provide clinical decision support to assist with antibiotic prescribing. Access and use of guidelines were variable. GPs who had more clinical experience were less likely to access guidelines than younger and less experienced GPs. Guideline use and guideline-concordant prescribing was facilitated if there was a practice culture encouraging evidence-based practice. However, a lack of access to guidelines and perceived patients’ expectation and demand for antibiotics were barriers to guideline-concordant prescribing. Furthermore, guidelines that were easy to access and navigate, free, embedded within EMRs and fit into the clinical workflow were seen as likely to enhance guideline use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Current barriers to the use of antibiotic guidelines include GPs’ experience, patient factors, practice culture, and ease of access and cost of guidelines. To reduce inappropriate antibiotic prescribing and to promote more rational use of antibiotic in the community, guidelines should be made available, accessible and easy to use, with minimal cost to practicing GPs. Integration of evidence-based antibiotic guidelines within the EMR in the form of a clinical decision support tool could optimise guideline use and increase guideline-concordant prescribing.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://dx.doi.org/10.1136/bmjopen-2018-028329" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Biezen, R., Roberts, C., Buising, K., Thursky, K., Boyle, D., Lau, P., Clark, C., Manski-Nankervis, J.A. (2019). How do general practitioners access guidelines and utilise electronic medical records to make clinical decisions on antibiotic use?. Results from an Australian qualitative study. BMJ Open, 9(8). DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://dx.doi.org/10.1136/bmjopen-2018-028329" target="_blank"&gt;&#xD;
      
           http://dx.doi.org/10.1136/bmjopen-2018-028329
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1586780807983-950860a50ece.jpg" length="128536" type="image/jpeg" />
      <pubDate>Sun, 04 Aug 2019 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/how-do-general-practitioners-access-guidelines-and-utilise-electronic-medical-records-to-make-clinical-decisions-on-antibiotic-use-results-from-an-australian-qualitative-study</guid>
      <g-custom:tags type="string">NCAS publications,Community,Community paper,GP</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1586780807983-950860a50ece.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1586780807983-950860a50ece.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Inappropriate antibiotics: patient attitudes critical</title>
      <link>https://www.ncas-australia.org/inappropriate-antibiotics-patient-attitudes-critical</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Arjun Rajkhowa and Jesse Schnall
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://insightplus.mja.com.au/2019/29/inappropriate-antibiotics-patient-attitude-critical/" target="_blank"&gt;&#xD;
      
           Medical Journal of Australia-Insight
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           )
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The UK has published the next iteration of its 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.gov.uk/government/publications/uk-5-year-action-plan-for-antimicrobial-resistance-2019-to-2024"&gt;&#xD;
      
           national strategy
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            to tackle antimicrobial resistance (AMR), and 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.amr.gov.au/australias-response/national-amr-strategy"&gt;&#xD;
      
           Australi
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           a
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
            is on the verge of doing the same. This has been, and will continue to be, an enormous undertaking, one that will hopefully help sustain the considerable efforts on managing and containing AMR that both countries have made in the past 5 years.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In both countries, and in many others, community prescribing (rather than hospital prescribing) 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://academic.oup.com/jac/article/73/suppl_2/ii2/4841822"&gt;&#xD;
      
           accounts
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            for the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/sites/default/files/migrated/AURA-2017-Second-Australian-report-on-Antimicrobial-Use-and-Resistance-in-human-health.pdf"&gt;&#xD;
      
           largest proportion
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            of antimicrobial use. Yet, while 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://bsac.org.uk/practical-guide-to-antimicrobial-stewardship-in-hospitals/"&gt;&#xD;
      
           UK
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            and 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/antimicrobial-stewardship/antimicrobial-stewardship-australian-health-care-2018"&gt;&#xD;
      
           Australian
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            hospitals have made significant progress through the establishment and operationalisation of frameworks and systems for the optimisation of antimicrobial use, the community has, arguably, 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://theconversation.com/factcheck-is-australias-use-of-antibiotics-in-general-practice-20-above-the-oecd-average-68657"&gt;&#xD;
      
           lagged behind
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Consequently, 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://medicinetoday.com.au/2019/april/regular-series/antimicrobial-stewardship-community-understanding-data"&gt;&#xD;
      
           initiatives to support GPs
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            to better manage infections in the community and to augment public awareness about appropriate antibiotic use are gaining greater prominence.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Patient attitudes can shape clinical decisions
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Public awareness is a key area of focus in the UK’s current strategy and will be one in Australia’s 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.amr.gov.au/australias-response/objective-1-communication-education-and-training"&gt;&#xD;
      
           next strategy
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            too. This emphasis on community awareness is crucial, because it can substantially affect how medicines are used.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A large 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://wellcome.ac.uk/sites/default/files/exploring-consumer-perspective-on-antimicrobial-resistance-jun15.pdf"&gt;&#xD;
      
           2015 UK survey
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            identified alarming public misconceptions about antibiotics. Some participants reported that they tended to think of antibiotics as a panacea for severe infections in general (rather than a targeted treatment for a specific subset of severe infections).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The survey indicated that severity, rather than type, of infection was a crucial determinant of some people’s approach to antibiotic use. Respondents reported that they would visit their GPs expecting to receive effective medication for severe illness. Antibiotics were perceived as being effective against, and appropriate for, severe illness, irrespective of the cause.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Doctors have 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://bmjopen.bmj.com/content/6/10/e012244"&gt;&#xD;
      
           reported
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            that such preconceptions play a crucial role in their decision making when prescribing antibiotics. The pressure to meet perceived patient expectations – to assuage patients’ fears and provide treatment that would be seen to justify the consultation – is significant. This predicament is exacerbated by limitations to diagnostic testing and the fear of missing potentially serious infections, which increase the incentive to prescribe antibiotics.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           While some patients appear to overestimate the therapeutic utility of antibiotics, many concurrently underestimate the public health threat of drug resistance. A 2019 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.kff.org/other/press-release/poll-most-americans-see-antibiotic-resistance-as-public-health-problem-nearly-half-have-not-taken-antibiotics-as-prescribed/"&gt;&#xD;
      
           American survey
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            has highlighted insufficient public concern about the problem of antibiotic overuse, with only just over half of respondents agreeing that this is a major problem. While most respondents reported knowing about the problem of drug-resistant infections, many did not appreciate the individual level risks posed by resistance and reported not taking antibiotics as prescribed.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antimicrobial stewardship
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Research on 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://bsac.org.uk/antimicrobial-stewardship-from-principles-to-practice-e-book/"&gt;&#xD;
      
           antimicrobial stewardship
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            – a broad range of principles and practices that aim to promote optimal use of antimicrobial medicines – has suggested that a few simple strategies could potentially reduce unwarranted antimicrobial utilisation while addressing doctors’ and patients’ concerns.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In the community, the practice of 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/28881007"&gt;&#xD;
      
           delayed prescribing
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            – whereby patients are asked to only fill a prescription if symptoms worsen – may be effective for conditions such as upper respiratory tract infections, which currently account for a large proportion of community antibiotic prescribing. Patients with conditions such as 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/11255901"&gt;&#xD;
      
           acute bronchitis
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , for which national guidelines do not recommend antibiotics, may find this strategy acceptable when implemented, though some studies have identified 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-017-4813-7"&gt;&#xD;
      
           mixed
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            patient preconceptions about the practice.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Shifting patient awareness
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Awareness campaigns by health care and governmental groups play a key role in supporting antimicrobial stewardship practices. Recent 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://antibioticguardian.com/"&gt;&#xD;
      
           initiatives in the U
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           K
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
            and elsewhere have been influential, primarily serving to augment pressure on medical and veterinary stakeholders to devise concrete methods to commit to (and demonstrate) more effective use of antimicrobial drugs. This awareness-raising effort sends an important message to the public, carrying the potential to positively affect community behaviour and expectations.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In contrast to evidence from the UK, 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://bmcfampract.biomedcentral.com/articles/10.1186/s12875-019-0936-5"&gt;&#xD;
      
           recent research
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            from Australia suggests that some patients do not necessarily expect to receive a prescription for antibiotics when they present to their GP with an infection. While doctors may perceive this expectation, patients often have other expectations, including that they will receive a diagnosis, prognosis and reassurance.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Community awareness of the threat of drug-resistant infections is shifting palpably, and while further research will help illuminate how this is influencing medical consultations, it is clear the issue is gaining public visibility.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           An alarming global presence
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Since the United Nations General Assembly 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.who.int/antimicrobial-resistance/events/UNGA-meeting-amr-sept2016/en/"&gt;&#xD;
      
           convened
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            to discuss the issue of AMR in 2016, media reporting on the issue has 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.idhjournal.com.au/article/S2468-0451(18)30142-1/fulltext"&gt;&#xD;
      
           continued apace
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           . And while the volume and 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.tandfonline.com/doi/abs/10.1080/17441692.2017.1336248?journalCode=rgph20"&gt;&#xD;
      
           quality
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            of AMR media reporting can vary across time and context, it has likely contributed significantly to growing community awareness about the threat of drug-resistant infections.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Social media commentary can range from the benign to the alarmist, with AMR at times perceived as yet another type of “doomsday scenario” confronting the planet. Discussions on Reddit, a social commentary site, see AMR mentioned not-infrequently on both science-focused and unrelated threads, evincing both sincere and facetious concerns about its ramifications.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           This can partly be attributed to the alarmist tenor of media discourse around “
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://link.springer.com/chapter/10.1057/9780230594647_10"&gt;&#xD;
      
           superbugs
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ” – with reports typically focusing on outbreaks and new discoveries about highly resistant strains of bacteria. Such reporting practices can be provocative, relying on fear-based messaging.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Clinicians and scientists have expressed their 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.nature.com/news/antibiotic-resistance-has-a-language-problem-1.21915#/b5"&gt;&#xD;
      
           reservations
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            about these trends, arguing that fear alone cannot support more meaningful discussion – and action – on AMR. Fear-based messaging, as also seen in the public discourse around 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://theconversation.com/climate-change-or-climate-crisis-to-really-engage-people-the-media-should-talk-about-solutions-118004"&gt;&#xD;
      
           climate change
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , can induce a sense of helplessness and, eventually, apathy.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Yet, while an exclusive focus on outbreaks and highly virulent drug-resistant pathogens can be counterproductive, alarmist language has also been 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://insightplus.mja.com.au/2017/21/war-on-superbugs-articulating-the-crisis-of-antimicrobial-resistance/"&gt;&#xD;
      
           effectively used
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            to rally support for government action on AMR.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           With the second Australian national strategy for AMR under preparation, some media reports have featured discussions about impending “
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.theaustralian.com.au/nation/government-crackdown-on-abuse-of-antibiotics/news-story/5199f8dcfadf09f6d292b18aa9f499d3"&gt;&#xD;
      
           crackdowns
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ” on antimicrobial prescribing.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Though the details of specific policy interventions are yet to be finalised, the impact of tough, direct interventions and hard-line messaging on AMR must be watched carefully.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Moving forward
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           All efforts aimed at optimising antimicrobial use are premised on the principle that prescribers must be 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://insightplus.mja.com.au/2017/2/milestones-challenges-in-antimicrobial-stewardship/"&gt;&#xD;
      
           better supported
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            to achieve best outcomes. This is the motivation that animates most work in this area.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Any programs and policy interventions that are supported by national AMR strategies must be underpinned by this principle. This will ensure that both prescribers and consumers feel confident about managing infections better.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Mon, 29 Jul 2019 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/inappropriate-antibiotics-patient-attitudes-critical</guid>
      <g-custom:tags type="string">Media,Community</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Stronger action to curb overuse of antibiotics</title>
      <link>https://www.ncas-australia.org/stronger-action-to-curb-overuse-of-antibiotics</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Arjun Rajkhowa and Jesse Schnall
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://pursuit.unimelb.edu.au/articles/stronger-action-to-curb-overuse-of-antibiotics" target="_blank"&gt;&#xD;
      
           Pursuit
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            , University of Melbourne)
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The inappropriate use of antibiotics and other antimicrobial drugs in Australia is continuing to fuel 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="file:///C:/Users/arajkhowa/Dropbox/aaNHMRC%20CRE%20NCAS/NCAS%20ADMIN/COMMS/Media/Articles/AR%20-%20drafts/AMR%20Strategy/While%20the%20decline%20in%20overall%20prescribing%20rates%20is%20a%20positive%20step,%20inappropriate%20prescribing%20practices%20persist.%20A%20large%20percentage%20of%20patients%20from%20participating%20MedicineInsight%20practices%20were%20prescribed%20antibiotics%20for%20conditions%20for%20which%20there"&gt;&#xD;
      
           a growing crisis of drug-resistant infections
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           And 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.theaustralian.com.au/nation/government-crackdown-on-abuse-of-antibiotics/news-story/5199f8dcfadf09f6d292b18aa9f499d3"&gt;&#xD;
      
           reports
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            that the Federal Government is moving to crack down on unnecessary prescription repeats indicate that it’s willing to take steps to address the problem.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           But a far broader package of policy interventions is needed to help manage and contain the problem of drug-resistant infections.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           For example, research at the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncas-australia.org/"&gt;&#xD;
      
           National Centre for Antimicrobial Stewardship
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (NCAS), based at the University of Melbourne, Royal Melbourne Hospital and Monash University, has found that many GPs simply don’t have access to key guidelines, which require paid subscriptions.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “The 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.racgp.org.au/"&gt;&#xD;
      
           Royal Australian College of General Practitioners
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (RACGP) Standards indicate that the use of guidelines, like the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.tg.org.au/"&gt;&#xD;
      
           Therapeutic Guidelines
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , is considered standard practice. But in one of our pilot studies, one quarter of practices didn’t have access to them,” says Dr Jo-Anne Manski-Nankervis, a general practitioner and researcher at the University of Melbourne’s Department of General Practice.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “Any barriers to their accessibility and use must be explored and remedied.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Dr Manski-Nankervis says guidelines could also be better integrated into the clinical workflow.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “Our qualitative work has identified that GPs want computerised decision-support incorporating guidelines integrated with electronic medical records in a way that fits within the clinical workflow. So, we are co-designing clinical decision-support tools with GPs to try to address this gap.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antimicrobial resistance is a natural phenomenon where microbes develop immunity to medications, making certain infections difficult or impossible to treat.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           This process is significantly accelerated by the increasing use of antimicrobials in humans, animals and the environment which, while killing off susceptible bugs, helps resistant bugs to proliferate more easily.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           While antibiotic prescribing in the community has 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/aura-2019/"&gt;&#xD;
      
           decreased
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            for the first time since national surveillance commenced, antibiotics are apparently still being overprescribed.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Unnecessary antibiotic repeats may be a key contributor to this issue.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Repeat prescriptions filled within 10 days generally represent an appropriate continuation of the original antibiotic treatment. But those filled after this time-period are more likely to be associated with inappropriate use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Part of the problem is that some prescribing software packages used by GPs generally include repeats for antibiotic prescriptions by default. Simply removing default repeats could help to curb misuse.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Yet, default repeats represent only one potential target for better antimicrobial stewardship in the community.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antibiotics 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/wp-content/uploads/2019/05/AURA-2019-Report.pdf"&gt;&#xD;
      
           continue to be prescribed
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            for typically viral conditions like sinus, ear and upper respiratory tract infections, for which they are generally not recommended in the national guidelines.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           For 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/sites/default/files/2019-06/AURA-2019-Information-Sheet-At-a-Glance%20%281%29.pdf"&gt;&#xD;
      
           example
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , over 50 per cent of patients with influenza and 90 per cent of patients with acute bronchitis receive antibiotics when antibiotics aren’t recommended for these conditions.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/antimicrobial-resistance/antimicrobial-use-and-resistance-australia-surveillance-system-aura/antimicrobial-prescribing-australian-residential-aged-care"&gt;&#xD;
      
           Aged care homes
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , where infections are thought to be common and prescription numbers are high, appear to have high rates of sub-optimal prescribing. A large number of prescriptions don’t include ‘review’ and ‘stop’ dates, potentially leading to prolonged and unnecessary treatment.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           It’s neither possible, nor desirable, to eliminate all prescribing outside the guidelines.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Indeed, in some instances, giving antibiotics against guideline recommendations may be justified, as may be the case for complex patients with weakened immune systems.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           But these cases are a minority, and don’t explain the observed high level of prescribing that goes against recommendations.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           As the gatekeepers of community medical care, GPs can contribute substantially to reversing this trend.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/wp-content/uploads/2019/05/AURA-2019-Report.pdf"&gt;&#xD;
      
           Numerous factors
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            push GPs to prescribe antimicrobial drugs, including time pressure, poor communication with patients and uncertain diagnoses.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/wp-content/uploads/2019/05/AURA-2019-Report.pdf"&gt;&#xD;
      
           GPs’ attitudes and beliefs
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            about antibiotic resistance are also a factor. 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://bmjopen.bmj.com/content/8/3/e020439"&gt;&#xD;
      
           Australian surveys
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            echo the findings of 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://academic.oup.com/jac/article/70/9/2465/722814"&gt;&#xD;
      
           international studies
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , which indicate that while most GPs accept the seriousness of resistant infections and know of strategies to reduce them, they tend to perceive other health professionals and healthcare settings as having greater responsibility for this problem.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Public misconceptions surrounding antibiotics and antibiotic resistance play a similar role.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;a href="https://academic.oup.com/jac/article/71/1/27/2363966"&gt;&#xD;
      
           International public surveys
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            have found that while most respondents understand that resistance is driven by excessive or unnecessary antibiotic use, they tend to underestimate their own risk from resistant infections, as well as their role in, and ability to minimise, the development of antibiotic resistance.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;a href="https://bmjopen.bmj.com/content/9/3/e026735"&gt;&#xD;
      
           Studies
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            of the Australian public have reported 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.nps.org.au/media/survey-reveals-australians-growing-concern-about-antibiotic-resistance"&gt;&#xD;
      
           similar findings
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           These attitudes may partly explain the pressure some patients place on GPs to prescribe antibiotics even when the cause is unlikely to warrant them.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;a href="http://www.annfammed.org/content/15/2/149.full"&gt;&#xD;
      
           Approximately 50 to 90 per cent
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            of surveyed Australian parents believe antibiotics help treat coughs, sore throats and ear infections, which are nearly always viral.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Even when antibiotics are prescribed for the right conditions, patients 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-017-4813-7"&gt;&#xD;
      
           don’t always understand or follow
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            GPs’ instructions on how and when to take them, and may fill repeat prescriptions unnecessarily.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Raising public awareness and improving understanding of drug-resistant infections is crucial to fighting this problem, and remains a core objective of Australia’s 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.amr.gov.au/australias-response/national-amr-strategy"&gt;&#xD;
      
           National Antimicrobial Resistance Strategy
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;a href="https://www.amr.gov.au/resources/australias-first-national-antimicrobial-resistance-strategy-2015-2019-progress-report"&gt;&#xD;
      
           Significant efforts toward this goal
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            have already been made, with a particular focus on awareness-raising among (and the training of) healthcare professionals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           We have also had some education of the public through media reporting and educational campaigns.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           But, as public misconceptions persist, more targeted, specific education and awareness initiatives will need to be implemented at scale.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           These campaigns must be aligned with programs that encourage proactive GP engagement, and equip or incentivise prescribers to engage in shared decision-making with their patients.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-017-4813-7"&gt;&#xD;
      
           Patients want doctors
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            to help them understand the benefits and harms of antibiotics, how they work and why they are prescribed or withheld, yet 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.annfammed.org/content/15/2/149.full#ref-18"&gt;&#xD;
      
           too often fail
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            to receive adequate explanations.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Quality improvement programs cannot be sustained without support from the government, professional colleges and providers, as well as some systemic interventions.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           To avoid leftover doses of medication, antibiotic repeats could be restricted by 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/wp-content/uploads/2019/05/AURA-2019-Report.pdf"&gt;&#xD;
      
           better aligning the amount of antibiotics dispensed
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            with the recommended duration of therapy.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A move to reduce the validity period of antibiotic prescriptions – currently 12 months – 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.pbs.gov.au/info/industry/listing/elements/pbac-meetings/pbac-outcomes/2015-03"&gt;&#xD;
      
           was considered by the Pharmaceutical Benefits Advisory Committee
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            in 2015, and would also help limit inappropriate use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           While prescribers are 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://bmjopen.bmj.com/content/8/3/e020439"&gt;&#xD;
      
           generally opposed to restrictive interventions
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , they are likely to welcome easy fixes to technical issues like default repeats.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           We need to work more pragmatically if we want to turn the tide on antimicrobial resistance.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           NCAS deputy director and infectious diseases physician, Associate Professor Kirsty Buising, acknowledges that managing infections is difficult and an ongoing challenge.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “As physicians and researchers, we need to find ways to support each other as we strive to improve together,” she says.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “We don’t know all the right answers yet, but we are working to find out what helps.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Mon, 15 Jul 2019 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/stronger-action-to-curb-overuse-of-antibiotics</guid>
      <g-custom:tags type="string">Media,Community</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Appraisal of the Australian Veterinary Prescribing Guidelines for antimicrobial prophylaxis for surgery in dogs and cats</title>
      <link>https://www.ncas-australia.org/appraisal-of-the-australian-veterinary-prescribing-guidelines-for-antimicrobial-prophylaxis-for-surgery-in-dogs-and-cats</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           L. Y. Hardefeldt, H. K. Crabb, K. E. Bailey, T. Johnstone, J. R. Gilkerson, H. Billman‐Jacobe and G. F. Browning
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The Australian Veterinary Prescribing Guidelines for antimicrobial prophylaxis for surgery on dogs and cats are evidence‐based guidelines for veterinary practitioners. Validation of these guidelines is necessary to ensure quality and implementability. Two validated tools, used for medical guideline appraisal, were chosen to assess the guidelines. The terminology from the GuideLine Implementability Appraisal (GLIA) and the Appraisal of Guidelines for Research and Evaluation version 2 (AGREE II) were adapted for use by veterinarians. A two‐phase evaluation approach was conducted. In the first phase of the evaluation, the GLIA tool was used by two specialist veterinary surgeons in clinical practice. The results of this phase were then used to modify the guidelines. In the second phase, the AGREE II tool was used by 6 general practitioners and 6 specialists to appraise the guidelines. In phase 1, the specialist surgeons either agreed or strongly agreed that the guidelines were executable, decidable, valid and novel, and that the guidelines would fit within the process of care. The surgeons were neutral on flexibility and measurability. Additional clarity around one common surgical procedure was added to the guidelines, after which the surgeons agreed that the guidelines were sufficiently flexible. In phase 2, 12 veterinarians completed the assessment using the AGREE II tool. In all sections the scaled domain score was greater than 70%. The overall quality of the guidelines was given a global scaled score of 76%. This assessment has demonstrated that the guidelines for antimicrobial prophylaxis for companion animal surgery are valid and appear implementable.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1111/avj.12848" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Hardefeldt, L., Crabb, H., Bailey, K., Johnstone, T., Gilkerson, J., Billman‐Jacobe, H., Browning, G. (2019). Appraisal of the Australian Veterinary Prescribing Guidelines for antimicrobial prophylaxis for surgery in dogs and cats. Australian Veterinary Journal, 97(9), 316-322. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1111/avj.12848" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1111/avj.12848
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1571772996211-2f02c9727629.jpg" length="129824" type="image/jpeg" />
      <pubDate>Sun, 07 Jul 2019 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/appraisal-of-the-australian-veterinary-prescribing-guidelines-for-antimicrobial-prophylaxis-for-surgery-in-dogs-and-cats</guid>
      <g-custom:tags type="string">Companion animal,NCAS publications,Veterinary,Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1571772996211-2f02c9727629.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1571772996211-2f02c9727629.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Using natural language processing and VetCompass to understand antimicrobial usage patterns in Australia</title>
      <link>https://www.ncas-australia.org/using-natural-language-processing-and-vetcompass-to-understand-antimicrobial-usage-patterns-in-australia</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           B. Hur, L. Y. Hardefeldt, K. Verspoor, T. Baldwin and J. R. Gilkerson
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Currently there is an incomplete understanding of antimicrobial usage patterns in veterinary clinics in Australia, but such knowledge is critical for the successful implementation and monitoring of antimicrobial stewardship programs.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : VetCompass Australia collects medical records from 181 clinics in Australia (as of May 2018). These records contain detailed information from individual consultations regarding the medications dispensed. One unique aspect of VetCompass Australia is its focus on applying natural language processing (NLP) and machine learning techniques to analyse the records, similar to efforts conducted in other medical studies.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : The free text fields of 4,394,493 veterinary consultation records of dogs and cats between 2013 and 2018 were collated by VetCompass Australia and NLP techniques applied to enable the querying of the antimicrobial usage within these consultations.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusion
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : The NLP algorithms developed matched antimicrobial in clinical records with 96.7% accuracy and an F1 Score of 0.85, as evaluated relative to expert annotations. This dataset can be readily queried to demonstrate the antimicrobial usage patterns of companion animal practices throughout Australia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://doi.org/10.1111/avj.12836" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          .
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    
          : Hur, B., Hardefeldt, L., Verspoor, K., Baldwin, T., Gilkerson, J. (2019). Using natural language processing and VetCompass to understand antimicrobial usage patterns in Australia. Australian Veterinary Journal. DOI:
          &#xD;
    &lt;a href="https://doi.org/10.1111/avj.12836" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1111/avj.12836
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1504868584819-f8e8b4b6d7e3.jpg" length="167147" type="image/jpeg" />
      <pubDate>Sun, 16 Jun 2019 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/using-natural-language-processing-and-vetcompass-to-understand-antimicrobial-usage-patterns-in-australia</guid>
      <g-custom:tags type="string">Companion animal,NCAS publications,Veterinary,Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1504868584819-f8e8b4b6d7e3.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1504868584819-f8e8b4b6d7e3.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial Use and Resistance in Australia: 2019 report</title>
      <link>https://www.ncas-australia.org/antimicrobial-use-and-resistance-in-australia-2019-report</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AURA+2019+graphic.PNG"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Antimicrobial use and resistance in Australia 2019: Third Australian report on antimicrobial use and resistance in human health was launched at in Sydney on 9 May 2019 by the Australian Commission on Safety and Quality in Health Care. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           AURA 2019 provides an overview of the results of various programs dedicated to surveillance of antimicrobial use and resistance in Australia, including NCAS' Hospital National Antimicrobial Prescribing Survey (NAPS) and the Aged Care National Antimicrobial Prescribing Survey (acNAPS) programs. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           It contains valuable data on antimicrobial use in the community and hospitals, identifies key emerging issues for antimicrobial resistance, and provides a detailed overview of Australia’s National Alert System for Critical Antimicrobial Resistance (CARAlert). 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           The report draws on findings that indicate that antibiotic use has been falling in Australian hospitals, a shift that will help to slow the spread of resistance. However, there are still concerning levels of inappropriate prescribing of antibiotics in hospitals and the community.
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            See
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/antimicrobial-resistance/antimicrobial-use-and-resistance-australia-surveillance-system-aura/aura-2019" target="_blank"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            .
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AURA+2019+graphic.PNG" length="124854" type="image/png" />
      <pubDate>Thu, 09 May 2019 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-use-and-resistance-in-australia-2019-report</guid>
      <g-custom:tags type="string">Surgical,Aged care,News and events,Hospital,NAPS reports,Community</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AURA+2019+graphic.PNG">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AURA+2019+graphic.PNG">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Visibility and transmission: complexities around promoting hand hygiene in young children – a qualitative study</title>
      <link>https://www.ncas-australia.org/visibility-and-transmission-complexities-around-promoting-hand-hygiene-in-young-children-a-qualitative-study</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Ruby Biezen, Danilla Grando, Danielle Mazza and Bianca Brijnath 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Effective hand hygiene practice can reduce transmission of diseases such as respiratory tract infections (RTIs) and gastrointestinal infections, especially in young children. While hand hygiene has been widely promoted within Australia, primary care providers’ (PCPs) and parents’ understanding of hand hygiene importance, and their views on hand hygiene in reducing transmission of diseases in the community are unclear. Therefore, the aim of this study was to explore the views of PCPs and parents of young children on their knowledge and practice of hand hygiene in disease transmission.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Using a cross-sectional qualitative research design, we conducted 30 in-depth interviews with PCPs and five focus groups with parents (n = 50) between June 2014 and July 2015 in Melbourne, Australia. Data were thematically analysed.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Participants agreed that hand hygiene practice was important in reducing disease transmissions. However, barriers such as variations of hand hygiene habits, relating visibility to transmission; concerns around young children being obsessed with washing hands; children already being ‘too clean’ and the need to build their immunity through exposure to dirt; and scepticism that hand hygiene practice was achievable in young children, all hindered participants’ motivation to develop good hand hygiene behaviour in young children.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusion
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Despite the established benefits of hand hygiene, sustained efforts are needed to ensure its uptake in routine care. To overcome the barriers identified in this study a multifaceted intervention is needed that includes teaching young children good hand hygiene habits, PCPs prompting parents and young children to practice hand hygiene when coming for an RTI consultation, reassuring parents that effective hand hygiene practice will not lead to abnormal psychological behaviour in their children, and community health promotion education campaigns.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1186/s12889-019-6729-x" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Biezen, R., Grando, D., Mazza, D., Brijnath, B. (2019). Visibility and transmission: complexities around promoting hand hygiene in young children–a qualitative study. BMC Public Health, 19(1), 398. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1186/s12889-019-6729-x" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1186/s12889-019-6729-x
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1584056866693-1f9d42e9feb6.jpg" length="205411" type="image/jpeg" />
      <pubDate>Wed, 10 Apr 2019 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/visibility-and-transmission-complexities-around-promoting-hand-hygiene-in-young-children-a-qualitative-study</guid>
      <g-custom:tags type="string">NCAS publications,Community,Community paper,GP</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1584056866693-1f9d42e9feb6.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1584056866693-1f9d42e9feb6.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Dissonant views: GPs’ and parents’ perspectives on antibiotic prescribing for young children with respiratory tract infections</title>
      <link>https://www.ncas-australia.org/dissonant-views-gps-and-parents-perspectives-on-antibiotic-prescribing-for-young-children-with-respiratory-tract-infections</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Ruby Biezen, Danilla Grando, Danielle Mazza and Bianca Brijnath 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Antibiotics are not recommended for treating uncomplicated respiratory tract infections (RTIs), despite this, antibiotic prescribing for this is widespread. General practitioners (GPs) report parental pressure and fear of losing patients if they do not prescribe antibiotics, however, parental views on antibiotics for RTIs are unclear. Therefore, this study examined GPs’ and parents’ perceptions regarding antibiotic prescribing for RTIs in young children.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : We conducted semi-structured interviews with 20 GPs, and a survey and focus groups with 50 parents and carers of children under the age of five between June 2014 and July 2015 in Melbourne, Australia. Qualitative data were thematically analysed using NVivo and quantitative data were analysed using SPSS.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : GPs believed that parents expect antibiotics for RTIs and were more likely to prescribe them if parents were insistent. They believed parents would go elsewhere if they did not prescribe antibiotics. GPs suggested that there would be less conflict if parents were better educated on appropriate antibiotics use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In contrast, parents demonstrated good knowledge of RTIs and appropriate antibiotic use. Their main expectation from GPs was to obtain a diagnosis, discuss management, and receive reassurance that the illness was not serious. Parental satisfaction with GPs was not dependent on receiving antibiotics (r = 0.658, p &amp;lt; 0.001), and they would not seek another GP if antibiotics were not prescribed (r = 0.655, p &amp;lt; 0.001).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusion
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : GPs and parents have dissonant views on antibiotic prescribing for RTI in young children. GPs perceived parents wanting a diagnosis and reassurance that their child is not severely ill as pressure to prescribe antibiotic. To overcome these barriers, targeted training for both GPs and parents to improve communication and reassurance that satisfaction is not related to receiving antibiotics may reduce unnecessary antibiotic prescribing for RTI in young children.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="/" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          .
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    
          : Biezen, R., Grando, D., Mazza, D., Brijnath, B. (2019). Dissonant views: GPs’ and parents’ perspectives on antibiotic prescribing for young children with respiratory tract infections. BMC Family Practice, 20(1), 46. DOI:
          &#xD;
    &lt;a href="https://doi.org/10.1186/s12875-019-0936-5" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1186/s12875-019-0936-5
          &#xD;
    &lt;/a&gt;&#xD;
    
          .
         &#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/medical-doctor-office.jpg" length="113471" type="image/jpeg" />
      <pubDate>Wed, 27 Mar 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/dissonant-views-gps-and-parents-perspectives-on-antibiotic-prescribing-for-young-children-with-respiratory-tract-infections</guid>
      <g-custom:tags type="string">NCAS publications,Community,Community paper,GP</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/medical-doctor-office.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/medical-doctor-office.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial dosing for common equine drugs: a content review and practical advice for veterinarians in Australia</title>
      <link>https://www.ncas-australia.org/antimicrobial-dosing-for-common-equine-drugs-a-content-review-and-practical-advice-for-veterinarians-in-australia</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           L. Y. Hardefeldt, H. K. Crabb, K. E. Bailey, J. R. Gilkerson, H. Billman‐Jacobe and G. F. Browning
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Appropriate dosing with antimicrobial agents is critical for effective treatment and to prevent the development of antimicrobial resistance.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : A review was undertaken of equine journal articles (Equine Veterinary Journal, Equine Veterinary Education, Australian Veterinary Journal, Australian Equine Veterinarian, Journal of Veterinary Internal Medicine and Journal of Equine Veterinary Science) between January 2015 and August 2018. Those with dosing regimens for procaine penicillin G, gentamicin or trimethoprim‐sulfonamide in adult horses were examined and evaluated. Pharmacokinetics and ‐dynamics of these drugs were also reviewed.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results and conclusion
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : The most frequently reported doses for penicillin, gentamicin and trimethoprim‐sulfonamide were 20–25,000 IU/kg, 6.6 mg/kg and 30 mg/kg, respectively. Veterinarians treating equine patients in Australia should be aware of the current recommended doses and inter‐dosing intervals to ensure efficacy in therapy and to preserve the usefulness of these antimicrobials for the future.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://doi.org/10.1111/avj.12791" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          .
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    
          : Hardefeldt, L., Crabb, H., Bailey, K., Gilkerson, J., Billman‐Jacobe, H., Browning, G. (2019). Antimicrobial dosing for common equine drugs: A content review and practical advice for veterinarians in Australia. Australian Veterinary Journal, 97, 103-107. DOI:
          &#xD;
    &lt;a href="https://doi.org/10.1111/avj.12791" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1111/avj.12791
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551098891-7a1c852f6c6b.jpg" length="348271" type="image/jpeg" />
      <pubDate>Tue, 26 Mar 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-dosing-for-common-equine-drugs-a-content-review-and-practical-advice-for-veterinarians-in-australia</guid>
      <g-custom:tags type="string">NCAS publications,Equine,Veterinary,Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551098891-7a1c852f6c6b.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551098891-7a1c852f6c6b.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>The Australian government's response on progress of the National Antimicrobial Resistance Strategy</title>
      <link>https://www.ncas-australia.org/the-australian-government-s-response-on-progress-of-the-national-antimicrobial-resistance-strategy</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;a&gt;&#xD;
    &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Australian+gov+logo.png" alt=""/&gt;&#xD;
  &lt;/a&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           The Senate Finance and Public Administration References Committee’s report Progress in the implementation of the recommendations of the 1999 Joint Expert Technical Advisory Committee on Antibiotic Resistance (JETACAR) was released in June 2013. It made 10 recommendations relating to enhanced monitoring and reporting of antibiotic usage and resistance in animals and humans, strengthening antibiotic stewardship and infection control measures in both acute and primary care settings, and increasing investments in research. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           This response addresses these recommendations and has been prepared by the Department of Health, incorporating input from other Australian Government agencies, including:
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Australian Commission on Safety and Quality in Health Care
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            National Health and Medical Research Council
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Department of Agriculture and Water Resources
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Australian Pesticides and Veterinary Medicines Authority, and
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Department of Industry, Innovation and Science.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           This report discusses NCAS' work on antimicrobial use surveillance and quality improvement nationally, particularly in relation to the National Antimicrobial Prescribing Survey. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            See
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.amr.gov.au/resources/australian-government-response-senate-finance-and-public-administration-references" target="_blank"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            .
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Australian+gov+logo.png" length="35189" type="image/jpeg" />
      <pubDate>Fri, 15 Mar 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/the-australian-government-s-response-on-progress-of-the-national-antimicrobial-resistance-strategy</guid>
      <g-custom:tags type="string">News and events</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Australian+gov+logo.png">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Australian+gov+logo.png">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Society for Healthcare Epidemiology of America Fellowship</title>
      <link>https://www.ncas-australia.org/society-for-healthcare-epidemiology-of-america-fellowship</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Noleen_Bennett_1_lr_crop.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Dr. Noleen Bennett of the VICNISS Coordinating Centre, NCAS and Guidance Group at the Royal Melbourne Hospital, and project officer for the Aged Care National Antimicrobial Prescribing Survey, has been selected as a Society for Healthcare Epidemiology of America (SHEA) International Ambassador in 2019. Dr. Bennett will be attending the SHEA Spring 2019 Conference in Boston, Massachusetts, in April.
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Noleen_Bennett_1_lr_crop.jpg" length="23903" type="image/jpeg" />
      <pubDate>Tue, 12 Mar 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/society-for-healthcare-epidemiology-of-america-fellowship</guid>
      <g-custom:tags type="string">News and events</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Noleen_Bennett_1_lr_crop.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Noleen_Bennett_1_lr_crop.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>NCAS at the Australian Society for Antimicrobials' Antimicrobials 2019</title>
      <link>https://www.ncas-australia.org/ncas-at-the-australian-society-for-antimicrobials-antimicrobials-2019</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/ASA+2019.PNG"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           NCAS-Guidance Group director Prof. Karin Thursky delivered a plenary talk at Antimicrobials 2019 titled 'Antimicrobial stewardship in Australia: Leaders or laggards?'. Prof. Thursky also delivered a presentation on the clinical stewardship work of the Guidance Group (Royal Melbourne Hospital). NCAS deputy director and Guidance Group director Assoc. Prof. Kirsty Buising delivered a talk titled 'A review of the new UK national strategy for tackling AMR'. Catherine George, Guidance Group project officer and antimicrobial stewardship pharmacist at the RMH, delivered a talk titled 'Partnering with consumers for the development of antimicrobial patient information tools'. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/ASA+2019.PNG" length="31999" type="image/png" />
      <pubDate>Tue, 12 Mar 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/ncas-at-the-australian-society-for-antimicrobials-antimicrobials-2019</guid>
      <g-custom:tags type="string">News and events</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/ASA+2019.PNG">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/ASA+2019.PNG">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial stewardship in Malaysia and Bhutan: NCAS' international collaborations</title>
      <link>https://www.ncas-australia.org/antimicrobial-stewardship-in-malaysia-and-bhutan-ncas-international-collaborations</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1510923119584-fc67ed7ff3de.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           NCAS collaborated with two teaching hospitals in Malaysia, the University Malaya Medical Centre and the Universiti Kebangsaan Malaysia Medical Centre, on a project titled ‘Implementation of the National Antimicrobial Prescribing Survey (NAPS) and identification of targets for quality improvement in two tertiary teaching hospitals in Malaysia’ (2019-20, funded by Joint Commission). Study lead Assoc. Prof. Sasheela Sri La Sri Ponnampalavanar is a consultant infectious diseases physician, and head of infection control and antimicrobial stewardship at the University Malaya Medical Centre in Malaysia. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           NCAS clinicians and researchers were part of a team from the Peter Doherty Institute for Infection and Immunity (University of Melbourne and Royal Melbourne Hospital) who visited Bhutan in March 2019 for a training program funded by the Fleming Fund in the UK. The Australian team delivered a series of One Health workshops covering diagnostics and stewardship practices, and will host clinical fellows from Bhutan for an intensive training program later in 2019. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1510923119584-fc67ed7ff3de.jpg" length="282064" type="image/jpeg" />
      <pubDate>Tue, 12 Mar 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-stewardship-in-malaysia-and-bhutan-ncas-international-collaborations</guid>
      <g-custom:tags type="string">News and events</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1510923119584-fc67ed7ff3de.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1510923119584-fc67ed7ff3de.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Optimising treatment of respiratory tract infections in nursing homes: nurse-initiated PCR testing</title>
      <link>https://www.ncas-australia.org/optimising-treatment-of-respiratory-tract-infections-in-nursing-homes-nurse-initiated-pcr-testing</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Leslie Dowson, Caroline Marshall, Kirsty Buising, N. Deborah Friedman, David C.M. Kong, Rhonda L. Stuart
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Highlights
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            :
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Nurse-initiated polymerase chain reaction testing is feasible in nursing homes.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Viruses are common among nursing home residents.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Nurse-initiated respiratory specimen testing is useful for infection prevention.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Further resources are required to impact antibiotic prescribing.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Diagnostic testing using polymerase chain reaction (PCR) is infrequently initiated for diagnosis of respiratory tract infections (RTIs) in nursing homes. The objectives of this study were to determine the feasibility of implementing nurse-initiated PCR testing of respiratory specimens in nursing home settings and to compare antibiotic prescribing prior to and during the implementation.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : This was a pragmatic, historically controlled study in 3 nursing homes (181 total beds) in Melbourne, Australia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : The number of PCR tests of respiratory specimens (over 12 months) increased from 5 to 67 when nurses could initiate the tests. Residents with RTI symptoms had a virus identified by PCR in 50.7% of tests, including 14 positive for influenza. Six outbreaks were identified. When clustering was taken into consideration, incidence rates of antibiotic days of therapy did not change (incidence rate ratio = 0.94, 95% confidence interval, 0.25-3.35, P = .92) despite identification of more viral pathogens.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : In nursing homes, nurse-initiated PCR testing of respiratory specimens is feasible and useful in terms of identifying the cause of many RTIs and outbreaks, and viruses are common in this context. However, the current study suggests the availability of these test results alone does not impact antibiotic prescribing.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Key words
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Nursing home, pneumonia, PCR, antibiotics, antimicrobial stewardship.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.ajic.2019.02.001" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Dowson L., Marshall C., Buising K., Friedman N. D., Kong D. C. M., Stuart R. L. (2019). Optimising treatment of respiratory tract infections in nursing homes: Nurse-initiated PCR testing. American Journal of Infection Control, 47(8), 911-915. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.ajic.2019.02.001" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1016/j.ajic.2019.02.001
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1584521764592-48f33fe7e088.jpg" length="141736" type="image/jpeg" />
      <pubDate>Tue, 05 Mar 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/optimising-treatment-of-respiratory-tract-infections-in-nursing-homes-nurse-initiated-pcr-testing</guid>
      <g-custom:tags type="string">NCAS publications,Community,Community paper,Aged care,Aged care paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1584521764592-48f33fe7e088.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1584521764592-48f33fe7e088.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Skin and soft tissue infections and current antimicrobial prescribing practices in Australian aged care residents</title>
      <link>https://www.ncas-australia.org/skin-and-soft-tissue-infections-and-current-antimicrobial-prescribing-practices-in-australian-aged-care-residents</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           N. J. Bennett, N. Imam, R. J. Ingram, R. S. James, K. L. Buising, A. L. Bull, C. S. Chen, K. A. Thursky and L. J. Worth
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           To determine the burden of skin and soft tissue infections (SSTI), the nature of antimicrobial prescribing and factors contributing to inappropriate prescribing for SSTIs in Australian aged care facilities, SSTI and antimicrobial prescribing data were collected via a standardised national survey. The proportion of residents prescribed ⩾1 antimicrobial for presumed SSTI and the proportion whose infections met McGeer et al. surveillance definitions were determined. Antimicrobial choice was compared to national prescribing guidelines and prescription duration analysed using a negative binomial mixed-effects regression model. Of 12 319 surveyed residents, 452 (3.7%) were prescribed an antimicrobial for a SSTI and 29% of these residents had confirmed infection. Topical clotrimazole was most frequently prescribed, often for unspecified indications. Where an indication was documented, antimicrobial choice was generally aligned with recommendations. Duration of prescribing (in days) was associated with use of an agent for prophylaxis (rate ratio (RR) 1.63, 95% confidence interval (CI) 1.08–2.52), PRN orders (RR 2.10, 95% CI 1.42–3.11) and prescription of a topical agent (RR 1.47, 95% CI 1.08–2.02), while documentation of a review or stop date was associated with reduced duration of prescribing (RR 0.33, 95% CI 0.25–0.43). Antimicrobial prescribing for SSTI is frequent in aged care facilities in Australia. Methods to enhance appropriate prescribing, including clinician documentation, are required.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1017/S0950268819000128" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Bennett, N., Imam, N., Ingram, R., James, R., Buising, K., Bull, A., Chen, C., Thursky, K., Worth, L. (2019). Skin and soft tissue infections and current antimicrobial prescribing practices in Australian aged care residents. Epidemiology and Infection, 147, E87. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1017/S0950268819000128" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1017/S0950268819000128
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           . 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AgedCare_NAPS-887x277.jpg" length="33417" type="image/jpeg" />
      <pubDate>Thu, 21 Feb 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/skin-and-soft-tissue-infections-and-current-antimicrobial-prescribing-practices-in-australian-aged-care-residents</guid>
      <g-custom:tags type="string">NCAS publications,Community,Community paper,Aged care,Aged care paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AgedCare_NAPS-887x277.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AgedCare_NAPS-887x277.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Similarities and differences in antimicrobial prescribing between major city hospitals and regional and remote hospitals in Australia</title>
      <link>https://www.ncas-australia.org/similarities-and-differences-in-antimicrobial-prescribing-between-major-city-hospitals-and-regional-and-remote-hospitals-in-australia</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Jaclyn L. Bishop, Thomas R. Schulz, David C.M.Kong, RodneyJames and Kirsty L.Buising
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Many regional and remote hospitals (RRHs) do not have the specialist services that usually support antimicrobial stewardship (AMS) programmes in major city hospitals. It is not known if this is associated with higher rates of inappropriate antimicrobial prescribing. The aim of this study was to identify similarities and differences in antimicrobial prescribing patterns between major city hospitals and RRHs in Australia. The Australian Hospital National Antimicrobial Prescribing Survey (H-NAPS) datasets from 2014, 2015 and 2016 (totalling 47,876 antimicrobial prescriptions) were analysed. The antimicrobial prescribed, indications for use, documentation of indication, recording of a review date and assessment of the appropriateness of prescribing were evaluated. Overall, inappropriate prescribing of antimicrobials was higher in RRHs than in major city hospitals (24.0% vs. 22.1%; P&amp;lt;0.001). Compared with major city hospitals, inappropriate prescribing of ceftriaxone was higher in RRHs (33.9% vs. 27.6%; P&amp;lt;0.001), as was inappropriate prescribing for cellulitis (25.7% vs. 19.0%; P≤0.001). A higher rate of inappropriate prescribing was noted for some high-risk infections in RRHs compared with major city hospitals, including Gram-positive bacteraemia with sepsis (12.6% vs. 6.5%; P=0.004), empiric therapy for sepsis (26.0% vs. 12.0%; P&amp;lt;0.001) and endocarditis (8.2% vs. 2.7%; P=0.02). To the authors’ knowledge, this is the largest study to date comparing antimicrobial prescribing of RRHs with major city hospitals. A key finding was that antimicrobial prescribing was more frequently inappropriate for some high-risk infections treated in RRHs. Targeted strategies that support appropriate antimicrobial prescribing in RRHs are required.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Keywords
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Antimicrobial; stewardship; hospital; appropriateness; rural
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.sciencedirect.com/science/article/abs/pii/S0924857918303017?via%3Dihub" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Bishop, J.L., Schulz, T.R., Kong, D.C.M., James, R., Buising, K.L. (2019). Similarities and differences in antimicrobial prescribing between Australian major-city hospitals and regional and remote hospitals. International Journal of Antimicrobial Agents, 53(2), 170-176. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.ijantimicag.2018.10.009" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1016/j.ijantimicag.2018.10.009
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hospital_NAPS.jpg" length="33263" type="image/jpeg" />
      <pubDate>Mon, 04 Feb 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/similarities-and-differences-in-antimicrobial-prescribing-between-major-city-hospitals-and-regional-and-remote-hospitals-in-australia</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper,Regional,NAPS,NAPS publications</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hospital_NAPS.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hospital_NAPS.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Effectiveness of interventions involving pharmacists on antibiotic prescribing by general practitioners: a systematic review and meta-analysis</title>
      <link>https://www.ncas-australia.org/effectiveness-of-interventions-involving-pharmacists-on-antibiotic-prescribing-by-general-practitioners-a-systematic-review-and-meta-analysis</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Sajal K. Saha, Lesley Hawes and Danielle Mazza
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : The use of community antibiotic stewardship programmes (ASPs) is rising; however, their effectiveness when pharmacists are involved is uncertain.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Objectives
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : To assess the effectiveness of ASPs involving pharmacists at improving antibiotic prescribing by general practitioners (GPs).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Medline, Embase, Emcare, PubMed, PsycINFO, Cochrane CENTRAL, CINAHL Plus and Web of Science databases were searched to February 2018. Randomised and non-randomised studies of ASPs involving pharmacists as interventionists to GPs were included. Primary outcomes were absolute changes in GPs’ antibiotic prescribing rate (APR) and antibiotic prescribing adherence rate (APAR) according to recommendations/guidelines. Meta-analysis used random effects models.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Fifteen studies reporting 18 trials were included in the meta-analysis: 8 assessed the APR and 10 the APAR. APR reductions (OR 0.86, 95% CI 0.78–0.95, moderate-certainty evidence) and APAR improvements (OR 1.96, 95% CI 1.56–2.45, high-certainty evidence) were observed at 6 months median intervention follow-up. High-quality randomised trials reduced the APR (OR 0.92, 95% CI 0.90–0.94) and increased the APAR (OR 2.55, 95% CI 2.16–3.01). Interventions were successful in decreasing the APR (OR 0.93, 95% CI 0.90–0.95) and increasing the APAR (OR 1.72, 95% CI 1.04–2.84) when implemented by a pharmacist–GP team. Interventions involving pharmacist–infectious disease professional teams also decreased the APR (OR 0.81, 95% CI 0.66–1.0) and increased the APAR (OR 2.36, 95% CI 1.87–2.96). GP education plus prescribing feedback, and group meetings were effective in both outcomes, whereas GP education, academic detailing and workshop training were effective in APAR outcome. However, substantial heterogeneity was demonstrated.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : ASPs involving pharmacists are effective in decreasing antibiotic prescribing and increasing guideline-adherent antibiotic prescribing by GPs.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1093/jac/dky572" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Saha, S.K., Hawes, L., Mazza, D. (2019). Effectiveness of interventions involving pharmacists on antibiotic prescribing by general practitioners: A systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy, 74(5), 1173-1181. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1093/jac/dky572" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1093/jac/dky572
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1542736667-069246bdbc6d.jpg" length="108473" type="image/jpeg" />
      <pubDate>Sun, 27 Jan 2019 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/effectiveness-of-interventions-involving-pharmacists-on-antibiotic-prescribing-by-general-practitioners-a-systematic-review-and-meta-analysis</guid>
      <g-custom:tags type="string">NCAS publications,Community,Community paper,GP</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1542736667-069246bdbc6d.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1542736667-069246bdbc6d.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>International observerships and training programs hosted by NCAS in 2018</title>
      <link>https://www.ncas-australia.org/international-observerships-and-training-programs-hosted-by-ncas-in-2018</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Wyman+photo.JPG"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           L-R: Catherine George, AMS pharmacist and Guidance Group project officer (Royal Melbourne Hospital) and Dr. Wai-man Hui. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           In 2018, NCAS hosted two international observers for antimicrobial stewardship training programs in Melbourne. In September 2018, the Malaysian Ministry of Health sent an official representative, Ms. Mardhiyah Kamal, who works for the division responsible for the country’s antimicrobial resistance strategy and action plan, to Melbourne for an observership with NCAS and the Royal Melbourne Hospital. This program involved training in supporting antimicrobial use surveillance and hospital stewardship programs. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           In November and December 2018, NCAS hosted Dr. Wai-man Hui, an infectious diseases physician from the Alice Ho Miu Ling Nethersole Hospital, a public hospital in Hong Kong, for a clinical observership and attachment at the Royal Melbourne Hospital. This program involved training in undertaking antimicrobial stewardship clinical ward rounds, and other clinical and administrative components of antimicrobial stewardship. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           As part of both programs, the observers attended meetings with colleagues at a number of other centres in Melbourne and Victoria, such as the Peter MacCallum Cancer Centre, Box Hill Hospital and Ballarat Base Hospital, and state health department groups in Australia. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Wyman+photo.JPG" length="397454" type="image/jpeg" />
      <pubDate>Sun, 16 Dec 2018 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/international-observerships-and-training-programs-hosted-by-ncas-in-2018</guid>
      <g-custom:tags type="string">News and events</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Wyman+photo.JPG">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Wyman+photo.JPG">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial stewardship in Canadian health standards</title>
      <link>https://www.ncas-australia.org/antimicrobial-stewardship-in-canadian-health-standards</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Professor%2BKarin%2BThursky.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           NCAS Director Prof. Karin Thursky was inivted to Ottawa in December 2018 as an external expert advisor to the antimicrobial stewardship accreditation working group for the Health Standards Organisation (Canada). 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Australia has been an 
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.doctorportal.com.au/mjainsight/2017/2/milestones-challenges-in-antimicrobial-stewardship/" target="_blank"&gt;&#xD;
      
                      
           early adopter
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
            of antimicrobial stewardship in hospitals. The Australian Commission on Safety and Quality in Health Care incorporated antimicrobial stewardship into hospital accreditation 
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.nationalstandards.safetyandquality.gov.au/3.-healthcare-associated-infection/antimicrobial-stewardship" target="_blank"&gt;&#xD;
      
                      
           standards
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
            in 2013, and has since required hospitals to establish and develop stewardship processes. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           A pilot project focused on implementing the Hospital National Antimicrobial Prescribing Survey is currently underway in Canada. A group of 20 hospitals, located around the country, are participating in the pilot project, which is scheduled to conclude in 2019. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Professor%2BKarin%2BThursky.jpg" length="1837844" type="image/png" />
      <pubDate>Sun, 16 Dec 2018 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-stewardship-in-canadian-health-standards</guid>
      <g-custom:tags type="string">News and events</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Professor%2BKarin%2BThursky.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Professor%2BKarin%2BThursky.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>NCAS researchers awarded grants in 2018</title>
      <link>https://www.ncas-australia.org/ncas-researchers-awarded-grants-in-2018</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/NHMRC+logo+1.png"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Congratulations to the NCAS researchers and collaborators who were awarded grants in 2018! 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           NCAS Director Prof. Karin Thursky (Peter MacCullum Cancer Centre, Royal Melbourne Hospital and University of Melbourne) and colleagues were awarded an NHMRC Project Grant for a project on antifungal stewardship in Australian hospitals: ‘Meeting the challenges of invasive fungal infection: Antifungal stewardship and effective surveillance in high-risk patient groups’.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           NCAS fellow Jaclyn Bishop (University of Melbourne) and colleagues were awarded a Western Alliance grant for a project on cellulitis management: ‘A novel “bundle of care” approach to cellulitis management in Western Victorian hospitals’. 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           NCAS investigator Dr. Trisha Peel (Alfred Health and Monash University) was awarded an NHMRC Translating Research into Practice Fellowship for a project on surgical antimicrobial prophylaxis prescribing: ‘Optimising patient outcomes following surgery: Improving uptake of evidence into practice for surgical antimicrobial prophylaxis’.  
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           NCAS collaborator Dr. Jo-Anne Manski-Nankervis (University of Melbourne) was awarded an NHMRC Translating Research into Practice Fellowship for a project on decision-support for antimicrobial prescribing in general practice: 'From simulation to translation: A new quality improvement program for antibiotic prescribing in general practice'. 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
            
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           NCAS collaborator Assoc. Prof. Sasheela Sri La Sri Ponnampalavanar (University Malaya Medical Centre, Malaysia) and colleagues received a Joint Commission grant for the project: 'Implementation of the National Antimicrobial Prescribing Survey (NAPS) and identification of targets for quality improvement in two tertiary teaching hospitals in Malaysia'. 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Congratulations once again to all the successful applicants for national and international grants in 2018! 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/NHMRC+logo+1.png" length="8647" type="image/png" />
      <pubDate>Sun, 16 Dec 2018 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/ncas-researchers-awarded-grants-in-2018</guid>
      <g-custom:tags type="string">News and events</g-custom:tags>
      <media:content medium="image" url="https://irp.cdn-website.com/md/pexels/dms3rep/multi/pexels-photo-1181534.jpeg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/NHMRC+logo+1.png">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial stewardship in Australian health care</title>
      <link>https://www.ncas-australia.org/antimicrobial-stewardship-in-australian-health-care</link>
      <description />
      <content:encoded />
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AMS+in+Australian+healthcare.png" length="204179" type="image/png" />
      <pubDate>Mon, 03 Dec 2018 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-stewardship-in-australian-health-care</guid>
      <g-custom:tags type="string">Hospital,Community,NCAS publications,Hospital paper,Community paper,Aged care,Aged care paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AMS+in+Australian+healthcare.png">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AMS+in+Australian+healthcare.png">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>The Hospital National Antimicrobial Prescribing Survey: 2017 report</title>
      <link>https://www.ncas-australia.org/the-hospital-national-antimicrobial-prescribing-survey-2017-report</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hospital+NAPS+2017.PNG"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           The results of the 2017 annual Hospital National Antimicrobial Prescribing Survey (NAPS) were officially released on 12 November, 2017.
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           The 2017 report summarises the results of a voluntary audit of 314 hospitals (228 public and 86 private) from across Australia, and analysis of 26,277 prescriptions for 17,366 patients.
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           The 2017 results show:
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Overall, almost one-quarter (23.5%) of prescriptions were assessed as inappropriate. Almost one-third (32.7%) were non-compliant with guidelines.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Inappropriate use was related to factors such as unnecessary use of broad-spectrum antimicrobials and incorrect duration of treatment.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Inappropriate prescribing was common for patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) (37.8% of prescriptions were assessed as inappropriate); this is an overall improvement since 2013, when 46% of prescribing for COPD was inappropriate.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Overall, surgical prophylaxis was the most common reason for antimicrobial prescriptions in hospitals, and for almost one third (30.5%) of cases, it was inappropriately given for more than 24 hours.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Just over three quarters (77.7%) of antibiotic prescriptions had a reason for prescribing documented in the medical notes, which is an overall improvement compared to 2013 when only 70.9% of prescriptions had an indication recorded.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Areas highlighted for quality improvement include documentation of review- or stop-dates and indications for antimicrobial prescriptions, and the ongoing high proportion of prolonged and non-compliant surgical prophylaxis prescriptions.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            See
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/ncas-publications"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            .
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hospital+NAPS+2017.PNG" length="112066" type="image/png" />
      <pubDate>Mon, 12 Nov 2018 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/the-hospital-national-antimicrobial-prescribing-survey-2017-report</guid>
      <g-custom:tags type="string">News and events,NCAS publications,NAPS reports,Hospital,Surgical</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hospital+NAPS+2017.PNG">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hospital+NAPS+2017.PNG">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Use of electronic medical records to describe general practitioner antibiotic prescribing patterns</title>
      <link>https://www.ncas-australia.org/use-of-electronic-medical-records-to-describe-general-practitioner-antibiotic-prescribing-patterns</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Lesley Hawes, Lyle Turner, Kirsty Buising and Danielle Mazza
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background and objectives
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : The computerised medical records of general practice patients can inform our understanding of antibiotic prescribing and assist in antimicrobial stewardship (AMS). The aim of this study was to describe Australian general practitioner (GP) antibiotic prescribing patterns using data extracted from electronic medical records (EMR).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Method
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : A descriptive analysis of patient records from 44 general practices, between 2010 and 2014, in the eastern region of metropolitan Melbourne was undertaken.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Of the 615,362 antibiotic prescriptions, cefalexin, amoxicillin–clavulanic acid, roxithromycin, doxycycline and clarithromycin were the most frequently prescribed antibiotics. Except for cefalexin, prescribing rates of the antibiotics increased in winter. Of 472,197 patients consulting a GP in one of these practices, 34.8% received an antibiotic at some point over the five years. There was a higher rate of prescribing per consultation in patients aged &amp;lt;20 years.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Discussion
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : This study shows that it is possible to examine EMR for antibiotic prescriptions, and that a descriptive analysis can identify AMS targets.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://pubmed.ncbi.nlm.nih.gov/31207679/" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    
          : Hawes L., Turner L., Buising K., Mazza D. (2018). Use of electronic medical records to describe general practitioner antibiotic prescribing patterns. Australian Journal for General Practitioners, 47, 796-800. DOI:
          &#xD;
    &lt;a href="https://pubmed.ncbi.nlm.nih.gov/31207679/" target="_blank"&gt;&#xD;
      
           10.31128/AJGP-05-18-4570
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1586314265219-192da32be7eb.jpg" length="155499" type="image/jpeg" />
      <pubDate>Sat, 10 Nov 2018 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/use-of-electronic-medical-records-to-describe-general-practitioner-antibiotic-prescribing-patterns</guid>
      <g-custom:tags type="string">NCAS publications,Community,Community paper,GP</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1586314265219-192da32be7eb.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1586314265219-192da32be7eb.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial prescribing in regional and remote hospitals</title>
      <link>https://www.ncas-australia.org/antimicrobial-prescribing-in-regional-and-remote-hospitals</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Arjun Rajkhowa
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://insightplus.mja.com.au/2018/43/antimicrobial-prescribing-in-regional-and-remote-hospitals/" target="_blank"&gt;&#xD;
      
           Medical Journal of Australia-Insight
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            )
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Australia has 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/clinical-care-standards/antimicrobial-stewardship-clinical-care-standard/"&gt;&#xD;
      
           national standards
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            that guide the safety and quality of care in hospitals. Antimicrobial stewardship – which refers to safety and quality initiatives for antimicrobial prescribing and use – has been incorporated into these standards. The way these standards have been implemented nationally is unique and, from an international perspective, exemplary.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           However, we know that remoteness from metropolitan centres of care can 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/atlas/"&gt;&#xD;
      
           influence
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            health care delivery, and that many hospitals outside metropolitan areas, with fewer resources, may need additional support to fully operationalise these standards.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/naps-2/?section=4"&gt;&#xD;
      
           national program
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            dedicated to the monitoring of antimicrobial use and prescribing enables analysis of use in hospitals by remoteness classification. A newly published 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ijaaonline.com/article/S0924-8579(18)30301-7/fulltext"&gt;&#xD;
      
           study
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , by 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncas-australia.org/"&gt;&#xD;
      
           National Centre for Antimicrobial Stewardship
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (NCAS) research fellow Jaclyn Bishop and colleagues, highlights differences in the quality of antimicrobial prescribing between metropolitan and non-metropolitan hospitals in Australia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Particular areas highlighted include differences in the treatment of cellulitis, Gram-positive bacteraemia with sepsis and endocarditis, and empiric therapy for sepsis. These findings point to a need for support for infection management and antimicrobial stewardship in regional and remote hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Distance from metropolitan centres of acute care (and associated resource constraints) can play an important role in determining clinicians’ approaches to, and ability to support, stewardship activities.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.journalofhospitalinfection.com/article/S0195-6701(18)30493-6/fulltext"&gt;&#xD;
      
           qualitative study
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            involving clinicians in regional hospitals, also by Jaclyn Bishop and colleagues, highlights a number of factors that can influence how clinicians perceive and approach efforts aimed at optimising infection management and antimicrobial prescribing. These include factors that can act as barriers to, and enablers of, stewardship, and should ideally inform planning and decision making around all quality initiatives.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Regional hospitals may not have adequate resources to cover the different elements and types of activities, such as decision support for antimicrobial prescribing and review of prescriptions, that antimicrobial stewardship encompasses.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Specialised infectious diseases expertise may be limited to a few hospitals, and pharmacists may not have sufficient time allocated for systematic audit and review activities. Clinicians in regional areas may work across multiple facilities and campuses, which can make dedicated site-specific programs difficult to sustain. Additionally, staff turnover or frequent changes in the workforce can have a disruptive impact on, and act as a barrier to, longer-term safety and quality programs.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           When auditing is undertaken as part of quality improvement and accreditation processes, smaller numbers of patients are usually audited; as such, the observed and reported patient cohort sizes or burden of infections may not be recognised by the local hospital executive as warranting additional staff resources, particularly for systematic programs. When audits identify areas of concern, the lack of local expert guidance may hinder translation of the findings into quality improvement actions.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Regional and remote hospitals may not have the resources to procure and maintain the information technology tools that facilitate surveillance and review of antimicrobial prescribing and consumption in some better resourced metropolitan hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Working in regional and remote areas entails and necessitates developing close relationships with other practitioners. Therefore, recommendations about feedback mechanisms and communication of advice to individual prescribers (and, indeed, review processes) need to adequately take the intricacies of the local professional and social context into account.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           While clinicians who participated in this 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.journalofhospitalinfection.com/article/S0195-6701(18)30493-6/fulltext"&gt;&#xD;
      
           study
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            credited the national standards with having raised the profile of antimicrobial stewardship, they argued that regional and remote hospitals have not necessarily been able to successfully navigate or incentivise practice changes, or increase resource allocation, in response to the adoption of these standards. Clinicians expressed concerns about potential discrepancies in quality improvement efforts between metropolitan and regional hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Strategies
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Dr David Kong is the deputy director of pharmacy at 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.bhs.org.au/"&gt;&#xD;
      
           Ballarat Health Services
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            in Ballarat, Victoria, and a chief investigator at NCAS. He says that participating strategically in 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/naps-2/?section=4"&gt;&#xD;
      
           quality audits
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , when resources allow time for such participation, and using the findings for feedback and comparison can help instil a culture of continuous improvement.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “Undertaking audits and feeding back results to end-users provides the end-user an opportunity to reflect on their practice,” he says. “If the feedback and results are provided to multiple end-users or units within the same institution, these results may also facilitate competition between groups and drive improvement.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Regional clinicians 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.journalofhospitalinfection.com/article/S0195-6701(18)30493-6/fulltext"&gt;&#xD;
      
           report
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            that having opportunities to “benchmark” local patterns of antimicrobial use against patterns in similar facilities would benefit their quality programs. Australia’s antimicrobial use surveillance 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/hospital-antimicrobial-use/"&gt;&#xD;
      
           programs
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            aim to facilitate this form of benchmarking.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Evette Buono is the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.cec.health.nsw.gov.au/"&gt;&#xD;
      
           New South Wales Clinical Excellence Commission
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ’s knowledge, evaluation and research program’s senior manager, and an associate investigator at NCAS. Referring to recent 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://academic.oup.com/jac/article/72/7/2110/3071680"&gt;&#xD;
      
           initiatives
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            by regional and small metropolitan hospitals in NSW, she highlights the potential benefits of collaboration across facilities and networks as a strategy:
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “Infectious diseases physicians, clinical microbiologists and antimicrobial stewardship pharmacists play a critical role in determining the success and credibility of an antimicrobial stewardship program, but smaller health care facilities are less likely to have these experts available on-site to provide hands-on support and advice,” she says.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “Collaborative antimicrobial stewardship efforts across multiple facilities offer a viable model of care for rural, regional and small metropolitan hospitals, where dedicated time and resources for antimicrobial stewardship are scarce. They also allow individuals from participating hospitals to learn from one another, building expertise and capability across the district or network, and are more likely to result in sustainable improvement.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Dr Thomas Schulz is an infectious diseases physician at the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.thermh.org.au/"&gt;&#xD;
      
           Royal Melbourne Hospital
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            and an associate investigator at NCAS. Dr Schulz runs 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.thermh.org.au/health-professionals/clinical-services/victorian-infectious-diseases-service-vids/refugee-health-1"&gt;&#xD;
      
           telehealth
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            services for some regional and small metropolitan hospitals in Victoria, and has described the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://journals.sagepub.com/doi/abs/10.1177/1357633X18806651?journalCode=jtta"&gt;&#xD;
      
           benefits
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            of telehealth for patients and clinicians who live in regional areas.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Education
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncas-australia.org/forum2018"&gt;&#xD;
      
           National Antimicrobial Resistance and Stewardship Forum
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            was held at the University of Melbourne on 1 and 2 November 2018. Hosted by the NCAS and co-sponsored by 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://bettersafercare.vic.gov.au/"&gt;&#xD;
      
           Safer Care Victoria
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , this forum included a number of specialised workshops for different professional groups, and presentations on antimicrobial resistance and stewardship in diverse settings, including regional and remote areas.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Mon, 05 Nov 2018 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-prescribing-in-regional-and-remote-hospitals</guid>
      <g-custom:tags type="string">NAPS,Media,Hospital,Regional</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antibiotic Allergy in Practice Workshop 2018</title>
      <link>https://www.ncas-australia.org/antibiotic-allergy-in-practice-workshop-2018</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Allergy.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            This was a one-day workshop hosted by Austin Health and in partnership with the National Centre for Infections in Cancer (NCIC), the Society of Hospital Pharmacists of Australia (SHPA) and Centre for Antibiotic Allergy and Research, which provided a comprehensive update on antibiotic allergy. Its program focused on the practical implementation of antibiotic allergy assessment, management and testing into hospital and AMS practice. Included were dedicated streams for pharmacists and physicians, including practical case scenarios and skin testing skills sessions. See
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.eventbrite.com.au/e/antibiotic-allergy-in-practice-workshop-2018-registration-46875623251" target="_blank"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            .
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Allergy.jpg" length="41701" type="image/jpeg" />
      <pubDate>Fri, 02 Nov 2018 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antibiotic-allergy-in-practice-workshop-2018</guid>
      <g-custom:tags type="string">News and events,Seminar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Allergy.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Allergy.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>National Antimicrobial Resistance and Stewardship Forum 2018</title>
      <link>https://www.ncas-australia.org/national-antimicrobial-resistance-and-stewardship-forum-2018</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/National+AMR+and+AMS+Forum+2018_University+of+Melbourne2.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           The National Antimicrobial Resistance and Stewardship Forum 2018 was held at the University of Melbourne in Melbourne, Victoria, on Thursday, 1st November, and Friday, 2nd November, 2018. This forum, organised jointly by a number of Australian clinical and research groups working on AMR and AMS, offered a dynamic program covering all facets of the response to antimicrobial resistance, including clinical infectious diseases and antimicrobial stewardship, translational science, new drug development, veterinary and agricultural medicine, and government, media and policy responses. As part of the forum, workshops focusing on different professional groups were delivered on Thursday, 1st November. The 2018 Forum was hosted by the National Centre for Antimicrobial Stewardship and co-sponsored by Safer Care Victoria. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Resources from the Forum have been shared with attendees and participants. See
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/forum2018"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            .
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Dates
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           : 1 and 2 November 2018
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Venue
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           : University of Melbourne
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/National+AMR+and+AMS+Forum+2018_University+of+Melbourne2.jpg" length="676351" type="image/jpeg" />
      <pubDate>Thu, 01 Nov 2018 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/national-antimicrobial-resistance-and-stewardship-forum-2018</guid>
      <g-custom:tags type="string">News and events,Seminar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/National+AMR+and+AMS+Forum+2018_University+of+Melbourne2.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/National+AMR+and+AMS+Forum+2018_University+of+Melbourne2.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>How do we close the gaps in appropriate antibiotic use?</title>
      <link>https://www.ncas-australia.org/how-do-we-close-the-gaps-in-appropriate-antibiotic-use</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Arjun Rajkhowa
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://pursuit.unimelb.edu.au/articles/how-do-we-close-the-gaps-in-appropriate-antibiotic-use" target="_blank"&gt;&#xD;
      
           Pursuit
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , University of Melbourne)
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Increasing rates of drug-resistant infections, driven in part by the misuse and overuse of antibiotics and other antimicrobial drugs, have led to promotion of appropriate use of these drugs being recognised as a key clinical priority, both 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.amr.gov.au/australias-response/national-amr-strategy"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            and 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.who.int/antimicrobial-resistance/global-action-plan/en/"&gt;&#xD;
      
           overseas
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In Australia, our 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/clinical-care-standards/antimicrobial-stewardship-clinical-care-standard/"&gt;&#xD;
      
           national standards
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            that guide the safety and quality of care in hospitals include criteria on appropriate use of antimicrobial drugs. The way these criteria were developed and have been implemented nationally is unique.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Maintaining compliance with these standards requires ongoing effort and some hospitals may need more support than others to meet their targets.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/naps-2/?section=4"&gt;&#xD;
      
           national program
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            that monitors antimicrobial prescribing describes variations in the quality of prescribing between metropolitan and non-metropolitan hospitals, with regional and remote hospitals 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/naps/"&gt;&#xD;
      
           reporting
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            higher rates of guideline non-compliant prescribing. Gaps in resources between metropolitan and non-metropolitan hospitals can 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/atlas/"&gt;&#xD;
      
           influence
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            healthcare delivery.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Supporting regional and remote hospitals’ efforts to meet prescribing quality targets is a goal shared by clinicians, researchers and government.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           So, how can quality and safety initiatives aimed at improving antimicrobial prescribing and use – clinically known as ‘antimicrobial stewardship’ – be encouraged outside metropolitan areas?
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           At the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncas-australia.org/"&gt;&#xD;
      
           National Centre for Antimicrobial Stewardship (NCAS)
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            at the Doherty Institute, University of Melbourne and Royal Melbourne Hospital, we are researching antimicrobial use and stewardship in regional and remote Australia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Building workforce capacity
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.rrh.org.au/journal/early_abstract/4442"&gt;&#xD;
      
           review
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            by NCAS research fellow Jaclyn Bishop and colleagues describes different models for antimicrobial stewardship programs at regional and remote hospitals, including those that run successfully without on-site local infectious diseases specialists.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           It finds that enhancing workforce capacity across the disciplines is key to sustaining the day-to-day operations of these programs.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Evette Buono, the New South Wales Clinical Excellence Commission’s senior manager for knowledge, evaluation and research, says regional and remote hospitals can face challenges in sourcing the expertise needed to support quality improvement for antimicrobial use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “Infectious diseases physicians, clinical microbiologists and specially trained pharmacists play a critical role in defining the success and credibility of an antimicrobial stewardship program, but smaller healthcare facilities are less likely to have these experts available on-site to provide hands-on support and advice.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Models of care already used by regional hospitals to address resource constraints, like 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://academic.oup.com/jac/article/72/7/2110/3071680"&gt;&#xD;
      
           networked or ‘hub-and-spoke’ models that are based on shared resources
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , offer an effective alternative.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “Collaborative antimicrobial stewardship efforts across multiple facilities offer a viable model of care for regional and small metropolitan hospitals, where dedicated time and resources for antimicrobial stewardship may be scarce,” says Ms Buono.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “They also allow individuals from participating hospitals to learn from one another, building expertise and capability across the district or network, and are more likely to result in sustainable improvement.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Strengthening clinical networks and access to off-site expertise, including through ‘
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.rrh.org.au/journal/article/4442"&gt;&#xD;
      
           tele-health
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ’, could help, but initiatives like these need sustained resourcing.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            The cultural factor
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.journalofhospitalinfection.com/article/S0195-6701(18)30493-6/fulltext"&gt;&#xD;
      
           qualitative study
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            examining barriers to, and enablers of, stewardship programs in regional Australia also highlights the importance of cultural factors, like a culture of independence and self-reliance among local clinicians, and familiarity with the local context.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Regional hospital staff 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://academic.oup.com/jac/article/70/9/2665/722162"&gt;&#xD;
      
           report
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            having a sense of pride in local institutions and a desire to deliver quality care locally. Quality improvement initiatives that include audits and feedback can build on this.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Dr David Kong, the deputy director of pharmacy at Ballarat Health Services, says that although regional hospitals generally have fewer resources and tools for extensive stewardship programs, they can strategically and intensively use audits to drive improvement.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “Undertaking audits and feeding back the results offers clinicians an opportunity to reflect on their practice,” he says.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “If the feedback and results are provided to multiple staff members or units within the same institution, these results may also facilitate competition between individuals and groups and drive improvement.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Antimicrobial prescribing audits
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Two national programs annually monitor antimicrobial usage in Australian hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/naps-2/?section=4"&gt;&#xD;
      
           National Antimicrobial Prescribing Survey
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (NAPS), administered by NCAS, reports on the quality of antimicrobial prescribing in Australian hospitals and aged care homes.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/nausp/?section=4"&gt;&#xD;
      
           National Antimicrobial Utilisation Surveillance Program
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , administered by the Department of Health in South Australia, reports on population-adjusted volumes of antimicrobial consumption in Australian hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Both programs contribute to the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/"&gt;&#xD;
      
           Antimicrobial Use and Resistance in Australia
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            project, which is supported by the Commonwealth Department of Health and coordinated by the Australian Commission on Safety and Quality in Health Care.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.naps.org.au/Default.aspx"&gt;&#xD;
      
           NAPS program
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            provides education and clinical assessment support to hospital staff nationally via webinar and phone consultations. Staff in regional hospitals are encouraged to use this off-site expertise to perform audits – both to disseminate and use their hospital-specific results, and to participate in national benchmarking.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A quality 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://academic.oup.com/jac/article/70/9/2665/722162"&gt;&#xD;
      
           target
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            identified by Australian 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.journalofhospitalinfection.com/article/S0195-6701(18)30493-6/fulltext"&gt;&#xD;
      
           studies
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            is enhancing capacity for benchmarking of antimicrobial prescribing data. Regional clinicians have 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.journalofhospitalinfection.com/article/S0195-6701(18)30493-6/fulltext"&gt;&#xD;
      
           reported
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            that comparing local patterns of antimicrobial use in specific clinical areas to patterns in other similar hospitals would be beneficial.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Australia’s 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/hospital-antimicrobial-use/"&gt;&#xD;
      
           antimicrobial utilisation surveillance programs
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            aim to address this by facilitating comparisons between similar facilities.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Associate Professor Kirsty Buising, deputy director of NCAS, says that while participating in audits helps maintain national surveillance, they should primarily be used to facilitate local feedback and action.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “It is important that we provide data to hospitals that they can then reflect on and use to drive change locally as appropriate. We need to support the use of data for action.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Thu, 01 Nov 2018 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/how-do-we-close-the-gaps-in-appropriate-antibiotic-use</guid>
      <g-custom:tags type="string">NAPS,Media,Hospital,Regional</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Qualitative study of the factors impacting antimicrobial stewardship program delivery in regional and remote hospitals</title>
      <link>https://www.ncas-australia.org/qualitative-study-of-the-factors-impacting-antimicrobial-stewardship-program-delivery-in-regional-and-remote-hospitals</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           J.L. Bishop, T.R. Schulz, D.C.M. Kong and K.L. Buising
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Abstract
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Many regional and remote (‘regional’) hospitals are without the specialist services that support antimicrobial stewardship (AMS) programs in hospitals in major cities. This can impact their ability to implement AMS activities.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Aim
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : To identify factors that impact on the delivery of AMS programs in regional hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Healthcare clinicians who have primary AMS responsibilities or provide AMS support to a health service or across health services with an Australian Statistical Geography Standard Remoteness classification of inner regional, outer regional, remote or very remote were recruited purposively and via snowballing. A series of focus groups and interviews were held, and the discussions were audiotaped and transcribed verbatim. The transcripts were coded by two researchers, and thematic analysis was undertaken using a framework method.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Findings
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Four focus groups and one interview were conducted (22 participants). Six main themes that impacted on AMS program delivery were identified: culture of independence and self-reliance by local clinicians, personal relationships, geographical location of the hospital influencing antimicrobial choice, local context, inability to meaningfully benchmark performance, and lack of resources. Possible strategies to support the delivery of AMS programs in regional hospitals proposed by participants were categorised into two main themes: those that may be best developed or managed centrally, and those that should be a local responsibility.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusion
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : AMS program delivery in regional hospitals is influenced by factors that are not present in hospitals in major cities. These findings provide a strong basis for the development of strategies to support regional hospitals to implement sustainable AMS programs.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Keywords
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Antimicrobial stewardship, hospital, rural, health service, barrier, enabler
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.journalofhospitalinfection.com/article/S0195-6701(18)30493-6/fulltext" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Bishop, J.L., Schulz, T.R., Kong, D.C.M., Buising, K.L. (2019). A qualitative study of the factors impacting antimicrobial stewardship program delivery in regional and remote hospitals. Journal of Hospital Infection, 101(4), 440-446. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.jhin.2018.09.014" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1016/j.jhin.2018.09.014
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551884170-09fb70a3a2ed.jpg" length="174165" type="image/jpeg" />
      <pubDate>Tue, 25 Sep 2018 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/qualitative-study-of-the-factors-impacting-antimicrobial-stewardship-program-delivery-in-regional-and-remote-hospitals</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper,Regional</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551884170-09fb70a3a2ed.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1551884170-09fb70a3a2ed.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Population-wide assessment of antimicrobial use in dogs and cats using a novel data source: a cohort study using pet insurance data</title>
      <link>https://www.ncas-australia.org/population-wide-assessment-of-antimicrobial-use-in-dogs-and-cats-using-a-novel-data-source-a-cohort-study-using-pet-insurance-data</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Laura Hardefeldt, Joshua Selinger, Mark Stevenson, James Gilkerson, Helen Crabb, Helen Billman-Jacobe, Karin Thursky, Kirsten Bailey, Magdoline Awad and Glenn Browning
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Highlights
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           :
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            First population level study of exposure to antimicrobials in companion animals.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Rate of exposure was less than half that of the coincident human population.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Critically important antimicrobials accounted for 8% of antimicrobials prescribed.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Incident rate of prescribing in dogs was 5.8 prescriptions per 10 dog-years.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Incident rate for prescribing in cats was 3.1 prescriptions per 10 cat-years.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Antimicrobial use in veterinary practice is under increasing scrutiny as a contributor to the rising risk of multidrug resistant bacterial pathogens. Surveillance of antimicrobial use in food animals is extensive globally, but population level data is lacking for companion animals. Lack of census data means cohorts are usually restricted to those attending veterinary practices, which precludes aggregating data from large cohorts of animals, independent of their need for veterinary intervention. The objective of this study was to investigate the exposure of dogs and cats to antimicrobials at a population level. A retrospective cohort study was performed using a novel data source; a pet insurance database. The rate of antimicrobial prescribing, and the rate of prescribing of critically important antimicrobials, was measured in a large population of dogs (813,172 dog-years) and cats (129,232 cat-years) from 2013 - 2017. The incidence rate of antimicrobial prescribing was 5.8 prescriptions per 10 dog years (95% CI 5.8–5.9 per 10 dog years) and 3.1 prescriptions per 10 cat years (95% CI 3.1–3.2 per 10 cat years). Critically important antimicrobials accounted for 8% of all the antimicrobials prescribed over the 4-year study. Cats were 4.8-fold more likely than dogs to be prescribed 3rd-generation cephalosporins. The level of antimicrobial exposure in dogs and cats was less than half that for the coincident human community. Data such as this provides a unique opportunity to monitor antimicrobial prescribing in veterinary medicine, which is a critical component of optimal antimicrobial stewardship.
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.vetmic.2018.09.010" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Hardefeldt, L. Y., Selinger, J., Stevenson, M. A., Gilkerson, J. R., Crabb, H., Billman-Jacobe, H.,... Browning, G. F. (2018). Population-wide assessment of antimicrobial use in dogs and cats using a novel data source–a cohort study using pet insurance data. Veterinary Microbiology, 225, 34-39. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.vetmic.2018.09.010" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1016/j.vetmic.2018.09.010
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1573435567032-ff5982925350.jpg" length="395407" type="image/jpeg" />
      <pubDate>Mon, 17 Sep 2018 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/population-wide-assessment-of-antimicrobial-use-in-dogs-and-cats-using-a-novel-data-source-a-cohort-study-using-pet-insurance-data</guid>
      <g-custom:tags type="string">Companion animal,NCAS publications,Veterinary,Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1573435567032-ff5982925350.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1573435567032-ff5982925350.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>National Centre for Infections in Cancer Symposium 2018</title>
      <link>https://www.ncas-australia.org/national-centre-for-infections-in-cancer-symposium-2018</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/NCIC-a263beab.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           The National Centre for Infections in Cancer Symposium in 2018, 'What's New in Cancer: What ID Needs to Know', was held at the Victorian Comprehensive Cancer Centre in Melbourne, Victoria, on 3rd August 2018. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Date
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           : 3 August 2018
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Venue
          
                    &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           : Victorian Comprehensive Cancer Centre
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Level 7 VCCC
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           305 Grattan St
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           Parkville, Vic, 3000
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            See
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://cancerandinfections.org/2018workshop/" target="_blank"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            .
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/NCIC-a263beab.jpg" length="12379" type="image/jpeg" />
      <pubDate>Fri, 03 Aug 2018 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/national-centre-for-infections-in-cancer-symposium-2018</guid>
      <g-custom:tags type="string">News and events,Seminar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/NCIC-a263beab.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/NCIC-a263beab.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>The Aged Care National Antimicrobial Prescribing Survey: 2017 report</title>
      <link>https://www.ncas-australia.org/the-aged-care-national-antimicrobial-prescribing-survey-2017-report</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/acNAPS+2017.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           The results of the 2017 annual Aged Care National Antimicrobial Prescribing Survey (acNAPS) were officially released on 30 July, 2018.
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           293 aged care homes participated during the data collection period between 19 June to 1 September 2017, representing all Australian states, provider types and remoteness classifications. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           The results include:
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            A high rate of use of antimicrobials for unconfirmed infections: almost one-third (33.2%) of antimicrobials were prescribed for residents who had no signs or symptoms of infection in the week prior to the antimicrobial start-date
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Prescriptions did not meet the criteria for an infection: just over half (51.6%) of prescriptions were for residents who did not have signs or symptoms of infection.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Duration of prescriptions: almost one-quarter (21.8%) of antimicrobials had been administered for longer than six months.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Widespread use of topical antimicrobials: accounting for just over one-quarter (29.5%) of prescriptions.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Incomplete documentation: the antimicrobial start- and stop-date were unknown for 49.3% of antimicrobials administered, while the indication for the antimicrobial was not documented for 22.1% of antimicrobials administered. 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            See
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/ncas-publications"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            .
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/acNAPS+2017.jpg" length="62367" type="image/jpeg" />
      <pubDate>Mon, 30 Jul 2018 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/the-aged-care-national-antimicrobial-prescribing-survey-2017-report</guid>
      <g-custom:tags type="string">News and events,NCAS publications,NAPS reports,Aged care,Community</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/acNAPS+2017.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/acNAPS+2017.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Improving how we manage sepsis</title>
      <link>https://www.ncas-australia.org/improving-how-we-manage-sepsis</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Arjun Rajkhowa
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://pursuit.unimelb.edu.au/articles/improving-how-we-manage-sepsis" target="_blank"&gt;&#xD;
      
           Pursuit
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , University of Melbourne)
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           You might know a family member or friend who arrived at hospital with the flu, a headache or a chest infection - whose condition took a sudden downward turn due to sepsis or septic shock.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Patients who develop sepsis can 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.abc.net.au/news/2018-03-08/sepsis-the-deadly-disease-killing-5000-australians-a-year/9484502"&gt;&#xD;
      
           deteriorate rapidly
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            and interventions that help clinicians recognise sepsis and expedite patient care can make a significant difference.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A newly published 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/30019016"&gt;&#xD;
      
           study
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            by University of Melbourne and 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.petermac.org/"&gt;&#xD;
      
           Peter MacCallum Cancer Centre
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            clinician-researchers, led by Professor Karin Thursky, has found that a standardised sepsis pathway facilitating early sepsis recognition and prompt treatment in a cancer hospital is delivering significant benefits and saving lives.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Improvements include:
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Earlier diagnosis
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Faster initiation of antibiotic therapy (55 minutes vs 110 minutes)
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Increased appropriateness of antibiotic therapy (90.1 per cent vs 76.1 per cent)
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Reduced ICU admissions (17.1 per cent vs 35.5 per cent)
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Reduced post-sepsis length of stay (7.5 days vs 9.9 days)
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Lower sepsis-related mortality (5.0 per cent vs. 16.2 per cent)
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Lower hospital admission costs (cost savings of $8,363 per patient)
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Sepsis in hospitals
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Sepsis is a life-threatening complication of an infection – an underlying infection triggers inflammatory responses throughout the body. If the patient doesn’t receive prompt and optimal treatment, it can lead to organ-failure and possibly death.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In 2016-17 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.bettercare.vic.gov.au/innovation-fund/sepsis-scaling"&gt;&#xD;
      
           in Victoria, Australia
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , 28,872 patients were diagnosed with sepsis and 3,258 of these patients died, representing a mortality rate of 11 per cent. Sepsis accounts for a significant proportion of 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/14963646"&gt;&#xD;
      
           intensive care unit admissions
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            in Australia and New Zealand, and the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciy342/5019029"&gt;&#xD;
      
           international literature
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            indicates that a high proportion of in-hospital mortality can be attributed to sepsis.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The risk of developing sepsis also increases with age, posing a threat to care of the elderly.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Infections and sepsis are commonly encountered in cancer management as patients with weakened immune systems, including those undergoing chemotherapy and radiotherapy, are more vulnerable. Control of infections is critical to cancer survival.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Signs of sepsis
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The early signs of sepsis may be a combination of high or low temperature, elevated heart rate, elevated breathing rate and high or low white blood cell count. Recognising these signs requires knowledge and vigilance by nursing and medical staff.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           During severe sepsis, the patient may experience confusion or an altered mental state, decreased urination, low platelet count, low temperature and chills, extreme weakness and unconsciousness.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Septic shock or advanced sepsis is accompanied by a significant drop in blood pressure despite resuscitation with fluids and usually requires intensive care management.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Clinicians and nursing staff need to recognise the signs of sepsis and initiate treatment quickly. But time constraints and competing priorities mean this may not always happen efficiently in hospitals, resulting in clinical deterioration, increased ICU admissions and higher mortality.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A sepsis pathway
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Clinicians at the Peter MacCallum Cancer Centre developed and implemented a whole-of-hospital sepsis pathway. Adapted from the New South Wales Clinical Excellence Commission’s 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.cec.health.nsw.gov.au/patient-safety-programs/adult-patient-safety/sepsis-kills"&gt;&#xD;
      
           Sepsis Kills
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            pathway for emergency departments, the hospital’s pathway focused on timely and appropriate recognition, resuscitation and referral of patients with sepsis (drawing on the core principles that underpin all international sepsis management guidelines).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The sepsis pathway prioritises six actions of initial sepsis management in the first hour: oxygen administration; the taking of two sets of blood cultures; testing of venous blood lactate levels; administration of rapid fluid resuscitation and appropriate antibiotic treatment.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Prior to implementation, staff across different hospital wards received standardised training to avoid any inconsistencies in care delivery. This training and education is ongoing.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A key aspect of the pathway is the inclusion of a checklist of signs and symptoms at the point of care, enabling nurses to initiate the pathway prior to medical review.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           This process saves valuable time and ensures nurses caring for patients can start critical pre-antibiotic treatment activities such as oxygen administration and cannulation, and take blood cultures and order a lactate test prior to the doctor’s arrival.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Serum lactate levels are important as they can help determine illness severity and prognosis. After the doctor’s arrival and confirmation of the diagnosis, fluid resuscitation and antibiotic treatment are initiated.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The pathway also provides different empiric first-dose antibiotic options based on suspected sites of infection, while also accounting for complications such as allergies and immune suppression.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           During the study period, this helped medical staff to quickly process antibiotic initiation decisions and contributed to increased appropriateness of treatment.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Timing is key in sepsis management.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Intensive monitoring and quick delivery of oxygen can help resuscitate the patient, but the benefits of early interventions decrease with delays.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           By streamlining what nurses can do at the point of care, this pathway facilitated quicker initiation of pre-antibiotic treatment activities – quicker testing and initial responses. Then, by streamlining consensus-based antibiotic treatment options, the pathway helped clinicians prescribe the initial antibiotic course, reducing time-to-antibiotics.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Scaling up the sepsis pathway project
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Lead author Professor Karin Thursky, who led the clinicians responsible for the sepsis pathway project at Peter MacCallum Cancer Centre, also led a sepsis pathway project at the Royal Melbourne Hospital, in which the existing pathway was adapted and appropriately modified for a general hospital setting.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Her team has since received a grant from 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www2.health.vic.gov.au/hospitals-and-health-services/quality-safety-service/better-care-victoria"&gt;&#xD;
      
           Better Care Victoria
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (Department of Health and Human Services, Victoria) to lead a state-wide implementation of the modified sepsis pathway, working with 11 hospitals and health services across Victoria.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “The delay in management of sepsis is what leads to serious negative outcomes for the patient. Timeliness of management of sepsis is absolutely critical. Early recognition has been demonstrated to reduce deaths, reduce length of stay in hospital and reduce admissions to the intensive care unit,” says Professor Thursky.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Kelly Sykes, project lead for the state-wide sepsis improvement project, 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.bettercare.vic.gov.au/innovation-fund/sepsis-scaling"&gt;&#xD;
      
           highlights
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            the importance of standardising care.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “Hospitals might find variations in how sepsis is recognised and managed across different wards in their facility. They need to consider that this variability poses a potential risk to patients,” she says.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Dr Douglas Travis, chair of Better Care Victoria, says the state-wide sepsis collaborative project aims to spread the benefits of quality improvement.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “Our hospitals do very good things but their achievements tend to stay in the one hospital. The aim of 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.bettercare.vic.gov.au/innovation-fund/sepsis-scaling"&gt;&#xD;
      
           Better Care Victoria
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            is to take good ideas and spread them to other places in Victoria so that the whole of the population can benefit from the good ideas that are generated in our public and private hospitals.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Sun, 29 Jul 2018 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/improving-how-we-manage-sepsis</guid>
      <g-custom:tags type="string">Media,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial prescribing for children in primary care</title>
      <link>https://www.ncas-australia.org/antimicrobial-prescribing-for-children-in-primary-care</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Jennifer Yan, Lesley Hawes, Lyle Turner, Danielle Mazza, Christopher Pearce and Jim Buttery
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Aim
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : To describe the patterns of antimicrobial prescribing in general practice for children aged ≤18 years.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : This is a review of routinely collected patient data extracted from computerised medical records from 39 general practices in eastern metropolitan Melbourne over a 5‐year period, 2010–2014. Main outcome measures: Proportion of paediatric consultations resulting in antibiotic prescription, type and frequency of antibiotics prescribed, antibiotic prescribing stratified by age, reason for indication and inter‐practice variation.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : There were 744 883 consultations for 89 983 individual paediatric patients and 85 913 prescriptions for antibiotics during the study period. Of these antibiotic prescriptions, 75 410 were associated with a consultation, and 10 503 (12.2% of all prescriptions) had no associated consultation in the data. On average, one in five individual children was prescribed an antibiotic each year. The most commonly prescribed antibiotics were cephalexin, amoxycillin/clavulanate, cefaclor, phenoxymethylpenicillin and roxithromycin. Less than 3% of all prescriptions were for amoxycillin. Prescribing of cefaclor and roxithromycin decreased, although cefaclor remained the third most common antibiotic choice for general practitioners. Peaks in prescribing were noted over winter months. Reason for prescription was not recorded for 82% of prescriptions. The frequency of antibiotic prescription per consultation varied substantially (2.1–19.7%) between general practitioner clinics. Overall, antibiotic prescribing decreased by 2.3% over the 5‐year period.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : This study provides a focused examination of antibiotic prescribing practices for children in Australian general practice. More information is required to better understand specific prescribing practices in children, including the low frequency of amoxycillin prescription and ongoing prescription of cefaclor.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://doi.org/10.1111/jpc.14105" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          .
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    
          : Yan J., Hawes L., Turner L., Mazza D., Pearce C., Buttery J. (2018). Antimicrobial prescribing for children in primary care. Journal of Paediatrics and Child Health, 55(1), 54-58. DOI:
          &#xD;
    &lt;a href="https://doi.org/10.1111/jpc.14105" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1111/jpc.14105
          &#xD;
    &lt;/a&gt;&#xD;
    
          .
         &#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576765608622-067973a79f53.jpg" length="199561" type="image/jpeg" />
      <pubDate>Mon, 23 Jul 2018 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-prescribing-for-children-in-primary-care</guid>
      <g-custom:tags type="string">NCAS publications,Community,Community paper,GP</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576765608622-067973a79f53.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576765608622-067973a79f53.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Dapsone safety in hematology patients: pathways to optimising Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients</title>
      <link>https://www.ncas-australia.org/dapsone-safety-in-hematology-patients-pathways-to-optimising-pneumocystis-jirovecii-pneumonia-prophylaxis-in-hematology-malignancy-and-transplant-recipients</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Karen F. Urbancic, Daisy Pisasale, Joel Wight and Jason A. Trubiano
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Dapsone may be used for
          &#xD;
    &lt;span&gt;&#xD;
      
           Pneumocystis jirovecii
          &#xD;
    &lt;/span&gt;&#xD;
    
          pneumonia (PJP) prophylaxis in hematology patients receiving immunosuppressive therapy or after hematopoietic stem cell transplant (HSCT) in the setting of trimethoprim‐sulfamethoxazole (TMP‐SMX) adverse drug reaction (ADR) history. Dapsone‐induced hematological toxicities such as oxidative hemolysis may limit use in these patients and modern assessments of dapsone allergy cross‐reactivity in non‐HIV patients with a sulfonamide allergy are largely absent. The aim of this single‐centre, retrospective study was to describe dapsone usage in hematology patients requiring PJP prophylaxis, including HSCT recipients, over a 12‐month period in terms of indications, incidence of dapsone‐attributed oxidative hemolysis, and immune cross‐reactivity in those previously labeled with a sulfonamide allergy, as well as describing potential opportunities for first‐line TMP‐SMX PJP prophylaxis reintroduction. Of 24 patients meeting the study inclusion criteria, 12 (50%) were receiving dapsone PJP prophylaxis post‐HSCT. No cases of breakthrough PJP infection were noted. Sixteen patients (67%) were initiated on dapsone to avoid the perceived risk of further myelosuppression with TMP‐SMX and five patients (21%) because of prior delayed immune‐mediated allergy to TMP‐SMX. None experienced rash with dapsone therapy. Six patients (25%) were successfully rechallenged on TMP‐SMX, including one patient with prior TMP‐SMX‐associated rash. Four (17%) patients had confirmed oxidative hemolysis, all resulting in dapsone cessation. Dapsone PJP prophylaxis in hematology patients was effective and safe, with non-life threatening dapsone‐related hemolysis noted in a small number. An absence of sulfonamide allergy cross‐reactivity was noted, suggesting greater TMP‐SMX rechallenges or desensitisation could be considered in those receiving dapsone.
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://doi.org/10.1111/tid.12968" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          .
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Urbancic, K.F., Pisasale, D., Wight, J., Trubiano, J.A. (2018). Dapsone safety in haematology patients: pathways to optimising Pneumocystis jirovecii pneumonia prophylaxis in haematology malignancy and transplant recipients. Transplant Infectious Disease, 20, e12968. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1111/tid.12968" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1111/tid.12968
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1533042789716-e9a9c97cf4ee.jpg" length="128162" type="image/jpeg" />
      <pubDate>Fri, 20 Jul 2018 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/dapsone-safety-in-hematology-patients-pathways-to-optimising-pneumocystis-jirovecii-pneumonia-prophylaxis-in-hematology-malignancy-and-transplant-recipients</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1533042789716-e9a9c97cf4ee.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1533042789716-e9a9c97cf4ee.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Implementation of a whole-of-hospital sepsis clinical pathway in a cancer hospital: impact on sepsis management, outcomes and costs</title>
      <link>https://www.ncas-australia.org/implementation-of-a-whole-of-hospital-sepsis-clinical-pathway-in-a-cancer-hospital-impact-on-sepsis-management-outcomes-and-costs</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Karin Thursky, Senthil Lingaratnam, Jasveer Jayarajan, Gabrielle M Haeusler, Benjamin Teh, Michelle Tew, Georgina Venn, Alison Hiong, Christine Brown, Vivian Leung, Leon J Worth, Kim Dalziel and Monica A Slavin
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Infection and sepsis are common problems in cancer management affecting up to 45% of patients and are associated with significant morbidity, mortality and healthcare utilisation.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Objective
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : To develop and implement a whole of hospital clinical pathway for the management of sepsis (SP) in a specialised cancer hospital and to measure the impact on patient outcomes and healthcare utilisation.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : A multidisciplinary sepsis working party was established. Process mapping of practices for recognition and management of sepsis was undertaken across all clinical areas. A clinical pathway document that supported nurse-initiated sepsis care, prompt antibiotic and fluid resuscitation was implemented. Process and outcome measures for patients with sepsis were collected preimplementation (April–December 2012), postimplementation cohorts (April–December 2013), and from January to December 2014.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : 323 patients were evaluated (111 preimplementation, 212 postimplementation). More patients with sepsis had lactate measured (75.0% vs 17.2%) and appropriate first dose antibiotic (90.1% vs 76.1%) (all p&amp;lt;0.05). Time to antibiotics was halved (55 vs 110 min, p&amp;lt;0.05). Patients with sepsis had lower rates of intensive care unit admission (17.1% vs 35.5%), postsepsis length of stay (7.5 vs 9.9 days), and sepsis-related mortality (5.0% vs 16.2%) (all p&amp;lt;0.05). Mean total hospital admission costs were lower in the SP cohort, with a significant difference in admission costs between historical and SP non-surgical groups of $A8363 (95% CI 81.02 to 16645.32, p=0.048) per patient on the pathway. A second cohort of 449 patients with sepsis from January to December 2014 demonstrated sustained improvement.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : The SP was associated with significant improvement in patient outcomes and reduced costs. The SP has been sustained since 2013, and has been successfully implemented in another hospital with further implementations underway in Victoria.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1136/bmjoq-2018-000355" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    
          : Thursky, K., Lingaratnam, S., Jayarajan, J., Haeusler, G.M., Teh, B., Tew, M., Venn, G. Hiong, A., Brown, C., Leung, V., Worth, L.J., Dalziel, K., Slavin, M A. (2018). Implementation of a whole-of-hospital sepsis clinical pathway in a cancer hospital: impact on sepsis management, outcomes and costs. BMJ Open Quality, 7(3), e000355. DOI:
          &#xD;
    &lt;a href="https://doi.org/10.1136/bmjoq-2018-000355" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1136/bmjoq-2018-000355
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            . 
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/hospital-building.jpg" length="113566" type="image/jpeg" />
      <pubDate>Thu, 05 Jul 2018 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/implementation-of-a-whole-of-hospital-sepsis-clinical-pathway-in-a-cancer-hospital-impact-on-sepsis-management-outcomes-and-costs</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper,Sepsis</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/hospital-building.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/hospital-building.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Surgical antibiotic prophylaxis: the evidence and understanding its impact on consensus guidelines</title>
      <link>https://www.ncas-australia.org/surgical-antibiotic-prophylaxis-the-evidence-and-understanding-its-impact-on-consensus-guidelines</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Courtney Ierano, Trisha Peel, Darshini Ayrton, Arjun Rajkhowa, Caroline Marshall and Karin Thursky
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Highlights
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           :
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Surgical site infections are complications of surgical care that may be prevented with appropriate surgical antibiotic prophylaxis (SAP). SAP is the most common indication for antimicrobial use in Australian hospitals; however, it is associated with high rates of inappropriate use.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Inappropriate SAP is associated with adverse consequences for both the patient and the community. The underlying reasons for inappropriate use, however, are not well delineated. Potential factors include the quality of the evidence base regarding SAP use and available guidelines.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            The evidence for SAP across a range of surgical procedures can vary in quality. Recommendations for SAP encompass multiple surgical procedures and combine many elements of antimicrobial prescribing, i.e., indication, antimicrobial agent, dose, route, timing and duration. The broad nature of these recommendations may reflect the lack of overall Level 1 evidence (per the National Health and Medical Research Council hierarchy). This may be a barrier to uptake of and compliance with guidelines such as Therapeutic Guidelines: Antibiotic.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Surgical site infections are complications of surgical care that may be prevented with appropriate surgical antibiotic prophylaxis (SAP). SAP is the most common indication for antimicrobial use in Australian hospitals; however, it is associated with high rates of inappropriate use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Inappropriate SAP is associated with adverse consequences for both the patient and the community. The underlying reasons for inappropriate use, however, are not well delineated. Potential factors include the quality of the evidence base regarding SAP use and available guidelines.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : The literature review focused on research classified as having Level 1 evidence according to the National Health and Medical Research Council (NHMRC) evidence hierarchy. Findings were then compared to the current Australian recommended guidelines (Therapeutic Guideline: Antibiotic Surgical Prophylaxis).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Overall, 50 systematic reviews (SR) and meta-analysis (MAs) were identified for the review. The evidence examined highlights that first-generation cephalosporins are the antimicrobial agents of choice and single-dose prophylaxis is effective for the majority of surgical procedures included in this review. There is limited evidence pertaining to a specific optimal antimicrobial, dosing and timing. Thus, there is no overarching Level 1 evidence combining all elements for an optimal SAP regimen (i.e., choice of agent, dose, route and duration) to support individual Therapeutic Guideline: Antibiotic recommendations, although there may be Level 1 evidence for the individual elements.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Considerable evidence supports the use of SAP; however, there are gaps in the evidence behind recommendations for the most appropriate SAP regimen for different surgical procedures. Expert consensus guideline development aims to narrow these gaps, but guideline implementability and uptake are influenced by multiple factors including the comprehensiveness of the evidence. Further research is warranted to examine guideline implementability and uptake, and to identify problematic areas surrounding surgical prophylaxis prescribing.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Keywords
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Antibiotic prophylaxis, infection control, evidence-based medicine, surgical wound infection.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.idh.2018.05.003" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Ierano, C., Peel, T., Ayton, D., Rajkhowa, A., Marshall, C., Thursky, K. (2018). Surgical antibiotic prophylaxis: The evidence and understanding its impact on consensus guidelines. Infection, Disease &amp;amp; Health, 23(3), 179-188. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.idh.2018.05.003" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1016/j.idh.2018.05.003
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .  
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1434626881859-194d67b2b86f.jpg" length="326882" type="image/jpeg" />
      <pubDate>Thu, 21 Jun 2018 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/surgical-antibiotic-prophylaxis-the-evidence-and-understanding-its-impact-on-consensus-guidelines</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper,Surgical</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1434626881859-194d67b2b86f.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1434626881859-194d67b2b86f.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Implementing antimicrobial stewardship programs in veterinary practices</title>
      <link>https://www.ncas-australia.org/implementing-antimicrobial-stewardship-programs-in-veterinary-practices</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Laura Y. Hardefeldt
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Highlights
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Comprehensive antimicrobial stewardship programs (ASPs) have been widely implemented in medical practice over the past decade to improve antimicrobial prescribing and reduce the pressure on the development of antimicrobial resistance. Most global and national action plans have called for implementation of ASPs in veterinary practices. Despite these calls, implementation of comprehensive ASPs in veterinary practices remains uncommon.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Medical ASPs have involved using restrictive interventions, which reduce the freedom of prescribers to select some antimicrobials, and persuasive interventions, which are aimed at driving behavioural change. Persuasive interventions are focused on addressing predisposing factors (practitioner education), reinforcing factors (audit and feedback) and enabling factors (decision support). Many ASPs have elements of both restriction and persuasion, but neither of these elements has been found to be more successful than the other over the long term. The main driver of ASPs has typically been the need to prevent future outbreaks of nosocomial multidrug-resistant infections in hospitals, with a secondary goal of reducing hospital costs without adversely affecting quality of care. Increasingly, ASPs are mandated by regulatory bodies that fund medical hospitals. While regulation does assist in ensuring widespread implementation of ASPs, the consistent financial benefits of effectively established ASPs have meant that many of these programs can be self-supporting in both large and small hospitals. There is strong evidence in the medical literature that planned interventions can change prescribing practices and can control infectious disease outcomes. While there are several opinion articles in the literature addressing antimicrobial stewardship in veterinary practice, there are no reports of hospital-style ASPs being implemented in veterinary...
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://dx.doi.org/10.1136/vr.k2563" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Hardefeldt, L.Y. (2018). Implementing antimicrobial stewardship programmes in veterinary practices. Veterinary Record, 182(24), 688-690. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://dx.doi.org/10.1136/vr.k2563" target="_blank"&gt;&#xD;
      
           http://dx.doi.org/10.1136/vr.k2563
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            . 
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/veterinarian-dog.jpg" length="141045" type="image/jpeg" />
      <pubDate>Thu, 14 Jun 2018 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/implementing-antimicrobial-stewardship-programs-in-veterinary-practices</guid>
      <g-custom:tags type="string">Companion animal,NCAS publications,Equine,Veterinary,Bovine (New Tag),Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/veterinarian-dog.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/veterinarian-dog.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Meeting the challenge for effective antimicrobial stewardship programs in regional, rural and remote hospitals: what can we learn from the published literature?</title>
      <link>https://www.ncas-australia.org/meeting-the-challenge-for-effective-antimicrobial-stewardship-programs-in-regional-rural-and-remote-hospitals-what-can-we-learn-from-the-published-literature</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Jaclyn Bishop, David CM Kong, Thomas R Schulz, Karin A Thursky and Kirsty L Buising
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Introduction
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Antimicrobial resistance (AMR) has been recognised as an urgent health priority, both nationally and internationally. Australian hospitals are required to have an antimicrobial stewardship (AMS) program, yet the necessary resources may not be available in regional, rural or remote hospitals. This review will describe models for AMS programs that have been introduced in regional, rural or remote hospitals internationally and showcase achievements and key considerations that may guide Australian hospitals in establishing or sustaining AMS programs in the regional, rural or remote hospital setting.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : A narrative review was undertaken based on literature retrieved from searches in Ovid Medline, Scopus, Web of Science and the grey literature. ‘Cited’ and ‘cited by’ searches were undertaken to identify additional articles. Articles were included if they described an AMS program in the regional, rural or remote hospital setting (defined as a bed size less than 300 and located in a non-metropolitan setting).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Eighteen articles were selected for inclusion. The AMS initiatives described were categorised into models designed to address two different challenges relating to AMS program delivery in regional, rural and remote hospitals. This included models to enable regional, rural and remote hospital staff to manage AMS programs in the absence of on-site infectious diseases (ID) trained experts. Non-ID doctor-led, pharmacist-led and externally led initiatives were identified. Lack of pharmacist resources was recognised as a core barrier to the further development of a pharmacist-led model.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The second challenge was access to timely off-site expert ID clinical advice when required. Examples where this had been overcome included models utilising visiting ID specialists, telehealth and hospital network structures. Formalisation of such arrangements is important to clarify the accountabilities of all parties and enhance the quality of the service.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Information technology was identified as a facilitator to a number of these models. The variance in availability of information technology between hospitals and cost limits the adoption of uniform programs to support AMS.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusion
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Despite known barriers, regional, rural and remote hospitals have implemented AMS programs. The examples highlighted show that difficulty recruiting ID specialists should not inhibit AMS programs in regional, rural and remote hospitals, as much of the day-to-day work of AMS can be done by non-experts. Capacity building and the strengthening of networks are core features of these programs.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Descriptions of how Australian regional, rural and remote hospitals have structured and supported their AMS programs would add to the existing body of knowledge sourced from international examples. Research into AMS programs predominantly led by GPs and nursing staff will provide further possible models for regional, rural and remote hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Keywords
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Antibiotics, antimicrobial stewardship, Australia, program delivery.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.rrh.org.au/journal/article/4442" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Bishop, J., Kong, D.C., Schulz, T.R., Thursky, K.A., Buising, K.L. (2018). Meeting the challenge for effective antimicrobial stewardship programs in regional, rural and remote hospitals: What can we learn from the published literature?. Rural and Remote Health, 18(2), 4442-4442. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.22605/RRH4442" target="_blank"&gt;&#xD;
      
           https://doi.org/10.22605/RRH4442
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1460925895917-afdab827c52f.jpg" length="242353" type="image/jpeg" />
      <pubDate>Wed, 23 May 2018 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/meeting-the-challenge-for-effective-antimicrobial-stewardship-programs-in-regional-rural-and-remote-hospitals-what-can-we-learn-from-the-published-literature</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper,Regional</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1460925895917-afdab827c52f.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1460925895917-afdab827c52f.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Prevalence of infections and antimicrobial prescribing in Australian aged care facilities: evaluation of modifiable and nonmodifiable determinants</title>
      <link>https://www.ncas-australia.org/prevalence-of-infections-and-antimicrobial-prescribing-in-australian-aged-care-facilities-evaluation-of-modifiable-and-nonmodifiable-determinants</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Noleen Bennett, Nabeel Imam, Rodney James, Caroline Chen, Ann Bull, Karin Thursky, Kirsty Buising and Leon Worth
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Infections in aged care residents are associated with poor outcomes, and inappropriate antimicrobial prescribing contributes to adverse events, such as the emergence of antimicrobial resistance. The objective of this study was to identify resident- and facility-level factors associated with infection and antimicrobial prescribing in Australian aged care residents.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Using data captured by a national point-prevalence survey (the Aged Care National Antimicrobial Prescribing Survey), risk and protective factors were determined by multivariate Poisson regression.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : In 2017, 292 facilities were surveyed. Infection prevalence was 2.9% (95% confidence interval [CI], 2.6%-3.2%), and antimicrobial use prevalence was 8.9% (95% CI, 8.4%-9.4%). Resident-level factors associated with infection prevalence included urinary catheterisation and hospital admission within the last 30 days; facility-level factors included state and multipurpose service provision. Resident-level factors associated with antimicrobial prescribing included infection signs and symptoms; facility-level factors included state, nonmetropolitan locality, and not-for-profit status. Availability of guidelines for urinary tract infection (UTI) management was associated with reduced antimicrobial prescribing.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Looking ahead, reports should be peer grouped by significant facility-level factors. Priority should be given to implementing UTI management guidelines and prevention of infection in residents with indwelling urinary catheters. Enhanced monitoring and prevention strategies are required for residents recently admitted to hospital.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Key words: Aged care, Australia, infection, antimicrobial prescribing, surveillance
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.ajic.2018.03.027" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Bennett, N., Imam, N., James, R., Chen, C., Bull, A., Thursky, K., Buising, K., Worth, L., (2018). Prevalence of infections and antimicrobial prescribing in Australian aged care facilities: Evaluation of modifiable and nonmodifiable determinants. American Journal of Infection Control, 46(10), 1148-1153. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.ajic.2018.03.027" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1016/j.ajic.2018.03.027
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AgedCare_NAPS-887x277.jpg" length="33417" type="image/jpeg" />
      <pubDate>Wed, 16 May 2018 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/prevalence-of-infections-and-antimicrobial-prescribing-in-australian-aged-care-facilities-evaluation-of-modifiable-and-nonmodifiable-determinants</guid>
      <g-custom:tags type="string">NCAS publications,Community,Community paper,Aged care,Aged care paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AgedCare_NAPS-887x277.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AgedCare_NAPS-887x277.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>The World Health Organisation's joint external evaluation of the international health regulations (IHR) core capacities of Australia: mission report</title>
      <link>https://www.ncas-australia.org/the-world-health-organisation-s-joint-external-evaluation-of-the-international-health-regulations-ihr-core-capacities-of-australia-mission-report</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/JEE.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Excerpt: Health security threats from infectious diseases and public health emergencies are inevitable and all countries are universally vulnerable. In recognition of this situation, WHO developed the International Health Regulations (IHR) 2005 to help the international community prevent, detect and respond to acute public health events with potential to cross borders and threaten populations worldwide. The IHR (2005) require that countries develop core capacities to manage acute public health events. In the Western Pacific Region, the Asia Pacific Strategy for Emerging Diseases (APSED) has been used as the action framework for building and strengthening core capacity under the IHR (2005). For over a decade, Australia has been supporting the implementation of APSED in the Western Pacific and South-East Asian regions. See
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://apps.who.int/iris/handle/10665/272362" target="_blank"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           .
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/JEE.jpg" length="106145" type="image/jpeg" />
      <pubDate>Wed, 02 May 2018 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/the-world-health-organisation-s-joint-external-evaluation-of-the-international-health-regulations-ihr-core-capacities-of-australia-mission-report</guid>
      <g-custom:tags type="string">News and events</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/JEE.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/JEE.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Project: Antimicrobial Stewardship Textbook and Training Package for Low- and Middle-Income Countries</title>
      <link>https://www.ncas-australia.org/project-antimicrobial-stewardship-textbook-and-training-package-for-low-and-middle-income-countries</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/who-logo.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           NCAS received a grant from the World Health Organisation's Western Pacific Regional Office for a project focused on developing a textbook and training package for hospital-based antimicrobial stewardship education and training in low- and middle-income countries. This project included the development of: 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            a textbook on hospital-based antimicrobial stewardship,
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            a series of presentations for training workshops, 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            tools for setting up stewardship programs,
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            information for different practitioner groups, 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            resources and policy templates,
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            a package of interventions, 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            information about surveillance and research activities, 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            advice on informing and influencing policymakers, and
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            examples from practice. 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/who-logo.jpg" length="152185" type="image/jpeg" />
      <pubDate>Wed, 02 May 2018 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/project-antimicrobial-stewardship-textbook-and-training-package-for-low-and-middle-income-countries</guid>
      <g-custom:tags type="string">News and events</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/who-logo.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/who-logo.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial labelling in Australia: a threat to antimicrobial stewardship?</title>
      <link>https://www.ncas-australia.org/antimicrobial-labelling-in-australia-a-threat-to-antimicrobial-stewardship</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           L. Y. Hardefeldt, J. R. Gilkerson, H. Billman‐Jacobe, M. A. Stevenson, K. Thursky, G. F. Browning and K. E. Bailey
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Antimicrobial resistance is a public health emergency, placing veterinary antimicrobial use under growing scrutiny. Antimicrobial stewardship, through appropriate use of antimicrobials, is a response to this threat. The need for antimicrobial stewardship in Australian veterinary practices has had limited investigation. A 2016 survey undertaken to investigate antimicrobial usage patterns by Australian veterinarians found that antimicrobial dose rates were varied and often inappropriate. Doses of procaine penicillin in horses and cattle were often low, with 68% and 90% of respondents, respectively, reporting doses that were unlikely to result in plasma concentrations above minimum inhibitory concentrations for common equine and bovine pathogens. Frequency of penicillin administration was also often inappropriate. Gentamicin doses in horses were largely appropriate (89% of dose rates appropriate), but 9% of respondents reported twice daily dosing. Amoxycillin and amoxycillin‐clavulanate were administered at the appropriate doses, or above, to dogs and cats by 54% and 70% of respondents, respectively. Here, we explore the potential reasons for inappropriate antimicrobial dose regimens and report that antimicrobial labels often recommend incorrect dose rates and thus may be contributing to poor prescribing practices. Changes to legislation are needed to ensure that antimicrobial drug labels are regularly updated to reflect the dose needed to effectively and safely treat common veterinary pathogens. This will be especially true if changes in legislation restrict antimicrobial use by veterinarians to the uses and doses specified on the label, thus hampering the current momentum towards improved antimicrobial stewardship.
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1111/avj.12677" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Hardefeldt, L.Y., Gilkerson, J.R., Billman‐Jacobe, H., Stevenson, M.A., Thursky, K., Browning, G.F., Bailey, K.E. (2018). Antimicrobial labelling in Australia: A threat to antimicrobial stewardship?. Australian Veterinary Journal, 96(5), 151-154. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1111/avj.12677" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1111/avj.12677
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Antibiotics-for-Infection-672x372-672x372.jpg" length="39457" type="image/jpeg" />
      <pubDate>Mon, 23 Apr 2018 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-labelling-in-australia-a-threat-to-antimicrobial-stewardship</guid>
      <g-custom:tags type="string">Companion animal,NCAS publications,Equine,Veterinary,Bovine (New Tag),Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Antibiotics-for-Infection-672x372-672x372.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Antibiotics-for-Infection-672x372-672x372.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Veterinary students’ knowledge and perceptions about antimicrobial stewardship and biosecurity: a national survey</title>
      <link>https://www.ncas-australia.org/veterinary-students-knowledge-and-perceptions-about-antimicrobial-stewardship-and-biosecurity-a-national-survey</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Laura Hardefeldt, Torben Nielsen, Helen Crabb, James Gilkerson, Richard Squires, Jane Heller, Claire Sharp, Rowland Cobbold, Jacqueline Norris and Glenn Browning
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          A better understanding of veterinary students’ perceptions, attitudes, and knowledge about antimicrobial stewardship and biosecurity could facilitate more effective education of future veterinarians about these important issues. A multi-center cross-sectional study was performed by administering a questionnaire to veterinary students expected to graduate in 2017 or 2018 in all Australian veterinary schools. Four hundred and seventy-six of 1246 students (38%) completed the survey. Many students were unaware of the high importance of some veterinary drugs to human medicine, specifically enrofloxacin and cefovecin (59% and 47% of responses, respectively). Fewer than 10% of students would use appropriate personal protective equipment in scenarios suggestive of Q fever or psittacosis. Students expected to graduate in 2018 were more likely to select culture and susceptibility testing in companion animal cases (OR 1.89, 95% CI 1.33–2.69, p &amp;lt; 0.001), and were more likely to appropriately avoid antimicrobials in large animal cases (OR 1.75, 95% CI 1.26–2.44, p = 0.001) than those expected to graduate in 2017. However, 2018 graduates were less likely to correctly identify the importance rating of veterinary antimicrobials for human health (OR 0.48, 95% CI 0.34–0.67, p &amp;lt; 0.001) than 2017 graduates. Students reported having a good knowledge of antimicrobial resistance, and combating resistance, but only 34% thought pharmacology teaching was adequate and only 20% said that teaching in lectures matched clinical teaching. Efforts need to be made to harmonise preclinical and clinical teaching, and greater emphasis is needed on appropriate biosecurity and antimicrobial stewardship.
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.3390/antibiotics7020034" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Hardefeldt, L.Y., Nielsen, T., Crabb, H., Gilkerson, J., Squires, R., Heller, J., Sharp, C., Cobbold, R., Norris, J., Browning, G. (2018). Veterinary students’ knowledge and perceptions about antimicrobial stewardship and biosecurity—a national survey. Antibiotics, 7(2), 34. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.3390/antibiotics7020034" target="_blank"&gt;&#xD;
      
           https://doi.org/10.3390/antibiotics7020034
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/woman-dog-vet-clinic_1186_777_d-778x465.dm.crop_143_64_778_465_v2OG.jpg" length="60554" type="image/jpeg" />
      <pubDate>Tue, 17 Apr 2018 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/veterinary-students-knowledge-and-perceptions-about-antimicrobial-stewardship-and-biosecurity-a-national-survey</guid>
      <g-custom:tags type="string">Companion animal,NCAS publications,Equine,Veterinary,Bovine (New Tag),Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/woman-dog-vet-clinic_1186_777_d-778x465.dm.crop_143_64_778_465_v2OG.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/woman-dog-vet-clinic_1186_777_d-778x465.dm.crop_143_64_778_465_v2OG.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Improving antibiotic prescribing by general practitioners: a protocol for a systematic review of interventions involving pharmacists</title>
      <link>https://www.ncas-australia.org/improving-antibiotic-prescribing-by-general-practitioners-a-protocol-for-a-systematic-review-of-interventions-involving-pharmacists</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Sajal K Saha, Lesley Hawes and Danielle Mazza
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Introduction
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Effective antibiotic options in general practice for patients with infections are declining significantly due to antibiotic over-prescribing and emerging antibiotic resistance. To better improve antibiotic prescribing by general practitioner (GP), pharmacist–GP collaborations have been promoted under antibiotic stewardship programmes. However, there is insufficient information about whether and how pharmacists help GPs to more appropriately prescribe antibiotics. This systematic review aims to determine whether pharmacist-led or pharmacist-involved interventions are effective at improving antibiotic prescribing by GPs.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods and analysis
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : A systematic review of English language randomised controlled trials (RCTs), cluster RCTs, controlled before-and-after studies and interrupted time series studies cited in MEDLINE, EMBASE, EMCARE, CINAHL Plus, PubMed, PsycINFO, Cochrane Central Register of Controlled Trials and Web of Science databases will be conducted. Studies will be included if a pharmacist is involved as the intervention provider and GPs are the intervention recipients in general practice setting. Data extraction and management will be conducted using Effective Practice and Organisation of Care data abstraction tools and a template for intervention description and replication. The Cochrane and ROBINS-I risk of bias assessment tools will be used to assess the methodological quality of studies. Primary outcome measures include changes (overall, broad spectrum and guidelines concordance) of GP-prescribed antibiotics. Secondary outcomes include quality of antibiotic prescribing, delayed antibiotic use, acceptability and feasibility of interventions. Meta-analysis for combined effect and forest plots, χ2 test and I2 statistics for detailed heterogeneity and sensitivity analysis will be performed if data permit. Grading of Recommendations Assessment, Development and Evaluation and Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols guidance will be used to report findings.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1136/bmjopen-2017-020583" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Saha, S.K., Hawes, L., Mazza, D. (2018). Improving antibiotic prescribing by general practitioners: a protocol for a systematic review of interventions involving pharmacists . BMJ Open, 8, e020583. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1136/bmjopen-2017-020583" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1136/bmjopen-2017-020583
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1556741533-e228ee50f8b8.jpg" length="153231" type="image/jpeg" />
      <pubDate>Wed, 11 Apr 2018 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/improving-antibiotic-prescribing-by-general-practitioners-a-protocol-for-a-systematic-review-of-interventions-involving-pharmacists</guid>
      <g-custom:tags type="string">NCAS publications,Community,Community paper,GP</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1556741533-e228ee50f8b8.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1556741533-e228ee50f8b8.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial susceptibility testing by Australian veterinary diagnostic laboratories</title>
      <link>https://www.ncas-australia.org/antimicrobial-susceptibility-testing-by-australian-veterinary-diagnostic-laboratories</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           L. Y. Hardefeldt, M. Marenda, H. Crabb, M. A. Stevenson, J. R. Gilkerson, H. Billman‐Jacobe and G. F. Browning
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : The national strategy for tackling antimicrobial resistance highlights the need for antimicrobial stewardship in veterinary practice and for surveillance of antimicrobial susceptibility in veterinary pathogens. Diagnostic laboratories have an important role in facilitating both of these processes, but it is unclear whether data from veterinary diagnostic laboratories are similar enough to allow for compilation and if there is consistent promotion of appropriate antimicrobial use embedded in the approaches of different laboratories to susceptibility testing.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : A cross‐sectional study of antimicrobial susceptibility testing and reporting procedures by Australian veterinary diagnostic laboratories was conducted in 2017 using an online questionnaire. All 18 veterinary diagnostic laboratories in Australia completed the questionnaire.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Kirby‐Bauer disc diffusion was the method predominantly used for antimicrobial susceptibility testing and was used to evaluate 86% of all isolates, although two different protocols were used across the 18 laboratories (CLSI 15/18, CDS 3/18). Minimum inhibitory concentrations were never reported by 61% of laboratories. Common isolates were consistently reported on across all species, except for gram‐negative isolates in pigs, for which there was some variation in the approach to reporting. There was considerable diversity in the panels of antimicrobials used for susceptibility testing on common isolates and no consistency was apparent between laboratories for any bacterial species.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusion
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : We recommend that nationally agreed and consistent antimicrobial panels for routine susceptibility testing should be developed and a uniform set of guidelines should be adopted by veterinary diagnostic laboratories in Australia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://doi.org/10.1111/avj.12685" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          .
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    
          : Hardefeldt, L.Y., Marenda, M., Crabb, H., Stevenson, M., Gilkerson, J., Billman‐Jacobe, H., Browning, G. (2018). Antimicrobial susceptibility testing by Australian veterinary diagnostic laboratories. Australian Veterinary Journal, 96, 142-146. DOI:
          &#xD;
    &lt;a href="https://doi.org/10.1111/avj.12685" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1111/avj.12685
          &#xD;
    &lt;/a&gt;&#xD;
    
          .   
         &#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1581091014534-898da33e356e.jpg" length="106024" type="image/jpeg" />
      <pubDate>Sat, 24 Mar 2018 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-susceptibility-testing-by-australian-veterinary-diagnostic-laboratories</guid>
      <g-custom:tags type="string">Companion animal,NCAS publications,Equine,Veterinary,Bovine (New Tag),Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1581091014534-898da33e356e.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1581091014534-898da33e356e.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Barriers to and enablers of implementing antimicrobial stewardship programs in veterinary practices</title>
      <link>https://www.ncas-australia.org/barriers-to-and-enablers-of-implementing-antimicrobial-stewardship-programs-in-veterinary-practices</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Laura Y. Hardefeldt, J. R. Gilkerson, H. Billman‐Jacobe, M. A. Stevenson, K. Thursky, K. E. Bailey and G. F. Browning
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Antimicrobial stewardship (AMS) programs are yet to be widely implemented in veterinary practice and medical programs are unlikely to be directly applicable to veterinary settings.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Objective
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : To gain an in‐depth understanding of the factors that influence effective AMS in veterinary practices in Australia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : A concurrent explanatory mixed-methods design was used. The quantitative phase of the study consisted of an online questionnaire to assess veterinarians’ attitudes to antimicrobial resistance (AMR) and antimicrobial use in animals, and the extent to which AMS currently is implemented (knowingly or unknowingly). The qualitative phase used semi‐structured interviews to gain an understanding of the barriers to and enablers of AMS in veterinary practices. Data were collected and entered into NVivo v.11, openly coded and analyzed according to mixed methods data analysis principles.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Companion animal, equine, and bovine veterinarians participated in the study. Veterinary practices rarely had antimicrobial prescribing policies. The key barriers were a lack of AMS governance structures, client expectations and competition between practices, cost of microbiological testing, and lack of access to education, training and AMS resources. The enablers were concern for the role of veterinary antimicrobial use in development of AMR in humans, a sense of pride in the service provided, and preparedness to change prescribing practices.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusion and clinical importance
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Our study can guide development and establishment of AMS programs in veterinary practices by defining the major issues that influence the prescribing behavior of veterinarians.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://doi.org/10.1111/jvim.15083" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          .
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    
          : Hardefeldt, L.Y., Gilkerson, J.R., Billman‐Jacobe, H., Stevenson, M.A., Thursky, K., Bailey, K.E., Browning, G.F. (2018). Barriers to and enablers of implementing antimicrobial stewardship programs in veterinary practices. Journal of Veterinary Internal Medicine, 32(3), 1092-1099. DOI:
          &#xD;
    &lt;a href="https://doi.org/10.1111/jvim.15083" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1111/jvim.15083
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1518914781460-a3ada465edec.jpg" length="230350" type="image/jpeg" />
      <pubDate>Thu, 22 Mar 2018 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/barriers-to-and-enablers-of-implementing-antimicrobial-stewardship-programs-in-veterinary-practices</guid>
      <g-custom:tags type="string">Companion animal,NCAS publications,Equine,Veterinary,Bovine (New Tag),Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1518914781460-a3ada465edec.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1518914781460-a3ada465edec.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Publication: Antimicrobial Stewardship: From Principles to Practice</title>
      <link>https://www.ncas-australia.org/publication-antimicrobial-stewardship-from-principles-to-practice</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/BSAC+AMS+ebook.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           NCAS researchers contributed to the British Society for Antimicrobial Chemotherapy's open-access textbook, Antimicrobial Stewardship: From Principles to Practice. This e-book provides: 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            An extensive overview of the day-to-day challenges posed by antimicrobial resistance.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Tools for setting up stewardship programmes.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Guidance on how to make the most of existing stewardship programmes.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Resources to apply the principles of stewardship to a wide range of professions, populations, and clinical/care settings.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Support for colleagues working in low and middle-income countries.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Advice on informing and influencing policymakers and journalists
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            An interactive, multimedia, platform with links to many videos, podcasts, and PDFs.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            See
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://bsac.org.uk/antimicrobial-stewardship-from-principles-to-practice-e-book/" target="_blank"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            .
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/BSAC+AMS+ebook.jpg" length="27671" type="image/jpeg" />
      <pubDate>Mon, 01 Jan 2018 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/publication-antimicrobial-stewardship-from-principles-to-practice</guid>
      <g-custom:tags type="string">News and events</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/BSAC+AMS+ebook.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/BSAC+AMS+ebook.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Why do we not want to recommend influenza vaccination to young children? A qualitative study of Australian parents and primary care providers</title>
      <link>https://www.ncas-australia.org/why-do-we-not-want-to-recommend-influenza-vaccination-to-young-children-a-qualitative-study-of-australian-parents-and-primary-care-providers</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Ruby Biezen, Danilla Grando, Danielle Mazza and Bianca Brijnath
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Highlights:
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Despite proven safety of influenza vaccines, uptake in young children is low.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Reasons for low uptake included negative publicity and lack of awareness of benefits.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Uncertainty of vaccine safety and efficacy led to reluctance to recommend by PCPs.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Interventions should target parental knowledge and update information to PCPs.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Including influenza vaccination in childhood immunisation schedule may increase uptake.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Introduction
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Influenza vaccination has been shown to be safe and effective against influenza and in the prevention of complicating secondary respiratory illnesses. However, its uptake in young children remains low. This study explored the views, attitudes and practices of parents and primary care providers (PCPs) on their knowledge and acceptance of influenza vaccination in children under 5.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Using a cross-sectional qualitative research design, we conducted 30 in-depth interviews with PCPs (i.e., general practitioners, practice nurses, maternal and child health nurses, and pharmacists) and five focus groups with parents (n = 50) between June 2014 and July 2015 in Melbourne, Australia. Data were thematically analysed.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Parents thought the vaccine could cause influenza, and influenza vaccination was not necessary for their children as they needed to build their own ‘immunity’. Parents said that they would consider vaccinating their children if recommended by their GP and if the influenza vaccine was part of the immunisation schedule. PCPs also expressed concerns regarding the efficacy of the vaccine as well as out-of-pocket costs incurred by families, and uncertainty regarding the mortality and morbidity of influenza in otherwise healthy children. However, they said they would recommend the vaccine to high-risk groups (e.g. children with chronic disease(s), and asthma).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusion
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Despite the established safety of influenza vaccines, barriers to uptake include concerns regarding the iatrogenic effects of vaccination, its administration schedule, and knowledge of influenza severity. Updated information on influenza and the efficacy of the vaccine, and incorporating influenza vaccination into the immunisation schedule may overcome some of these barriers to increase influenza vaccination in this vulnerable cohort.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.vaccine.2017.12.066" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Biezen, R., Grando, D., Mazza, D., Brijnath, B. (2018). Why do we not want to recommend influenza vaccination to young children?: A qualitative study of Australian parents and primary care providers. Vaccine, 36(6), 859-865. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.vaccine.2017.12.066" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1016/j.vaccine.2017.12.066
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576765608622-067973a79f53.jpg" length="199561" type="image/jpeg" />
      <pubDate>Sun, 17 Dec 2017 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/why-do-we-not-want-to-recommend-influenza-vaccination-to-young-children-a-qualitative-study-of-australian-parents-and-primary-care-providers</guid>
      <g-custom:tags type="string">NCAS publications,Community,Community paper,GP</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576765608622-067973a79f53.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1576765608622-067973a79f53.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Surgical antimicrobial prophylaxis</title>
      <link>https://www.ncas-australia.org/surgical-antimicrobial-prophylaxis</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Courtney Ierano, Jo-Anne Manski-Nankervis, Rod James, Arjun Rajkhowa, Trisha Peel and Karin Thursky
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.nps.org.au/australian-prescriber/articles/surgical-antimicrobial-prophylaxis" target="_blank"&gt;&#xD;
      
           Australian Prescriber
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           )
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Summary
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Surgical antimicrobial prophylaxis is the most common indication for antimicrobial use in Australian hospitals. However, it is associated with high rates of inappropriate use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Effective use of antimicrobials to prevent infection is essential to reduce risks associated with surgical procedures. Efforts need to be made to maximise the quality of surgical antimicrobial prophylaxis prescribing.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Procedural prophylaxis (before or during surgery) is not indicated for all surgeries, especially minor procedures. Post-procedural prophylaxis, including the use of topical antimicrobials, is rarely indicated yet frequently prescribed.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The Therapeutic Guidelines: Antibiotic is a key reference for all Australian prescribers.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           GPs can have a significant role in optimising surgical antimicrobial prophylaxis and reducing the burden of inappropriate antimicrobial use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read more
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.nps.org.au/australian-prescriber/articles/surgical-antimicrobial-prophylaxis" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Tue, 14 Nov 2017 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/surgical-antimicrobial-prophylaxis</guid>
      <g-custom:tags type="string">NAPS,Surgical,Hospital paper,Media,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>The Surgical National Antimicrobial Prescribing Survey: 2016 report</title>
      <link>https://www.ncas-australia.org/the-surgical-national-antimicrobial-prescribing-survey-2016-report</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/SNAPS+2016.jpg"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           The results of the 2016 annual Surgical National Antimicrobial Prescribing Survey (SNAPS) were officially released on 10 November, 2017.
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           67 hospitals (public and private) participated during the data collection period between April and November 2016. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            4,507 surgical episodes were included, of which 93.2% involved an incisional procedure. Key findings from the 2016 SNAPS include: 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Antimicrobials – administered either immediately prior to or during the surgical procedure (procedural) – were prescribed in 2,641 surgical episodes (58.6%), with a total of 3,189 individual doses. 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Of these 43.4% had at least one inappropriate prescribing element. The most common element of inappropriate procedural antimicrobial prescribing was incorrect timing (n=481, 45.7%). 
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Post-procedural prophylactic antimicrobials (antimicrobials prescribed following, but directly relating to, the procedure for the purposes of prophylaxis) were prescribed in 1,248 (27.7%) episodes.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Of these, 59.9% had at least one inappropriate prescribing element. The most common element of inappropriate post-procedural antimicrobial prescribing was that post-procedural prophylaxis was not required (n=503, 40.3%).
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            All Australian hospitals are encouraged to participate in the 2018 SNAPS. See the report
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/ncas-publications"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            .
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/SNAPS+2016.jpg" length="45664" type="image/jpeg" />
      <pubDate>Fri, 10 Nov 2017 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/the-surgical-national-antimicrobial-prescribing-survey-2016-report</guid>
      <g-custom:tags type="string">News and events,NCAS publications,NAPS reports,Hospital,Surgical</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/SNAPS+2016.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/SNAPS+2016.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobials in aged care: overused and underdocumented</title>
      <link>https://www.ncas-australia.org/antimicrobials-in-aged-care-overused-and-underdocumented</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Noleen Bennett
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://insightplus.mja.com.au/2017/43/antimicrobials-in-aged-care-overused-and-underdocumented/" target="_blank"&gt;&#xD;
      
           Medical Journal of Australia-Insight
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           )
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Monitoring the quality of antimicrobial use in aged care homes (ACHs) is important, as elderly residents are especially vulnerable to infections and, therefore, more likely to be receiving antimicrobial therapy.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The Aged Care National Antimicrobial Prescribing Survey (AC-NAPS) is an annual survey of antimicrobial prescribing practices in Australian ACHs. The primary aim of this survey is to help ACHs improve their antimicrobial use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The results of the 2017 AC-NAPS survey, conducted between 19 June and 1 September 2017, have now been communicated to all 293 participating ACHs in order to facilitate local quality improvement initiatives.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The first AC-NAPS was piloted in 2015. Its findings have been detailed in a comprehensive 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           public report
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           . The results of the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           2016 AC-NAPS
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            are now also available in a report.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Data collection
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           On the day of the survey, nurses, pharmacists and infection control practitioners collect data about residents who have signs and symptoms of infection or have been prescribed an antimicrobial. To increase their sample size, some ACHs also choose to collect data about antimicrobials that were prescribed and completed in the month prior to the day of the survey. Data are collected from different sources, such as residents’ histories and medication charts, and are submitted to the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           acNAPS program
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            at the National Centre for Antimicrobial Stewardship (NCAS) via the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           online data entry portal
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Findings from 2017
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In 2017, the medication charts of 12 344 permanent, respite or transitional care residents were reviewed. On the day of the survey, the proportion of residents who were prescribed at least one antimicrobial was 8.9%, while the proportion of residents who had signs or symptoms of infection was 2.9%. Cephalexin (20.0%) was the most commonly prescribed antimicrobial. Skin or soft tissue (31.7%), urinary tract (26.7%) and respiratory tract (20.8%) infections were the three most common indications for prescribing antimicrobials.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Other key findings included:
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            A high rate of use of antimicrobials for unconfirmed infections: almost one-third (33.2%) of antimicrobials were prescribed for residents who had no signs or symptoms of infection in the week prior to the antimicrobial start-date. Further, 51.6% of suspected infections did not meet the 
           &#xD;
      &lt;/span&gt;&#xD;
      &lt;a href="/"&gt;&#xD;
        
            McGeer and colleagues
           &#xD;
      &lt;/a&gt;&#xD;
      &lt;span&gt;&#xD;
        
             criteria (a set of widely referenced and internationally recognised infection definitions that have been specifically developed for use in ACHs).
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Prolonged duration of prescriptions: almost one-quarter (21.8%) of antimicrobials had been administered for longer than 6 months.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Widespread use of topical antimicrobials: topical antimicrobials accounted for over one-quarter (29.5%) of prescriptions.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Incomplete documentation: the indication for the antimicrobial was not documented for 22.1% of antimicrobials administered, and the review- or stop-date was not documented for 49.3% of antimicrobials administered.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           These findings show that there is scope for improvement of antimicrobial use in Australian ACHs.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Feedback
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           On completing their data entry, each ACH can generate customised reports and examine their local issues. Importantly, ACHs are able to undertake the acNAPS any time during the year for local use; however, only data collected during the official survey period are included in the public reports.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Participating ACHs are encouraged to report their results to residents and their carers, administrative and clinical staff, and off-site general practitioners and pharmacists. The underlying assumption is that these reports act as a platform to educate ACH residents and staff about appropriate antimicrobial use. They also provide an incentive to make clinical policy and practice changes, and can be presented to accreditation organisations as evidence of quality improvement initiatives. Considered together, these approaches are anticipated to yield better outcomes for residents.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Future AC-NAPS
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Improving the safety and quality of care in the aged care sector is a 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           national priority
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           It is for this reason that it is recommended that all Australian ACHs participate in the acNAPS in 2018 and use it as a quality improvement tool. It is commendable that those ACHs that have previously participated are now developing and implementing antimicrobial stewardship strategies to address the problems identified.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           AC-NAPS is a collaborative project between the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           NCAS
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           Guidance Group
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (Royal Melbourne Hospital), the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           Victorian Healthcare Associated Infection Surveillance System
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            Coordinating Centre (Royal Melbourne Hospital) and the participating ACHs. It is supported by funding from the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           Australian Commission on Safety and Quality in Health Care
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            under the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/"&gt;&#xD;
      
           Antimicrobial Use and Resistance in Australia
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            project.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Sun, 05 Nov 2017 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobials-in-aged-care-overused-and-underdocumented</guid>
      <g-custom:tags type="string">NAPS,Media,Aged care,Community</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>National Antimicrobial Resistance Forum</title>
      <link>https://www.ncas-australia.org/national-antimicrobial-resistance-forum</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;a&gt;&#xD;
    &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Sketch-e84c9b55.png" alt="" title=""/&gt;&#xD;
  &lt;/a&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          This forum brought together groups from varying scientific disciplines, including medicine, veterinary science, nursing, the pharmaceutical and agricultural industry. It reflected on ambitions to respond to the challenges of antimicrobial resistance with a unified One Health approach.
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          The scientific meeting was a collaboration between Queensland Statewide Antimicrobial Stewardship Program, CRE REDUCE, the University of Queensland's Institute for Molecular Bioscience, the National Centre for Antimicrobial Stewardship and Queensland University of Technology. It was held in Brisbane over Thursday, 2nd November and Friday, 3rd November 3, 2017. See
          
                    &#xD;
    &lt;a href="https://www.ncas-australia.org/forum2017" target="_top"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    
                    
          .
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;p&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Sketch-e84c9b55.png" length="216627" type="image/png" />
      <pubDate>Wed, 01 Nov 2017 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/national-antimicrobial-resistance-forum</guid>
      <g-custom:tags type="string">News and events,Seminar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Sketch-e84c9b55.png">
        <media:description>thumbnail</media:description>
      </media:content>
    </item>
    <item>
      <title>The Aged Care National Antimicrobial Prescribing Survey: 2016 report</title>
      <link>https://www.ncas-australia.org/the-aged-care-national-antimicrobial-prescribing-survey-2016-report</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Sketch-95a94a13.png"/&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           The results of the 2016 annual Aged Care National Antimicrobial Prescribing Survey (acNAPS) were officially released on 26 October, 2017.
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           251 aged care homes participated during the data collection period between 27 June to 9 September 2016, representing all Australian states, provider types and remoteness classifications. 
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           The results include:
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            A high rate of use of antimicrobials for unconfirmed infections: almost one-third (32.4%) of antimicrobials were prescribed for residents who had no signs or symptoms of infection in the week prior to the antimicrobial start-date
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Prescriptions did not meet the criteria for an infection: just over two-thirds (67.2%) of prescriptions were for residents who did not have signs or symptoms of infection.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Duration of prescriptions: almost one-quarter (23%) of antimicrobials had been administered for longer than six months.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Widespread use of topical antimicrobials: accounting for just over one-quarter (26.9%) of prescriptions.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            Incomplete documentation: the antimicrobial start-date was unknown for 32% of antimicrobials administered, while the indication for the antimicrobial was not documented for 22.1% of antimicrobials administered, and the review- or stop-date was not documented for 49.9% of antimicrobials administered.
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
                        
            See the report
           
                      &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="/ncas-publications"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
                      
           .
          
                    &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Sketch-95a94a13.png" length="77849" type="image/png" />
      <pubDate>Thu, 26 Oct 2017 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/the-aged-care-national-antimicrobial-prescribing-survey-2016-report</guid>
      <g-custom:tags type="string">News and events,NCAS publications,NAPS reports,Aged care,Community</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Sketch-95a94a13.png">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Sketch-95a94a13.png">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>An Introduction to Infection Control &amp; Antimicrobial Stewardship Course</title>
      <link>https://www.ncas-australia.org/an-introduction-to-infection-control-antimicrobial-stewardship-course</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;a&gt;&#xD;
    &lt;img src="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1516841273335-e39b37888115.jpg" alt="" title=""/&gt;&#xD;
  &lt;/a&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          NCAS, in collaboration with the Australian Society for Infectious Diseases (ASID), organised a 2-day course providing practical advice on how to run an infection control and antimicrobial stewardship service. It included workshops and guidelines on how to deal with tricky situations, and interactive panel discussions of real life scenarios, dealing with the day-to-day problems and challenges faced by doctors. Panels consisted of experienced infectious diseases physicians, microbiologists and infection control practitioners. Read more about the course
          
                    &#xD;
    &lt;a href="https://www.asid.net.au/events/event/an-introduction-to-infection-control-antimicrobial-stewardship" target="_blank"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    
                    
          .
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Attendees included:
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;ul&gt;&#xD;
      &lt;li&gt;&#xD;
        
                        
            Advanced trainees in infectious diseases and microbiology
            
                        &#xD;
        &lt;br/&gt;&#xD;
      &lt;/li&gt;&#xD;
      &lt;li&gt;&#xD;
        
                        
            Infectious diseases physicians
            
                        &#xD;
        &lt;br/&gt;&#xD;
      &lt;/li&gt;&#xD;
      &lt;li&gt;&#xD;
        
                        
            Microbiologists
            
                        &#xD;
        &lt;br/&gt;&#xD;
      &lt;/li&gt;&#xD;
      &lt;li&gt;&#xD;
        
                        
            Any doctor with responsibilities for infection control or antimicrobial stewardship
           
                      &#xD;
      &lt;/li&gt;&#xD;
    &lt;/ul&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;p&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1516841273335-e39b37888115.jpg" length="136625" type="image/jpeg" />
      <pubDate>Fri, 20 Oct 2017 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/an-introduction-to-infection-control-antimicrobial-stewardship-course</guid>
      <g-custom:tags type="string">News and events,Seminar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1516841273335-e39b37888115.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
    </item>
    <item>
      <title>Drug resistance: how we keep track of whether antibiotics are being used responsibly</title>
      <link>https://www.ncas-australia.org/drug-resistance-how-we-keep-track-of-whether-antibiotics-are-being-used-responsibly</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Kirsty Buising and Karin Thursky
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://theconversation.com/drug-resistance-how-we-keep-track-of-whether-antibiotics-are-being-used-responsibly-82446" target="_blank"&gt;&#xD;
      
           The Conversation
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           )
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           While we know increasing numbers of bacteria all over the world are becoming more resistant to existing antibiotics, we need to learn more about how antibiotics are being used in healthcare settings.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           We know overuse and inappropriate use of antibiotics contribute to resistance, so it’s important we monitor antimicrobial use and develop strategies to improve practice. Australia now has a 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.health.gov.au/internet/main/publishing.nsf/Content/1803C433C71415CACA257C8400121B1F/%24File/amr-strategy-2015-2019.pdf"&gt;&#xD;
      
           national strategy
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            to do so.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Importantly, a 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/what-is-aura/"&gt;&#xD;
      
           national surveillance report
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            provides an overview of annually-updated data and analyses from relevant 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/resources-page/"&gt;&#xD;
      
           programs
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           . This covers 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/clinical+resources/clinical+programs/antimicrobial+stewardship/national+antimicrobial+utilisation+surveillance+program+nausp"&gt;&#xD;
      
           drug consumption in participating hospitals
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.naps.org.au/Default.aspx"&gt;&#xD;
      
           appropriateness of use in participating hospitals
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , and prescribing 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.nps.org.au/"&gt;&#xD;
      
           data from GPs
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            and 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/publications/antimicrobial-prescribing-and-infections-in-australian-residential-aged-care-facilities-results-of-the-2015-aged-care-national-antimicrobial-prescribing-survey-pilot/"&gt;&#xD;
      
           residential aged-care facilities
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           While some programs provide representative estimates of drug consumption, the National Antimicrobial Prescribing Survey (
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.naps.org.au/Default.aspx"&gt;&#xD;
      
           NAPS
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ) is unique, in that it assesses the quality of individual patient prescriptions. This means it looks at whether prescriptions were compliant with clinical practice guidelines for the given indications (including drug choice and dose), and whether the overall drug use was appropriate and safe.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Assessing these factors helps to identify areas of inappropriate use and inform changes in clinical practice.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           What the surveys found
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/wp-content/uploads/2014/11/Web-Accessible-2013-NAPS-Report.pdf"&gt;&#xD;
      
           2013-14
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , 151 hospitals (132 public and 19 private) from all states and territories participated in the NAPS. From that, 12,800 prescriptions for antimicrobial drugs were analysed. In 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.naps.org.au/Resources/Antimicrobial-prescribing-practice-in-Australian-hospitals-Results-of-the-2015-National-Antimicrobial-Prescribing-Survey.pdf"&gt;&#xD;
      
           2015-16
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , 281 hospitals (213 public and 68 private) participated in the audit, and 22,021 prescriptions for antimicrobial drugs were analysed.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In 2015, on average, 40% of patients in hospitals were administered an antibiotic. Of these, 72% were found to have needed them as they were prescribed, and 35% had a review- or stop-date documented.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Overall, 23% of prescriptions for antibiotics for hospitalised patients were deemed to be non-compliant with prescribing guidelines (40% in 2013-14), and 22% were assessed as inappropriate (29% in 2013-14).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Specific areas that needed attention were identified. In 2015, 40% of prescriptions for the prevention of surgical site infections were assessed as inappropriate. This was mainly because of incorrect duration (30%) and incorrect dose or frequency (28%), or because they were given for a procedure that does not require antibiotics to be used as preventatives (22%). Knowing these common errors means we can give feedback to doctors and, in some cases, help clarify guidelines or develop new ones.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Why does over-prescribing happen?
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           There are complex reasons why therapeutic drugs, including antibiotics, are sometimes inappropriately prescribed. These can include institutional or systemic cultures that have been in place for a long time. Knowledge gaps are an issue. Despite access to good-quality prescribing guidelines in hospitals, guidelines may not be consulted frequently. The fear of missing infections or adverse outcomes may contribute to excessive or inappropriate treatment.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Sometimes, a lack of resources means staff don’t have the time to review a diagnosis and adjust treatments in a timely way. Some staff may recognise inappropriate use but are fearful about speaking up or contradicting another doctor. Cultural factors such as medical hierarchies can define the workflow in hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Until recently, there may have been a view that antibiotics “do no harm” and that prescribing “just in case”, or giving more than is necessary, has no consequence.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;h2&gt;&#xD;
    &lt;span&gt;&#xD;
      
           What can we do about it?
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/h2&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           There are no quick fixes when it comes to improving antibiotic prescribing, but concerted efforts can lead to change. Much progress has already been made in several countries, and 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.doctorportal.com.au/mjainsight/2017/2/milestones-challenges-in-antimicrobial-stewardship/"&gt;&#xD;
      
           Australia has been a leader
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            in initiatives aimed at using antibiotics properly and responsibly in hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Programs aimed at improving antibiotic use are referred to as “antimicrobial stewardship”. Australian hospitals were early adopters and initiators of antimicrobial stewardship programs.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           It’s widely recognised that alongside education and training for individual doctors, setting up systems that support better decision-making within hospitals is key to enhancing patient safety and care. Many Australian hospitals have 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.doctorportal.com.au/mjainsight/2017/26/evidence-based-solutions-for-antimicrobial-stewardship/"&gt;&#xD;
      
           decision-support and approval systems
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            to monitor and control when and how antibiotics are used. This is sometimes coupled with post-prescription reviews by teams of experts, 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.doctorportal.com.au/mjainsight/2017/32/antimicrobial-stewardship-hospital-standards-update-in-2018/?platform=hootsuite"&gt;&#xD;
      
           although this should happen more
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Regular auditing and feedback allow problem areas to be identified and strategies to be developed. The NAPS enables pharmacists and doctors in one facility to compare their performance with that of similar facilities.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In addition to providing a national overview of hospital prescribing and helping facilities monitor their performance over time, the NAPS serves to increase awareness of guidelines and appropriate prescribing in hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Through regular surveillance and the adoption of stewardship programs, we know we can improve antibiotic prescribing and patient care in hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Mon, 02 Oct 2017 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/drug-resistance-how-we-keep-track-of-whether-antibiotics-are-being-used-responsibly</guid>
      <g-custom:tags type="string">Media,Hospital,Community,NAPS publications</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Cross-sectional study of antimicrobials used for surgical prophylaxis by bovine veterinary practitioners in Australia</title>
      <link>https://www.ncas-australia.org/cross-sectional-study-of-antimicrobials-used-for-surgical-prophylaxis-by-bovine-veterinary-practitioners-in-australia</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Laura Y. Hardefeldt, Glenn F. Browning, Karin A. Thursky, James R. Gilkerson, Helen Billman-Jacobe, Mark A. Stevenson and Kirsten E. Bailey
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Antimicrobials are widely used in veterinary practices, but there has been no investigation of antimicrobial classes used or the appropriateness of their use in bovine practice. This study investigated antimicrobial use for surgical prophylaxis in bovine practice in Australia. A cross-sectional study of veterinarian antimicrobial usage patterns was conducted using an online questionnaire. Information solicited included respondent’s details, the frequency with which antimicrobials were used for specific surgical conditions (including the dose, timing and duration of therapy) and details of practice antimicrobial use policies and sources of information about antimicrobials. In total, 212 members of the Australian veterinary profession working in bovine practice completed the survey. Antimicrobials were always or frequently used by more than 75 per cent of respondents in all scenarios. Generally, antimicrobial drug choice was appropriate for the reported surgical conditions. Procaine penicillin and oxytetracycline accounted for 93 per cent of use. However, there was a wide range of doses used, with underdosing and inappropriate timing of administration being common reasons for inappropriate prophylactic treatment. There was very low use of critically important antimicrobials (3.3 per cent of antimicrobials reported). Antimicrobial use guidelines need to be developed and promoted to improve the responsible use of antimicrobials in bovine practice.
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="http://dx.doi.org/10.1136/vr.104375" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          .
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    
          : Hardefeldt L.Y., Browning G.F., Thursky K.A., Gilkerson J.R., Billman-Jacobe H., Stevenson M.A., Bailey K.E. (2017). Cross-sectional study of antimicrobials used for surgical prophylaxis by bovine veterinary practitioners in Australia. Veterinary Record, 181, 426. DOI:
          &#xD;
    &lt;a href="http://dx.doi.org/10.1136/vr.104375" target="_blank"&gt;&#xD;
      
           http://dx.doi.org/10.1136/vr.104375
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1549488235-42996ae3b650.jpg" length="435536" type="image/jpeg" />
      <pubDate>Sun, 10 Sep 2017 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/cross-sectional-study-of-antimicrobials-used-for-surgical-prophylaxis-by-bovine-veterinary-practitioners-in-australia</guid>
      <g-custom:tags type="string">NCAS publications,Veterinary,Bovine (New Tag),Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1549488235-42996ae3b650.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1549488235-42996ae3b650.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial stewardship: hospital standards update in 2018</title>
      <link>https://www.ncas-australia.org/antimicrobial-stewardship-hospital-standards-update-in-2018</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Karin Thursky
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://insightplus.mja.com.au/2017/32/antimicrobial-stewardship-hospital-standards-update-in-2018/?platform=hootsuite" target="_blank"&gt;&#xD;
      
           Medical Journal of Australia-Insight
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           )
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           An 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1016/j.cmi.2017.07.013"&gt;&#xD;
      
           expert commentary published in Clinical Microbiology and Infection
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (CMI) has highlighted the urgent need to support and fund teams of specialist health workers (including infectious diseases specialists, microbiologists, pharmacists and nurses) for antimicrobial stewardship (AMS) in hospitals and the community.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In this article, we argue that investment in AMS teams is key to optimising infection control practices, improving clinical outcomes and preventing the rise of resistant pathogens.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           AMS teams can undertake a number of critical functions, such as providing expert guidance to prescribers and health care providers, monitoring antimicrobial use and resistance, instituting and managing approval and audit processes, and delivering staff education.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The CMI commentary, whose lead author is Professor Céline Pulcini, secretary of the European Society of Clinical Microbiology and Infectious Diseases’ Study Group for Antimicrobial Stewardship, and an infectious diseases physician at Nancy University Hospital and University of Lorraine, France, brings together perspectives from clinicians around the world. It highlights the importance of investing in specialised staff and resources for infection control and antimicrobial stewardship in health care settings globally.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           As one of the authors, I would like to elaborate on how this specifically applies to Australia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/wp-content/uploads/2017/08/AURA-2017-Second-Australian-report-on-Antimicrobial-Use-and-Resistance-in-human-health.pdf"&gt;&#xD;
      
           AURA (Antimicrobial Use and Resistance in Australia) 2017: second Australian report on antimicrobial use and resistance in human health
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , released on 3 August 2017, presents a comprehensive overview of the results of 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/resources-page/"&gt;&#xD;
      
           various programs
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            dedicated to surveillance of antimicrobial use and resistance in Australia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/wp-content/uploads/2017/08/AURA-2017-Second-Australian-report-on-Antimicrobial-Use-and-Resistance-in-human-health.pdf"&gt;&#xD;
      
           We know from analysis of Pharmaceutical Benefits Scheme and Repatriation Pharmaceutical Benefits Scheme data that in 2015, 44.7% of the Australian population (10.7 million people) had at least one antimicrobial dispensed
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The National Antimicrobial Prescribing Survey (NAPS), which is annually conducted by our team at the National Centre for Antimicrobial Stewardship, measures the quality of antimicrobial use in hospitals. The 2015 NAPS found that, on any given day in Australian hospitals in 2015, on average, 40.5% of patients were being administered an antimicrobial. Around 23% of antimicrobial prescriptions were found to be noncompliant with guidelines, and 21.9% were considered inappropriate.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           We know that antibiotics for surgical prophylaxis are often given for too long. In 2015, 40.5% of surgical prophylaxis prescriptions captured in the NAPS were deemed inappropriate, mainly because of incorrect duration (29.9%) and incorrect dose or frequency (27.6%); or because they were given for a procedure that does not require antibiotics (22%). Almost 40% of cefalexin prescriptions in hospital were deemed inappropriate, and the most inappropriate use of cefalexin was for surgical prophylaxis, urinary tract infections and pneumonia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The Aged Care NAPS (AcNAPS) program looks at antimicrobial prescribing and infections in residential aged care facilities (RACFs). The 2015 Aged Care NAPS pilot, in which 186 RACFs participated, found that 65% of prescriptions did not have a documented review- or stop-date, and that 31% of antimicrobial prescriptions were given for more than 6 months. In about 32% of cases, the indication or reason for the prescription was not written in the notes; and about 20% of prescriptions were for residents who did not have any visible signs and symptoms of infection.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/wp-content/uploads/2017/08/AURA-2017-Second-Australian-report-on-Antimicrobial-Use-and-Resistance-in-human-health.pdf"&gt;&#xD;
      
           Changes in antimicrobial resistance patterns are being monitored
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           . Compared with 2014, there has been an increase in fluoroquinolone resistance in 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Escherichia coli
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (+2.5%) and 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Shigella sonnei
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (+10.9%).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Carbapenemase-producing Enterobacteriaceae (CPE) and vancomycin-resistant enterococci (VRE) are notable among pathogens of concern in Australia, as is community-acquired methicillin-resistant 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Staphylococcus aureus
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (MRSA).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The launch of AURA 2017 provided leading clinicians and policy-makers another opportunity to deliberate on the next steps for Australia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           It is important to note that 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://insightplus.mja.com.au/2017/2/milestones-challenges-in-antimicrobial-stewardship/"&gt;&#xD;
      
           Australia has made notable progress
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            in the field of AMS.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Since the introduction of AMS as a key criterion in the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/assessment-to-the-nsqhs-standards/"&gt;&#xD;
      
           Australian Commission on Safety and Quality in Health Care
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ’s hospital accreditation standards in 2013, Australian hospitals have been required to show that they have taken essential steps towards better management of antimicrobial use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Localised development, implementation and reinforcement of policies on medication use, and enhanced staff education (aimed at familiarising prescribers, nurses and infection control practitioners with guidelines on antimicrobial use and restrictions) have been shown to be effective interventions.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Regular auditing, including through the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncas-australia.org/auditing"&gt;&#xD;
      
           NAPS
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (since 2011), which, as mentioned earlier, assesses the quality of antimicrobial use by measuring concordance with prescribing guidelines and appropriateness of prescribing, has led to increased awareness of patterns of prescribing and the identification of areas that require improvement. These steps towards better management of antimicrobial use have been facilitated by investment in staff and infrastructure.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           While hospitals recognise the value of establishing and directing resources towards specialised AMS teams, the process is being hindered by the complexities of the jurisdictional health care system, as well as the disparities between rural/regional hospitals and well-resourced tertiary hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In our paper in CMI, we presented an overview of the results of our survey on national staffing standards for antimicrobial stewardship in 26 countries.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In Australia, there is currently no consensus on staffing recommendations within the national accreditation standards. However, as documented in Antimicrobial Stewardship in Australian Hospitals, a publication of the Australian Commission on Safety and Quality in Health Care, clinicians in hospitals with existing programs suggest that for every 100 acute beds, at least 10 hours (0.3 full-time equivalent [FTE] units) of senior pharmacist time and 3.5 hours (0.1 FTE) of lead clinician time per week should be dedicated to AMS activities. A minimum of 4 FTE per 1000 acute-care beds is recommended. For rural and regional hospitals, access to experts through networks or telehealth is recommended.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In some European countries, such as the Netherlands, Belgium and France, AMS is well-embedded in clinical practice. In the Netherlands, AMS is considered part of the baseline standard of care, and FTE staffing figures are not routinely specified. In Belgium, the federal government provides dedicated funding to all acute-care hospitals and chronic-care hospitals with over 150 beds to hire a trained antibiotic treatment manager for their AMS team. In France, hospital AMS programs are often underpinned by well-defined programs of core activities, including daily advice to prescribers. Hospital-based AMS specialists are also expected to participate in regional outpatient networks.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           We believe that consensus on a list of activities for AMS and workforce needs is required. The ‘gold standard’ involves teams that include infectious diseases specialists, microbiologists, pharmacists, and nurses.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Most Australian states have committed to 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.health.qld.gov.au/clinical-practice/guidelines-procedures/diseases-infection/antimicrobial-stewardship"&gt;&#xD;
      
           statewide programs
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            to coordinate the implementation of AMS. In Victoria, following the publication of the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www2.health.vic.gov.au/hospitals-and-health-services/quality-safety-service/hospital-safety-and-quality-review"&gt;&#xD;
      
           Duckett report in 2016
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , there has been a focus on safety and quality in health care and a new drive towards a statewide approach.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           AMS teams at many large tertiary hospitals are led by infectious diseases physicians and clinical pharmacists. Some smaller and regional hospitals, lacking specialist infectious diseases support, have nurses and infection control practitioners leading AMS initiatives, usually as part of another role.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A national survey undertaken by the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncas-australia.org/"&gt;&#xD;
      
           National Centre for Antimicrobial Stewardship
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            highlights that approximately 50% of respondent hospitals (301) have funded time allocated for AMS. This study, when published, will provide granular details on resource allocation for AMS in the Australian hospital sector.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antimicrobial stewardship is a labour-intensive service that requires sufficient resources to effectively monitor prescriptions. Our best hospital IT systems cannot substitute for expert review and oversight of antimicrobials once they have been prescribed. We know from the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/national-priorities/amr-and-au-surveillance-project/national-antimicrobial-prescribing-survey-naps/"&gt;&#xD;
      
           NAPS data
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            that one in four prescriptions is inappropriate. Once you consider that about 40% of inpatients are actually on an antibiotic at any point in time, you can understand the magnitude of our task.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Investment in resources such as decision support and audit tools is also important. 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://insightplus.mja.com.au/2017/26/evidence-based-solutions-for-antimicrobial-stewardship/"&gt;&#xD;
      
           The use of decision support, approval and post-prescription review tools
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            has been associated with improved prescribing patterns and patient outcomes, and lower drug acquisition costs.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           It is anticipated that an update of the hospital accreditation standards will be implemented in 2018, and there is likely to be renewed emphasis on refining elements such as approval processes and auditing.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           While the hospital sector in Australia has seen considerable progress, much more can be done to improve prescribing in primary care and the community, and in veterinary and agricultural settings. The private sector is also under pressure to introduce AMS services as part of the accreditation framework. However, determining the cost effectiveness of AMS is a difficult undertaking, and business cases for comprehensive AMS remain a “hard sell” for many institutions in the current climate.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           This CMI commentary by our colleagues from around the world brings renewed focus on global imperatives for greater investment in specialised infectious diseases and AMS expertise in health care settings – for improved management of antimicrobial use, and the preservation of the effectiveness of existing and new antimicrobial drugs.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           It is important to remember that AMS is, first and foremost, about enhancing patient safety and improving health outcomes.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Mon, 21 Aug 2017 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-stewardship-hospital-standards-update-in-2018</guid>
      <g-custom:tags type="string">Media,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial Use and Resistance in Australia: 2017 report</title>
      <link>https://www.ncas-australia.org/antimicrobial-use-and-resistance-in-australia-2017-report</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;a&gt;&#xD;
    &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AURA+2017+1.png" alt="" title=""/&gt;&#xD;
  &lt;/a&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;i&gt;&#xD;
      
                      
           Antimicrobial Use and Resistance in Australia 2017: Second Australian report on antimicrobial use and resistance in human health
          
                    &#xD;
    &lt;/i&gt;&#xD;
    
                    
          was launched at an event at Sydney’s St Vincent’s Hospital on 3 August 2017 by the Australian Commission on Safety and Quality in Health Care.
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          AURA 2017 provides an overview of the results of
          
                    &#xD;
    &lt;a href="https://www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/resources-page/"&gt;&#xD;
      
                      
           various programs
          
                    &#xD;
    &lt;/a&gt;&#xD;
    
                    
          dedicated to surveillance of antimicrobial use and resistance in Australia, including NCAS'
          
                    &#xD;
    &lt;a href="https://www.ncas-australia.org/naps"&gt;&#xD;
      
                      
           Hospital National Antimicrobial Prescribing Survey (NAPS) and the Aged Care National Antimicrobial Prescribing Survey (acNAPS)
          
                    &#xD;
    &lt;/a&gt;&#xD;
    
                    
          programs.
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          It contains valuable data on antimicrobial use in the community and hospitals, identifies key emerging issues for antimicrobial resistance, and gives a detailed overview of Australia’s first National Alert System for Critical Antimicrobial Resistances (CARAlert).
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          The report draws on findings that indicate that antibiotic use has been falling in Australian hospitals, a shift that will help to slow the spread of resistance. However, there are still concerning levels of inappropriate prescribing of antibiotics in hospitals and the community.
          
                    &#xD;
    &lt;br/&gt;&#xD;
    &lt;br/&gt;&#xD;
    
                    
          Read the report
          
                    &#xD;
    &lt;a href="https://www.safetyandquality.gov.au/publications/second-australian-report-on-antimicrobial-use-and-resistance-in-human-health/" target="_blank"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    
                    
          .
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;p&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AURA+2017+1.png" length="60302" type="image/png" />
      <pubDate>Wed, 02 Aug 2017 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-use-and-resistance-in-australia-2017-report</guid>
      <g-custom:tags type="string">News and events,NCAS publications,NAPS reports,Hospital,Surgical,Aged care,Community</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/AURA+2017+1.png">
        <media:description>thumbnail</media:description>
      </media:content>
    </item>
    <item>
      <title>Evidence-based solutions for antimicrobial stewardship</title>
      <link>https://www.ncas-australia.org/evidence-based-solutions-for-antimicrobial-stewardship</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Arjun Rajkhowa
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://insightplus.mja.com.au/2017/26/evidence-based-solutions-for-antimicrobial-stewardship/" target="_blank"&gt;&#xD;
      
           Medical Journal of Australia-Insight
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           )
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           On 29 June 2017, the Australasian Society for Infectious Diseases and Australian Society for Antimicrobials held a national summit on antimicrobial resistance in Melbourne. As 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.theage.com.au/victoria/if-this-fails-shell-lose-her-leg-australias-looming-superbug-crisis-20170627-gx01jk.html" target="_blank"&gt;&#xD;
      
           recent cases of drug-resistant infections
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            in Australia have shown, antimicrobial resistance may have devastating consequences.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Australian experts and stakeholders from diverse backgrounds gathered at the summit to reflect on the efficacy of ongoing interventions in different health care settings, and on actions that need to be taken urgently in the coming years.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Professor Brendan Murphy, the Chief Medical Officer of Australia, said that exigent organisational change is required to deal with the problem. To facilitate organisational change, health care settings need evidence-based solutions.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Practical and innovative solutions that have been developed and successfully implemented in recent years are now being adopted more systematically.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Many major hospitals around the world that have instituted antimicrobial stewardship (AMS) programs – aimed at optimising antimicrobial treatment, improving patient safety and reducing inappropriate use of antimicrobials – are adopting electronic approval systems and protocols to enhance their programs’ efficacy. Independent evaluations of IT-supported AMS interventions are showing promising results.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           An article 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/28333302" target="_blank"&gt;&#xD;
      
           published in July 2017 in the Journal of Antimicrobial Chemotherapy
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , by Dr Stuart Bond and colleagues from NSW, presents the results of a significant multisite Australian study that examined the impact of coordinated, network-wide AMS programs that were supported by a centrally-deployed computerised decision support system (CDSS).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A CDSS is an electronic tool or application that augments clinical decision making by providing relevant information to clinicians at the point of care. 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/16771625" target="_blank"&gt;&#xD;
      
           CDSSs for AMS range from mobile applications containing guidelines to approvals-based and advanced systems
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           An approvals-based CDSS can enhance decision making by instituting formulary control, providing recommendations for targeted treatment on the basis of local or national clinical practice guidelines, monitoring guideline adherence by prescribers, and enabling post-prescription review and unit- or hospital-wide feedback and auditing.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Previous studies examining the impact of the implementation of CDSS-supported AMS programs within individual sites (
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/18667084" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/18550680" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.mja.com.au/journal/2013/198/5/prescribing-trends-and-after-implementation-antimicrobial-stewardship-program" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/21982143" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.mja.com.au/journal/2004/180/9/impact-electronic-antibiotic-advice-and-approval-system-antibiotic-prescribing" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/22953616" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , and 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/20215130" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ) have shown positive effects, such as the reduced use of targeted antimicrobials, reduced drug acquisition costs, lower rates of health care-associated Clostridium difficile infections (HCA-CDI), and increased susceptibility of bacterial isolates to key antimicrobials.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Few studies have examined the aggregate clinical outcomes of network-wide, multisite AMS programs that are underpinned by a centrally-deployed CDSS, and fewer still have included non-metropolitan hospitals in their remit. Dr Bond, from Wollongong Hospital and the University of Wollongong, and colleagues argue that theirs may be the first such study.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           This is significant for two primary reasons. The first is that multisite studies draw on a significantly enlarged evidence base and thus show that the outcomes of AMS programs are generalisable and scalable. The second is that non-metropolitan hospitals are a salient target group for clinical improvement. 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/26080364" target="_blank"&gt;&#xD;
      
           Research has shown that non-metropolitan hospitals specifically, and health care settings in regional and remote areas more broadly, face considerable barriers to the implementation of AMS programs
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           . Lack of resources and access to clinical experts may compound problems associated with inappropriate prescribing.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The implementation of a centrally-deployed CDSS across a network of hospitals (operating on the basis of a “hub and spoke” model) may help overcome some of these barriers and enhance patient care in non-metropolitan settings. This study shows the efficacy of one such initiative.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In 2012, multisite AMS programs supported by a centrally-deployed CDSS (Guidance MS, developed by the not-for-profit Guidance Group at the Royal Melbourne Hospital) were implemented across a network of 12 hospitals spanning the South Eastern Sydney and Illawarra Shoalhaven Local Health Districts and the Sydney Children’s Hospital.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The CDSS enables formulary control and guideline development, mandates and monitors guideline adherence by prescribers through a system of alerts and approvals, and encompasses post-prescription review and prospective auditing features. It can be integrated with existing clinical systems, such as electronic medication management or e-prescribing systems and microbiology systems, to facilitate seamless access to real time, updated patient data.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In addition to sharing the CDSS, the hospitals shared AMS strategies, educational material and similar sets of guidelines (including antimicrobial formulary restrictions).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Prior to the implementation of the CDSS, AMS activities at some of these hospitals were restricted to phone-based advice, formal ID physician consultations, selective antimicrobial susceptibility reporting, and the restriction of antifungals and reserve antibacterials.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The authors conducted an interrupted time-series study examining antimicrobial use and patient outcomes across five of the network’s hospitals from 2010 to 2014 – the other hospitals in the network were excluded from this study’s remit due to their varying implementation timelines and the lack of comparable data. The effects of the intervention on targeted antimicrobial use, drug acquisition costs and HCA-CDI rates were analysed.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The study found that, after intervention, antimicrobials targeted for increased use rose from 223 to 293 defined daily doses per 1000 occupied bed days per month, an increase of 32%. Conversely, antimicrobials targeted for decreased use fell from 254 to 196 defined daily doses per 1000 occupied bed days per month, a decrease of 23%.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antimicrobials targeted for increased use included benzylpenicillin, doxycycline and aminopenicillins, whereas antimicrobials targeted for decreased use included third-generation cephalosporins, macrolides, antipseudomonal b-lactam and b-lactamase inhibitor combinations, fluoroquinolones and carbapenems.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The costs of drug acquisition decreased initially (-$64 551/month), then increased (+$7273/month). HCA-CDI rates decreased after intervention, as did the proportional length of stay measures as well as mortality for key respiratory infections and bacteraemia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Lead author Dr Bond explains how the CDSS-supported AMS program was implemented in his health district and highlights its impacts:
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “Illawarra Shoalhaven Local Health District (ISLHD) implemented a formal AMS program in May 2012, following the employment of an AMS pharmacist in April 2011 and a significant one-year education and development phase. This program was supported by a centrally-deployed clinical decision support system that was used across three health services, ISLHD, South Eastern Sydney Local Health District and Sydney Children’s Hospital. Regular AMS ward rounds were supported by the CDSS, which also facilitated post-prescription review and feedback. Multisite implementation of this program resulted in the sharing of resources across services, and improved access to resources for the smaller hospital sites that did not have onsite infectious diseases and pharmacist expertise.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           This study found that the strategy led to desired changes in targeted antimicrobial use, reduced antimicrobial costs, reduced HCA-CDI rates, and there was no observable increase in proportional length of stay or mortality. Although the desired effects on targeted use diminished over time, measures could be put in place to counteract the diminishing effects. Dr Bond points out that “it will be necessary to maintain the observed changes to patterns of antimicrobial use through education and to continuously monitor antimicrobial resistance patterns”. Ongoing support for interventions and program adherence will enable the outcomes to be sustainably maintained.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Professor Karin Thursky and Associate Professor Kirsty Buising, infectious diseases physicians at the Royal Melbourne Hospital and directors of the Guidance program, note that this study reaffirms the importance of clinical decision support and auditing tools to AMS programs.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Associate Professor Buising says: “This system provides a comprehensive workflow to support AMS. It incorporates decision support and pre-prescription approval to help guide prescribers. Expert prescribers and AMS teams can also use the system in a more targeted fashion to manage their workflow and to triage patients for post-prescription review and interventions. The reports generated from the system help AMS teams to better understand prescribing behaviours at their site.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Noting that AMS programs are intrinsically multifaceted, Professor Buising points out that the effects observed in the evaluation of an AMS program may be influenced by a number of factors.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “Nevertheless, it is very encouraging to see these results – that the implementation of this system across multiple sites was accompanied by improved clinical outcomes. It is especially important to see that this evaluation included many regional hospitals. This CDSS is the only system of its kind that has been evaluated independently from the developers, and at sites that aren’t just tertiary hospitals. This is a very important study.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Focusing on the value of systemic support for AMS programs, Professor Thursky says: “We need to remember that decision support tools produce the best outcomes when they are embedded in strong systems. For AMS programs to be successful, a systemic approach involving support for personnel, infrastructure and education is essential.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Mon, 10 Jul 2017 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/evidence-based-solutions-for-antimicrobial-stewardship</guid>
      <g-custom:tags type="string">Guidance,Media,Hospital</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial Resistance Summit</title>
      <link>https://www.ncas-australia.org/antimicrobial-resistance-summit</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;a&gt;&#xD;
    &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Capture+AMR+Summit.JPG" alt="" title=""/&gt;&#xD;
  &lt;/a&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          The problem of antibiotic resistance is one of the foremost issues that will affect health care worldwide, including Australia, in the coming decades. The World Health Organization (WHO) identified antimicrobial resistance as one of three greatest threats to human health, jeopardising patient safety and public health. A high-level meeting on antimicrobial resistance was held on 21 September 2016 at the United Nations General Assembly to accelerate global commitments and enhance national multi-sectoral efforts to combat this threat. The Executive Councils of the Australasian Society for Infectious Diseases (
          
                    &#xD;
    &lt;a href="https://www.asid.net.au/"&gt;&#xD;
      
                      
           ASID
          
                    &#xD;
    &lt;/a&gt;&#xD;
    
                    
          ) and the Australian Society for Antimicrobials (
          
                    &#xD;
    &lt;a href="http://www.asainc.net.au/"&gt;&#xD;
      
                      
           ASA
          
                    &#xD;
    &lt;/a&gt;&#xD;
    
                    
          ) strongly believe that there is a requirement for a debate within Australia on what actions need to be taken to address the issue in the coming years, and have organised a ‘
          
                    &#xD;
    &lt;a href="https://www.asid.net.au/events/event/antimicrobial-resistance-summit"&gt;&#xD;
      
                      
           Summit on Antimicrobial Resistance
          
                    &#xD;
    &lt;/a&gt;&#xD;
    
                    
          ’ to be held in Melbourne on 29 June 2017.
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          The Summit will run directly after the
          
                    &#xD;
    &lt;a href="https://www.google.com.au/url?sa=t&amp;amp;rct=j&amp;amp;q=&amp;amp;esrc=s&amp;amp;source=web&amp;amp;cd=1&amp;amp;cad=rja&amp;amp;uact=8&amp;amp;ved=0ahUKEwjruYTAtK3TAhWBmpQKHUTODZ4QFggoMAA&amp;amp;url=https%3A%2F%2Fwww.phaa.net.au%2Fevents%2Fevent%2FCDCC-2017&amp;amp;usg=AFQjCNGQ93FOJtYtic-BUDRmxNfc0bpXnA"&gt;&#xD;
      
                      
           Communicable Diseases Control Conference
          
                    &#xD;
    &lt;/a&gt;&#xD;
    
                    
          26-28 June, Melbourne.
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;p&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Capture+AMR+Summit.JPG" length="39168" type="image/jpeg" />
      <pubDate>Wed, 28 Jun 2017 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-resistance-summit</guid>
      <g-custom:tags type="string">News and events,Seminar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Capture+AMR+Summit.JPG">
        <media:description>thumbnail</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobials used for surgical prophylaxis by equine veterinary practitioners in Australia</title>
      <link>https://www.ncas-australia.org/antimicrobials-used-for-surgical-prophylaxis-by-equine-veterinary-practitioners-in-australia</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           L. Y. Hardefeldt, G. F. Browning, K. Thursky, J. R. Gilkerson, H. Billman‐Jacobe, M. A. Stevenson and K. E. Bailey
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Antimicrobials are widely used in Australian veterinary practices, but no investigation into the classes of antimicrobials used, or the appropriateness of use in horses, has been conducted.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Objectives
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : The aim of the study was to describe antimicrobial use for surgical prophylaxis in equine practice in Australia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Study design
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Cross‐sectional questionnaire survey.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : An online questionnaire was used to document antimicrobial usage patterns. Information solicited in the questionnaire included demographic details of the respondents, the frequency with which antimicrobials were used for specific surgical conditions (including the dose, timing and duration of therapy) and practice antimicrobial use policies and sources of information about antimicrobials and their uses.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : A total of 337 members of the Australian veterinary profession completed the survey. Generally, the choice of antimicrobial was appropriate for the specified equine surgical condition, but the dose and duration of therapy varied greatly. While there was poor optimal compliance with British Equine Veterinary Association guidelines in all scenarios (range 1–15%), except removal of a nonulcerated dermal mass (42%), suboptimal compliance (compliant antimicrobial drug selection but inappropriate timing, dose or duration of therapy) was moderate for all scenarios (range 48–68%), except for an uninfected contaminated wound over the thorax, where both optimal and suboptimal compliance was very poor (1%). Veterinarians practicing at a university hospital had higher odds of compliance than general practice veterinarians (Odds ratio 3.2, 95% CI, 1.1–8.9, P = 0.03).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Main limitations
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Many survey responses were collected at conferences which may introduce selection bias, as veterinarians attending conferences may be more likely to have been exposed to contemporary antimicrobial prescribing recommendations.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Antimicrobial use guidelines need to be developed and promoted to improve the responsible use of antimicrobials in equine practice in Australia. An emphasis should be placed on antimicrobial therapy for wounds and appropriate dosing for procaine penicillin.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://beva.onlinelibrary.wiley.com/doi/abs/10.1111/evj.12709" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Hardefeldt L.Y., Browning G.F., Thursky K., Gilkerson J.R., Billman‐Jacobe H., Stevenson M.A., Bailey K.E. (2017). Antimicrobials used for surgical prophylaxis by equine veterinary practitioners in Australia. Equine Veterinary Journal, 50(1), 65-72. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1111/evj.12709" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1111/evj.12709
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1463748465553-80db1e6ff830.jpg" length="889080" type="image/jpeg" />
      <pubDate>Mon, 12 Jun 2017 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobials-used-for-surgical-prophylaxis-by-equine-veterinary-practitioners-in-australia</guid>
      <g-custom:tags type="string">NCAS publications,Equine,Veterinary,Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1463748465553-80db1e6ff830.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1463748465553-80db1e6ff830.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>War on superbugs: articulating the crisis of antimicrobial resistance</title>
      <link>https://www.ncas-australia.org/war-on-superbugs-articulating-the-crisis-of-antimicrobial-resistance</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Arjun Rajkhowa
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://insightplus.mja.com.au/2017/21/war-on-superbugs-articulating-the-crisis-of-antimicrobial-resistance/" target="_blank"&gt;&#xD;
      
           Medical Journal of Australia-Insight
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            )
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A May 2017 commentary in 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Nature
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.nature.com/news/antibiotic-resistance-has-a-language-problem-1.21915#/b5" target="_blank"&gt;&#xD;
      
           Antibiotic resistance has a language problem
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ,
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
             
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           by Dr Marc Mendelson and colleagues has called for a reassessment of the language used to describe the crisis of antimicrobial resistance. They argue in favour of the standardisation of terminology among experts and the tempering of news coverage.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citing surveys conducted by the World Health Organization (WHO) and Wellcome Trust, they argue that the issue of antimicrobial resistance has a basic public recognition and awareness problem. The 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://apps.who.int/medicinedocs/documents/s22245en/s22245en.pdf" target="_blank"&gt;&#xD;
      
           WHO survey,
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            involving nearly 10 000 people from 12 countries, found that most people were unaware of the term “antimicrobial resistance”, and that only one-fifth had heard of the acronym “AMR”, which is the shorthand that most scientists use to refer to the phenomenon.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           On the other hand, a greater number of people had heard of the terms “antibiotic resistance” and “drug resistance”.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Clarity of nomenclature
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Does language make much of a difference, and can it help increase recognition and awareness? Evidently, it does and can. As the commentary argues, the use of appropriate or strategic terms and phrases has the potential to make substantial changes in people’s engagement with issues of significance.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “Global warming”, we are informed by a 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0138996" target="_blank"&gt;&#xD;
      
           2015 study
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , has more of an impact than “climate change”. This study, based on an analysis of social media content, suggests that the former term connotes and conveys a sense of impending danger, whereas the latter, though perhaps more accurate, simply denotes a process of “change” without necessarily evoking sentiment. It is semantically objective and dispassionate.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           What scientists and physicians choose to call a disease may have social implications. The decision in 1986 to name the virus that caused AIDS “human immunodeficiency virus (HIV)”, rather than “human T-cell lymphotropic virus (HTLV-III)” or “lymphadenopathy-associated virus (LAV)”, helped illuminate public understanding of the condition. With this coinage, the public came to grasp more easily that this was a virus that attacked the body’s immune system. Mendelson and colleagues hint in passing that this choice even served to mitigate some of the fear, hostility and opprobrium that were then widely associated with the disease, although this is a claim that would be difficult to substantiate. Disease nomenclature can make a difference, but it would be difficult to attribute changes in social attitudes, norms and perceptions to semantic alterations.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Nevertheless, clarity of meaning is undoubtedly necessary and useful. When it comes to AMR, Mendelson et al argue, cross-sectoral use of varying terminology can be confusing. Their suggestion to the United Nations that “drug-resistant infections” be used more frequently is, therefore, a prudent one, given that the WHO and Wellcome Trust surveys show greater recognition of this term. Further, this will help as patients become more aware of specific infections and antimicrobial treatments.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           War on superbugs?
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A pertinent question that the Nature article raises is around whether the use of martial metaphors – such as “war on superbugs” and others – in media coverage helps or hinders public understanding.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “Much of the rhetoric around drug resistance has pitched humans in a fight against bacteria. For instance, people frequently refer to ‘the war against superbugs’, or the ‘fight against AMR’. Also — in the pursuit of an enemy — responsibility for the increase of antibiotic-resistant bacteria in humans is often placed at the door of animal-health professionals, the livestock industry, farmers and veterinary surgeons. […]
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “The war narrative also fails to recognize our symbiotic relationships with bacteria. The more we go on the ‘attack’, the more likely we are to interrupt the vital roles of bacteria in our guts and airways and on our skin. Around 100 trillion bacteria live in our intestines alone, and most of these help us to stay in good health.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Martial metaphors are no doubt hyperbolic. But a critical counter-question here is: could “inflammatory” language in fact help reinforce the urgency of the problem? Does news coverage that’s replete with martial metaphors have the effect of increasing public awareness of the issue and galvanising demands for action?
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           If public awareness of the problem has remained low, as suggested by the surveys cited, then these hyperbolic evocations of battle and war are not necessarily achieving their intended aim of alarming the public. But given that there is widespread recognition of the urgency of the problem among clinicians and policymakers, perhaps the sense of urgency that suffuses expert discourses on the issue, complemented by “war-like” rhetoric in some media coverage, is generating some tangible and not necessarily deleterious results.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Language in this field is significant insofar as messages and campaigns can lead to concrete action, and in this regard, continuing coverage of the problem – some of it sensationalistic – has presumably had an impact on policymakers.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           When Dame Sally Davies in the UK likened the “catastrophic threat” of antibiotic resistance to “terrorism and climate change” and “a ticking time bomb” at the launch of her 2013 report, the problem arguably gained new prominence among British health experts and policymakers, as 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.independent.co.uk/news/science/chief-medical-officer-dame-sally-davies-resistance-to-antibiotics-risks-health-catastrophe-to-rank-8528442.html" target="_blank"&gt;&#xD;
      
           this report
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            suggests.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Mendelson and colleagues are right to point out, however, that the use of phrases like “war on bugs” could be misconstrued by general readers, possibly leading some to think of all bacteria as pathogenic, for instance. Nevertheless, such misunderstandings can be averted. Disseminating clear and concise information about specific bugs and infections would enhance public understanding of what’s going on in this area.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The authors also raise the important issue of the attribution of blame in media reporting, suggesting that pointing fingers at farmers and veterinarians, for instance, will do little more than alienate target audiences. This is correct. Communication that focuses on “blame”, per se, will most likely aggravate rather than engage clinicians, prescribers and agricultural users. These are the target audiences of advocates of antimicrobial stewardship (AMS) and as such it is crucial that they remain on side.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           However, as far as stewardship is concerned, relaying information about appropriate prescribing and the management of often deadly infections, while also pointing out exactly where things are going wrong, is a necessary and not easy balancing act.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           When surveillance of antimicrobial use and survey data yield significant insights into where inappropriate prescribing is rife, it is necessary that this information is disseminated, to clinicians as well as the public. Given that the aim of AMS research and the clinical interventions that may follow is to improve patient safety, the onus is predominantly on clinicians, prescribers and users in all sectors to engage with the information constructively and proactively.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Antimicrobial stewardship
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           From the outset, antimicrobial stewardship programs have focused on optimising patient safety and outcomes. As the National Centre for Antimicrobial Stewardship’s director, Professor Karin Thursky, described it in an earlier 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://insightplus.mja.com.au/2017/2/milestones-challenges-in-antimicrobial-stewardship/"&gt;&#xD;
      
           article
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            for MJA Insight, the aim of antimicrobial stewardship is “optimis[ing] the use of antimicrobial drugs”.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “The objective is to ensure that people who need these drugs receive them, but also to avoid unnecessary use, minimise toxicity of therapy, and importantly, minimise the impact of the selection of pathogens with antimicrobial resistance.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           When it comes to language around antimicrobial stewardship, articulating the aim as optimising treatment or increasing appropriateness of treatment, rather than reducing overall antimicrobial use, may be more useful. Likewise with patient safety. In communicating the importance of AMS programs to hospital management, emphasising patient safety, rather than the financial benefits of reduced use solely, would be more appropriate.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           When it comes to communications, there are two distinct streams of activity: one that is clinically focused and directed, and the other that is aimed at the general public. In the first stream, the focus is on communicating the research to drive improvement activities in health care settings; in the latter, the focus is on increasing awareness of the problem and potentially augmenting some pressure on stakeholders to get things right. The two require different approaches.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           While communicating with patients, some of whom may have misconceptions about AMR, it may be necessary to clarify what the problems are, says Associate Professor Kirsty Buising, an infectious diseases physician at the Royal Melbourne Hospital and deputy director of the National Centre for Antimicrobial Stewardship.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “It may be necessary to explain that it is the bugs that are changing (they are acquiring ways to avoid being killed by the drug), and not the drugs that are changing (antibiotics are getting weaker or losing their power) or the patient who is changing (‘I am becoming immune to antibiotics because I’ve had so many’).”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Further, as Dr Kirsten Schaffer from Dublin discussed in a presentation on public engagement and AMR at the 2017 European Congress of Clinical Microbiology and Infectious Diseases in Vienna, people need to learn more about how AMR can affect them and those around them. People don’t often see it as a problem that applies to them or their local community. On a practical level, patients who are aware of the problems would not expect antibiotics for viral infections when they visit their GP, for instance. What and how we communicate about AMR can affect people’s behaviour.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           As a 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.who.int/selection_medicines/committees/expert/21/applications/s6_antibiotic_awareness_campaigns.pdf?ua=1" target="_blank"&gt;&#xD;
      
           WHO report on AMR awareness campaigns
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , published in May 2017, observed, “it seems essential to base the campaigns’ messages more rigorously on scientific evidence and behavioral change concepts, while considering the particular context of each country.” This report, which surveyed experts around the world on whether or not their jurisdictions had any public or clinician-focused awareness campaigns and canvassed the key messages disseminated through these campaigns, found that while many countries could not point to specific initiatives, most of those that could recounted the use of consistent and action-oriented messages – such as around judicious use of antibiotics, hand hygiene, etc.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Moreover, this report also suggests that there is growing awareness of the significance of a “One Health” approach to the problem, which can potentially translate to more impactful awareness-raising efforts.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Mon, 05 Jun 2017 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/war-on-superbugs-articulating-the-crisis-of-antimicrobial-resistance</guid>
      <g-custom:tags type="string">Media,Community</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial prescribing in dogs and cats in Australia: results of the Australasian Infectious Disease Advisory Panel Survey</title>
      <link>https://www.ncas-australia.org/antimicrobial-prescribing-in-dogs-and-cats-in-australia-results-of-the-australasian-infectious-disease-advisory-panel-survey</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           L. Y. Hardefeldt, S. Holloway, D. J. Trott, M. Shipstone, V. R. Barrs, R. Malik, M. Burrows, S. Armstrong, G. F. Browning and M. Stevenson
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Investigations of antimicrobial use in companion animals are limited. With the growing recognition of the need for improved antimicrobial stewardship, there is urgent need for more detailed understanding of the patterns of antimicrobial use in this sector.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Objectives
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : To investigate antimicrobial use for medical and surgical conditions in dogs and cats by Australian veterinarians.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : A cross‐sectional study was performed over 4 months in 2011. Respondents were asked about their choices of antimicrobials for empirical therapy of diseases in dogs and cats, duration of therapy, and selection based on culture and susceptibility testing, for common conditions framed as case scenarios: 11 medical, 2 surgical, and 8 dermatological.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : A total of 892 of the 1,029 members of the Australian veterinary profession that completed the survey satisfied the selection criteria. Empirical antimicrobial therapy was more common for acute conditions (76%) than chronic conditions (24%). Overall, the most common antimicrobial classes were potentiated aminopenicillins (36%), fluoroquinolones (15%), first‐ and second‐generation cephalosporins (14%), and tetracyclines (11%). Third‐generation cephalosporins were more frequently used in cats (16%) compared to dogs (2%). Agreement with Australasian Infectious Disease Advisory Panel (AIDAP) guidelines (generated subsequently) was variable ranging from 0 to 69% between conditions.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions and clinical importance
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Choice of antimicrobials by Australian veterinary practitioners was generally appropriate, with relatively low use of drugs of high importance, except for the empirical use of fluoroquinolones in dogs, particularly for otitis externa and 3rd‐generation cephalosporins in cats. Future surveys will determine whether introduction of the 2013 AIDAP therapeutic guidelines has influenced prescribing habits.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://doi.org/10.1111/jvim.14733" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          .
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    
          : Hardefeldt L.Y., Holloway S., Trott D.J., Shipstone M., Barrs V.R., Malik R., Burrows M., Armstrong S., Browning G.F., Stevenson M. (2017). Antimicrobial prescribing in dogs and cats in Australia: Results of the Australasian Infectious Disease Advisory Panel Survey. Journal of Veterinary Internal Medicine, 31, 4, 1100-1107. DOI:
          &#xD;
    &lt;a href="https://doi.org/10.1111/jvim.14733" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1111/jvim.14733
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1585849847025-256a1488e653.jpg" length="180889" type="image/jpeg" />
      <pubDate>Tue, 16 May 2017 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-prescribing-in-dogs-and-cats-in-australia-results-of-the-australasian-infectious-disease-advisory-panel-survey</guid>
      <g-custom:tags type="string">Companion animal,NCAS publications,Veterinary,Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1585849847025-256a1488e653.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1585849847025-256a1488e653.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobials used for surgical prophylaxis by companion animal veterinarians in Australia</title>
      <link>https://www.ncas-australia.org/antimicrobials-used-for-surgical-prophylaxis-by-companion-animal-veterinarians-in-australia</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Laura Y. Hardefeldt, Glenn F. Browning, Karin Thursky, James R. Gilkerson, Helen Billman-Jacobe, Mark A. Stevenson and Kirsten E. Bailey
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Highlights
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           :
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Prophylactic antimicrobial use was common for companion animal surgery.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Choice of antimicrobial drug was generally appropriate.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Long duration and inappropriate timing of antibiotics caused low optimal compliance.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Companion animal only veterinarians had higher odds of optimal compliance.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Antimicrobials are widely used in veterinary practices, but there has been no investigation into the classes of antimicrobials used or the appropriateness of their use in surgical prophylaxis. Antimicrobial usage guidelines were published by the Australian Infectious Disease Advisory Panel (AIDAP) in 2013, but there has been no investigation of compliance with them. This study aimed to investigate antimicrobial use for surgical prophylaxis in companion animal practice and assess compliance with AIDAP guidelines for selected conditions by conducting a cross-sectional study of antimicrobial usage patterns of Australian veterinarians using an online questionnaire. Information solicited included: details of the respondent, the frequency with which antimicrobials were used for specific surgical conditions (including dose and duration) and practice antimicrobial use policies and sources of information about antimicrobial drugs and their uses. A total of 886 members of the Australian veterinary profession completed the survey. Few (22%) reported that their practice that had an antimicrobial use policy. Generally, the choice of antimicrobial drug was appropriate for the given surgical conditions. There was poor compliance with AIDAP guidelines for non-use of antimicrobials for routine neutering. Veterinarians caring solely for companion animals had higher odds of optimal compliance with guidelines than veterinarians in mixed species practices (OR 1.4, 95%CI 1.1–1.9). Recent graduates (&amp;gt;2011) had lower odds of compliance than older graduates (OR 0.8, 95%CI 0.6–0.9). The findings suggest that antimicrobial use guidelines need to be expanded and promoted to improve the responsible use of antimicrobials in small animal practice in Australia.
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    
          Read the full paper
          &#xD;
    &lt;a href="https://doi.org/10.1016/j.vetmic.2017.03.027" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    
          .
         &#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    
          : Hardefeldt L.Y., Browning G.F., Thursky K., Gilkerson J.R., Billman-Jacobe H., Stevenson M.A., Bailey K.E. (2017). Antimicrobials used for surgical prophylaxis by companion animal veterinarians in Australia. Veterinary Microbiology, 203, 301-7. DOI:
          &#xD;
    &lt;a href="https://doi.org/10.1016/j.vetmic.2017.03.027" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1016/j.vetmic.2017.03.027
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/veterinarian-clinic-dog-cat.jpg" length="212259" type="image/jpeg" />
      <pubDate>Thu, 23 Mar 2017 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobials-used-for-surgical-prophylaxis-by-companion-animal-veterinarians-in-australia</guid>
      <g-custom:tags type="string">Companion animal,NCAS publications,Veterinary,Veterinary paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/veterinarian-clinic-dog-cat.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/veterinarian-clinic-dog-cat.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Milestones, challenges in antimicrobial stewardship</title>
      <link>https://www.ncas-australia.org/milestones-challenges-in-antimicrobial-stewardship</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Karin Thursky
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://insightplus.mja.com.au/2017/2/milestones-challenges-in-antimicrobial-stewardship/" target="_blank"&gt;&#xD;
      
           Medical Journal of Australia-Insight
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           )
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Antimicrobial-resistant pathogens, such as carbapenem-resistant
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Enterobacteriaceae
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            and methicillin-resistant 
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Staphylococcus aureus
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , pose a serious threat to modern medicine.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           While antimicrobial resistance (AMR) was recognised decades ago — indeed, 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://mmbr.asm.org/content/74/3/417.full" target="_blank"&gt;&#xD;
      
           soon after the development of the first antibiotics
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            — the problem has 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.cdc.gov/drugresistance/biggest_threats.html" target="_blank"&gt;&#xD;
      
           increased rapidly in recent years
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , and there are fears that it may be beginning to exceed our ability to control the situation. Though doctors and researchers have been 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.doctorportal.com.au/mjainsight/2015/5/stop-antibiotics-experts/" target="_blank"&gt;&#xD;
      
           reflecting on therapeutic interventions
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            to come to grips with the problem, we are still in the early stages of setting up system-wide countervailing strategies and policies. Indeed, only recently have system-wide efforts started gaining momentum.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In September 2016, the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.un.org/pga/71/event-latest/high-level-meeting-on-antimicrobial-resistance/" target="_blank"&gt;&#xD;
      
            General Assembly
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            of the United Nations gathered to discuss AMR. This was only the fourth time in history that a health issue had prompted such action, demonstrating the importance of the problem globally. The result was a draft resolution that called for action to ensure the appropriate use of antimicrobials across animal and human health.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In November 2016, Australia released an 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.health.gov.au/internet/main/publishing.nsf/Content/1803C433C71415CACA257C8400121B1F/$File/AMR-Implementation-Plan.pdf" target="_blank"&gt;&#xD;
      
           implementation plan
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            to accompany its 2015 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.health.gov.au/internet/main/publishing.nsf/Content/ohp-amr.htm#tocstrategy" target="_blank"&gt;&#xD;
      
           National Antimicrobial Resistance Strategy
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            and outline areas requiring attention.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A key strategy involves the implementation of antimicrobial stewardship (AMS), i.e., activities designed to optimise the use of antimicrobial drugs. The objective is to ensure that people who need these drugs receive them, but also to avoid unnecessary use, minimise toxicity of therapy, and importantly, minimise the impact of the selection of pathogens with antimicrobial resistance.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A key objective of Australia’s national research agenda and health policy should be to develop effective AMS systems in all the sectors in which antimicrobials are primarily used. This includes hospitals, community care settings (including general practice and aged care settings), veterinary medicine and agriculture. This takes into account the concept of 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncas-australia.org/one-health" target="_blank"&gt;&#xD;
      
           One Health
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , which posits that human health, animal health and the environment are all interconnected and that antimicrobial use in one sector will influence another.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Australian stewardship – advancements in the field
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           At the outset, it should be noted that Australia has been fairly advanced in terms of its thinking on AMS, at least with respect to hospitals and the tertiary care sector, and is internationally recognised as a leader in the field.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Australia is one of a handful of countries to have developed comprehensive national 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://tgldcdp.tg.org.au/etgcomplete" target="_blank"&gt;&#xD;
      
           guidelines
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            for 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.clinicalguidelines.gov.au/portal/2406/therapeutic-guidelines-antibiotic-version-15" target="_blank"&gt;&#xD;
      
           antibiotic prescribing
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            in hospitals and general practice. The 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/" target="_blank"&gt;&#xD;
      
           Australian Commission on Safety and Quality in Health Care
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (ACSQHC) has introduced strong clinical standards that emphasise medication safety and infection prevention, and since 2013 has required all hospitals to take action with regard to AMS.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The ACSQHC is working on updating a publication, 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/wp-content/uploads/2011/01/Antimicrobial-stewardship-in-Australian-Hospitals-2011.pdf" target="_blank"&gt;&#xD;
      
           Antimicrobial stewardship in Australian hospitals
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , which was released in 2011 and helped to guide activity in the sector. The new book, which is due for publication in 2017, will expand on areas such as community care, aged care, paediatrics, veterinary and livestock medicine, and dental care.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           An update of the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/accreditation-and-the-nsqhs-standards/resources-to-implement-the-nsqhs-standards/#NSQHS-Standards" target="_blank"&gt;&#xD;
      
           National Safety and Quality Health Service
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            hospital standards for accreditation is in progress. The standards for AMS programs are set to be further refined in light of hospitals’ experience of implementation. There is likely to be an emphasis on delineating restriction rules and approval processes, auditing and providing feedback to prescribers, and monitoring the appropriateness of use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/our-work/clinical-care-standards/antimicrobial-stewardship-clinical-care-standard/" target="_blank"&gt;&#xD;
      
           national clinical care standards for AMS
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            released in 2014 are directed towards individual prescribers and their patients. These standards are intended to ensure that practitioners use best practice when prescribing antimicrobials, and that patients are properly informed about appropriate antimicrobial use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           These are huge achievements and help to increase awareness and clearly define expectations regarding antimicrobial use. Prescribers and consumers are being asked to rethink the way we approach antimicrobial drugs, to recognise that they are a “precious resource”, and that their use needs to be rationalised to ensure that they are protected and remain effective for future generations.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Auditing antimicrobial prescribing practices in Australia
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In order to take action to improve prescribing practices, we first need to understand what is currently happening and then identify where improvement is required. Gathering such data has previously been very problematic. A large body of work has been undertaken by the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncas-australia.org/" target="_blank"&gt;&#xD;
      
           National Centre for Antimicrobial Stewardship
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (NCAS) to develop standardised auditing tools that will help provide more meaningful data on the appropriateness of antimicrobial use.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.naps.org.au/Default.aspx" target="_blank"&gt;&#xD;
      
           National Antimicrobial Prescribing Survey
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            (NAPS) is a voluntary audit undertaken annually by hospitals from across Australia. It provides a snapshot of antimicrobial prescribing across public and private hospitals of all sizes, in different geographic locations, and with varied levels of expert support. The audit enables assessments of the appropriateness of prescriptions, and is a 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/wp-content/uploads/2016/06/AURA-2016-Summary-Report.pdf"&gt;&#xD;
      
           key component
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            of the incipient 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/what-is-aura/"&gt;&#xD;
      
           Antimicrobial Use and Resistance in Australia (AURA)
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            Surveillance System, which the ACSQHC has established with funding from the Department of Health.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           International studies often cite that half of all antimicrobial prescriptions are inappropriate. In fact, the Australian 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.safetyandquality.gov.au/national-priorities/amr-and-au-surveillance-project/national-antimicrobial-prescribing-survey-naps/" target="_blank"&gt;&#xD;
      
           NAPS done since 2013
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            show that Australia has higher appropriateness rates, at around 70% (although a goal of more than 95% has been set). Poor prescribing has been identified in certain areas, such as the treatment of respiratory infections (e.g., chronic obstructive pulmonary disease) and surgical prophylaxis. These findings help to target the activity of AMS programs within hospitals, and can directly inform broader initiatives such as national guidelines.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The survey’s remit, hitherto only encompassing hospitals, has now been extended to the 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.naps.org.au/Resources/2016_Aged_Care_NAPS_information_sheet_for_homepage_20160804.pdf" target="_blank"&gt;&#xD;
      
           aged care sector
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            as well. A 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://ncascre.files.wordpress.com/2015/08/acnaps-print-copy.pdf" target="_blank"&gt;&#xD;
      
           report
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            released in 2016 and based on an audit of Australian aged care facilities showed disturbing rates of prolonged antimicrobial prescriptions and poor documentation of indications for use among residents.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Areas of need
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           It has been shown that the rates of antimicrobial prescribing in the Australian community on a per capita basis are about 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://theconversation.com/factcheck-is-australias-use-of-antibiotics-in-general-practice-20-above-the-oecd-average-68657" target="_blank"&gt;&#xD;
      
           10% above the Organisation for Economic Co-operation and Development average
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           . We do not, however, have a detailed understanding of the appropriateness of such prescribing, and thus the areas requiring action are not yet entirely clear. There is an urgent need to gather such data and to meaningfully analyse it to drive improvement activities. 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="http://www.nps.org.au/"&gt;&#xD;
      
           NPS MedicineWise
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
            has been an active group in this area, but more action is urgently required.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Similarly, the level of detail on antimicrobial usage in the veterinary and agricultural sectors is currently inadequate in Australia. Although data on volumes of drugs imported for animal use confirm that Australia has very low levels of antimicrobial use, the reasons for use and the appropriateness of such use are poorly understood. NCAS is undertaking research into antimicrobial usage for both companion animals and livestock.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Another challenge facing AMS researchers in Australia is the lack of data linkage between antimicrobial usage and antimicrobial resistance. The patterns of pathogens being identified in patients are likely to be influenced by patterns of antimicrobial drug exposure in the local environment (for humans, animals and agriculture). To date, we have a poor understanding of the interrelationships between these.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           How do we improve prescribing behaviour?
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           There is no doubt that urgent action needs to be taken to improve prescribing behaviours. In busy health care settings, we know that to be successful, AMS solutions must ultimately fit comfortably into the clinical workflow. Information technology, therefore, will play a crucial role – either at the “front-end”, providing decision support about antimicrobial choice, or at the “back-end”, aggregating data for effective and useful reporting.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           One program, 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncas-australia.org/Guidance_Group" target="_blank"&gt;&#xD;
      
           Guidanc
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           e
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           , developed at the Royal Melbourne Hospital, has been adopted by over 60 hospitals across Australia since 2005 to assist their AMS programs. As the innovation arm of NCAS, the Guidance team is now working with hospitals to implement electronic management systems for AMS. A key aim is to support interoperability between hospital systems, stewardship programs and NAPS. It is imperative that community prescribing software follows suit. It should be integrated with appropriate decision support to promote better prescribing practices in accordance with Australian recommendations. This will, however, need to be guided by careful health services research to ensure that solutions meet the needs of prescribers across each health care sector.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           It is important to recognise that antimicrobial stewardship is not just about the prevention of antimicrobial resistance; its focus, first and foremost, is patient safety.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Mon, 23 Jan 2017 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/milestones-challenges-in-antimicrobial-stewardship</guid>
      <g-custom:tags type="string">Media,Hospital,Community</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>The Hospital National Antimicrobial Prescribing Survey: 2015 report</title>
      <link>https://www.ncas-australia.org/the-hospital-national-antimicrobial-prescribing-survey-2015-report</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;a&gt;&#xD;
    &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/2015+NAPS.png" alt="" title=""/&gt;&#xD;
  &lt;/a&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          The results from the 2015 annual Hospital National Antimicrobial Prescribing Survey (NAPS) have been released in our latest report: 281 hospitals participated (213 public and 68 private) during the data collection period between September 2015 to February 2016, representing all Australian states, territories and remoteness classifications.
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Initial results demonstrated that for antimicrobial prescriptions:
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;ul&gt;&#xD;
      &lt;li&gt;&#xD;
        
                        
            72.5% had an indication documented
            
                        &#xD;
        &lt;br/&gt;&#xD;
      &lt;/li&gt;&#xD;
      &lt;li&gt;&#xD;
        
                        
            35.5% has a review or stop date documented
           
                      &#xD;
      &lt;/li&gt;&#xD;
      &lt;li&gt;&#xD;
        
                        
            23.3% were non-compliant with prescribing guidelines
            
                        &#xD;
        &lt;br/&gt;&#xD;
      &lt;/li&gt;&#xD;
      &lt;li&gt;&#xD;
        
                        
            27.4% of the surgical prophylaxis prescriptions continued beyond 24 hours
            
                        &#xD;
        &lt;br/&gt;&#xD;
      &lt;/li&gt;&#xD;
    &lt;/ul&gt;&#xD;
    &lt;div&gt;&#xD;
      
                      
           The most common antimicrobials prescribed were:
          
                    &#xD;
    &lt;/div&gt;&#xD;
    &lt;div&gt;&#xD;
      &lt;ul&gt;&#xD;
        &lt;li&gt;&#xD;
          
                          
             cefazolin - 13.6%
             
                          &#xD;
          &lt;br/&gt;&#xD;
        &lt;/li&gt;&#xD;
        &lt;li&gt;&#xD;
          
                          
             ceftriaxone - 9.0%
             
                          &#xD;
          &lt;br/&gt;&#xD;
        &lt;/li&gt;&#xD;
        &lt;li&gt;&#xD;
          
                          
             metronidazole - 6.5%
             
                          &#xD;
          &lt;br/&gt;&#xD;
        &lt;/li&gt;&#xD;
        &lt;li&gt;&#xD;
          
                          
             amoxicillin–clavulanate - 6.3%
             
                          &#xD;
          &lt;br/&gt;&#xD;
        &lt;/li&gt;&#xD;
        &lt;li&gt;&#xD;
          
                          
             piperacillin–tazobactam - 6.3%
             
                          &#xD;
          &lt;br/&gt;&#xD;
        &lt;/li&gt;&#xD;
      &lt;/ul&gt;&#xD;
    &lt;/div&gt;&#xD;
    &lt;div&gt;&#xD;
      
                      
           The most common indications for prescribing antimicrobials were:
           
                      &#xD;
      &lt;br/&gt;&#xD;
    &lt;/div&gt;&#xD;
    &lt;ul&gt;&#xD;
      &lt;li&gt;&#xD;
        
                        
            surgical prophylaxis - 15.5%
            
                        &#xD;
        &lt;br/&gt;&#xD;
      &lt;/li&gt;&#xD;
      &lt;li&gt;&#xD;
        
                        
            community-acquired pneumonia - 10.5%
            
                        &#xD;
        &lt;br/&gt;&#xD;
      &lt;/li&gt;&#xD;
      &lt;li&gt;&#xD;
        
                        
            medical prophylaxis - 7.6%
            
                        &#xD;
        &lt;br/&gt;&#xD;
      &lt;/li&gt;&#xD;
      &lt;li&gt;&#xD;
        
                        
            sepsis 5.7%
            
                        &#xD;
        &lt;br/&gt;&#xD;
      &lt;/li&gt;&#xD;
      &lt;li&gt;&#xD;
        
                        
            urinary tract infection - 5.0%
            
                        &#xD;
        &lt;br/&gt;&#xD;
      &lt;/li&gt;&#xD;
    &lt;/ul&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Areas highlighted for quality improvement include documentation of review or stop dates and indications for antimicrobial prescriptions and the ongoing high proportion of prolonged and non-compliant surgical prophylaxis prescriptions. See
          
                    &#xD;
    &lt;a href="https://www.ncas-australia.org/ncas-publications" target="_blank"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    
                    
          .
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;p&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/2015+NAPS.png" length="38120" type="image/png" />
      <pubDate>Mon, 16 Jan 2017 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/the-hospital-national-antimicrobial-prescribing-survey-2015-report</guid>
      <g-custom:tags type="string">News and events,NCAS publications,NAPS reports,Hospital,Surgical</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/2015+NAPS.png">
        <media:description>thumbnail</media:description>
      </media:content>
    </item>
    <item>
      <title>The tiny drop fighting the big problem of antibiotic resistance</title>
      <link>https://www.ncas-australia.org/the-tiny-drop-fighting-the-big-problem-of-antibiotic-resistance</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Errol Hunt
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            (Published in
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://pursuit.unimelb.edu.au/articles/the-tiny-drop-fighting-the-big-problem-of-antibiotic-resistance" target="_blank"&gt;&#xD;
      
           Pursuit
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            , University of Melbourne)
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Cradling a three-week-old chicken in one hand, Glenn Browning raises an eyedropper to its tiny eye and administers a vaccine.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “One drop, and it’s protected for life,” he says, releasing the chick and lifting another. “That’s why farmers are using it. Compare this with the impossible task of catching and treating a handful of diseased chickens in a shed of 10,000 birds.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The vaccine, developed by Professor Browning’s team at the University of Melbourne’s Asia-Pacific Centre for Animal Health (APCAH), is against the chicken respiratory-disease bacterium 
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Mycoplasma gallisepticum
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           .
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           There’s keen interest in the team’s work due to the rising, and disturbing, problem of antibiotic resistance among bacteria that infect humans. Many pathogens are developing resistance to some of our most-effective antibiotics.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “Bacteria are incredibly efficient at passing genetic material to one another,” says Professor Browning. “So if a bacterium infecting these chickens develops resistance to particular antibiotics, it can pass that resistance on to another bacterium that can infect us.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The World Health Organization calls antibiotic resistance one of the greatest threats to human health, and says the problem is increasing more quickly than anyone expected. Diseases once easily treated by a course of antibiotics can now pose a significant threat to life, and cannot be stopped by even our most-effective “last resort” drugs.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           And the problem is going to get worse. In coming decades, medical researchers expect to see the rise of “superbugs” that are simply impossible to treat by antibiotics. A major report released in the UK earlier this year warned that, by the year 2050, the number of deaths due to these superbugs could be as high as those due to cancer.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Even in the 18 months it took to write that report, it’s estimated that as many as a million people may have died because of antibiotic-resistant bacterial infections.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           No wonder the global health industry is mobilising.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           At the frontline of the battle against antibiotic resistance is a campaign to stop the overuse and misuse of antibiotics in both humans and animals. Australia is leading internationally on both fronts.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           You’ve probably seen signs in the waiting room of your local GP referring to the problem. Some explain why the GP won’t necessarily give you the antibiotic you’re asking for, if there’s no need for it. Others explain why it’s vital you finish the course of drugs, even if symptoms have eased.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Both overuse of antibiotics and incomplete use of antibiotics can encourage bacteria to develop resistance to a particular drug.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           However, use of antibiotics in human medicine is outmatched by use on animals by a factor of two to one.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           On high-intensity farms in countries such as China, the US and Spain, farmers use antibiotics to guard against common, chronic respiratory infections that spread between animals kept in close proximity. For chicken farmers, it’s a preventative measure against infections that can cause weight loss, a reduction in egg production, and deaths caused by a range of respiratory infections.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           In Australia, use of antibiotics on farms is relatively tightly regulated. Overseas it’s a different story. From a country such as India, where antibiotics may be available over the counter and their use on farms is unregulated, it is possible for resistant bacteria to make their way to Europe, the Americas or Australasia.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “New antibiotic-resistant strains of bacteria can cross international borders easily, whether in packaged food products or with humans as their unknowing hosts,” says Professor Karin Thursky, who works with Professor Browning at the National Centre for Antimicrobial Stewardship (
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncas-australia.org/home"&gt;&#xD;
      
           NCAS
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      
           ).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           It was recently found that another superbug resistant to last-resort treatments, and only identified in China at the end of 2015, had already spread to more than 19 countries.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           With superbugs crossing borders with such ease, it’s clear that any solution must be international.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Professor Browning’s chicken vaccine is one small but important part of that solution, and is effective because his team has worked with farmers internationally to find out what works.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “It’s just not feasible for large-scale farmers to treat individual sick animals,” says Professor Browning. “Imagine isolating one sick bird in a shed of 10,000 chickens, and injecting that bird with antibiotics three times a day. It just can’t be done.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           So instead, farmers use “blanket” antibiotic treatments on an entire herd or shed, dosing the food or water supply, precisely the type of antibiotic use that promotes the development of antibiotic-resistant bacteria.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The vaccine that Professor Browning’s team has developed targets the same respiratory infections that farmers overseas control through antibiotics.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           To create their vaccines, his team takes advantage of one of bacteria’s own weapons: mutation. Bacteria mutate extremely quickly – it’s how they evolve to reinfect the same individual again and again; it’s how some bacteria can skip between humans and animals; and it’s how bacteria develop resistance to antibiotics.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “We accelerate that mutation,” says Professor Browning. “Then, we select variants of that bacterium that are less virulent than the original.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “We developed the Mycoplasma vaccine by selecting a closely-related strain that cannot survive the warmer temperatures of a bird’s lungs.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           That weakness means the infection lodges in the bird’s nasal passage instead. The bird’s immune system then develops antibodies to fight off any future infections, without the bird ever becoming ill.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           That “learned” immune response remains effective for the rest of the bird’s life – which is key to ensuring that it’s a more effective tool than antibiotics.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           The theory is simple: if farmers have access to a simpler, cheaper, one-off vaccine to protect their flock or herd, they will no longer need antibiotic treatments.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “We’re giving the farmers alternatives that are better for their productivity, better for the animals, and better for human health,” says Professor Browning.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           And it works. There has been a 90 per cent reduction in the use of antibiotics on poultry farms where the vaccine has been introduced.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           It is now being commercialised throughout the world, and has recently been introduced to China, where antibiotics are widely used in farming.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Yet the vaccine and other agriculture projects are not the end of the battle. This is a multi-pronged offensive. Professor Browning’s team is also working with the veterinary industry, where overuse and misuse of antibiotics follows much the same pattern as in human medicine: vets prescribing antibiotics when they’re not necessarily needed, and clients not always ensuring that their animals complete each course of prescribed antibiotics.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Meanwhile, Professor Thursky and her team at the National Centre for Antimicrobial Stewardship are using health service research to understand the problems of antibiotic prescribing in human medicine, in hospitals, aged care homes and general practice.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “We are very lucky in Australia to have mandatory antimicrobial stewardship programs in our public and private hospitals, and fantastic tools to measure and report the appropriate use of antibiotics,” says Professor Thursky.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           “We need to do the same in all these other areas – outside of hospitals. Great data allows us to lead changes in practice and better policies, because we actually find out what the prescribers are doing and what the drivers of those behaviours are.”
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           It’s a huge, multidisciplinary effort. Just as Professor Browning and his researchers have worked with farmers and vets, Professor Thursky’s research fellows have worked side by side with hospitals, aged care and general practices. The two streams – animal and human – are sharing their work in a true “one health” effort.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg" length="182583" type="image/jpeg" />
      <pubDate>Thu, 15 Dec 2016 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/the-tiny-drop-fighting-the-big-problem-of-antibiotic-resistance</guid>
      <g-custom:tags type="string">Media,Veterinary</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1476242906366-d8eb64c2f661.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Ongoing medication shortages</title>
      <link>https://www.ncas-australia.org/ongoing-medication-shortages</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;a&gt;&#xD;
    &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/0409-6509-01_tcm81-3584-350x350.jpg" alt="" title=""/&gt;&#xD;
  &lt;/a&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          There is currently an Australia-wide shortage of various antimicrobials, including intravenous acyclovir, vancomycin and metronidazole. Meropenem has also been flagged a medication that is in low supply and should be used sparingly. There is no indication as to when these medications will again become readily available. This was recently highlighted in the Australian media.
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          The use of these vital medications should be reserved for those situations where there is a clear need for the antimicrobial over other available therapies. Prescriptions should be discontinued as soon as possible based on clinical indication and status of the patient, with daily monitoring of the need for ongoing therapy.
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
          Fact-sheets regarding these medication shortages, outlining patient management and the possible use of alternative antimicrobials, are available
          
                    &#xD;
    &lt;a href="https://www.ncas-australia.org/Education" target="_blank"&gt;&#xD;
      
                      
           here
          
                    &#xD;
    &lt;/a&gt;&#xD;
    
                    
          .
         
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;p&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1558956397-d89fe6bb84e7.jpg" length="362930" type="image/jpeg" />
      <pubDate>Tue, 13 Dec 2016 05:00:22 GMT</pubDate>
      <guid>https://www.ncas-australia.org/ongoing-medication-shortages</guid>
      <g-custom:tags type="string">News and events</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1558956397-d89fe6bb84e7.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial use in Australian hospitals: how much and how appropriate?</title>
      <link>https://www.ncas-australia.org/antimicrobial-use-in-australian-hospitals-how-much-and-how-appropriate</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           John Turnidge, Karin Thursky, Caroline Chen, Vicki McNeil and Irene Wilkinson
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Summary
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;ul&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Antimicrobial agents play a central role in modern health care, especially in the hospital setting. This article describes the currently available information on the volumes of antimicrobial use in Australian hospitals, the appropriateness of that use, and the levels of compliance with nationally or locally endorsed prescribing guidelines.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            The data presented here come from the 2014 National Antimicrobial Utilisation Surveillance Program report and the 2013 and 2014 National Antimicrobial Prescribing Survey reports and are based on voluntary participation in the two programs.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            While the results can be considered indicative only, they show that Australia has high volumes of prescribing in hospitals, and that in certain circumstances and conditions these are inappropriate and/or not compliant with national or local prescribing guidelines.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            In 2014, the national aggregate use rate for antimicrobials was 936 defined daily doses per 1000 occupied bed days. In the same year, the overall rate of appropriate prescribing was 72%, and compliance with guidelines was 74% where this was assessable. The rate of surgical antimicrobial prophylaxis exceeding the benchmark of 24 hours was high (36%), as was the inappropriate prescribing for infective exacerbations of chronic obstructive pulmonary disease (38%).
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
    &lt;li&gt;&#xD;
      &lt;span&gt;&#xD;
        
            The findings indicate that there is room for improvement in antimicrobial prescribing in Australian hospitals, and provides insights into where the efforts for improvement might be directed.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/li&gt;&#xD;
  &lt;/ul&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        &lt;br/&gt;&#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.5694/mja15.00899" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Turnidge, J.D., Thursky, K., Chen, C.S., McNeil, V.R., Wilkinson, I.J. (2016). Antimicrobial use in Australian hospitals: How much and how appropriate?. Medical Journal of Australia, 205(10), S16-S20. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.5694/mja15.00899" target="_blank"&gt;&#xD;
      
           https://doi.org/10.5694/mja15.00899
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            . 
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hospital_NAPS.jpg" length="33263" type="image/jpeg" />
      <pubDate>Sun, 20 Nov 2016 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-use-in-australian-hospitals-how-much-and-how-appropriate</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper,NAPS,NAPS paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hospital_NAPS.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hospital_NAPS.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>NCAS Annual Forum 2016</title>
      <link>https://www.ncas-australia.org/ncas-annual-forum</link>
      <description />
      <content:encoded>&lt;h3&gt;&#xD;
  
                  
                  
  9 November 2016

                
                &#xD;
&lt;/h3&gt;&#xD;
&lt;div&gt;&#xD;
  &lt;a&gt;&#xD;
    &lt;img src="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/15134_13454-2400x3600.jpg" alt="" title=""/&gt;&#xD;
  &lt;/a&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
                    
    The NCAS Annual Forum 2016 was held at the Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Melbourne.
    
                    
                    &#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
                    
    The aim of the day was to bring AMS stakeholders together to network, discuss and hear about the latest developments in human and animal AMS, both locally and internationally.
  
                  
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
                    
    The day commenced with presentations by the Director of NCAS, Professor Karin Thursky, the Deputy Director of NCAS, A/Professor Kirsty Buising, and many of the NCAS Chief Investigators. 
  
                  
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/div&gt;&#xD;
  &lt;div&gt;&#xD;
    
                    
                    
    The afternoon session highlighted the original research being undertaken by 
    
                    
                    &#xD;
    &lt;a href="https://www.ncas-australia.org/research-fellows"&gt;&#xD;
      
                      
                      
      NCAS PhD students
    
                    
                    &#xD;
    &lt;/a&gt;&#xD;
    
                    
                    
    . The program and webinar recordings of both the morning and afternoon sessions are available to view 
    
                    
                    &#xD;
    &lt;a href="https://www.ncas-australia.org/ncas-annual-forum-2016" target="_top"&gt;&#xD;
      
                      
                      
      here
    
                    
                    &#xD;
    &lt;/a&gt;&#xD;
    
                    
                    
    . 
  
                  
                  &#xD;
  &lt;/div&gt;&#xD;
  &lt;p&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/15134_13454-2400x3600.jpg" length="1409456" type="image/jpeg" />
      <pubDate>Tue, 08 Nov 2016 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/ncas-annual-forum</guid>
      <g-custom:tags type="string">News and events,Seminar</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/15134_13454-2400x3600.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
    </item>
    <item>
      <title>Antimicrobial allergy ‘labels’ drive inappropriate antimicrobial prescribing: lessons for stewardship</title>
      <link>https://www.ncas-australia.org/antimicrobial-allergy-labels-drive-inappropriate-antimicrobial-prescribing-lessons-for-stewardship</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           J. A. Trubiano, C. Chen, A. C. Cheng, M. L. Grayson, M. A. Slavin and K. A. Thursky on behalf of the National Antimicrobial Prescribing Survey (NAPS)
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Background
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : The presence of antimicrobial allergy designations (‘labels’) often substantially reduces prescribing options for affected patients, but the frequency, accuracy and impacts of such labels are unknown.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : The National Antimicrobial Prescribing Survey (NAPS) is an annual de-identified point prevalence audit of Australian inpatient antimicrobial prescribing using standardised definitions of guideline compliance, appropriateness and indications. Data were extracted for 2 years (2013–14) and compared for patients with an antimicrobial allergy label (AAL) and with no AAL (NAAL).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Among 21 031 patients receiving antimicrobials (33 421 prescriptions), an AAL was recorded in 18%, with inappropriate antimicrobial use significantly higher in the AAL group versus the NAAL group (OR 1.12, 95% CI 1.05–1.22, P &amp;lt; 0.002). Patterns of antimicrobial use were significantly influenced by AAL, with lower β-lactam use (AAL versus NAAL; OR 0.47, 95% CI 0.43–0.50, P &amp;lt; 0.001) and higher quinolone (OR 2.07, 95% CI 1.83–2.34, P &amp;lt; 0.0001), glycopeptide (OR 1.59, 95% CI 1.38–1.83, P &amp;lt; 0.0001) and carbapenem (OR 1.74, 95% CI 1.43–2.13, P &amp;lt; 0.0001) use. In particular, among immunocompromised patients, AAL was associated with increased rates of inappropriate antimicrobial use (OR 1.68, 95% CI 1.21–2.30, P = 0.003), as well as increased use of quinolones (OR 1.88, 95% CI 1.16–3.03, P = 0.02) and glycopeptides (OR 1.82, 95% CI 1.17–2.84, P = 0.01).
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : AALs are common and appear to be associated with higher rates of inappropriate prescribing and increased use of broad-spectrum antimicrobials. Improved accuracy in defining AALs is likely to be important for effective antimicrobial stewardship (AMS), with efforts to ‘de-label’ inappropriate AAL patients a worthwhile feature of future AMS initiatives.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1186/s13756-015-0063-6" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Trubiano, J.A., Leung, V.K., Chu, M.Y., Worth, L.J., Slavin, M.A., Thursky, K.A. (2015). The impact of antimicrobial allergy labels on antimicrobial usage in cancer patients. Antimicrobial Resistance and Infection Control, 4, 23. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1186/s13756-015-0063-6" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1186/s13756-015-0063-6
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .  
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1434626881859-194d67b2b86f.jpg" length="326882" type="image/jpeg" />
      <pubDate>Wed, 17 Feb 2016 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/antimicrobial-allergy-labels-drive-inappropriate-antimicrobial-prescribing-lessons-for-stewardship</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper,Allergy</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1434626881859-194d67b2b86f.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1434626881859-194d67b2b86f.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Monitoring the appropriateness of surgical antibiotic prophylaxis prescribing in Australia: valid and meaningful indicators provide 'data for action'</title>
      <link>https://www.ncas-australia.org/monitoring-the-appropriateness-of-surgical-antibiotic-prophylaxis-prescribing-in-australia-valid-and-meaningful-indicators-provide-data-for-action</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Ann Bull, Karin Thursky, Michael Richards and Leon Worth
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/26673601" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Bull, A.L., Thursky K.A., Richards M.J., Worth L.J. (2016). Monitoring the appropriateness of surgical antibiotic prophylaxis prescribing in Australia: Valid and meaningful indicators provide 'data for action'. Anaesthetic Intensive Care, 44(1), 121-2.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Surgical_NAPS.jpg" length="34430" type="image/jpeg" />
      <pubDate>Fri, 01 Jan 2016 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/monitoring-the-appropriateness-of-surgical-antibiotic-prophylaxis-prescribing-in-australia-valid-and-meaningful-indicators-provide-data-for-action</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper,Surgical,NAPS</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Surgical_NAPS.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Surgical_NAPS.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>A mixed-methods study of the barriers and enablers in implementing antimicrobial stewardship programs in Australian regional and rural hospitals</title>
      <link>https://www.ncas-australia.org/a-mixed-methods-study-of-the-barriers-and-enablers-in-implementing-antimicrobial-stewardship-programmes-in-australian-regional-and-rural-hospitals</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Rodney James, Susan Luu, Minyon Avent, Caroline Marshall, Karin Thursky and Kirsty Buising
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Objectives
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : The Australian Commission on Safety and Quality in Health Care released recommendations for antimicrobial stewardship programmes to be established within all Australian healthcare facilities. However, implementation practices are not well defined. The aim of this study was to gain an understanding of factors affecting implementation of antimicrobial stewardship programmes within Australian regional and rural hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : This study was designed whereby a preliminary quantitative process was used to contribute to a principally qualitative study. Site visits to regional and rural hospitals in Queensland, New South Wales, Victoria and South Australia were planned to assess factors impacting on implementation of antimicrobial stewardship. Subsequently researchers identified issues requiring further exploration with specific key informant interviews and focus group discussions. Data were collected between May and October 2012 and entered into Nvivo10, openly coded and analysed according to mixed methods data analysis principles.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Regional and rural hospitals were not conducting many of the recommended activities and seven major themes emerged. The key barriers were perceived to be lack of access to education, resources and specialist support. The enablers were a flatter governance structure, greater sense of pride, desire for success and good internet and tele-health access.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : This study helps us to identify where efforts should be focused to facilitate the establishment of antimicrobial stewardship programmes in regional and rural hospitals, by describing the gaps and limitations of current programmes and the major issues currently being faced, providing recommendations to better guide activities that support regional and rural hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1093/jac/dkv159" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : James R., Luu S., Avent M., Marshall C., Thursky K., Buising K. (2015). A mixed-methods study of the barriers and enablers in implementing antimicrobial stewardship programmes in Australian regional and rural hospitals. Journal of Antimicrobial Chemotherapy, 70(9), 2665-70. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1093/jac/dkv159" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1093/jac/dkv159
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            . 
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/hospital-building.jpg" length="113566" type="image/jpeg" />
      <pubDate>Mon, 15 Jun 2015 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/a-mixed-methods-study-of-the-barriers-and-enablers-in-implementing-antimicrobial-stewardship-programmes-in-australian-regional-and-rural-hospitals</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper,Regional</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/hospital-building.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/dmip/dms3rep/multi/hospital-building.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Measuring antimicrobial prescribing quality in Australian hospitals: development and evaluation of a national antimicrobial prescribing survey tool</title>
      <link>https://www.ncas-australia.org/measuring-antimicrobial-prescribing-quality-in-australian-hospitals-development-and-evaluation-of-a-national-antimicrobial-prescribing-survey-tool</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Rodney James, Lydia Upjohn, Menino Cotta, Susan Luu, Caroline Marshall, Kirsty Buising and Karin Thursky
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Objectives
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Antimicrobial stewardship (AMS) programmes have been developed with the intention of reducing inappropriate and unnecessary use of antimicrobials, while improving the quality of patient care and locally helping prevent the development of antimicrobial resistance. An important aspect of AMS programmes is the qualitative assessment of prescribing through antimicrobial prescribing surveys (APS), which are able to provide information about the prescribing behaviour within institutions. Owing to lack of standardisation of audit tools and the resources required, qualitative methods for the assessment of antimicrobial use are not often performed. The aim of this study was to design an audit tool that was appropriate for use in all Australian hospitals, suited to local user requirements and included an assessment of the overall appropriateness of the prescription.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : In November 2011, a pilot APS was conducted across 32 hospitals to assess the usability and generalisability of a newly designed audit tool. Following participant feedback, this tool was revised to reflect the requirements of the respondents. A second pilot study was then performed in November 2012 across 85 hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : These surveys identified several areas that can be targets for quality improvement at a national level, including: documentation of indication; surgical prophylaxis prescribed for &amp;gt;24 h; compliance with prescribing guidelines; and the appropriateness of the prescription.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : By involving the end users in the design and evaluation, we have been able to provide a practical and relevant APS tool for quantitative and qualitative data collection in a wide range of Australian hospital settings.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1093/jac/dkv047" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : James R., Upjohn L., Cotta M., Luu S., Marshall C., Buising K., Thursky K. (2015). Measuring antimicrobial prescribing quality in Australian hospitals: Development and evaluation of a national antimicrobial prescribing survey tool . Journal of Antimicrobial Chemotherapy, 70(6), 1912-8. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1093/jac/dkv047" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1093/jac/dkv047
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .  
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hospital_NAPS.jpg" length="33263" type="image/jpeg" />
      <pubDate>Wed, 25 Feb 2015 13:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/measuring-antimicrobial-prescribing-quality-in-australian-hospitals-development-and-evaluation-of-a-national-antimicrobial-prescribing-survey-tool</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper,NAPS,NAPS publications</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hospital_NAPS.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/d820f98f/dms3rep/multi/Hospital_NAPS.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Implementing antimicrobial stewardship in the Australian private hospital system: a qualitative study</title>
      <link>https://www.ncas-australia.org/implementing-antimicrobial-stewardship-in-the-australian-private-hospital-system-a-qualitative-study</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Menino O. Cotta, Megan S. Robertson, Caroline Marshall, Karin A. Thursky, Danny Liew and Kirsty L. Buising
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Abstract
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Objective
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : To explore organisational factors and barriers contributing to limited uptake of antimicrobial stewardship (AMS) in Australian private hospitals and to determine solutions for AMS implementation.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Methods
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : A qualitative study using a series of focus group discussions was conducted in a large private hospital making use of a semistructured interview guide to facilitate discussion among clinical and non-clinical stakeholders. A thematic analysis using five sequential components that mapped and interpreted emergent themes surrounding AMS implementation was undertaken by a multidisciplinary team of researchers.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Results
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Analysis revealed that autonomy of consultant specialists was perceived as being of greater significance in private hospitals compared with public hospitals. Use of an expert team providing antimicrobial prescribing advice and education without intruding on existing patient–specialist relationships was proposed by participants as an acceptable method of introducing AMS in private hospitals. There was more opportunity for nursing and pharmacist involvement, as well as empowering patients. Opportunities were identified for the hospital executive to market an AMS service as a feature that promoted excellence in patient care.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Conclusions
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Provision of advice from experts, championing by clinical leaders, marketing by hospital executives and involving nurses, pharmacists and patients should be considered during implementation of AMS in private hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           What is known about the topic?
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Hospital-wide AMS programs have been shown to be an effective means to address the problem of accelerating antimicrobial resistance. However, current literature predominantly focuses on evaluation of AMS activities rather than on improving implementation success. In addition, most research on hospital AMS programs is from the public hospital sector. AMS is now part of new National Safety and Quality Health Service accreditation standards mandatory for all Australian hospitals; however, uptake of AMS in private hospitals lags behind public hospitals. Australian private hospitals are fundamentally different to public hospitals and there is more information needed to determine how AMS can best be introduced in these hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           What does this paper add?
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Further investigation on how AMS can be implemented into private hospitals is urgently required. The qualitative work detailed in the present study provides a means of tailoring AMS strategies on the basis of organisational factors that may be considered unique to Australian private hospitals.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           What are the implications for practitioners?
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Clinical and hospital executive stakeholders in the private hospital sector will be able to use solutions presented herein as a blueprint for designing sustainable AMS programs within their private healthcare facilities.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Read the full paper
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://www.publish.csiro.au/ah/AH14111" target="_blank"&gt;&#xD;
      
           here
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Citation
          &#xD;
    &lt;/span&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            : Cotta M.O., Robertson M.S., Marshall C., Thursky K.A., Liew D., Buising K.L. (2015). Implementing antimicrobial stewardship in the Australian private hospital system: A qualitative study. Australian Health Review, 39(3), 315-22. DOI:
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
    &lt;a href="https://doi.org/10.1071/AH14111" target="_blank"&gt;&#xD;
      
           https://doi.org/10.1071/AH14111
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            .
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1542744173-05336fcc7ad4.jpg" length="147832" type="image/jpeg" />
      <pubDate>Tue, 15 Jul 2014 14:00:00 GMT</pubDate>
      <guid>https://www.ncas-australia.org/implementing-antimicrobial-stewardship-in-the-australian-private-hospital-system-a-qualitative-study</guid>
      <g-custom:tags type="string">NCAS publications,Hospital,Hospital paper</g-custom:tags>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1542744173-05336fcc7ad4.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/photo-1542744173-05336fcc7ad4.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
  </channel>
</rss>
